FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Alexander, NDE
   Souza, WV
   Rodrigues, LC
   Braga, C
   Sa, A
   Bezerra, LCA
   Martelli, CMT
AF Alexander, Neal D. E.
   Souza, Wayner V.
   Rodrigues, Laura C.
   Braga, Cynthia
   Sa, Andre
   Albuquerque Bezerra, Luciana Caroline
   Turchi Martelli, Celina Maria
CA MERG
TI Spatiotemporal Analysis of the Population Risk of Congenital
   Microcephaly in Pernambuco State, Brazil
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE congenital microcephaly; Zika; Brazil; arbovirus
ID SURVEILLANCE
AB Since an outbreak in Brazil, which started in 2015, Zika has been recognized as an important cause of microcephaly. The highest burden of this outbreak was in northeast Brazil, including the state of Pernambuco. The prevalence of congenital microcephaly in Pernambuco state was estimated from the RESP (Registro de Eventos em Saude Publica) surveillance system, from August 2015 to August 2016 inclusive. The denominators were estimated at the municipality level from official demographic data. Microcephaly was defined as a neonatal head circumference below the 3rd percentile of the Intergrowth standards. Smoothed maps of the prevalence of microcephaly were obtained from a Bayesian model which was conditional autoregressive (CAR) in space, and first order autoregressive in time. A total of 742 cases were identified. Additionally, high and early occurrences were identified in the Recife Metropolitan Region, on the coast, and in a north-south band about 300 km inland. Over a substantial part of the state, the overall prevalence, aggregating over the study period, was above 0.5%. The reasons for the high occurrence in the inland area remain unclear.
C1 [Alexander, Neal D. E.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Souza, Wayner V.; Braga, Cynthia; Sa, Andre; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50740465 Recife, PE, Brazil.
   [Albuquerque Bezerra, Luciana Caroline] State Hlth Dept Pernambuco, BR-50751530 Recife, PE, Brazil.
RP Alexander, NDE (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
EM neal.alexander@lshtm.ac.uk; wayner@cpqam.fiocruz.br;
   laura.rodrigues@lshtm.ac.uk; braga@cpqam.fiocruz.br;
   andre.sa@cpqam.fiocruz.br; lua_cad@yahoo.com.br; turchicm@gmail.com
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Alexander, Neal/0000-0002-6707-7876
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308974/2018-2, 303661/2017-8]; ZikaPLAN [734584]; ZIKAlliance consortia
   - European Union's Horizon 2020 research and innovation programme
   [734548]; MRC UKMedical Research Council UK (MRC); DFID-MRC
   [MR/K012126/1]; UK Medical Research Council (MRC)Medical Research
   Council UK (MRC); UK Department for International Development (DFID);
   European UnionEuropean Union (EU)
FX C.M.T.M. receives CNPq scholarship #308974/2018-2. W.V.S. receives CNPq
   scholarship #303661/2017-8. This work was supported by the ZikaPLAN
   (Grant Agreement No. 734584) and ZIKAlliance (Grant Agreement No.
   734548) consortia, funded by European Union's Horizon 2020 research and
   innovation programme. N.D.E.A. receives support from the MRC UK and
   DFID-MRC Grant Reference MR/K012126/1: This award is jointly funded by
   the UK Medical Research Council (MRC) and the UK Department for
   International Development (DFID) under the MRC/DFID Concordat agreement
   and is also part of the EDCTP2 programme supported by the European
   Union.
CR Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Benchimol EI, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001885, 10.1016/j.zefq.2016.07.010]
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   deAraujo T.V.B, 2017, LANCET INFECT DIS
   DeSilva M, 2016, JAMA-J AM MED ASSOC, V316, P1823, DOI 10.1001/jama.2016.14432
   Elliott P, 1995, Stat Methods Med Res, V4, P137, DOI 10.1177/096228029500400204
   Franca GVA, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/s1679-49742018000200014
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Instituto de Pesquisa Economica Aplicada; Fundacao Joao Pinheiro; Programa das Nacoes Unidas para o Desenvolvimento, 2014, ATL DES HUM NAS REG
   Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#
   Lawson A., 2013, BAYESIAN DIS MAPPING
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, MIN SAUD INV AUM CAS
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude, 2019, B EPIDEMIOLOGICO
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Paixao ES, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007721
   R Core Team, 2015, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Spiegelhalter D., 2003, WINBUGS VERSION 1 4
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 32
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB 1
PY 2020
VL 17
IS 3
AR 700
DI 10.3390/ijerph17030700
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KR7GF
UT WOS:000517783300025
PM 31973162
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Santos, ICD
   Braga, C
   de Souza, WV
   de Oliveira, ALS
   Regis, LN
AF da Silva Santos, Isabella Cristina
   Braga, Cynthia
   de Souza, Wayner Vieira
   Sa de Oliveira, Andre Luiz
   Regis, Leda Narcisa
TI The influence of meteorological variables on the oviposition dynamics of
   Aedes aegypti (Diptera: Culicidae) in four environmentally distinct
   areas in northeast Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Aedes; meteorological concepts; time series studies
ID CLIMATE; SURVEILLANCE; INFORMATION; ABUNDANCE
AB BACKGROUND Fluctuations in climate have been associated with variations in mosquito abundance.
   OBJECTIVES To analyse the influence of precipitation, temperature, solar radiation, wind speed and humidity on the oviposition dynamics of Aedes aegypti in three distinct environmental areas (Brasilia Teimosa, Morro da ConceicAo/Alto Jose do Pinho and Dois Innaos/Pintos) of the city of Recife and the Fernando de Noronha Archipelago northeastern Brazil.
   METHODS Time series study using a database of studies previously carried out in the areas. The eggs were collected using spatially distributed geo-referenced sentinel ovitraps (S-OVTs). Meteorological satellite data were obtained from the IRI climate data library. The association between meteorological variables and egg abundance was analysed using autoregressive models.
   FINDINGS Precipitation was positively associated with egg abundance in three of the four study areas with a lag of one month. Higher humidity (beta= 45.7; 95% CI: 26.3 - 65.0) and lower wind speed (beta= -125.2; 95% CI: -198.8 - -51.6) were associated with the average number of eggs in the hill area.
   MAIN CONCLUSIONS The effect of climate variables on oviposition varied according to local environmental conditions. Precipitation was a main predictor of egg abundance in the study settings.
C1 [da Silva Santos, Isabella Cristina] Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Saude Publ, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Braga, Cynthia] Fundacao Oswaldo Cruz Fiocruz, Dept Parasitol, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [de Souza, Wayner Vieira] Fundacao Oswaldo Cruz Fiocruz, Dept Saude Colet, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Sa de Oliveira, Andre Luiz] Fundacao Oswaldo Cruz Fiocruz, Nucleo Estat & Geoproc, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Regis, Leda Narcisa] Fundacao Oswaldo Cruz Fiocruz, Dept Entomol, Inst Aggeu Magalhaes, Recife, PE, Brazil.
RP Santos, ICD (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Saude Publ, Inst Aggeu Magalhaes, Recife, PE, Brazil.
EM isabella.santos2008@hotmail.com
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); National Advisory Board of Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq) [303953/2018-7, 306222/2013-2]
FX CNPq.; CB (scholarship 303953/2018-7) and WVS (scholarship
   306222/2013-2) receive partial support from the National Advisory Board
   of Scientific and Technological Development (CNPq).
CR Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Christophers S.R., 1960, AEDES AEGYPTI YELLOW
   Chuang TW, 2017, PLOS ONE, V12, P1
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Clements AN, 2006, BIOL MOSQUITOES SENS, VII
   Cortes F, 2018, ACTA TROP, V182, P190, DOI 10.1016/j.actatropica.2018.03.006
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   del Corral J, 2012, GEOSPATIAL HEALTH, V6, pS15
   Dickerson CZ, 2007, THESIS
   DONALISIO M. R., 2017, REV SAUDE PUBL, V51, P1
   Estallo EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127820
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Hribar LJ, 2010, J VECTOR ECOL, V35, P339, DOI 10.1111/j.1948-7134.2010.00092.x
   Jayathilake TAHDG, 2015, J VECTOR DIS, V52, P245
   MAGALHAES T, 2017, PLOS NEGLECT TROP D, V26, P1
   Mogi M, 2014, J MED ENTOMOL, V51, P572, DOI 10.1603/ME13178
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis LN, 2014, ACTA TROP, V137, P80, DOI 10.1016/j.actatropica.2014.04.010
   Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158
   Silva MGNM, 2011, 33 ANN INT C IEEE EN
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Surendran Sinnathamby N., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P276
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Zahouli JBZ, 2017, PLOS NEGLECT TROP D, V11, P1
NR 29
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e200046
DI 10.1590/0074-02760200046
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA MO3WX
UT WOS:000551461500001
PM 32667460
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Lima, SS
   Braga, MC
   Vanderlei, LCD
   Luna, CF
   Frias, PG
AF de Lima, Suzanne Santos
   Braga, Maria Cynthia
   de Moraes Vanderlei, Lygia Carmen
   Luna, Carlos Feitosa
   Frias, Paulo Germano
TI Assessment of the impact of prenatal, childbirth, and neonatal care on
   avoidable neonatal deaths in Pernambuco State, Brazil: an adequacy study
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Health Programs and Plans; Neonatal Mortality; Health Impact Assessment
ID MORTALITY; HEALTH; INTERVENTIONS; STILLBIRTHS
AB This study aimed to assess the impact of programs for prenatal, childbirth, and neonatal care (Mother Owl and Stork Network) on avoidable neonatal mortality in Pernambuco State, Brazil, using the adequacy approach. We analyzed the trend in avoidable neonatal mortality and the impact of these programs on avoidable neonatal mortality in four health regions in the state from 2000 to 2016. The Mortality Information System (SIM) and the Information System on Live Births (SINASC) and official documents were used as the data sources. Deaths were classified according to the Brazilian List of Avoidable Causes of Deaths Via Interventions by the Unified National Health System. Linear regression and joinpoint methods were used to analyze tendencies and identifying turning points in the neonatal mortality curves. There was a sharp drop in avoidable neonatal mortality in the state, especially in early neonatal mortality. Except for the I-Recife region, where there was a downturn in the mortality curves after implementation of the Stork Network, there was no association between the turning points in the curves and the periods with the programs' implementation in the regions. Other factors appear to have led to the improvement of these indicators, such as the expansion of the high-risk network. Strengthening this network can thus help reduce avoidable neonatal deaths, especially early deaths.
C1 [de Lima, Suzanne Santos] Univ Pernambuco, Recife, PE, Brazil.
   [Braga, Maria Cynthia; Luna, Carlos Feitosa] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [de Moraes Vanderlei, Lygia Carmen; Frias, Paulo Germano] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
RP de Lima, SS (corresponding author), Rua Jose de Alencar 447,Apto 401, BR-50070030 Recife, PE, Brazil.
EM suzanne-lima@hotmail.com
RI Murphy, Georgina/AAG-4805-2020; de Frias, Paulo Germano/S-1889-2019;
   Braga, Maria Cynthia/A-8204-2013; Vanderlei, Lygia Carmen/AAX-9132-2020
OI Murphy, Georgina/0000-0001-5978-483X; de Frias, Paulo
   Germano/0000-0003-4497-8898; Braga, Maria Cynthia/0000-0002-7862-6455;
   Vanderlei, Lygia Carmen/0000-0002-3610-3699; Feitosa Luna,
   Carlos/0000-0001-9277-4086
CR Akseer N, 2015, INT J GYNECOL OBSTET, V131, pS43, DOI 10.1016/j.ijgo.2015.03.017
   Araujo JP, 2014, REV BRAS ENFERM, V67, P1000, DOI 10.1590/0034-7167.2014670620
   Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3
   Carlo WA, 2016, J PEDIAT-BRAZIL, V92, P543, DOI 10.1016/j.jped.2016.08.001
   de Frias PG, 2010, CAD SAUDE PUBLICA, V26, P671, DOI 10.1590/S0102-311X2010000400010
   Goldenberg Robert L, 2015, Matern Health Neonatol Perinatol, V1, P3, DOI 10.1186/s40748-014-0004-z
   Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10
   Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213
   Leal MD, 2018, CIENC SAUDE COLETIVA, V23, P1915, DOI [10.1590/1413-81232018236.03942018, 10.1590/1413-81232018236.039420181]
   Leal Maria do Carmo, 2015, Rev. Bras. Saude Mater. Infant., V15, P91, DOI 10.1590/S1519-38292015000100008
   Lehtonen L, 2017, SEMIN FETAL NEONAT M, V22, P153, DOI 10.1016/j.siny.2017.02.006
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Malta DC, 2007, EPIDEMIOL SERV SAUDE, V16, P233
   *ORG MUND SAUD, 1996, CLASS EST INT DOENC
   Ortiz LP, 2008, SAO PAULO PERSPECT, V22, P19
   Rodrigues NCP, 2016, J PEDIAT-BRAZIL, V92, P567, DOI 10.1016/j.jped.2016.03.004
   Roos N, 2016, BEST PRACT RES CL OB, V36, P30, DOI 10.1016/j.bpobgyn.2016.06.002
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104
   Taucher E, 1979, Notas Poblacion, V7, P35
   The UN Inter-Agency Group for Child Mortality Estimation, 2018, LEV TRENDS CHILD MOR
   Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6
   World Health Organization, EV NEWB ACT PLAN END
NR 22
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2020
VL 36
IS 2
AR e00039719
DI 10.1590/0102-311X00039719
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KT1YF
UT WOS:000518808500001
PM 32130315
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Xavier, A
   Oliveira, H
   Aguiar-Santos, A
   Barbosa, W
   da Silva, E
   Braga, C
   Bonfim, C
   Medeiros, Z
AF Xavier, Amanda
   Oliveira, Heloize
   Aguiar-Santos, Ana
   Barbosa Junior, Walter
   da Silva, Ellyda
   Braga, Cynthia
   Bonfim, Cristine
   Medeiros, Zulma
TI Assessment of transmission in areas of uncertain endemicity for
   lymphatic filariasis in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WUCHERERIA-BANCROFTI INFECTION; IMMIGRANTS; RISK; MICROFILARIAE;
   DIAGNOSIS; CHILDREN; REGION; RECIFE; STATE; ICT
AB Author summary Lymphatic filariasis is a parasitic disease that can cause incapacity and chronic complications. The World Health Organization aims to eliminate lymphatic filariasis as a public health problem worldwide by 2020. Four municipalities in the Metropolitan Region of Recife (Brazil) are endemic, of which three have undergone mass drug administration (MDA). However, the epidemiological status of filariasis in nine adjoining areas is unknown. Therefore, a literature review was conducted to identify reports of the vector and human cases in these nine municipalities. A review of data starting in 1967 from eight scientific reports highlighted the circulation of microfilaremia, infection of Culex quinquefasciatus with Wuchereria bancrofti, and morbidity owing to lymphatic filariasis. However, no surveillance was proposed in these areas. Therefore, in 2016, a survey of 17,222 children aged 6-10 years and enrolled in urban schools in the nine municipalities was conducted. One child from a municipality in which MDA was conducted tested positive for lymphatic filariasis, but no other case was diagnosed in her family. Our results showed no transmission of lymphatic filariasis in these nine municipalities. However, population migration and socioenvironmental conditions that favor mosquito breeding grounds indicate the need for surveillance in these areas.
   Background The objective of the Global Program to Eliminate Lymphatic Filariasis (GPELF) is to phase out this endemic disease as a public health problem by 2020. Validation of elimination is obtained from the World Health Organization through evidence of non-transmission in countries that have already been subjected to mass drug administration (MDA) and in places adjoining these endemic areas. While three municipalities in Brazil have completed MDA, the epidemiological situation remains uncertain in nine adjoining municipalities. To determine the epidemiological status, this study was to perform a review of the literature and a school-based survey to describe the past and recent endemicity of lymphatic filariasis (LF) theses nine municipalities in Brazil. Methodology/Principle findings For review of the literature, both formal and informal literature sources were accessed since the first reports of filariasis in the Metropolitan Region of Recife, Brazil. We conducted a school-based survey in 2016 using immunochromatographic card tests (ICTs) among schoolchildren aged 6-10 years living in nine municipalities contiguous with the endemic areas in which MDA was conducted. Our review of the literature identified eight studies involving surveys demonstrating that microfilariae had been circulating in eight of the municipalities since 1967, with a low prevalence of microfilaremia, isolated autochthonous cases, and treatment of individual cases. The school-based survey included 17,222 children in 185 urban schools in the nine areas of Brazil with uncertain endemicity. One child affected by allochthonous transmission was antigen positive based on ICT and lived in a municipality adjacent to Recife; this child's family came from Recife, but no other case was diagnosed within the family.
C1 [Xavier, Amanda; Oliveira, Heloize; Medeiros, Zulma] Univ Pernambuco, Programa Posgrad Ciencias Saude, Recife, PE, Brazil.
   [Oliveira, Heloize] Agencia Pernambucana Vigilancia Sanitaria, Secretaria Saude Estado Pernambuco, Recife, PE, Brazil.
   [Aguiar-Santos, Ana; Barbosa Junior, Walter; da Silva, Ellyda; Braga, Cynthia; Medeiros, Zulma] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil.
   [Bonfim, Cristine] Fundacao Joaquim Nabuco, Minist Educ, Diretoria Pesquisas Sociais, Recife, PE, Brazil.
   [Bonfim, Cristine] Univ Fed Pernambuco, Programa Posgrad Saude Colet, Recife, PE, Brazil.
RP Xavier, A (corresponding author), Univ Pernambuco, Programa Posgrad Ciencias Saude, Recife, PE, Brazil.
EM amanda-xavier@hotmail.com
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Foundation for the Support of Science and Technology
   of the State of Pernambuco (FACEPE) [APQ 0359-4.06/13]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and by the
   Foundation for the Support of Science and Technology of the State of
   Pernambuco (FACEPE) - APQ 0359-4.06/13. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bonfim C, 2011, TROP MED INT HEALTH, V16, P748, DOI 10.1111/j.1365-3156.2011.02758.x
   Brandao E, 2015, INT HEALTH, V7, P324, DOI 10.1093/inthealth/ihv053
   Center for Global Health Division of Parasitic Diseases and Malaria, 2011, LYMPH FIL EL AM
   Christiana O, 2014, TRAVEL MED INFECT DI, V12, P95, DOI 10.1016/j.tmaid.2013.02.006
   da Silva EF, 2017, REV SOC BRAS MED TRO, V50, P256, DOI 10.1590/0037-8682-0407-2016
   DENNIS DT, 1971, J PARASITOL, V57, P1146, DOI 10.2307/3277886
   DOBBIN jr., 1968, Revta Soc. Bras. M ed. trov., V2, P9
   Dobbin Junior JE, 1967, REV BRAS MALARIOL, V19, P44
   Dorkenoo MA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2843-3
   Dreyer G, 1996, TROP MED INT HEALTH, V1, P264
   Fox LM, 2005, AM J TROP MED HYG, V72, P642, DOI 10.4269/ajtmh.2005.72.642
   Gass KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005944
   Gounoue-Kamkumo R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1317-x
   Hooper PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003333
   Ichimori K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003328
   Instituto Brasileiro de Geografia e Estatistica, 2016, EST DEM 2016 AGL SUB
   Instituto Brasileiro de Geografia e Estatistica, 2017, PESQ NAC AM DOM CONT
   Lima JL, 2015, AN 11 C BRAS SAUD CO
   Medeiros Z, 1999, TROP MED INT HEALTH, V4, P499, DOI 10.1046/j.1365-3156.1999.00427.x
   Medeiros Zulma, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P263, DOI 10.1590/S0036-46652006000500005
   Medeiros Zulma, 2004, Rev. bras. epidemiol., V7, P73, DOI 10.1590/S1415-790X2004000100009
   Ministerio da Saude (Brasil) M, 1990, PROGR CONTR FIL REL
   Ministerio da Saude (Brasil) M, 2000, REUN AV PROGR CONTR, P58
   Moraga P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1166-x
   Mwingira U, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005748
   Nascimento JB, 2018, REV PATOL TROP, V47, P217
   Netto MJ, 2016, ACTA TROP, V163, P54, DOI 10.1016/j.actatropica.2016.07.006
   Nunes L. V., 2016, Asian Pacific Journal of Tropical Disease, V6, P521, DOI 10.1016/S2222-1808(16)61081-2
   Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491
   [Pernambuco Recife SEdSSEdVeS], 2017, REC SEDSSEDVES, P46
   Ramaiah KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002079
   Rawlinson T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002685
   Shamsuzzaman AKM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005340
   Srividya A, 2000, TROP MED INT HEALTH, V5, P64, DOI 10.1046/j.1365-3156.2000.00515.x
   Stone CM, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000021
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Wanji S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1556-8
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   WHO/Department of Control of Neglected Tropical Diseases, 2018, WKLY EPIDEMIOL REC, V92, P594
   Witt C, 2001, TROP MED INT HEALTH, V6, P582, DOI 10.1046/j.1365-3156.2001.00765.x
   World Health Organization, 2016, STRENGTH ASS LYMPH F
   World Health Organization WHO, 2017, VAL EL LF PUBL HLTH, P24
   World Health Organization WHO, 2013, MAN MORB PREV DIS, P53
   World Health Organization WHO, 2013, LYMPH FIL TRAIN MON, P81
   World Health Organization WHO, 2011, MON EP ASS MASS DRUG, P78
   Zuchi A, 2017, ACTA TROP, V176, P192, DOI 10.1016/j.actatropica.2017.08.010
NR 46
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2019
VL 13
IS 11
AR e0007836
DI 10.1371/journal.pntd.0007836
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA JW8DT
UT WOS:000503278100052
PM 31765388
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Gaspar, LMD
   Braga, C
   de Albuquerque, GDM
   Silva, MPN
   Maruza, M
   Montarroyos, UR
   de Albuquerque, MDPM
AF da Silva Gaspar, Lucijane Maria
   Braga, Cynthia
   Militao de Albuquerque, Gabriela Diniz
   Nascimento Silva, Maria Patricia
   Maruza, Magda
   Montarroyos, Ulisses Ramos
   Pessoa Militao de Albuquerque, Maria de Fatima
TI Knowledge, attitudes and practices of community health agents regarding
   pulmonary tuberculosis in a capital city in northeastern Brazil
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Tuberculosis; Community health agents; Knowledge; Attitudes and
   practices in health
ID MYCOBACTERIUM-TUBERCULOSIS; WORKERS; INFECTION
AB This article analyses the knowledge, attitudes and practices of community health agents (CHAs) regarding tuberculosis in Recife, a municipality with a high incidence of tuberculosis and high treatment dropout rates in Brazil. The cross-sectional study was conducted with a representative sample of CHAs and a standardized questionnaire. The frequencies of the variables related to knowledge, attitudes and practices were described, and the association between satisfactory knowledge and appropriate practices of CHAs was analysed. Of the 401 eligible CHAs, 385 (96.0%) were interviewed. The majority were women (87.5%) aged >= 40 years (66.0%) and had been on the job for more than nine years (74.5%). A large percentage (61.7%) had satisfactory knowledge about tuberculosis, and this knowledge (75.8%) was associated with appropriate practices (p = 0.008). Regarding attitudes, 97.1% of CHAs were believed to be at risk of contracting tuberculosis, and 53.2% attributed this risk to their job. The results suggest the need for investment in training actions that may help improve tuberculosis indicators in the municipality.
C1 [da Silva Gaspar, Lucijane Maria] Secretaria Saude Recife, Unidade Saude Familia Bianor Teodosio, Av Hildebrando Vasconcelos S-N, BR-52160000 Recife, PE, Brazil.
   [Braga, Cynthia] Inst Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil.
   [Militao de Albuquerque, Gabriela Diniz; Nascimento Silva, Maria Patricia] Univ Pernambuco, Fac Enfermagem Nossa Senhor Gracas, Recife, PE, Brazil.
   [Maruza, Magda] Secretaria Saude Estado Pernambuco, Hosp Correia Picanco, Recife, PE, Brazil.
   [Montarroyos, Ulisses Ramos] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.
   [Pessoa Militao de Albuquerque, Maria de Fatima] Inst Aggeu Magalhaes, Dept Saude Colet NESC, Recife, PE, Brazil.
RP Gaspar, LMD (corresponding author), Secretaria Saude Recife, Unidade Saude Familia Bianor Teodosio, Av Hildebrando Vasconcelos S-N, BR-52160000 Recife, PE, Brazil.
EM jane.gaspar@hotmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020; Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Diniz Militao de Albuquerque,
   Gabriela/0000-0003-4786-7851; Albuquerque, Maria de Fatima P.
   Militao/0000-0002-4999-4160; Montarroyos, Ulisses
   Ramos/0000-0001-8967-5693
CR Abd Wahab F, 2016, MALAYS J MED SCI, V23, P25, DOI 10.21315/mjms2016.23.6.3
   Bristow CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-801
   Crispim JD, 2012, ACTA PAUL ENFERM, V25, P721
   Dantas DNA, 2011, REV RENE, V12, P980
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Ferreira V, 2011, REV SAUDE PUBL, V45, P40, DOI 10.1590/S0034-89102010005000055
   Gazetta CE, 2008, REV LAT-AM ENFERM, V16, P306, DOI 10.1590/S0104-11692008000200021
   Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3
   Hijjar Miguel Aiub, 2007, Rev. Saúde Pública, V41, P50, DOI [10.1590/S0034-89102007000800008, 10.1590/s0034-89102007000800008]
   Ibanes AS, 2013, ABCS HLTH SCI, V38, P25, DOI DOI 10.7322/ABCSHS.V38I1.5
   Instituto Brasileiro de Geografia e Estatistica (IBGE), CAR POP DOM
   Kirkwood Betty R, 2003, ESSENTIAL MED STAT
   Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7
   Ministerio da Saude (MS), 2001, TUB INF AG COM SAUD
   Ministerio da Saude (MS), 2017, CART AG COM SAUD TUB
   Ministerio da Saude (MS), 2017, PLAN NAC PEL FIM TUB
   Ministerio da Saude (MS), 2017, B EP TUB, V48
   Ministerio da Saude (MS). Secretaria de Vigilancia em Saude, 2011, MANUAL RECOMENDACOES
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Pan American Health Organization (PAHO), 2014, TUB AM REG REP 9 EP
   Pinto ESG, 2014, CIENC CUID SAUDE, V13, P519
   Prefeitura do Recife. Secretaria de Saude, 2014, PLAN MUN SAUD 2014 2
   Rodrigues PM, 2009, J BRAS PNEUMOL, V35, P351, DOI 10.1590/S1806-37132009000400009
   Rogerio WP, 2015, CAD SAUDE PUBLICA, V31, P2199, DOI 10.1590/0102-311X00152414
   Santos Joseney, 2007, Rev. Saúde Pública, V41, P89, DOI 10.1590/s0034-89102007000800012
   Scatolin Beatriz Estuque, 2014, Texto contexto - enferm., V23, P261, DOI 10.1590/0104-07072014001600012
   Rocha GSS, 2015, CAD SAUDE PUBLICA, V31, P1483, DOI 10.1590/0102-311X00112414
   Temesgen C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0593-2
   Wei MFP, 2009, REV ENFERM UERJ, V17, P563
   *WHO, 2008, GLOB TUB CONTR SURV
   World Health Organization, 2016, GLOB TUB REP 2016
   World Health Organization (WHO), 2008, ADVOCACY COMMUNICATI
   World Health Organization (WHO), 2015, IMPL TB STRAT ESS
NR 33
TC 0
Z9 0
U1 0
U2 1
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD OCT
PY 2019
VL 24
IS 10
BP 3815
EP 3824
DI 10.1590/1413-812320182410.01722018
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JA6SO
UT WOS:000487972300023
PM 31577012
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Souza, WV
   Braga, C
   de Araujo, TVB
   Ximenes, RAA
   Albuquerque, MDPM
   Montarroyos, UR
   Miranda, DB
   Cordeiro, MT
   Dhalia, R
   Marques, ETA
   Rodrigues, LC
   Martelli, CMT
   de Brito, CAA
   Batista, JDL
   Bezerra, LCA
   Rocha, MAW
   Carvalho, MDCG
   Silva, PFS
   Pastich, F
   Valongueiro, S
   Melo, AP
   Montarroyos, U
   Ramos, RCF
   Brandao, SP
AF Castanha, Priscila M. S.
   Souza, Wayner V.
   Braga, Cynthia
   Barreto de Araujo, Thalia Velho
   Ximenes, Ricardo A. A.
   Albuquerque, Maria de Fatima P. M.
   Montarroyos, Ulisses R.
   Miranda-Filho, Democrito B.
   Cordeiro, Marli T.
   Dhalia, Rafael
   Marques, Ernesto T. A., Jr.
   Rodrigues, Laura C.
   Martelli, Celina M. T.
   Antunes de Brito, Carlos Alexandre
   Lyra Batista, Joanna d'Arc
   Albuquerque Bezerra, Luciana Caroline
   Wanderley Rocha, Maria Angela
   Costa Gomes Carvalho, Maria Durce
   Sobral Silva, Paula Fabiana
   Pastich, Fabiana
   Valongueiro, Sandra
   Melo, Ana Paula
   Montarroyos, Ulisses
   Ferreira Ramos, Regina Coeli
   Brandao Filho, Sinval Pinto
CA Microcephaly Epidemic Res Grp
TI Perinatal analyses of Zika- and dengue virus-specific neutralizing
   antibodies: A microcephaly case-control study in an area of high dengue
   endemicity in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LOAD
AB Laboratory confirmation of Zika virus (ZIKV) infection during pregnancy is challenging due to cross-reactivity with dengue virus (DENV) and limited knowledge about the kinetics of anti-Zika antibody responses during pregnancy. We described ZIKV and DENV serological markers and the maternal-fetal transfer of antibodies among mothers and neonates after the ZIKV microcephaly outbreak in Northeast Brazil (2016). We included 89 microcephaly cases and 173 neonate controls at time of birth and their mothers. Microcephaly cases were defined as newborns with a particular head circumference (2 SD below the mean). Two controls without microcephaly were matched by the expected date of delivery and area of residence. We tested maternal serum for recent (ZIKV genome, IgM and IgG3 anti-NS1) and previous (ZIKV and DENV neutralizing antibodies [NAbs]) markers of infection. Multiple markers of recent or previous ZIKV and DENV infection in mothers were analyzed using principal component analysis (PCA). At delivery, 5.6% of microcephaly case mothers and 1.7% of control mothers were positive for ZIKV IgM. Positivity for ZIKV IgG3 anti-NS1 was 8.0% for case mothers and 3.5% for control mothers. ZIKV NAbs was slightly higher among mothers of cases (69.6%) than that of mothers of controls (57.2%; p = 0.054). DENV exposure was detected in 85.8% of all mothers. PCA discriminated two distinct components related to recent or previous ZIKV infection and DENV exposure. ZIKV NAbs were higher in newborns than in their corresponding mothers (p<0.001). We detected a high frequency of ZIKV exposure among mothers after the first wave of the ZIKV outbreak in Northeast Brazil. However, we found low sensitivity of the serological markers to recent infection (IgM and IgG3 anti-NS1) in perinatal samples of mothers of microcephaly cases. Since the neutralization test cannot precisely determine the time of infection, testing for ZIKV immune status should be performed as early as possible and throughout pregnancy to monitor acute Zika infection in endemic areas.
C1 [Castanha, Priscila M. S.; Souza, Wayner V.; Braga, Cynthia; Barreto de Araujo, Thalia Velho; Albuquerque, Maria de Fatima P. M.; Cordeiro, Marli T.; Dhalia, Rafael; Marques, Ernesto T. A., Jr.; Martelli, Celina M. T.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Ximenes, Ricardo A. A.; Montarroyos, Ulisses R.; Miranda-Filho, Democrito B.] Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Martelli, CMT (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Recife, PE, Brazil.
EM turchicm@gmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020; Souza, Wayner V/H-3798-2013;
   Marques, Ernesto T. A/L-4967-2013; Dhalia, Rafael/AAD-5432-2020; Braga,
   Maria Cynthia/A-8204-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health, Pan American Health Organization,
   Enhancing Research Activity in Epidemic Situations; National Advisory
   Board of Scientific and Technological Development (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq])National Council for
   Scientific and Technological Development (CNPq) [306708/2014-0,
   308818/2013-0, 308590/2013-9, 308491/2013-0, 304174/2014-9,
   306222/2013-2]; European Union's Horizon 2020 research and innovation
   programme under Zika-PLAN [734584]; CuraZika
FX This study was funded by the Brazilian Ministry of Health, Pan American
   Health Organization, Enhancing Research Activity in Epidemic Situations.
   Some of the investigators received partial support from the National
   Advisory Board of Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]; scholarship
   306708/2014-0 to CMTM, 308818/2013-0 to RAAX, 308590/2013-9 to DBM-F,
   308491/2013-0 to MFPMA, 304174/2014-9 to CB, and 306222/2013-2 to WVS).
   LCR is partly funded by the European Union's Horizon 2020 research and
   innovation programme under Zika-PLAN (grant agreement no. 734584). The
   study also received parcial support from CuraZika to ETAM. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazilian Minister of Health, 2017, MONITORAMENTO DOS CA
   Brazilian Minister of Health, 2017, 57 BRAZ MIN HLTH
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Pan American Health Organization, 2019, EP UPD YELL FEV 25 J
   Pan American Health Organization, 2018, EP REP BRAZ
   Pan American Health Organization, 2018, REG ZIK EP UPD AM
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Simmons G, 2018, CLIN INFECT DIS, V66, P1181, DOI 10.1093/cid/cix972
   SMFM Consult Series #39, 2016, J INFECT DIS, V214, pB9
   World Health Organization, 2018, ZIK VIR SIT REP
   World Health Organization, 2018, ZIK VIR FACT SHEET
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 46
TC 7
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007246
DI 10.1371/journal.pntd.0007246
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300043
PM 30856223
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ramesh, A
   Cameron, M
   Spence, K
   Spaans, RH
   Melo-Santos, MAV
   Paiva, MHS
   Guedes, DRD
   Barbosa, RMR
   Oliveira, CMF
   Sa, A
   Jeffries, CL
   Castanha, PMS
   Oliveira, PAS
   Walker, T
   Alexander, N
   Braga, C
AF Ramesh, Anita
   Cameron, Mary
   Spence, Kirstin
   Spaans, Remy Hoek
   Melo-Santos, Maria A., V
   Paiva, Marcelo H. S.
   Guedes, Duschinka R. D.
   Barbosa, Rosangela M. R.
   Oliveira, Claudia M. F.
   Sa, Andre
   Jeffries, Claire L.
   Castanha, Priscila M. S.
   Oliveira, Paula A. S.
   Walker, Thomas
   Alexander, Neal
   Braga, Cynthia
TI Development of an urban molecular xenomonitoring system for lymphatic
   filariasis in the Recife Metropolitan Region, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CULEX MOSQUITOS DIPTERA; WUCHERERIA-BANCROFTI INFECTION;
   MARK-RELEASE-RECAPTURE; GRAVID AEDES TRAP; RIO-DE-JANEIRO; VECTOR
   CONTROL; QUINQUEFASCIATUS DIPTERA; NORTHEASTERN TANZANIA;
   SOUTHERN-CALIFORNIA; DIAGNOSTIC-TOOLS
AB Introduction
   Molecular xenomonitoring (MX) pathogen detection in the mosquito rather than human is a promising tool for lymphatic filariasis (LF) surveillance. In the Recife Metropolitan Region (RMR), the last LF focus in Brazil, Culex quinquefasciatus mosquitoes have been implicated in transmitting Wuchereria bancrofti parasites. This paper presents findings on the ideal mosquito collection method, mosquito dispersion, W. bancrofti infection in mosquitoes and W. bancrofti antigen in humans to aid MX development.
   Methods
   Experiments occurred within two densely populated urban areas of Olinda, RMR, in July and August 2015. U.S. Centers for Disease Control and Prevention (CDC) light traps were compared to battery-powered aspirators as collection methods, and mosquito dispersion was measured by mosquito mark release recapture (MMRR). Female Cx. quinquefasciatus were tested by PCR for W. bancrofti infection, and study area residents were screened by rapid tests for W. bancrofti antigen.
   Results
   Aspirators caught 2.6 times more total Cx. quinquefasciatus, including 38 times more blood fed and 5 times more gravid stages, than CDC light traps. They also collected 123 times more Aedes aegypti. Of the 9,644 marked mosquitoes released, only ten (0.01%) were recaptured, nine of which were < 50m (34.8m median, 85.4m maximum) from the release point. Of 9,169 unmarked mosquitoes captured in the MMR, 38.3% were unfed, 48.8% blood-fed, 5.5% semi-gravid, and 7.3% gravid. PCR on 182 pools (1,556 mosquitoes) found no evidence of W. bancrofti infection in Cx. quinquefasciatus. Rapid tests on 110 of 111 eligible residents were all negative for W. bancrofti antigen.
   Conclusions
   Aspirators were more effective than CDC light traps at capturing Ae. aegyptiand all but unfed stages of Cx. quinquefasciatus. Female Cx. quinquefasciatus traveled short (< 86m) distances in this urban area. Lack of evidence for W. bancrofti infection in mosquitoes and antigen in humans in these fine-scale studies does not indicate that LF transmission has ceased in the RMR. A MX surveillance system should consider vector-specific collection methods, mosquito dispersion, and spatial scale but also local context, environmental factors such as sanitation, and host factors such as infection prevalence and treatment history.
C1 [Ramesh, Anita; Oliveira, Paula A. S.; Braga, Cynthia] FIOCRUZ Pernambuco, IAM, Dept Parasitol, Recife, PE, Brazil.
   [Ramesh, Anita; Alexander, Neal] LSHTM, Dept Infect Dis Epidemiol, London, England.
   [Cameron, Mary; Spence, Kirstin; Spaans, Remy Hoek; Jeffries, Claire L.; Walker, Thomas] LSHTM, Dept Dis Control, London, England.
   [Melo-Santos, Maria A., V; Paiva, Marcelo H. S.; Guedes, Duschinka R. D.; Barbosa, Rosangela M. R.; Oliveira, Claudia M. F.] FIOCRUZ PE, IAM, Dept Entomol, Recife, PE, Brazil.
   [Sa, Andre] FIOCRUZ PE, IAM, Ctr Geoproc & Stat, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] FIOCRUZ PE, IAM, Dept Virol, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Med Sci, Biol Sci Inst, Recife, PE, Brazil.
RP Ramesh, A (corresponding author), FIOCRUZ Pernambuco, IAM, Dept Parasitol, Recife, PE, Brazil.; Ramesh, A (corresponding author), LSHTM, Dept Infect Dis Epidemiol, London, England.
EM anita.ramesh@lshtm.ac.uk
RI Braga, Maria Cynthia/A-8204-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Barbosa, Rosangela/AAC-3339-2020; Walker,
   Thomas/B-9198-2014
OI Braga, Maria Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Barbosa, Rosangela/0000-0002-1171-598X;
   Cameron, Mary/0000-0001-5693-082X; Spence, Kirstin/0000-0002-1220-4698;
   Hoek Spaans, Remy/0000-0002-6926-4747; Walker,
   Thomas/0000-0002-3545-012X
FU Brazilian National Council for Scientific and Technological Development
   (CNPq: cnpq.br) / British Council 'Science Without Borders / Bright
   Young Talent' [401575/2014-4]; Wellcome Trust)/Enhancing Research
   Activity in Epidemic Situations (ERAES) [ER1603B]; CNPq/British Council
   [401575/2014-4]; UK Medical Research Council (MRC)Medical Research
   Council UK (MRC) [MR/K012126/1]; UK Department for International
   Development (DFID) under the MRC/DFID Concordat agreement; European
   UnionEuropean Union (EU); CB - FIOCRUZ core; CNPq Productivity Award
   [304174/2014-9]; Wellcome Trust/Royal Society [101285/Z/13/Z]; NATIONAL
   CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER
FX This work was supported by the Brazilian National Council for Scientific
   and Technological Development (CNPq: cnpq.br) / British Council
   (www.britishcouncil.org) 'Science Without Borders / Bright Young Talent'
   [401575/2014-4] awarded to CB for AR. The Wellcome Trust
   (www.wellcome.ac.uk)/Enhancing Research Activity in Epidemic Situations
   (ERAES), [ER1603B] awarded to AR and CU provided additional laboratory
   funding. Salary support was provided as follows: AR CNPq/British Council
   [401575/2014-4]; MC - LSHTM/ITD core; PMSC: Brazilian Agency for Support
   and Evaluation of Graduate Education (CAPES), National Postdoctoral
   Program; PASO: CAPES/National Doctoral Program; CU and TW - Wellcome
   Trust (www.wellcome.ac.uk)/Royal Society (royalsociety.org)
   [101285/Z/13/Z]; NA -MRC UK and DFID, MRC Grant Reference MR/K012126/1:
   award jointly funded by the UK Medical Research Council (MRC) and the UK
   Department for International Development (DFID) under the MRC/DFID
   Concordat agreement and is also part of the EDCTP2 programme supported
   by the European Union; CB - FIOCRUZ core and CNPq Productivity Award
   [304174/2014-9]. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469
   [Anonymous], 2012, SELECTED CLIMATIC DA
   Bockarie MJ, 2007, AM J TROP MED HYG, V77, P591, DOI 10.4269/ajtmh.2007.77.591
   Braga C, 2001, Cad Saude Publica, V17, P1211, DOI 10.1590/S0102-311X2001000500021
   Braga Cynthia, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P125, DOI 10.1590/S0036-46652003000300002
   Cartaxo MFS, 2011, T ROY SOC TROP MED H, V105, P491, DOI 10.1016/j.trstmh.2011.05.004
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   Ciota AT, 2012, J MED ENTOMOL, V49, P35, DOI 10.1603/ME11077
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   de Resende MC, 2013, MEM I OSWALDO CRUZ, V108, P1024, DOI 10.1590/0074-0276130128
   de Souza DK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1091-z
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188
   Dhimal M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003035
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Elizondo-Quiroga A, 2006, J AM MOSQUITO CONTR, V22, P10, DOI 10.2987/8756-971X(2006)22[10:GCASOC]2.0.CO;2
   Fischer P, 2007, AM J TROP MED HYG, V76, P502, DOI 10.4269/ajtmh.2007.76.502
   Fontes G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-272
   Friesen KM, 2013, J AM MOSQUITO CONTR, V29, P102, DOI 10.2987/12-6323R.1
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276
   Hamer GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002768
   Hapairai LK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0886-2
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Ichimori K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003328
   Instituto Brasileiro de Geografia e Estatistica (IBGE), DAD GER MUN OL REC P
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2017, CENS DEM 2010 AGL SU
   Irish SR, 2015, J AM MOSQUITO CONTR, V31, P107, DOI 10.2987/14-6420R.1
   Irish SR, 2015, AM J TROP MED HYG, V93, P983, DOI 10.4269/ajtmh.15-0234
   Irish SR, 2013, T ROY SOC TROP MED H, V107, P15, DOI 10.1093/trstmh/trs001
   Kay BH, 2013, MED VET ENTOMOL, V27, P267, DOI 10.1111/j.1365-2915.2012.01044.x
   Laney SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000602
   Lapointe DA, 2008, J MED ENTOMOL, V45, P600, DOI 10.1603/0022-2585(2008)45[600:DOCQDC]2.0.CO;2
   Laporta GZ, 2008, J AM MOSQUITO CONTR, V24, P21, DOI 10.2987/5664.1
   Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x
   Maciel-de-Freitas R, 2008, MEM I OSWALDO CRUZ, V103, P602, DOI 10.1590/S0074-02762008000600016
   Maia MF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-124
   Medeiros MCI, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005347
   Molyneux David, 2003, Filaria J, V2, P13, DOI 10.1186/1475-2883-2-13
   Molyneux DH, 2002, ANN TROP MED PARASIT, V96, pS15, DOI 10.1179/000349802125002374
   Okorie PN, 2016, T ROY SOC TROP MED H, V110, P90, DOI 10.1093/trstmh/trv104
   Onyango SA, 2013, J MED ENTOMOL, V50, P1140, DOI 10.1603/ME12206
   Owusu IO, 2015, T ROY SOC TROP MED H, V109, P628, DOI 10.1093/trstmh/trv070
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Pilotte N, 2017, TRENDS PARASITOL
   Plichart Catherine, 2006, Filaria J, V5, P2, DOI 10.1186/1475-2883-5-2
   Prefeitura do Recife- Secretaria de Saude, 2002, DIR EP VIG SAUD PROG
   RACHOU RENE G., 1954, REV BRASIL MALARIOL E DOENCAS TROP, V6, P377
   Ramaiah KD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003319
   Ramaiah KD, 2013, T ROY SOC TROP MED H, V107, P293, DOI 10.1093/trstmh/trt011
   Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2
   Ramzy RMR, 1997, T ROY SOC TROP MED H, V91, P156, DOI 10.1016/S0035-9203(97)90205-4
   Ramzy RMR, 2002, ANN TROP MED PARASIT, V96, pS55, DOI 10.1179/000349802125002383
   Rao RU, 2006, AM J TROP MED HYG, V74, P826, DOI 10.4269/ajtmh.2006.74.826
   Rao RU, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003281
   Rebollo MP, 2014, PARASITOLOGY, V141, P1912, DOI 10.1017/S0031182014001231
   Regis L, 2000, T ROY SOC TROP MED H, V94, P488, DOI 10.1016/S0035-9203(00)90061-0
   Reisen WK, 2003, J MED ENTOMOL, V40, P820, DOI 10.1603/0022-2585-40.6.820
   REISEN WK, 1991, J MED ENTOMOL, V28, P357, DOI 10.1093/jmedent/28.3.357
   REISEN WK, 1992, J MED ENTOMOL, V29, P531, DOI 10.1093/jmedent/29.3.531
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Barbosa RMR, 2011, MEM I OSWALDO CRUZ, V106, P451, DOI 10.1590/S0074-02762011000400011
   Schmaedick MA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003087
   Schoeler GB, 2004, J AM MOSQUITO CONTR, V20, P6
   SCHREIBER ET, 1988, J AM MOSQUITO CONTR, V4, P300
   Subramanian S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005519
   Thornton JH, 2016, J VECTOR ECOL, V41, P265, DOI 10.1111/jvec.12221
   Vasuki V, 2016, J VECTOR DIS, V53, P77
   Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   WHO, 2011, LYMPH FIL MON EP ASS
   Wijegunawardana Asha Dilrukshi, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P381, DOI [10.1016/S2221-1691(13)60080-5, 10.1016/S2221-1691(13)60081-7]
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
   Williams SA, 2002, ANN TROP MED PARASIT, V96, pS41, DOI 10.1179/000349802125002356
   World Health Organization, 2010, GLOB PROGR EL LYMPH
   World Health Organization (WHO), 1992, 5 REP WHO EXP COMM F
   Zar JH, 1999, BIOSTATISTICAL ANAL
   Zeldenryk LM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001366
NR 78
TC 2
Z9 2
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006816
DI 10.1371/journal.pntd.0006816
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100038
PM 30325933
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Eder, M
   Cortes, F
   Filha, NTD
   de Franca, GVA
   Degroote, S
   Braga, C
   Ridde, V
   Martelli, CMT
AF Eder, Marcus
   Cortes, Fanny
   de Siqueira Filha, Noemia Teixeira
   Araujo de Franca, Giovanny Vinicius
   Degroote, Stephanie
   Braga, Cynthia
   Ridde, Valery
   Turchi Martelli, Celina Maria
TI Scoping review on vector-borne diseases in urban areas: transmission
   dynamics, vectorial capacity and co-infection
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Review
DE Arboviruses; Disease vectors; Coinfection; Urban population;
   Epidemiology; Review
ID MALARIA TRANSMISSION; RISK-FACTORS; PLASMODIUM-FALCIPARUM;
   ENVIRONMENTAL-FACTORS; DENGUE VIRUS; ZIKA VIRUS; SAO-PAULO; OUTBREAK;
   URBANIZATION; INFECTION
AB Background: Transmission dynamics, vectorial capacity, and co-infections have substantial impacts on vector-borne diseases (VBDs) affecting urban and suburban populations. Reviewing key factors can provide insight into priority research areas and offer suggestions for potential interventions.
   Main body: Through a scoping review, we identify knowledge gaps on transmission dynamics, vectorial capacity, and co-infections regarding VBDs in urban areas. Peer-reviewed and grey literature published between 2000 and 2016 was searched. We screened abstracts and full texts to select studies. Using an extraction grid, we retrieved general data, results, lessons learned and recommendations, future research avenues, and practice implications. We classified studies by VBD and country/continent and identified relevant knowledge gaps. Of 773 articles selected for full-text screening, 50 were included in the review: 23 based on research in the Americas, 15 in Asia, 10 in Africa, and one each in Europe and Australia. The largest body of evidence concerning VBD epidemiology in urban areas concerned dengue and malaria. Other arboviruses covered included chikungunya and West Nile virus, other parasitic diseases such as leishmaniasis and trypanosomiasis, and bacterial rickettsiosis and plague. Most articles retrieved in our review combined transmission dynamics and vectorial capacity; only two combined transmission dynamics and co-infection. The review identified significant knowledge gaps on the role of asymptomatic individuals, the effects of co-infection and other host factors, and the impacts of climatic, environmental, and socioeconomic factors on VBD transmission in urban areas. Limitations included the trade-off from narrowing the search strategy (missing out on classical modelling studies), a lack of studies on co-infections, most studies being only descriptive, and few offering concrete public health recommendations. More research is needed on transmission risk in homes and workplaces, given increasingly dynamic and mobile populations. The lack of studies on co-infection hampers monitoring of infections transmitted by the same vector.
   Conclusions: Strengthening VBD surveillance and control, particularly in asymptomatic cases and mobile populations, as well as using early warning tools to predict increasing transmission, were key strategies identified for public health policy and practice.
C1 [Eder, Marcus] Publ Hlth England Sierra Leone Country Off, Freetown, Sierra Leone.
   [Eder, Marcus; Braga, Cynthia; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Inst IAM, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50 Recife, PE, Brazil.
   [Cortes, Fanny] Univ Pernambuco UPE, Recife, PE, Brazil.
   [de Siqueira Filha, Noemia Teixeira] Univ Liverpool Liverpool Sch Trop Med, London, England.
   [Araujo de Franca, Giovanny Vinicius] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Degroote, Stephanie; Ridde, Valery] Univ Montreal, Sch Publ Hlth ESPUM, Montreal, PQ, Canada.
   [Ridde, Valery] Univ Paris 05, Univ Paris Sorbonne Cites, ERL INSERM SAGESUD, IRD,French Inst Res Sustainable Dev,CEPED, Paris, France.
RP Martelli, CMT (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Inst IAM, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50 Recife, PE, Brazil.
EM turchicm@gmail.com
RI ridde, valery/AAV-1016-2020; Ridde, Valery/AAD-2736-2019; Braga, Maria
   Cynthia/A-8204-2013; Araujo de Franca, Giovanny Vinicius/L-7385-2018
OI Ridde, Valery/0000-0001-9299-8266; Braga, Maria
   Cynthia/0000-0002-7862-6455; Araujo de Franca, Giovanny
   Vinicius/0000-0002-7530-2017; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Degroote, Stephanie/0000-0002-7942-7992
FU VERDAS Consortium
FX VERDAS Consortium.
CR Ali M, 2003, USE GEOGRAPHIC INFOR, P634
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Amaku M, 2016, EPIDEMIOL INFECT, V144, P3435, DOI 10.1017/S0950268816001448
   Anders KL, 2015, HOUSEHOLDS FOCI DENG
   ANDERSON R M, 1991
   Araujo R V, 2015, SAO PAULO URBAN HEAT, P146
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Carver S, 2008, INT J INFECT DIS, V12, P528, DOI 10.1016/j.ijid.2008.02.008
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005
   Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019
   Camargo-Neves Vera Lucia Fonseca de, 2003, Rev. Soc. Bras. Med. Trop., V36, P27, DOI 10.1590/S0037-86822003000700009
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   de Souza CE, 2015, REV SOC BRAS MED TRO, V48, P11, DOI 10.1590/0037-8682-0281-2014
   Dev V, 2004, AM J TROP MED HYG, V71, P451, DOI 10.4269/ajtmh.2004.71.451
   Dhiman RC, 2013, ALTITUDE TEMPERATURE, P220
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Ebenezer A, 2016, J VECTOR DIS, V53, P46
   El Sayed BB, 2000, ACTA TROP, V75, P163, DOI 10.1016/S0001-706X(99)00098-4
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fouque F, 2004, EPIDEMIOLOGICAL ENTO, P41
   Girod R, 2011, ANN TROP MED PARASIT, V105, P107, DOI 10.1179/136485911X12899838683322
   Godsey MS, 2012, AM J TROP MED HYG, V87, P1125, DOI 10.4269/ajtmh.2012.11-0700
   Gould LH, 2005, OUTBREAK YELLOW FEVE, P1247
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012
   Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Ho K, 2011, EPIDEMIOLOGY CONTROL, P263
   Hoffmann TC, 2014, BMJ, V348, pg1687
   Ivan E, 2012, ACTA TROP, V124, P179, DOI 10.1016/j.actatropica.2012.08.004
   Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118
   Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008
   Lee Y, 2009, ANN ACAD MED SINGAP, V38, P840
   Martinez-Vega RA, 2015, PLOS NEGLECT TROP D, V9, P1
   Medrano-Mercado N, 2008, MEM I OSWALDO CRUZ, V103, P423, DOI 10.1590/S0074-02762008000500003
   Mendez F, 2006, AM J TROP MED HYG, V74, P678, DOI 10.4269/ajtmh.2006.74.678
   Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x
   Muller DA, 2001, ACTA TROP, V78, P155, DOI 10.1016/S0001-706X(01)00067-5
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nielsen CF, 2008, AM J TROP MED HYG, V78, P53, DOI 10.4269/ajtmh.2008.78.53
   Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   Perkins TA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P99, DOI 10.1079/9781845939649.0099
   Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662
   Pham HV, 2009, INT J EPIDEMIOL, V38, P1634, DOI 10.1093/ije/dyp244
   Reiner RC, 2014, P NATL ACAD SCI US
   Reiter P, 2003, TEXAS LIFESTYLE LIMI, P86
   Rezza G, 2007, INFECT CHIKUNGUNYA V, P1840
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, P1, DOI DOI 10.1371/journal.pntd.0001370
   Salazar PM, 2007, REV PANAM SALUD PUBL, V22, P75, DOI 10.1590/S1020-49892007000700001
   Salomon OD, 2006, MEM I OSWALDO CRUZ, V101, P295, DOI 10.1590/S0074-02762006000300013
   Sanchez L, 2006, AEDES AEGYPTI LARVAL, P800
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3
   Seidahmed OME, 2012, SPATIAL TEMPORAL PAT
   Sissoko MS, 2015, AM J TROP MED HYG, V93, P790, DOI 10.4269/ajtmh.14-0765
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Struchiner CJ, 2015, PLOS ONE, P1
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Teixeira MG, 2015, NEW EPIDEMIOLOGIC PR, P220
   Thomaz Soccol V, 2009, NEW FOCUS CUTANEOUS, P308
   Uranw S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-21
   Vasconcelos PFC, 2001, EPIDEMIC JUNGLE YELL, P598
   Wertheim HFL, 2012, ATLAS HUM INFECT DIS, P33
   WHO, 2016, VECT BORN DIS
   Wilson ML, 2015, INT CTR EXCELL MAL S, V3, P110, DOI DOI 10.4269/AJTMH.14-0834
   World Health Organization, 2016, WORLD MALARIA REPORT
   World Health Organization, 2016, JOINT EXT EV TOOL IN
   World Health Organization, 2017, NEGL TROP DIS FACT S
   World Health Organization, 2014, WHO GLOB HLTH EXP AT
   Woyessa A, 2004, ETHIOP J HEALTH DEV, V18, P2, DOI DOI 10.4314/ejhd.v18i1.9858
   Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014
   Yang T, 2009, EPIDEMIOLOGY VECTOR, P148
   Ye Y, 2010, GLOB HEAL ACTIO 0107, V2
   Zhang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-544
   Zhao XQ, 2013, MARINE MICROBIOLOGY: BIOACTIVE COMPOUNDS AND BIOTECHNOLOGICAL APPLICATIONS, P267
NR 81
TC 18
Z9 18
U1 0
U2 30
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-5162
EI 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD SEP 3
PY 2018
VL 7
AR 90
DI 10.1186/s40249-018-0475-7
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GS4WW
UT WOS:000443658500001
PM 30173661
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-01
ER

PT J
AU de Araujo, TVB
   Ximenes, RADA
   Miranda, DD
   Souza, WV
   Montarroyos, UR
   de Melo, APL
   Valongueiro, S
   de Albuquerque, MDPM
   Braga, C
   Brandao, SP
   Cordeiro, MT
   Vazquez, E
   Cruz, DDS
   Henriques, CMP
   Bezerra, LCA
   Castanha, PMD
   Dhalia, R
   Marques, ETA
   Martelli, CMT
   Rodrigues, LC
AF Barreto de Araujo, Thalia Velho
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Souza, Wayner Vieira
   Montarroyos, Ulisses Ramos
   Lopes de Melo, Ana Paula
   Valongueiro, Sandra
   Pessoa Militao de Albuquerque, Maria de Fatima
   Braga, Cynthia
   Brandao Filho, Sinval Pinto
   Cordeiro, Marli Tenorio
   Vazquez, Enrique
   Souza Cruz, Danielle di Cavalcanti
   Pessanha Henriques, Claudio Maierovitch
   Albuquerque Bezerra, Luciana Caroline
   da Silva Castanha, Priscila Mayrelle
   Dhalia, Rafael
   Azevedo Marques-Junior, Ernesto Torres
   Turchi Martelli, Celina Maria
   Rodrigues, Laura Cunha
CA Investigators Microcephaly Epidem
TI Association between microcephaly, Zika virus infection, and other risk
   factors in Brazil: final report of a case-control study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID BIRTH-DEFECTS; GESTATIONAL-AGE; PREGNANCY; INFANTS; FETUSES; SMOKING
AB Background A Zika virus epidemic emerged in northeast Brazil in 2015 and was followed by a striking increase in congenital microcephaly cases, triggering a declaration of an international public health emergency. This is the final report of the first case-control study evaluating the potential causes of microcephaly: congenital Zika virus infection, vaccines, and larvicides. The published preliminary report suggested a strong association between microcephaly and congenital Zika virus infection.
   Methods We did a case-control study in eight public maternity hospitals in Recife, Brazil. Cases were neonates born with microcephaly, defined as a head circumference of 2 SD below the mean. Two controls without microcephaly were matched to each case by expected date of delivery and area of residence. We tested the serum of cases and controls and the CSF of cases for detection of Zika virus genomes with quantitative RT-PCR and for detection of IgM antibodies with capture-IgM ELISA. We also tested maternal serum with plaque reduction neutralisation assays for Zika and dengue viruses. We estimated matched crude and adjusted odds ratios with exact conditional logistic regression to determine the association between microcephaly and Zika virus infection.
   Findings We screened neonates born between Jan 15 and Nov 30, 2016, and prospectively recruited 91 cases and 173 controls. In 32 (35%) cases, congenital Zika virus infection was confirmed by laboratory tests and no controls had confirmed Zika virus infections. 69 (83%) of 83 cases with known birthweight were small for gestational age, compared with eight (5%) of 173 controls. The overall matched odds ratio was 73.1 (95% CI 13.0-infinity) for microcephaly and Zika virus infection after adjustments. Neither vaccination during pregnancy or use of the larvicide pyriproxyfen was associated with microcephaly. Results of laboratory tests for Zika virus and brain imaging results were available for 79 (87%) cases; within these cases, ten were positive for Zika virus and had cerebral abnormalities, 13 were positive for Zika infection but had no cerebral abnormalities, and 11 were negative for Zika virus but had cerebral abnormalities.
   Interpretation The association between microcephaly and congenital Zika virus infection was confirmed. We provide evidence of the absence of an effect of other potential factors, such as exposure to pyriproxyfen or vaccines (tetanus, diphtheria, and acellular pertussis, measles and rubella, or measles, mumps, and rubella) during pregnancy, confirming the findings of an ecological study of pyriproxyfen in Pernambuco and previous studies on the safety of Tdap vaccine administration during pregnancy.
C1 [Barreto de Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Miranda-Filho, Democrito de Barros; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [Souza, Wayner Vieira; Pessoa Militao de Albuquerque, Maria de Fatima; Braga, Cynthia; Brandao Filho, Sinval Pinto; Cordeiro, Marli Tenorio; da Silva Castanha, Priscila Mayrelle; Dhalia, Rafael; Azevedo Marques-Junior, Ernesto Torres; Turchi Martelli, Celina Maria] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Lopes de Melo, Ana Paula] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Souza Cruz, Danielle di Cavalcanti] Inst Materno Infantil Fernando Figueira, Recife, PE, Brazil.
   [Pessanha Henriques, Claudio Maierovitch] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Albuquerque Bezerra, Luciana Caroline] State Hlth Dept Pernambuco, Recife, PE, Brazil.
   [Azevedo Marques-Junior, Ernesto Torres] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
EM thalia@ufpe.br
RI Braga, Maria Cynthia/A-8204-2013; Souza, Wayner V/H-3798-2013;
   Brandao-Filho, Sinval Pinto/AAP-4792-2020; Marques, Ernesto T.
   A/L-4967-2013; Da Silva Castanha, Priscila Mayrelle/G-1785-2012; Dhalia,
   Rafael/AAD-5432-2020; Montarroyos, Ulisses/AAJ-7527-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Brandao-Filho, Sinval
   Pinto/0000-0003-3768-2810; Marques, Ernesto T. A/0000-0003-3826-9358; Da
   Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Turchi Martelli,
   Celina Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health; Pan American Health Organization;
   Enhancing Research Activity in Epidemic Situations; Medical Research
   CouncilMedical Research Council UK (MRC) [MC_PC_15088] Funding Source:
   researchfish
FX Brazilian Ministry of Health, Pan American Health Organization, and
   Enhancing Research Activity in Epidemic Situations.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022
   HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto de Pesquisa Economica Aplicada, 2014, SIT SOC POP NEGR EST
   Ko TJ, 2014, PEDIATR NEONATOL, V55, P20, DOI 10.1016/j.pedneo.2013.05.005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Ministerio da Saude (BR), 2014, INF TECN IMPL VAC AD
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   STATA, EX LOG REGR REF MAN, P507
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Walls T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009536
   WHO, 2016, SCREEN ASS MAN NON I
NR 33
TC 109
Z9 111
U1 5
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2018
VL 18
IS 3
BP 328
EP 336
DI 10.1016/S1473-3099(17)30727-2
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FX2ZO
UT WOS:000425938000040
PM 29242091
OA Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU de Albuquerque, MDPM
   de Souza, WV
   Araujo, TVB
   Braga, MC
   Miranda, DD
   Ximenes, RAD
   de Melo, DA
   de Brito, CAA
   Valongueiro, S
   de Melo, APL
   Brandao, SP
   Martelli, CMT
AF Pessoa Militao de Albuquerque, Maria de Fatima
   de Souza, Wayner Vieira
   Barreto Araujo, Thalia Velho
   Braga, Maria Cynthia
   Miranda-Filho, Democrito de Barros
   de Alencar Ximenes, Ricardo Arraes
   de Melo Filho, Djalma Agripino
   Antunes de Brito, Carlos Alexandre
   Valongueiro, Sandra
   Lopes de Melo, Ana Paula
   Brandao-Filho, Sinval Pinto
   Turchi Martelli, Celina Maria
TI The microcephaly epidemic and Zika virus: building knowledge in
   epidemiology
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Zika Virus; Microcephaly; Epidemics
ID BRAZIL; INFECTION; OUTBREAK; TRANSMISSION; ASSOCIATION; ANTIBODY;
   INFANTS; CAUSAL; BRAIN; CHILD
AB In August 2015, pediatric neurologists at public hospitals in Recife, Pernambuco State, Brazil, observed an increase in the number of disproportional microcephaly cases associated with other congenital anomalies. The fact caused social commotion and mobilization of the academic community and led the Brazilian Ministry of Health to declare a national public health emergency, followed by the declaration of a Public Health Emergency of International Concern by the World Health Organization. The hypothesis for the phenomenon was congenital Zika virus (ZIKV) infection, based on spatial-temporal correlation and the clinical-epidemiological characteristics of the two epidemics. Further evidence accumulated, and within the scope of epidemiological reasoning fulfilled the criteria that gave support to the hypothesis. The plausibility of the hypothesis is based on the neurotropism of ZIKV, demonstrated in animals, affecting neural progenitors in the developing brain, and in humans, due to neurological complications in adults following infection. Isolation of viral RNA and antigens in the amniotic fluid of infected mothers and in brains of newborns and fetuses with microcephaly further demonstrated the consistency of the hypothesis. The criterion of temporality was met by identifying adverse pregnancy outcomes in a cohort of mothers with a history of rash and positive ZIKV serology. Finally, the first case-control study demonstrated a strong association between microcephaly and congenital ZIKV infection. The knowledge built with the epidemiological paradigm was supported by the scientific community, thereby establishing the consensus for a causal relationship between ZIKV and the microcephaly epidemic.
C1 [Pessoa Militao de Albuquerque, Maria de Fatima; de Souza, Wayner Vieira; Braga, Maria Cynthia; Brandao-Filho, Sinval Pinto; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Ave Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
   [Barreto Araujo, Thalia Velho; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil.
   [Miranda-Filho, Democrito de Barros] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [de Melo Filho, Djalma Agripino] Univ Fed Pernambuco, Nucleo Saude Publ & Desenvolvimento Social, Recife, PE, Brazil.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Med Clin, Recife, PE, Brazil.
   [Lopes de Melo, Ana Paula] Univ Fed Pernambuco, Dept Saude Comunitaria, Recife, PE, Brazil.
RP de Souza, WV (corresponding author), Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Ave Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
EM wayner@cpqam.fiocruz.br
RI Brandao-Filho, Sinval Pinto/AAP-4792-2020; Souza, Wayner V/H-3798-2013;
   Braga, Maria Cynthia/A-8204-2013
OI Brandao-Filho, Sinval Pinto/0000-0003-3768-2810; Braga, Maria
   Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beltrame A, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.150869
   Bermudez-Tamayo C, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0198-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costa F, 2018, LANCET INFECT DIS, V18, P236, DOI 10.1016/S1473-3099(17)30697-7
   Czeresnia D, 1998, TEORIA EPIDEMIOLOGIC, P63
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Departamento de Vigilancia das Doencas Transmissiveis Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Evans D, POSSIBLE LINK PYRIPR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fine PEM, 2013, LANCET, V381, P1249, DOI 10.1016/S0140-6736(13)60766-7
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   GIESECKE J, 2002, MODERN INFECT DIS EP
   Hanzlik E, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060047
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   KUHN T.S., 1998, ESTRUTURA REVOLUCOES
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Luz KG, 2015, EPIDEMIOL SERV SAUDE, V24, P785, DOI 10.5123/S1679-49742015000400021
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Melo Filho D., EPIDEMIOLOGIA SOCIAL
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Ministerio da Saude, MIN SAUD CONF REL EN
   Ministerio da Saude, 012015 MIN SAUD
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nelvo Romário Vieira, 2016, Sex., Salud Soc. (Rio J.), V0, P246, DOI 10.1590/1984-6487.sess.2016.24.11.r
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2017, ZIK EP UPD SIT SUMM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Porta M, 2014, DICT EPIDEMIOLOGY
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rothman K.J., MODERN EPIDEMIOLOGY
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   Secretaria Executiva de Vigilancia em Saude Secretaria Estadual de Saude do Estado de Pernambuco, 4315 SEVSDGCDA
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vogel G, 2016, SCIENCE, V354, P1088, DOI 10.1126/science.354.6316.1088
   Walls T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009536
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 9
Z9 9
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 10
AR e00069018
DI 10.1590/0102-311X00069018
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GX3WF
UT WOS:000447657100001
PM 30328996
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU da Silva, JSF
   Braga, C
   Duarte, FM
   Oliveira, P
   Luna, CF
   Marcondes, M
   Araujo, J
   Grilis, MR
   Melo, PFAD
   Brandao, E
   Rocha, A
AF da Silva, Jennifer S. F.
   Braga, Cynthia
   Duarte, Felipe M.
   Oliveira, Paula
   Luna, Carlos Feitosa
   Marcondes, Marcia
   Araujo, Josue
   Grilis, Maria Rosangela
   de Souza Melo, Paula Fernanda A.
   Brandao, Eduardo
   Rocha, Abraham
TI Effectiveness of annual single doses of diethylcarbamazine citrate among
   bancroftian filariasis infected individuals in an endemic area under
   mass drug administration in Brazil
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Lymphatic filariasis; Wuchereria bancrofti; mass drug administration;
   diethylcarbamazine citrate; prevention and control
ID LYMPHATIC FILARIASIS; WUCHERERIA-BANCROFTI; ALBENDAZOLE; ANTIGEN;
   MICROFILAREMIA; EFFICACY; ANTIBODY; TRIAL
AB The Global Program to Eliminate Lymphatic Filariasis has achieved extraordinary success in reducing transmission and preventing morbidity through mass drug administration (MDA) to the population at-risk. Brazil is the only currently using diethylcarbamazine citrate (DEC) alone for MDA, so an assessment of its effectiveness is needed. We report the trends of filarial markers in a cohort of 175 individuals infected with Wuchereria bancrofti in areas that underwent MDA in the city of Olinda, Northeastern Brazil. The prospective study was conducted between 2007 and 2012 (corresponding to five annual MDA rounds). The quantification of microfilaraemia (QMFF) was assessed by filtration. Circulating filarial antigen (CFA) was detected through immunochromatographic point-of-care test (POCT-ICT) and Og4C3-ELISA whereas antifilarial antibody titres (IgG4) were assessed through Bm14 assay. The CFA and IgG4 titres were measured by Optical Density (OD). The main characteristics at baseline, MDA coverage and the trend of filarial infection markers during follow up were described. The trend of filarial markers in relation to time (years of MDA), sex and age were analysed through Generalized Estimating Equations (GEE) models. The models demonstrated a significant decrease in all markers during MDA. The probability of remaining positive by QMFF and POCT-ICT diminished 70% and 46%, respectively, after each MDA round. There was a significant annual drop in CFA (-0.290 OD) and IgG4 antibodies titres (-0.303 OD). This study provides evidence that MDA with DEC alone can be effective in the elimination of LF in Brazil.
C1 [da Silva, Jennifer S. F.; Braga, Cynthia; Oliveira, Paula; Luna, Carlos Feitosa; Araujo, Josue; Grilis, Maria Rosangela; de Souza Melo, Paula Fernanda A.; Brandao, Eduardo; Rocha, Abraham] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Natl Ctr Lymphat Filariasis, Recife, PE, Brazil.
   [Duarte, Felipe M.] Fed Inst Pernambuco, Recife, PE, Brazil.
   [Marcondes, Marcia] Municipal Hlth Secretariat Recife, Recife, PE, Brazil.
   [Rocha, Abraham] Lab Hosp Otavio Freitas, Recife, PE, Brazil.
RP Rocha, A (corresponding author), Natl Ctr Lymphat Filariasis, Aggeu Magalhaes Res Ctr, UFPE Campus, Recife, PE, Brazil.
EM rocha@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
FU Secretaria de Vigilancia em Saude/Fundacao Oswaldo Cruz/Fundacao para o
   Desenvolvimento Tecnologico em Saude - Vice-Presidencia de Pesquisa e
   Laboratorios de Referencia [FIOCRUZ/FIOTEC/VPPLR-002-LIV11-2-1,
   FIO-15-2-2]
FX This research was funded by the Secretaria de Vigilancia em
   Saude/Fundacao Oswaldo Cruz/Fundacao para o Desenvolvimento Tecnologico
   em Saude - Vice-Presidencia de Pesquisa e Laboratorios de Referencia
   [FIOCRUZ/FIOTEC/VPPLR-002-LIV11-2-1, FIO-15-2-2 Project].
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P441
   Bockarie MJ, 2007, AM J TROP MED HYG, V76, P62, DOI 10.4269/ajtmh.2007.76.62
   Bockarie MJ, 2010, CURR OPIN INFECT DIS, V23, P617, DOI 10.1097/QCO.0b013e32833fdee5
   Braga C, 2001, Cad Saude Publica, V17, P1211, DOI 10.1590/S0102-311X2001000500021
   Braga Cynthia, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P125, DOI 10.1590/S0036-46652003000300002
   Buxton SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003276
   Critchley J, 2005, COCHRANE DB SYST REV, V19
   Freedman DO, 2001, TROP MED INT HEALTH, V6, P37, DOI 10.1046/j.1365-3156.2001.00666.x
   Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215
   Helmy H, 2006, T ROY SOC TROP MED H, V100, P656, DOI 10.1016/j.trstmh.2005.08.015
   Huppatz C, 2008, TROP MED INT HEALTH, V13, P292, DOI 10.1111/j.1365-3156.2008.02002.x
   IBGE, 2010, CENS DEM
   Kilon AD, 2014, WKLY EPIDEMIOL REC, V89, P409
   Lau CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003297
   Lima AW, 2012, REV SOC BRAS MED TRO, V45, P745, DOI 10.1590/S0037-86822012000600017
   Melrose Wayne D, 2003, Expert Rev Anti Infect Ther, V1, P571, DOI 10.1586/14787210.1.4.571
   MH Ministry of Health, 2009, GUID SURV EL LYMPH F
   NHF. National Health Foundation . National epidemiology center, 1997, B EPIDEMIOL, V1, P12
   Noroes J, 1997, T ROY SOC TROP MED H, V91, P78, DOI 10.1016/S0035-9203(97)90405-3
   Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491
   Ramaiah KD, 2011, T ROY SOC TROP MED H, V105, P431, DOI 10.1016/j.trstmh.2011.04.006
   Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2
   Rizzo JA, 2007, ANN TROP MED PARASIT, V101, P423, DOI 10.1179/136485907X176517
   Rocha A., 2010, Revista de Patologia Tropical, V39, P233
   Rocha A, 2009, MEM I OSWALDO CRUZ, V104, P621, DOI 10.1590/S0074-02762009000400015
   Simonsen PE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000696
   Simonsen PE, 2005, T ROY SOC TROP MED H, V99, P541, DOI 10.1016/j.trstmh.2004.11.016
   Tisch DJ, 2008, AM J TROP MED HYG, V78, P289, DOI 10.4269/ajtmh.2008.78.289
   Wamae CN, 2011, ACTA TROP, V120, pS33, DOI 10.1016/j.actatropica.2010.09.009
   Weil GJ, 2011, ACTA TROP, V120, pS19, DOI 10.1016/j.actatropica.2010.04.010
   Weil GJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000344
   WHO, 2017, WKLY EPIDEMIOL REC, V92, P97
   World Health Organization, 2011, GLOB PROGR EL LYMPH
   World Health Organization Global Programme to Eliminate Lymphatic Filariasis, 2012, WEEKLY EPIDEMIOLOGIC, V37, P345
NR 34
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2018
VL 112
IS 5
BP 274
EP 280
DI 10.1080/20477724.2018.1498821
PG 7
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA HC3QU
UT WOS:000451718000005
PM 30111259
OA Green Published
DA 2020-12-01
ER

PT J
AU Magalhaes, T
   Braga, C
   Cordeiro, MT
   Oliveira, ALS
   Castanha, PMS
   Maciel, APR
   Amancio, NML
   Gouveia, PN
   Peixoto-da-Silva, VJ
   Peixoto, TFL
   Britto, H
   Lima, PV
   Lima, ARS
   Rosenberger, KD
   Jaenisch, T
   Marques, ETA
AF Magalhaes, Tereza
   Braga, Cynthia
   Cordeiro, Marli T.
   Oliveira, Andre L. S.
   Castanha, Priscila M. S.
   Maciel, Ana Paula R.
   Amancio, Nathalia M. L.
   Gouveia, Pollyanne N.
   Peixoto-da-Silva, Valter J., Jr.
   Peixoto, Thaciana F. L.
   Britto, Helena
   Lima, Priscilla V.
   Lima, Andreza R. S.
   Rosenberger, Kerstin D.
   Jaenisch, Thomas
   Marques, Ernesto T. A.
TI Zika virus displacement by a chikungunya outbreak in Recife, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Background
   Several arboviruses, including dengue virus (DENV), Zika virus (ZIKV) and chikungunya virus (CHIKV), transmitted by Aedes mosquitoes, circulate in northeast Brazil. Diseases caused by these viruses are of great public health relevance, however, their epidemiological features in areas where the three viruses co-circulate are scarce. Here, we present analyses of molecular and serological diagnostics in a prospective study of acute febrile patients recruited from May 2015 to May 2016 in Recife, Brazil.
   Methods
   Two hundred sixty-three acute febrile patients with symptoms suggestive of an arboviral disease who attended an urgent heath care clinic in the Recife Metropolitan Region in northeast Brazil were enrolled. Acute and convalescent blood samples were collected and tested using molecular and serological assays for infection with DENV, ZIKV and CHIKV.
   Results
   Quantitative real-time reverse-transcriptase polymerase chain reactions (qRTPCR) performed on acute phase sera detected no patients positive for DENV, but 26 (9.9%) positive for ZIKV and 132 (50.2%) positive for CHIKV. There were a few suspected and only one confirmed dengue case. Specific serological assays for ZIKV and CHIKV confirmed the qRTPCR data. Analyses of DENV IgM and IgG ELISAs in the context of qRTPCR results suggested high levels of cross reactive antibodies in ZIKV-positive samples. Results from neutralization assays highly corroborated those from qRTPCR and ZIKV ELISA, indicating very few positive DENV cases. ZIKV infections were temporally clustered in the first months of the study and started to decrease concomitantly with an increase in CHIKV infections in August 2015. The proportion of CHIKV infections increased significantly in September 2015 and remained high until the end of the study period, with an average of 84.7% of recruited patients being diagnosed from August 2015 to May 2016. ZIKV infections exhibited a female bias and the cases were spread over the study site, while CHIKV cases had a male bias and were spatially clustered in each month.
   Conclusions
   In 2015 +/- 2016 in the Recife Metropolitan Region, we detected the tail end of a Zika epidemic, which was displaced by a chikungunya epidemic. Few dengue cases were identified despite a high number of official dengue notifications in the area during this period. We show here important epidemiological features of these cases.
C1 [Magalhaes, Tereza; Cordeiro, Marli T.; Castanha, Priscila M. S.; Lima, Priscilla V.; Lima, Andreza R. S.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Lab Virol & Expt Therapeut, Recife, PE, Brazil.
   [Magalhaes, Tereza] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.
   [Braga, Cynthia] Fiocruz MS, IAM, Dept Parasitol, Recife, PE, Brazil.
   [Braga, Cynthia; Britto, Helena] Inst Integral Med Prof Fernando Figueira, Recife, PE, Brazil.
   [Oliveira, Andre L. S.] Fiocruz MS, IAM, Stat & Geoproc Lab, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Med Sci, Recife, PE, Brazil.
   [Maciel, Ana Paula R.; Amancio, Nathalia M. L.; Gouveia, Pollyanne N.; Peixoto-da-Silva, Valter J., Jr.; Peixoto, Thaciana F. L.] IMIP, Urgent Hlth Care Unit, Paulista, Brazil.
   [Rosenberger, Kerstin D.; Jaenisch, Thomas] Heidelberg Univ Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Res DZIF, Partner Site Heidelberg, Heidelberg, Germany.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Magalhaes, T; Marques, ETA (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Lab Virol & Expt Therapeut, Recife, PE, Brazil.; Magalhaes, T (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab AIDL, Ft Collins, CO 80523 USA.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
EM tereza.magalhaes@colostate.edu; emarques@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013; Magalhaes, Tereza/V-6632-2019; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012; Marques, Ernesto T.
   A/L-4967-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Marques, Ernesto T. A/0000-0003-3826-9358
FU European Union's Seventh Framework Programme for research, technological
   development and demonstrationEuropean Union (EU) [FP7-281803 IDAMS,
   IDAMS 45]; State of Pernambuco funding agency (Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco-FACEPE) [PPSUS
   APQ-0302-4.01/13]; European Union's Horizon 2020 Research and Innovation
   Programme under ZIKAlliance [734548]; National Institute of Allergy and
   Infectious Diseases of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI129464]; ZikaCura (PITT-FIOCRUZ Alliance); Brazilian national
   funding agency (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico of Brazil-CNPq) [472360/2013-2]
FX This study was funded by the European Union's Seventh Framework
   Programme for research, technological development and demonstration
   (grant FP7-281803 IDAMS; http://www.idams.eu/), where it has been
   designated with publication reference number IDAMS 45; the State of
   Pernambuco funding agency (Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco-FACEPE; grant PPSUS APQ-0302-4.01/13); the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   (grant 734548); the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (grant R21AI129464); the
   ZikaCura (PITT-FIOCRUZ Alliance); and the Brazilian national funding
   agency (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of
   Brazil-CNPq; grant 472360/2013-2). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the funding agencies. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Aubry M, 2017, EMERG INFECT DIS, V23
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Governo do Estado de Pernambuco, 2015, B PLUV
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Ministerio da Saude Brasil, 2017, MON CAS DENG FEBR CH, V52
   Ministerio da Saude Brasil, 2015, PROT VIG RESP PEL VI
   Ministerio da Saude Brasil, 2015, MON CAS DENG FEBR CH, V48
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Organizaco Pan-Americana da Saude, 2016, B SEM
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 42
TC 22
Z9 22
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2017
VL 11
IS 11
AR e0006055
DI 10.1371/journal.pntd.0006055
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA VI3XC
UT WOS:000480724600001
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Montarroyos, UR
   Silveira, SMM
   Albuquerque, GDM
   Mello, MJG
   Lopes, KGS
   Cordeiro, MT
   Marques, ETA
   Martelli, CMT
   Braga, C
AF Castanha, P. M. S.
   Montarroyos, U. R.
   Silveira, S. M. M.
   Albuquerque, G. D. M.
   Mello, M. J. G.
   Lopes, K. G. S.
   Cordeiro, M. T.
   Marques, E. T. A., Jr.
   Martelli, C. M. T.
   Braga, C.
TI Incidence and risk factors for Dengue virus (DENV) infection in the
   first 2 years of life in a Brazilian prospective birth cohort
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Children; cohort; dengue virus; incidence
ID HEMORRHAGIC-FEVER; ANTIBODIES; CHILDREN; TRANSMISSION; NORTHEAST;
   RESPONSES; SEVERITY; KINETICS; INFANTS
AB This study assessed the incidence and risk factors for dengue virus (DENV) infection among children in a prospective birth cohort conducted in the city of Recife, a hyperendemic dengue area in Northeast Brazil. Healthy pregnant women (n = 415) residing in Recife who agreed to have their children followed were enrolled. Children were followed during their first 24 months of age (May/2011-June/2014), before the 2015 Zika virus outbreak. DENV infection was detected by reverse-transcriptase polymerase chain reaction and/or serology (anti-DENV IgM/IgG). The incidence rates per 1000 person-years (py) and its association with risk factors by age bands (0-12, > 12-30 months) were estimated through Poisson regression models. Forty-nine dengue infections were detected; none progressed to severe forms. The incidence rates were 107.6/1000py (95% CI 76.8-150.6) and 93.3/1000py (95% CI 56.1-154.4) in the first and second years of age, respectively. Male children (risk ratios (RR) = 2.33; 95% CI 1.09-4.98) and those born to DENV-naive mothers (RR = 2.42; 95% CI 1.01-5.80) were at greater risk of infection in the first year of age. In the second year, children born to Caucasian/Asian descent skin colour mothers had a threefold higher risk of infection (RR = 3.34; 95% CI: 1.08-10.33). These data show the high exposure of children to DENV infection in our setting and highlight the role of biological factors in this population's susceptibility to infection.
C1 [Castanha, P. M. S.; Albuquerque, G. D. M.; Lopes, K. G. S.; Cordeiro, M. T.; Marques, E. T. A., Jr.; Martelli, C. M. T.; Braga, C.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Av Prof Moraes Rego S-N,Campus UFPE, Recife, PE, Brazil.
   [Castanha, P. M. S.; Montarroyos, U. R.] Univ Pernambuco, Fac Med Sci, Biol Sci Inst, Recife, PE, Brazil.
   [Silveira, S. M. M.; Mello, M. J. G.; Braga, C.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
RP Castanha, PMS (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Av Prof Moraes Rego S-N,Campus UFPE, Recife, PE, Brazil.
EM castanha.priscila@gmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020; Marques, Ernesto T. A/L-4967-2013;
   Braga, Maria Cynthia/A-8204-2013; amsalu, ribka/G-8780-2019; Da Silva
   Castanha, Priscila Mayrelle/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU National Council for Scientific and Technological Development of the
   Brazilian government [482915/2010-2 MCT/CNPq-14/2010]; Strategic Program
   to Support Health Research/PAPES VI [407697/2012-8]
FX We thank the mothers and their infants, for participating in the study;
   and the nurses and clinical staff from IMIP who assisted with the study.
   This work was supported by the National Council for Scientific and
   Technological Development of the Brazilian government (C.B., grant
   482915/2010-2 MCT/CNPq-14/2010); and the Strategic Program to Support
   Health Research/PAPES VI (C.B., grant 407697/2012-8).
CR Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117
   Clapham H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004262
   Clayton D, 1993, STAT MODELS EPIDEMIO, P3421
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Del Principe D, 2013, CURR MOL MED, V13, P499
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/J.JCV.2014.02.009, 10.1016/j.jcv.2014.02.009]
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Raza FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089868
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
NR 38
TC 4
Z9 4
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2017
VL 145
IS 14
BP 2971
EP 2979
DI 10.1017/S095026881700214X
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FK0ZG
UT WOS:000413208700011
PM 28918772
OA Bronze
DA 2020-12-01
ER

PT J
AU Degroote, S
   Osorio, L
   Parra, LG
   Garcia, JA
   Torres, L
   Garcia, V
   Parra, B
   Fournet, F
   Bonnet, E
   Jourdain, F
   Bermudez-Tamayo, C
   Marcos-Marcos, J
   De Labry, AO
   Eder, MK
   Braga, C
   Martelli, CMT
   Siqueira, N
   Cortes, F
   Carabali, M
   Campeau, L
   Dagenais, C
   Ridde, V
AF Degroote, S.
   Osorio, L.
   Parra, L. G.
   Garcia, J. A.
   Torres, L.
   Garcia, V.
   Parra, B.
   Fournet, F.
   Bonnet, E.
   Jourdain, F.
   Bermudez-Tamayo, C.
   Marcos-Marcos, J.
   De labry, A. Olry
   Eder, M. K.
   Braga, C.
   Martelli, C. M. T.
   Siqueira, N.
   Cortes, F.
   Carabali, M.
   Campeau, L.
   Dagenais, C.
   Ridde, V.
TI Urban health interventions and vector-borne and other infectious
   diseases of poverty: an international collaboration to analyse knowledge
   gaps
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Degroote, S.; Campeau, L.; Dagenais, C.; Ridde, V.] Univ Montreal, Inst Rech Sante Publ, Montreal, PQ, Canada.
   [Osorio, L.; Torres, L.; Garcia, V.] Univ Valle, Escuela Salud Publ, Cali, Colombia.
   [Parra, L. G.; Garcia, J. A.] Univ Valle, Escuela Med, Cali, Colombia.
   [Parra, B.] Univ Valle, Escuela Ciencias Basicas, Cali, Colombia.
   [Fournet, F.; Bonnet, E.] Inst Rech Dev, Montpellier, France.
   [Jourdain, F.] Ctr Natl Expertise Vecteurs, Montpellier, France.
   [Bermudez-Tamayo, C.; Marcos-Marcos, J.; De labry, A. Olry] Escuela Andaluza Salud Publ, Granada, Spain.
   [Eder, M. K.; Braga, C.; Martelli, C. M. T.; Siqueira, N.] Fiocruz PE, Inst Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
   [Cortes, F.] Univ Pernambuco, Recife, PE, Brazil.
   [Carabali, M.] McGill Univ, Montreal, PQ, Canada.
RI ridde, valery/AAV-1016-2020; Ridde, Valery/AAD-2736-2019; Bonnet,
   Emmanuel/ABA-8374-2020; Bermudez-Tamayo, Clara/AAB-7321-2019; Lara, Luis
   Gabriel Parra/X-3966-2018; Braga, Maria Cynthia/A-8204-2013
OI Ridde, Valery/0000-0001-9299-8266; Bermudez-Tamayo,
   Clara/0000-0002-2964-6361; Lara, Luis Gabriel Parra/0000-0002-4877-1117;
   Braga, Maria Cynthia/0000-0002-7862-6455
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2017
VL 22
SU 1
SI SI
MA 7P3
BP 303
EP 303
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6VU
UT WOS:000412896900721
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Nascimento, EJM
   Braga, C
   Cordeiro, MT
   de Carvalho, OV
   de Mendonca, LR
   Azevedo, EAN
   Franca, RFO
   Dhalia, R
   Marques, ETA
AF Castanha, Priscila M. S.
   Nascimento, Eduardo J. M.
   Braga, Cynthia
   Cordeiro, Marli T.
   de Carvalho, Otavio V.
   de Mendonca, Leila R.
   Azevedo, Elisa A. N.
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
TI Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not
   Alter the Production of Interleukin 6 in Fc gamma RII-Expressing K562
   Cells
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID DEPENDENT ENHANCEMENT; VIRUS
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; de Carvalho, Otavio V.; de Mendonca, Leila R.; Azevedo, Elisa A. N.; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Inst Biol Sci, Fac Med Sci, Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), Ctr Vaccine Res, 3501 Fifth Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu
RI Braga, Maria Cynthia/A-8204-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Marques, Ernesto T. A/L-4967-2013; Dhalia,
   Rafael/AAD-5432-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Marques, Ernesto T. A/0000-0003-3826-9358;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education; Center for Vaccine Research, University of Pittsburgh;
   Fogarty Training Program [D43TW006592 Pitt GIDRTP/323 NIH]; National
   Council for Scientific and Technological DevelopmentNational Council for
   Scientific and Technological Development (CNPq) [482915/2010-2
   MCT/CNPq-321 14/2010]; Strategic Program to Support Health
   Research/PAPES VI [322 407697/2012-8]; National Institute of Allergy and
   Infectious Diseases, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI56541]
FX This work was supported by the Brazilian Federal Agency for Support and
   Evaluation of Graduate Education; Center for Vaccine Research,
   University of Pittsburgh; Fogarty Training Program (grant number
   D43TW006592 Pitt GIDRTP/323 NIH to P. M. S. C.); National Council for
   Scientific and Technological Development (grant number 482915/2010-2
   MCT/CNPq-321 14/2010); Strategic Program to Support Health
   Research/PAPES VI (grant number 322 407697/2012-8); and National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health (grant number U19 AI56541).
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
NR 10
TC 4
Z9 4
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2017
VL 216
IS 5
BP 614
EP 615
DI 10.1093/infdis/jix346
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FG6UY
UT WOS:000410532400015
PM 28931227
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Nascimento, EJM
   Braga, C
   Cordeiro, MT
   de Carvalho, OV
   de Mendonca, LR
   Azevedo, EAN
   Franca, RFO
   Dhalia, R
   Marques, ETA
AF Castanha, Priscila M. S.
   Nascimento, Eduardo J. M.
   Braga, Cynthia
   Cordeiro, Marli T.
   de Carvalho, Otavio V.
   de Mendonca, Leila R.
   Azevedo, Elisa A. N.
   Franca, Rafael F. O.
   Dhalia, Rafael
   Marques, Ernesto T. A.
TI Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; antibody dependent enhancement; dengue antibodies
AB Anti-Flavivirus antibodies are highly cross-reactive and may facilitate Zika virus (ZIKV) infection through the antibody-dependent enhancement (ADE) mechanism. We demonstrate that dengue-specific antibodies enhance the infection of a primary Brazilian ZIKV isolate in a Fc gamma RII-expressing K562 cell line. In addition, we demonstrate that serum samples from dengue-immune pregnant women enhanced ZIKV infection. These findings highlight the need for epidemiological studies and animal models to further confirm the role of ADE in the development of congenital and neurological complications associated with ZIKV infections.
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; de Carvalho, Otavio V.; de Mendonca, Leila R.; Azevedo, Elisa A. N.; Franca, Rafael F. O.; Dhalia, Rafael; Marques, Ernesto T. A.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Inst Biol Sci, Fac Med Sci, Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [de Carvalho, Otavio V.] Univ Fed Vicosa, Vicosa, MG, Brazil.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), Ctr Vaccine Res, 3501 5th Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM marques@pitt.edu
RI amsalu, ribka/G-8780-2019; Dhalia, Rafael/AAD-5432-2020; Marques,
   Ernesto T. A/L-4967-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Braga, Maria Cynthia/A-8204-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Braga, Maria Cynthia/0000-0002-7862-6455;
   Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)CAPES; Center for Vaccine Research, University of
   Pittsburgh; Fogarty Training Program [D43TW006592 Pitt GIDRTP/ 323 NIH];
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [482915/2010-2 MCT/CNPq-321 14/2010]; Strategic Program to
   Support Health Research/PAPES VI [322 407697/2012-8]; National Institute
   of Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19 AI56541]
FX This work was supported by the Brazilian Federal Agency for Support and
   Evaluation of Graduate Education (CAPES); Center for Vaccine Research,
   University of Pittsburgh; Fogarty Training Program (D43TW006592 Pitt
   GIDRTP/ 323 NIH to P. M. S. C.); National Council for Scientific and
   Technological Development (CNPq) (482915/2010-2 MCT/CNPq-321 14/2010);
   Strategic Program to Support Health Research/PAPES VI (322
   407697/2012-8); and the National Institute of Allergy and Infectious
   Diseases (U19 AI56541).
CR Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
NR 15
TC 66
Z9 68
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 1
PY 2017
VL 215
IS 5
BP 781
EP 785
DI 10.1093/infdis/jiw638
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ER2PO
UT WOS:000398636500018
PM 28039355
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU de Albuquerque, MDPM
   de Souza, WV
   Mendes, ADG
   Lyra, TM
   Ximenes, RAA
   Araujo, TVB
   Braga, C
   Miranda, DB
   Martelli, CMT
   Rodrigues, LC
AF Militao de Albuquerque, Maria de Fatima P.
   de Souza, Wayner V.
   Mendes, Antnio da Cruz G.
   Lyra, Tereza M.
   Ximenes, Ricardo A. A.
   Araujo, Thalia V. B.
   Braga, Cynthia
   Miranda-Filho, Democrito B.
   Martelli, Celina M. T.
   Rodrigues, Laura C.
TI Pyriproxyfen and the microcephaly epidemic in Brazil - an ecological
   approach to explore the hypothesis of their association
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; microcephaly; pyriproxyfen larvicide
AB The microcephaly epidemic in Brazil generated intense debate regarding its causality, and one hypothesised cause of this epidemic, now recognised as congenital Zika virus syndrome, was the treatment of drinking water tanks with pyriproxyfen to control Aedes aegypti larvae. We present the results of a geographical analysis of the association between the prevalence of microcephaly confirmed by Fenton growth charts and the type of larvicide used in the municipalities that were home to the mothers of the affected newborns in the metropolitan region of Recife in Pernambuco, the state in Brazil where the epidemic was first detected. The overall prevalence of microcephaly was 82 per 10,000 live births in the three municipalities that used the larvicide Bti (Bacillus thuringiensis israelensis) instead of pyriproxyfen, and 69 per 10,000 live births in the eleven municipalities that used pyriproxyfen. The difference was not statistically significant. Our results show that the prevalence of microcephaly was not higher in the areas in which pyriproxyfen was used. In this ecological approach, there was no evidence of a correlation between the use of pyriproxyfen in the municipalities and the microcephaly epidemic.
C1 [Militao de Albuquerque, Maria de Fatima P.; de Souza, Wayner V.; Mendes, Antnio da Cruz G.; Lyra, Tereza M.; Braga, Cynthia; Martelli, Celina M. T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.; Araujo, Thalia V. B.; Miranda-Filho, Democrito B.] Univ Pernambuco, Recife, PE, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, London, England.
EM laura.rodrigues@lshtm.ac.uk
RI Souza, Wayner V/H-3798-2013; Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
   Funding Source: Medline
CR Abrasco, 2016, NOT TECN MICR DOENC
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   Brasil-Ministerio da Saude do Brasil, 2016, MICR MIN SAUD CONF 1
   CES-Conselho Estadual de Saude de Pernambuco, 2016, GRUP TRAB SE REUN DI
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   EBC-Empresa Brasil de Comunicacao S/ A-Agencia Brasil, 2016, RS SUSP US LARV PYR
   Evans D, 2016, 048538V1 BIORXIV
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regis LN, 2014, ACTA TROP, V137, P80, DOI 10.1016/j.actatropica.2014.04.010
   SWETOX-Swedish Toxicology Science Research Center, 2016, PYR MICR INV POT TIE
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO World Health Organization, 2016, ZIK VIR MICR GUILL B
   WHO-World Health Organization, 2006, SPEC PUBL HLTH PEST
   World Health Organization (WHO), 2008, GUID DRINK WAT QUAL
NR 14
TC 17
Z9 17
U1 1
U2 12
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD DEC
PY 2016
VL 111
IS 12
BP 774
EP 776
DI 10.1590/0074-02760160291
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EH0FD
UT WOS:000391437500009
PM 27812601
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU de Araujo, TVB
   Rodrigues, LC
   Ximenes, RADA
   Miranda-Filho, DDB
   Montarroyos, UR
   de Melo, APL
   Valongueiro, S
   de Albuquerque, MDFPM
   Souza, WV
   Braga, C
   Filho, SPB
   Cordeiro, MT
   Vazquez, E
   Cruz, DDCS
   Henriques, CMP
   Bezerra, LCA
   Castanha, PMDS
   Dhalia, R
   Marques-Junior, ETA
   Martell, CMT
AF de Araujo, Thalia Velho Barreto
   Rodrigues, Laura Cunha
   Ximenes, Ricardo Arraes de Alencar
   Miranda-Filho, Democrito de Barros
   Montarroyos, Ulisses Ramos
   de Melo, Ana Paula Lopes
   Valongueiro, Sandra
   de Albuquerque, Maria de Fcitima Pessoa Militao
   Souza, Wayner Vieira
   Braga, Cynthia
   Filho, Sinval Pinto Brandao
   Cordeiro, Marli Tenorio
   Vazquez, Enrique
   Cruz, Danielle Di Cavalcanti Souza
   Henriques, Clciudio Maierovitch Pessanha
   Bezerra, Luciana Caroline Albuquerque
   Castanha, Priscila Mayrelle da Silva
   Dhalia, Rafael
   Marques-Junior, Ernesto Torres Azevedo
   Martelli, Celina Maria Turchi
TI Association between Zika virus infection and microcephaly in Brazil,
   January to May, 2016: preliminary report of a case-control study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID AMERICA; FETAL
AB Background The microcephaly epidemic, which started in Brazil in 2015, was declared a Public Health Emergency of International Concern by WHO in 2016. We report the preliminary results of a case-control study investigating the association between microcephaly and Zika virus infection during pregnancy.
   Methods We did this case-control study in eight public hospitals in Recife, Brazil. Cases were neonates with microcephaly. Two controls (neonates without microcephaly), matched by expected date of delivery and area of residence, were selected for each case. Serum samples of cases and controls and cerebrospinal fluid samples of cases were tested for Zika virus-specific IgM and by quantitative RT-PCR. Laboratory-confirmed Zika virus infection during pregnancy was defined as detection of Zika virus-specific IgM or a positive RT-PCR result in neonates. Maternal serum samples were tested by plaque reduction neutralisation assay for Zika virus and dengue virus. We estimated crude odds ratios (ORs) and 95% CIs using a median unbiased estimator for binary data in an unconditional logistic regression model. We estimated ORs separately for cases with and without radiological evidence of brain abnormalities.
   Findings Between Jan 15, 2016, and May 2, 2016, we prospectively recruited 32 cases and 62 controls. 24 (80%) of 30 mothers of cases had Zika virus infection compared with 39 (64%) of 61 mothers of controls (p=0.12). 13 (41%) of 32 cases and none of 62 controls had laboratory-confirmed Zika virus infection; crude overall OR 55.5 (95% CI 8.6-infinity); OR 113.3 (95% CI 14.5-infinity) for seven cases with brain abnormalities; and OR 24.7 (95% CI 2.9-infinity) for four cases without brain abnormalities.
   Interpretation Our data suggest that the microcephaly epidemic is a result of congenital Zika virus infection. We await further data from this ongoing study to assess other potential risk factors and to confirm the strength of association in a larger sample size.
C1 [de Araujo, Thalia Velho Barreto; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [Ximenes, Ricardo Arraes de Alencar] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [de Melo, Ana Paula Lopes] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Ximenes, Ricardo Arraes de Alencar; Miranda-Filho, Democrito de Barros; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fcitima Pessoa Militao; Souza, Wayner Vieira; Braga, Cynthia; Filho, Sinval Pinto Brandao; Cordeiro, Marli Tenorio; Castanha, Priscila Mayrelle da Silva; Marques-Junior, Ernesto Torres Azevedo; Martelli, Celina Maria Turchi] Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fcitima Pessoa Militao; Filho, Sinval Pinto Brandao; Cordeiro, Marli Tenorio; Castanha, Priscila Mayrelle da Silva; Dhalia, Rafael; Marques-Junior, Ernesto Torres Azevedo; Martelli, Celina Maria Turchi] Oswaldo Cruz Fdn Fiocruz, Recife, PE, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Cruz, Danielle Di Cavalcanti Souza] Inst Materno Infantil Fernando Figueira, Recife, PE, Brazil.
   [Henriques, Clciudio Maierovitch Pessanha] Fiocruz Brasilia, Brasilia, DF, Brazil.
   [Bezerra, Luciana Caroline Albuquerque] Pernambuco State Hlth Dept, Recife, PE, Brazil.
   [Martelli, Celina Maria Turchi] Univ Fed Goias, Dept Community Hlth, Goiania, Go, Brazil.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
RI Da Silva Castanha, Priscila Mayrelle/G-1785-2012; Souza, Wayner
   V/H-3798-2013; Marques, Ernesto T. A/L-4967-2013; Braga, Maria
   Cynthia/A-8204-2013; Montarroyos, Ulisses/AAJ-7527-2020; Brandao-Filho,
   Sinval Pinto/AAP-4792-2020; Dhalia, Rafael/AAD-5432-2020
OI Da Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Marques,
   Ernesto T. A/0000-0003-3826-9358; Braga, Maria
   Cynthia/0000-0002-7862-6455; Brandao-Filho, Sinval
   Pinto/0000-0003-3768-2810; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health; Pan American Health Organization;
   Enhancing Research Activity in Epidemic Situations; Medical Research
   CouncilMedical Research Council UK (MRC) [MC_PC_15088] Funding Source:
   researchfish
FX Brazilian Ministry of Health, Pan American Health Organization, and
   Enhancing Research Activity in Epidemic Situations.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Brasil Ministerio da Satide, 2016, 32 BRAS MIN SAUD
   Brasil Ministerio da Saude, 2015, 12015 BRAS MIN SAUD
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Organization W. H., 2016, WHO DIR GEN SUMM OUT
   Pan American Health Organization World Health Organization, 2015, EP AL NEUR SYNDR CON
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   University of Calgary, FENT PRET GROWTH CHA
   WHO, 2016, WHOZIKVMOC163REV3WHO
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 39
TC 190
Z9 195
U1 0
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1356
EP 1363
DI 10.1016/S1473-3099(16)30318-8
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800045
PM 27641777
OA Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Salvi, CCB
   Braga, MC
   Figueiroa, JN
   Batista, M
AF Bresani Salvi, Cristiane Campello
   Braga, Maria Cynthia
   Figueiroa, Jose Natal
   Batista Filho, Malaquias
TI Could the erythrocyte indices or serum ferritin predict the therapeutic
   response to a trial with oral iron during pregnancy? Results from the
   Accuracy study for Maternal Anaemia diagnosis (AMA)
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Anaemia; Iron-Deficiency; Pregnancy; Erythrocyte Indices; Sensitivity
   and Specificity; Ferrous Sulfate
ID DEFICIENCY ANEMIA; CLINICAL-TRIAL; WOMEN; SUPPLEMENTATION; HEMOGLOBIN;
   PREVALENCE; CHILDREN; TESTS; AGE
AB Background: Treatment of maternal iron-deficiency anaemia can reduce risks of prematurity and low birth weight; hence a reliable diagnosis of maternal iron needs is critical. However, erythrocyte indices and serum ferritin have shown a weak correlation with iron status during pregnancy. This study verified the accuracy of those tests to predict the responsiveness to a therapeutic test with oral iron as reference standard for iron deficiency in pregnant women.
   Methods: A prospective diagnostic study phase 3 was conducted in a single prenatal care center in Northeast Brazil. Between August 2011 and October 2012 a consecutive sampling included 187 women in their 2nd-3rd trimesters of low-risk pregnancy and having anaemia (haemoglobin <11.0 g/dL). Until December 2012, 139 women completed a trial with daily pills of ferrous sulfate (40 mg of iron), during 23 to 125 days. Haemoglobin (Hb), other erythrocyte indices and ferritin (index-tests) were assessed pre-treatment by automated analyzers. Hb was performed also post-treatment to assess the therapeutic response by its post-pretreatment differences. We estimated sensitivity (Se), specificity (Sp), predictive values (PV), likelihood ratios (LR), diagnostic Odds Ratio (OR), area under Receiver Operating Characteristic curve (AUC), accuracy ratio and agreement coefficient of the index-tests against an increase of at least 0.55 Hb Z-score (reference standard test). We calculated the Z-scores according to the reference population from Centers for Disease Control and Prevention.
   Results: Hb had a mean increase of 0.24 Z-score after 30 iron pills (p 0.013). All index-tests demonstrated PV- above 70 %, PV+ around 40 %, LR around 1.0, and AUC of 0.5 to 0.6. Hb and haematocrit had Se of 50 % (95 % CI 40 to 70); and Sp of 59 % (95 % CI 43 to 74) and 47 % (95 % CI 38 to 57), respectively. Ferritin, Mean Corpuscular Volume, Mean Corpuscular Haemoglobin, Mean Corpuscular Haemoglobin Concentration and Red blood cell Distribution Width had Se below 40 % with Sp above 70 %.
   Conclusions: Erythrocyte indices and ferritin could not predict the iron needs of anemic pregnant women. Increases of Hb Z-scores after a short treatment with oral iron may be a reliable therapeutic test.
C1 [Bresani Salvi, Cristiane Campello; Batista Filho, Malaquias] Inst Med Integral Prof Fernando Figueira IMIP, Nutr Res Grp, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
   [Bresani Salvi, Cristiane Campello] INSS MPS, Av Jorn Mario Melo 343, BR-50040010 Recife, PE, Brazil.
   [Braga, Maria Cynthia; Figueiroa, Jose Natal; Batista Filho, Malaquias] Inst Materno Infantil Pernambuco, Postgrad Program Maternal & Child Hlth, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
   [Braga, Maria Cynthia] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Postgrad Program Publ Hlth, CPQAM FIOCRUZ, Av Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50670420 Recife, PE, Brazil.
RP Salvi, CCB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Nutr Res Grp, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.; Salvi, CCB (corresponding author), INSS MPS, Av Jorn Mario Melo 343, BR-50040010 Recife, PE, Brazil.
EM cristiane.bresani@inss.gov.br
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
FU governmental agency National Council for Scientific and Technological
   Development CNPq
FX The authors inform that this study received funding from the
   governmental agency National Council for Scientific and Technological
   Development CNPq, the authors are independent from this funder.
CR Abdelrahman EG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-168
   Beaton GH, 1999, EFFICACOY INTERMITTE
   Berger J, 1997, NUTR REV, V55, P247, DOI 10.1111/j.1753-4887.1997.tb01612.x
   Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7
   Bresani CC, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-13
   Salvi CCB, 2014, REV PANAM SALUD PUBL, V36, P110
   Cao C, 2013, NUTR REV, V71, P35, DOI 10.1111/j.1753-4887.2012.00550.x
   Casanova BF, 2005, AM J OBSTET GYNECOL, V193, P460, DOI 10.1016/j.ajog.2004.12.008
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897
   Choi JW, 2001, ANN HEMATOL, V80, P26, DOI 10.1007/s002770000229
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Grotto Helena Z. W., 2008, Rev. Bras. Hematol. Hemoter., V30, P390, DOI 10.1590/S1516-84842008000500012
   Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443
   Jaime-Pérez José Carlos, 2015, Rev. Bras. Hematol. Hemoter., V37, P178, DOI 10.1016/j.bjhh.2015.02.002
   Knottnerus JA, 2002, EVIDENCE BASE CLIN D, P39
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lurie S, 2000, EUR J OBSTET GYN R B, V93, P185, DOI 10.1016/S0301-2115(00)00290-6
   MARGOLIS HS, 1981, AM J CLIN NUTR, V34, P2158
   Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195
   Milman N, 2000, ACTA OBSTET GYN SCAN, V79, P89, DOI 10.1034/j.1600-0412.2000.079002089.x
   Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2
   Mukhopadhyay A, 2004, NATL MED J INDIA, V17, P135
   Mumtaz Z, 2000, J NUTR, V130, P2697
   Parker JA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-56
   Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x
   Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4
   Puolakka J, 1980, Acta Obstet Gynecol Scand Suppl, V95, P57
   Reveiz L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003094.pub2
   Rukuni R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0679-9
   Sackett D, 2002, EVIDENCE BASE CLIN D, P19
   Sloan NL, 2002, AM J PUBLIC HEALTH, V92, P288, DOI 10.2105/AJPH.92.2.288
   Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9
   Sultana G S, 2011, Bangladesh Med Res Counc Bull, V37, P102
   Tam KF, 1999, OBSTET GYNECOL, V93, P427, DOI 10.1016/S0029-7844(98)00422-0
   Thorpe SJ, 1997, CLIN CHEM, V43, P1582
   Tiwari Manu, 2013, Med J Armed Forces India, V69, P31, DOI 10.1016/j.mjafi.2012.07.016
   van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x
   Volpi E, 1991, Minerva Ginecol, V43, P387
   WHO, 2011, WHONMHNHDMNM112
   WHO, 2008, WORLDWIDE PREVALENCE
   WHO, 2011, WHONMHNHDMNM111
   World Health Organization, 2001, IR DEF AN ASS PREV C
   Wright CM, 2004, ARCH DIS CHILD, V89, P1028, DOI 10.1136/adc.2003.047407
   Yip R, 1998, MMWR RECOMM REP, V47, P1
NR 44
TC 2
Z9 2
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 12
PY 2016
VL 16
AR 218
DI 10.1186/s12884-016-1005-x
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DT4UK
UT WOS:000381476400001
PM 27516193
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Braga, C
   Cordeiro, MT
   Souza, AI
   Silva, CD
   Martelli, CMT
   van Panhuis, WG
   Nascimento, EJM
   Marques, ETA
AF Castanha, Priscila M. S.
   Braga, Cynthia
   Cordeiro, Marli T.
   Souza, Ariani I.
   Silva, Claudeir D., Jr.
   Martelli, Celina M. T.
   van Panhuis, Willem G.
   Nascimento, Eduardo J. M.
   Marques, Ernesto T. A.
TI Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and
   Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE dengue; placental transfer; IgG; newborn; antibody dependent enhancement
ID TRANSPLACENTAL TRANSFER; HEMORRHAGIC-FEVER; IGG SUBCLASSES; LIFE;
   PATHOGENESIS; PREGNANCY; MEASLES; DECAY; FCRN
AB Background. Maternal-fetal transferred dengue virus ( DENV)-specific antibodies have been implicated in the immunopathogenesis of dengue during infancy. Methods. A prospective birth cohort was established in a dengue-endemic area in the Northeast Region of Brazil. DENV-specific immunoglobulin G ( IgG) and DENV-1-4 serotype-specific neutralizing antibody ( NAb) levels were assessed in 376 paired maternal and umbilical cord blood samples. The kinetics of enhancing activity by maternally acquired DENV antibodies was determined in serum samples from children enrolled in the cohort. Results. Mothers were mostly immune to DENV-3 alone ( 53.7%) or combined with DENV-4 ( 30.6%). Levels of DENV-specific IgG, DENV-3 NAbs, and DENV-4 NAbs were significantly higher in newborns than in their respective mothers. Mothers immune to a single serotype transferred greater levels of DENV-specific IgG ( P =.02) and DENV-3 NAbs ( P =.04) than mothers immune to multiple DENV serotypes. Maternally acquired DENV-3 NAbs disappeared in > 90% of the children by the age of 4 months. The peak enhancing activity was detected by the age of 2 months ( P <.0001) and rapidly declined by the age of 4 months ( P =.0035). Conclusions. Unlike Asian infants, the enhancing activity of DENV infection by maternally transferred DENV antibodies occurs at earlier ages in Brazilian children. These findings might explain the low occurrence of severe dengue among infants in our setting.
C1 [Castanha, Priscila M. S.; Braga, Cynthia; Cordeiro, Marli T.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Braga, Cynthia; Souza, Ariani I.; Silva, Claudeir D., Jr.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Martelli, Celina M. T.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [van Panhuis, Willem G.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Nascimento, EJM (corresponding author), Ctr Vaccine Res, 3501 5th Ave,9052 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.
EM ejmn@pitt.edu
RI Souza, Ariani I/C-1568-2015; de Souza, Ariani Impieri/AAR-6884-2020;
   Braga, Maria Cynthia/A-8204-2013; Van Panhuis, Willem/S-5495-2019;
   Marques, Ernesto T. A/L-4967-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012
OI Souza, Ariani I/0000-0002-7917-5983; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Braga, Maria Cynthia/0000-0002-7862-6455;
   Van Panhuis, Willem/0000-0002-7278-9982; Marques, Ernesto T.
   A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Dias da Silva Junior,
   Claudeir/0000-0002-5216-5697
FU National Council for Scientific and Technological Development of the
   Brazilian government [482915/2010-2 MCT/CNPq-14/2010]; Strategic Program
   to Support Health Research/PAPES VI [407697/2012-8]; Fogarty Training
   Program [D43TW006592 Pitt GIDRTP/NIH]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW006592, D43TW006592, D43TW006592, D43TW006592, D43TW006592,
   D43TW006592, D43TW006592, D43TW006592, D43TW006592, D43TW006592] Funding
   Source: NIH RePORTER
FX This work was supported by the National Council for Scientific and
   Technological Development of the Brazilian government (grant
   482915/2010-2 MCT/CNPq-14/2010), the Strategic Program to Support Health
   Research/PAPES VI (grant 407697/2012-8), and the Fogarty Training
   Program (grant D43TW006592 Pitt GIDRTP/NIH to P. M. S. C.).
CR Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00095815
   Brazilian Ministry of Health. Sistema de Informacao sobre Agravos de Notificacao (SINAN), 2012, SIST INF AGR NOT SIN
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845
   deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077
   Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010
   Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/J.JCV.2014.02.009, 10.1016/j.jcv.2014.02.009]
   Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808
   Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   THEIN S, 1993, J MED VIROL, V40, P102, DOI 10.1002/jmv.1890400205
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   van Panhuis WG, 2011, AM J TROP MED HYG, V85, P355, DOI 10.4269/ajtmh.2011.11-0125
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
NR 33
TC 19
Z9 19
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2016
VL 214
IS 2
BP 265
EP 272
DI 10.1093/infdis/jiw143
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DR3SM
UT WOS:000379822900014
PM 27056951
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Albuquerque, MDPM
   Araujo, TVB
   Barkokebas, A
   Bezerra, LCA
   Braga, C
   Brandao, SP
   Brito, CAA
   Cabral, RG
   Carneiro, AR
   Carvalho, MDCG
   Cordeiro, MT
   Costa, I
   Cunha, ASC
   Cruz, DDCS
   Dhalia, R
   Hazin, AN
   Katz, L
   Marques, ETA
   Martelli, CMT
   Miranda, DB
   Moraes, MMC
   Mota, C
   Van der Linden, V
   Ramos, RCF
   Rocha, MAW
   Silva, PFS
   Souza, WV
   Van der Linden, A
   Ximenes, RAA
   Batista, JDL
   Vazquez, E
   Coelho, GE
   Cortez-Escalante, JJ
   Duarte, E
   Henriques, CMP
   Melo, CFCA
   Oliveira, WK
   Schuler-Faccini, L
   Aldighieri, S
   Almiron, M
   Mendez-Rico, J
   Ramon-Pardo, P
   Rodrigues, LC
AF Albuquerque, Maria de Fatima P. M.
   Araujo, Thalia V. B.
   Barkokebas, Andreza
   Bezerra, Luciana Caroline A.
   Braga, Cynthia
   Brandao-Filho, Sinval P.
   Brito, Carlos Alexandre A.
   Cabral, Renata G.
   Carneiro, Adriana R.
   Carvalho, Maria Durce C. G.
   Cordeiro, Marli T.
   Costa-, Iran, Jr.
   Cunha, Adriana S. C.
   Cruz, Danielle D. C. S.
   Dhalia, Rafael
   Hazin, Adriano N.
   Katz, Leticia
   Marques, Ernesto T. A.
   Martelli, Celina Maria T.
   Miranda-Filho, Democrito B.
   Moraes, Monica Maria C.
   Mota, Cristina
   Van der Linden, Vanessa
   Ramos, Regina C. F.
   Rocha, Maria Angela W.
   Silva, Paula Fabiana S.
   Souza, Wayner V.
   Van der Linden, Ana
   Ximenes, Ricardo A. A.
   Batista, Joanna d'Arc L.
   Vazquez, Enrique
   Coelho, Giovanini E.
   Cortez-Escalante, Juan J.
   Duarte, Elisete
   Henriques, Claudio M. P.
   Melo, Carlos Frederico C. A.
   Oliveira, Wanderson K.
   Schuler-Faccini, Lavinia
   Aldighieri, Sylvain
   Almiron, Maria
   Mendez-Rico, Jairo
   Ramon-Pardo, Pilar
   Rodrigues, Laura C.
CA Microcephaly Epidemic Res Grp
TI Microcephaly in Infants, Pernambuco State, Brazil, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We studied the clinical characteristics for 104 infants born with microcephaly in the delivery hospitals of Pernambuco State, Brazil, during 2015. Testing is ongoing to exclude known infectious causes. However, microcephaly peaked in October and demonstrated central nervous system abnormalities with brain dysgenesis and intracranial calcifications consistent with an intrauterine infection.
C1 [Martelli, Celina Maria T.] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes, NESC, Ave Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
RP Martelli, CMT (corresponding author), Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes, NESC, Ave Prof Moraes Rego S-N,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM turchicm@gmail.com
RI Folador, Adriana R.C./H-6410-2016; Souza, Wayner V/H-3798-2013;
   Oliveira, Wanderson/AAF-5182-2019; Dhalia, Rafael/AAD-5432-2020;
   Marques, Ernesto T. A/L-4967-2013; SCHULER-FACCINI, LAVINIA/C-8309-2013;
   Batista, Joanna d'Arc L/O-9933-2014; Braga, Maria Cynthia/A-8204-2013
OI Oliveira, Wanderson/0000-0002-9662-1930; Marques, Ernesto T.
   A/0000-0003-3826-9358; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460;
   Batista, Joanna d'Arc L/0000-0002-3703-2845; Braga, Maria
   Cynthia/0000-0002-7862-6455; Souza, Wayner/0000-0002-0939-9332; Brandao
   Filho, Sinval/0000-0003-3768-2810; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health; Pernambuco State Health Department; Pan
   American Health Organization; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [306489/2010-4, 308311/2009-4,
   308590/2013-9, 301779/2009-0, 304174/2014-9, 306222/2013-2]; Medical
   Research CouncilMedical Research Council UK (MRC) [MC_PC_15088] Funding
   Source: researchfish
FX We are thankful for the support of the Brazilian Ministry of Health,
   Pernambuco State Health Department and Pan American Health Organization
   for their support.r The authors received partial support from the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (scholarship 306489/2010-4 to C.M.T.M., 308311/2009-4 to RAAX,
   308590/2013-9 to D.B.M.F., 301779/2009-0 to M.F.P.M.A., 304174/2014-9 to
   C.B., and 306222/2013-2 to W.V.S.).
CR Brazilian Ministry of Health, 2015, EP B ZIK VIR DAT
   Brazilian Ministry of Health, 2015, EPIDEMIOLOGICAL B
   Brazilian Ministry of Health, 2015, MIN HLTH CONF REL ZI
   Brazilian Ministry of Health, 2015, PROT MON RESP MICR O
   Pereira APE, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00160313
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Pan American Health Organisation, NEUR SYNDR CONG MALF
   Trimm F, 2004, PEDIAT MOD, V2, P1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 52
Z9 53
U1 0
U2 9
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2016
VL 22
IS 6
BP 1090
EP 1093
DI 10.32032/eid2206.160062
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DN0YY
UT WOS:000376794200022
PM 27071041
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Souza, AI
   Ferreira, ALCG
   Arraes, MA
   Moura, BM
   Braga, MC
AF Souza, Ariani Impieri
   Carneiro Gomes Ferreira, Ana Laura
   Arraes, Matheus Alencar
   Moura, Bruno Marcelo
   Braga, Maria Cynthia
TI Dengue as a cause of fever during pregnancy: a report of two cases
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Dengue; Pregnant women; Vertical transmission
ID TRANSMISSION; INFECTION
AB Dengue infection has not been routinely investigated among pregnant women and parturients with acute febrile syndrome in endemic settings. Here, we report two cases of dengue fever detected at the time of delivery in parturients enrolled in a cohort prospective study conducted in a hospital in Recife, Brazil. The parturients reported fever onset within seven days prior to delivery, and dengue infection was confirmed upon detection of viral ribonucleic acid (RNA) by using the reverse transcriptasepolymerase chain reaction. Dengue infection should be considered as a diagnostic possibility in cases of fever during pregnancy and labor, especially in endemic areas.
C1 [Souza, Ariani Impieri; Carneiro Gomes Ferreira, Ana Laura; Braga, Maria Cynthia] Inst Med Integral Prof Fernando Figueira, Programa Posgrad Stricto Sensu Saude Materno Infa, Recife, PE, Brazil.
   [Souza, Ariani Impieri; Arraes, Matheus Alencar; Moura, Bruno Marcelo] Fac Pernambucana Saude, Curso Med, Recife, PE, Brazil.
   [Braga, Maria Cynthia] Fundacao Oswaldo Cruz, Dept Parasitol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP Souza, AI (corresponding author), Inst Med Integral Prof Fernando Figueira, Programa Posgrad Stricto Sensu Saude Materno Infa, Recife, PE, Brazil.; Souza, AI (corresponding author), Fac Pernambucana Saude, Curso Med, Recife, PE, Brazil.
EM ariani@imip.org.br
RI Braga, Maria Cynthia/A-8204-2013; de Souza, Ariani
   Impieri/AAR-6884-2020; Souza, Ariani I/C-1568-2015; amsalu,
   ribka/G-8780-2019
OI Braga, Maria Cynthia/0000-0002-7862-6455; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Souza, Ariani I/0000-0002-7917-5983; 
CR Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Alvarenga CF, 2009, AM J INFECT DIS, V5, P288, DOI 10.3844/ajidsp.2009.288.293
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/J.JCV.2014.02.009, 10.1016/j.jcv.2014.02.009]
   Phongsamart W, 2008, PEDIATR INFECT DIS J, V27, P500, DOI 10.1097/INF.0b013e318167917a
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sinhabahu Vindika Prasad, 2014, BMC Res Notes, V7, P795, DOI 10.1186/1756-0500-7-795
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Wing DA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.006
NR 12
TC 1
Z9 1
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2016
VL 49
IS 3
BP 380
EP 382
DI 10.1590/0037-8682-0306-2015
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ6YW
UT WOS:000379354400021
PM 27384840
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, C
   de Albuquerque, MFPM
   Cordeiro, MT
   Castanha, PMS
   Ramesh, A
   Alexander, N
   de Mello, MJG
   Marques, ETA
   Martelli, CMT
AF Braga, Cynthia
   Pessoa Militao de Albuquerque, Maria de Fatima
   Cordeiro, Marli Tenorio
   Castanha, Priscila M. S.
   Ramesh, Anita
   Alexander, Neal
   de Mello, Maria Julia G.
   Marques, Ernesto T. A., Jr.
   Turchi Martelli, Celina M.
TI Prospective birth cohort in a hyperendemic dengue area in Northeast
   Brazil: methods and preliminary results
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Passive Immunization; Dengue; Cohort Studies
ID VIRUS-INFECTIONS; HEMORRHAGIC-FEVER; FOLLOW-UP; ANTIBODIES; INFANTS;
   SEROTYPES; RESPONSES
AB Dengue cases have increased in younger age groups in Brazil. Maternal anti-dengue antibodies can have a protective effect in the first months of life, but their decline can increase the risk of severe dengue. A prospective birth cohort was established in 2011-2012 in the city of Recife, Pernambuco State, Brazil, to determine the incidence of serotype-specific dengue infection and the kinetics of transferred maternal anti-dengue antibodies in the first years of life. This article describes the design, methods and preliminary results of this cohort study. 354 children underwent clinical and laboratory monitoring for two years, with 15% losses to follow-up. The overall rate of new infections was approximately 10% in the first year of follow-up. Information on the force of serotype-specific dengue infection and the evaluation of transferred maternal antibodies can contribute to understanding dengue etiopathogenesis.
C1 [Braga, Cynthia; Pessoa Militao de Albuquerque, Maria de Fatima; Cordeiro, Marli Tenorio; Castanha, Priscila M. S.; Marques, Ernesto T. A., Jr.; Turchi Martelli, Celina M.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Moraes Rego S-N, Recife, PE, Brazil.
   [Braga, Cynthia; de Mello, Maria Julia G.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Ramesh, Anita; Alexander, Neal] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Turchi Martelli, Celina M.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
RP Braga, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Moraes Rego S-N, Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013; Marques, Ernesto T. A/L-4967-2013; Da
   Silva Castanha, Priscila Mayrelle/G-1785-2012
OI Braga, Maria Cynthia/0000-0002-7862-6455; Marques, Ernesto T.
   A/0000-0003-3826-9358; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [304174/2014-9,
   308491/2013-0, 306489/2010-4]; United Kingdom Medical Research Council
   (MRC)Medical Research Council UK (MRC); Department for International
   Development (DFID) [MR/K012126/1]; Medical Research CouncilMedical
   Research Council UK (MRC) [MR/K012126/1] Funding Source: researchfish
FX The authors of this study would like to thank Dr. Clarence Tam and Dr.
   Lyda Osorio for their methodological input during the inception of this
   cohort. We would also like to thank the Brazilian National Research
   Council (CNPq), which provided financial support to C. Braga
   (304174/2014-9), M. F. P. M. Albuquerque (308491/2013-0), and C. M. T.
   Martelli (306489/2010-4). N. Alexander receives salary support from the
   United Kingdom Medical Research Council (MRC) and the Department for
   International Development (DFID) (MR/K012126/1).
CR [Anonymous], 2013, DENG DIAGN MAN CLIN
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183
   Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Kassanjee R, 2014, AIDS RES HUM RETROV, V30, P45, DOI [10.1089/aid.2013.0113, 10.1089/AID.2013.0113]
   Kirkwood B.R., 2003, ESSENTIAL MED STAT
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/J.JCV.2014.02.009, 10.1016/j.jcv.2014.02.009]
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V7, pe2126
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2009, DIAGN EV SER, V3
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133
   World Health Organization, 2012, GLOB STRAT DENG PREV
   Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357
NR 31
TC 5
Z9 5
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2016
VL 32
IS 1
AR e00095815
DI 10.1590/0102-311X00095815
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF7WY
UT WOS:000371569700005
PM 26886185
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU de Souza, WV
   de Araujo, TVB
   Albuquerque, MDPM
   Braga, MC
   Ximenes, RAD
   Miranda, DD
   Bezerra, LCA
   Dimech, GS
   de Carvalho, PI
   de Assuncao, RS
   Santos, RH
   de Oliveira, WK
   Rodrigues, LC
   Martelli, CMT
AF de Souza, Wayner Vieira
   Barreto de Araujo, Thalia Velho
   Militao Albuquerque, Maria de Fatima P.
   Braga, Maria Cynthia
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Albuquerque Bezerra, Luciana Caroline
   Dimech, George Santiago
   de Carvalho, Patricia Ismael
   de Assuncao, Romildo Siqueira
   Santos, Roselene Hans
   de Oliveira, Wanderson Kleber
   Rodrigues, Laura Cunha
   Turchi Martelli, Celina Maria
TI Microcephaly in Pernambuco State, Brazil: epidemiological
   characteristics and evaluation of the diagnostic accuracy of cutoff
   points for reporting suspected cases
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Microcephaly; Zika Virus Infection; Epidemiological Surveillance; Data
   Accuracy
AB The increase in the number of reported cases of microcephaly in Pernambuco State, and Northeast Brazil, characterized an epidemic that led the Brazilian Ministry of Health to declare a national public health emergency. The Brazilian Ministry of Health initially defined suspected cases as newborns with gestational age (GA) >= 37 weeks and head circumference (HC) <= 33cm, but in December 2015 this cutoff was lowered to 32cm. The current study aimed to estimate the accuracy, sensitivity, and specificity of different cutoff points for HC, using ROC curves, with the Fenton and Intergrowth (2014) curves as the gold standard. The study described cases reported in Pernambuco from August 8 to November 28, 2015, according to sex and GA categories. The Fenton and Intergrowth methods provide HC growth curves according to GA and sex, and microcephaly is defined as a newborn with HC below the 3rd percentile in these distributions. Of the 684 reported cases, 599 were term or post-term neonates. For these, the analyses with ROC curves show that according to the Fenton criterion the cutoff point with the largest area under the ROC curve, with sensitivity greater than specificity, is 32cm for both sexes. Using the Intergrowth method and following the same criteria, the cutoff points are 32cm and 31.5cm for males and females, respectively. The cutoff point identified by the Fenton method (32cm) coincided with the Brazilian Ministry of Health recommendation. Adopting Intergrowth as the standard, the choice would be 32cm for males and 31.5cm for females. The study identified the need to conduct critical and on-going analyses to evaluate cutoff points, including other characteristics for microcephaly case definition.
C1 [de Souza, Wayner Vieira; Militao Albuquerque, Maria de Fatima P.; Braga, Maria Cynthia; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Miranda-Filho, Democrito de Barros] Univ Pernambuco, Recife, PE, Brazil.
   [Albuquerque Bezerra, Luciana Caroline; Dimech, George Santiago; de Carvalho, Patricia Ismael; de Assuncao, Romildo Siqueira; Santos, Roselene Hans] Secretaria Estadual Saude Pernambuco, Secretaria Execut Vigilancia Saude, Recife, PE, Brazil.
   [de Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Rodrigues, Laura Cunha] Univ London, London Sch Hyg & Trop Med, London, England.
RP de Souza, WV (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, Ave Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM wayner@cpqam.fiocruz.br
RI Souza, Wayner V/H-3798-2013; Oliveira, Wanderson/AAF-5182-2019; Braga,
   Maria Cynthia/A-8204-2013
OI Oliveira, Wanderson/0000-0002-9662-1930; Braga, Maria
   Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Brazilian Ministry of Health; Pernambuco State Health Secretariat
   (SES-PE); Pan American Health Organization; National Council for
   Scientific and Technological Development - CNPqNational Council for
   Scientific and Technological Development (CNPq) [306489/2010-4,
   308311/2009-4, 308590/2013-9, 301779/2009-0, 304174/2014-9,
   306222/2013-2]; Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15088] Funding Source: researchfish
FX The authors wish to acknowledge the support of the Brazilian Ministry of
   Health, the Pernambuco State Health Secretariat (SES-PE), and the Pan
   American Health Organization. The authors received partial support from
   the National Council for Scientific and Technological Development - CNPq
   (grants 306489/2010-4 for C.M.T.M., 308311/2009-4 for R.A.A.X.,
   308590/2013-9 for D.B.M.F., 301779/2009-0 for M.F.P.M.A., 304174/2014-9
   for M.C.B., and 306222/2013-2 for W.V.S.). We also wish to thank Dr.
   Enrique Vazquez (Pan American Health Organization, Brasilia, Brazil) for
   his attentive reading of the manuscript and important suggestions.
CR Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   [Ministerio da Saude Secretaria de Vigilancia em Saude], 2015, PROC PREL SER AD VIG
   Ministerio da Saude, MIN SAUD CONF REL EN
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   [Secretaria Estadual de Saude Secretaria Executiva de Vigilancia em Saude], 2015, PROT CLIN EP INV CAS
   [Secretaria Estadual de Saude Secretaria Executiva de Vigilancia em Saude], 2015, 4315 SECR EX VIG SAU
   Sene A, 2015, DIARIO PERNAMBUCO
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 10
TC 3
Z9 3
U1 0
U2 54
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2016
VL 32
IS 4
AR e00017216
DI 10.1590/0102-311X00017216
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK7CJ
UT WOS:000375082200005
PM 27143306
OA DOAJ Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Ximenes, RAA
   Figueiredo, GM
   Cardoso, MRA
   Stein, AT
   Moreira, RC
   Coral, G
   Crespo, D
   dos Santos, AA
   Montarroyos, UR
   Braga, MC
   Pereira, LMMB
AF Ximenes, Ricardo A. A.
   Figueiredo, Gerusa M.
   Cardoso, Maria Regina A.
   Stein, Airton T.
   Moreira, Regina C.
   Coral, Gabriela
   Crespo, Deborah
   dos Santos, Alex A.
   Montarroyos, Ulisses R.
   Braga, Maria Cynthia
   Pereira, Leila M. M. B.
CA Hepatitis Study Grp
TI Population-Based Multicentric Survey of Hepatitis B Infection and Risk
   Factors in the North, South, and Southeast Regions of Brazil, 10-20
   Years after the Beginning of Vaccination
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RIO-DE-JANEIRO; VIRUS-INFECTION; UNITED-STATES; BLOOD-DONORS;
   PREVALENCE; EPIDEMIOLOGY; CHILDREN; MARKERS; HEALTH; HIV
AB A population-based hepatitis survey was carried out to estimate the prevalence of hepatitis B virus (HBV) infection and its predictive factors for the state capitals from the north, south, and southeast regions of Brazil. A multistage cluster sampling was used to select, successively, census tracts, blocks, households, and residents in the age group 10-69 years in each state capital. The prevalence of hepatitis B surface antigen (HBsAg) was lower than 1% in the north, southeast, and south regions. Socioeconomic condition was associated with HBV infection in north and south regions. Variables related to the blood route transmission were associated with HBV infection only in the south whereas those related to sexual behavior were associated with HBV infection in the north and south regions. Drug use was associated in all regions, but the type of drug differed. The findings presented herein highlight the diversity of the potential transmission routes for hepatitis B transmission in Brazil. In one hand, it reinforces the importance of national control strategies of large impact already in course (immunization of infants, adolescents, and adults up to 49 years of age and blood supply screening). On the other hand, it shows that there is still room for further control measures targeted to different groups within each region.
C1 [Ximenes, Ricardo A. A.] Univ Pernambuco, Hosp Univ Oswaldo Cruz, Fac Ciencias Med Pernambuco, BR-50100130 Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [Figueiredo, Gerusa M.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Cardoso, Maria Regina A.] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, Brazil.
   [Stein, Airton T.; Coral, Gabriela] Fundacao Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil.
   [Moreira, Regina C.] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Crespo, Deborah] Secretaria Saude Publ Estado Para, Belem, Para, Brazil.
   Inst Bioestat, Belem, Para, Brazil.
   [Montarroyos, Ulisses R.] Univ Pernambuco, Inst Ciencias Biol, BR-50100130 Recife, PE, Brazil.
   [Braga, Maria Cynthia] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Pereira, Leila M. M. B.] Inst Figado Pernambuco, Recife, PE, Brazil.
   [dos Santos, Alex A.] Inst Bioestat IBCT, Belem, Para, Brazil.
RP Ximenes, RAA (corresponding author), Univ Pernambuco, Hosp Univ Oswaldo Cruz, Fac Ciencias Med Pernambuco, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM raaximenes@uol.com.br; gfigueiredo@usp.br; rcardoso@usp.br;
   astein@via-rs.net; regina.moreira7@gmail.com; g.coral@terra.com.br;
   dcrespo@amazon.com.br; bioestat4@yahoo.com.br;
   ulisses_montarroyos@yahoo.com.br; braga@cpqam.fiocruz.br;
   leilapereira@pq.cnpq.br
RI Montarroyos, Ulisses/AAJ-7527-2020; AT, Stein/AAD-8391-2020; Figueiredo,
   Gerusa M/B-6660-2014; Stein, Airton T/E-3333-2010; Moreira, Regina
   C/B-1488-2016; Braga, Maria Cynthia/A-8204-2013; Stein,
   Airton/Q-2218-2015
OI AT, Stein/0000-0002-8756-8699; Figueiredo, Gerusa M/0000-0001-9657-9675;
   Stein, Airton T/0000-0002-8756-8699; Moreira, Regina
   C/0000-0002-8208-8776; Braga, Maria Cynthia/0000-0002-7862-6455; Stein,
   Airton/0000-0002-8756-8699; Miranda, Angelica/0000-0002-5556-8379
CR Al-Faleh FZ, 1999, J INFECTION, V38, P167, DOI 10.1016/S0163-4453(99)90245-1
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602
   Ximenes RAD, 2010, CAD SAUDE PUBLICA, V26, P1693, DOI 10.1590/S0102-311X2010000900003
   de Matos MAD, 2013, MEM I OSWALDO CRUZ, V108, P386, DOI 10.1590/S0074-02762013000300019
   Diel R, 2005, MED MICROBIOL IMMUN, V194, P193, DOI 10.1007/s00430-005-0237-6
   El Khouri Marcelo, 2005, Clinics, V60, P29, DOI 10.1590/S1807-59322005000100007
   Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206
   Lewis-Ximenez LL, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-26
   Liang Jian-hua, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1336
   Luna EJA, 2009, VACCINE, V27, P5326, DOI 10.1016/j.vaccine.2009.06.096
   McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14
   Ministerio da Saude, 2003, 30 AN PNI DEVEP SVS
   Miranda AE, 2008, AIDS BEHAV, V12, pS25, DOI 10.1007/s10461-008-9378-0
   Braga WSM, 2012, REV SOC BRAS MED TRO, V45, P13, DOI 10.1590/S0037-86822012000100004
   Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046
   Ni YH, 2001, ANN INTERN MED, V135, P796, DOI 10.7326/0003-4819-135-9-200111060-00009
   Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P1107, DOI 10.1590/S0100-879X1999000900009
   Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Patavino GM, 2012, TRANSFUSION, V52, P151, DOI 10.1111/j.1537-2995.2011.03248.x
   Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60
   Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240
   Pereira RARD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-34
   Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009
   Silveira T R, 1999, Rev Panam Salud Publica, V6, P378
   Souto FJD, 1997, ANN TROP MED PARASIT, V91, P411, DOI 10.1080/00034989761030
   Souto FJD, 1999, GASTROENTEROL ENDOSC, V18, P143
   Souza Milta Gomes de, 2004, Rev. Soc. Bras. Med. Trop., V37, P391, DOI 10.1590/S0037-86822004000500004
   Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1
   Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622
   Wu H X, 2005, Int J Med Sci, V2, P143
   Wu Hao, 2010, Clin Liver Dis, V14, P61, DOI 10.1016/j.cld.2009.11.012
   Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3
NR 34
TC 20
Z9 20
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2015
VL 93
IS 6
BP 1341
EP 1348
DI 10.4269/ajtmh.15-0216
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CY6TD
UT WOS:000366540800036
PM 26503280
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Castanha, PMD
   Nascimento, EJ
   Cordeiro, MT
   Souza, AI
   Silva, CD
   Panhuis, WG
   Martelli, CT
   Marques, ET
   Braga, C
AF Da Silva Castanha, Priscila M.
   Nascimento, Eduardo J.
   Cordeiro, Marli T.
   Souza, Ariani I.
   Silva, Claudeir D., Jr.
   Panhuis, Willem G.
   Martelli, Celina T.
   Marques, Ernesto T., Jr.
   Braga, Cynthia
TI INFLUENCE OF MATERNAL IGG PROFILE ON PLACENTAL TRANSFER OF DENGUE
   VIRUS-SPECIFIC ANTIBODIES TO NEONATES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Da Silva Castanha, Priscila M.; Cordeiro, Marli T.; Braga, Cynthia] Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Nascimento, Eduardo J.; Marques, Ernesto T., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Souza, Ariani I.; Silva, Claudeir D., Jr.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Panhuis, Willem G.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Martelli, Celina T.] Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
RI de Souza, Ariani Impieri/AAR-6884-2020; Braga, Maria
   Cynthia/A-8204-2013; Marques, Ernesto T. A/L-4967-2013
OI de Souza, Ariani Impieri/0000-0002-7917-5983; Braga, Maria
   Cynthia/0000-0002-7862-6455; Marques, Ernesto T. A/0000-0003-3826-9358
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 150
BP 45
EP 46
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844101150
DA 2020-12-01
ER

PT J
AU Martelli, CMT
   Siqueira, JB
   Parente, MPPD
   Zara, ALDA
   Oliveira, CS
   Braga, C
   Pimenta, FG
   Cortes, F
   Lopez, JG
   Bahia, LR
   Mendes, MCO
   da Rosa, MQM
   de Siqueira, NT
   Constenla, D
   de Souza, WV
AF Turchi Martelli, Celina Maria
   Siqueira Junior, Joao Bosco
   Palha Dias Parente, Mirian Perpetua
   de Sene Amancio Zara, Ana Laura
   Oliveira, Consuelo Silva
   Braga, Cynthia
   Pimenta Junior, Fabiano Geraldo
   Cortes, Fanny
   Guillermo Lopez, Juan
   Bahia, Luciana Ribeiro
   Ooteman Mendes, Marcia Costa
   Machado da Rosa, Michelle Quarti
   de Siqueira Filha, Noemia Teixeira
   Constenla, Dagna
   de Souza, Wayner Vieira
TI Economic Impact of Dengue: Multicenter Study across Four Brazilian
   Regions
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GLOBAL BURDEN; AMERICA; HEALTH; SURVEILLANCE; HISTORY; DISEASE
AB Background
   Dengue is an increasing public health concern in Brazil. There is a need for an updated evaluation of the economic impact of dengue within the country. We undertook this multicenter study to evaluate the economic burden of dengue in Brazil.
   Methods
   We estimated the economic burden of dengue in Brazil for the years 2009 to 2013 and for the epidemic season of August 2012-September 2013. We conducted a multicenter cohort study across four endemic regions: Midwest, Goiania; Southeast, Belo Horizonte and Rio de Janeiro; Northeast: Teresina and Recife; and the North, Belem. Ambulatory or hospitalized cases with suspected or laboratory-confirmed dengue treated in both the private and public sectors were recruited. Interviews were scheduled for the convalescent period to ascertain characteristics of the dengue episode, date of first symptoms/signs and recovery, use of medical services, work/school absence, household spending (out-of-pocket expense) and income lost using a questionnaire developed for a previous cost study. We also extracted data from the patients' medical records for hospitalized cases. Overall costs per case and cumulative costs were calculated from the public payer and societal perspectives. National cost estimations took into account cases reported in the official notification system (SINAN) with adjustment for underreporting of cases. We applied a probabilistic sensitivity analysis using Monte Carlo simulations with 90% certainty levels (CL).
   Results
   We screened 2,223 cases, of which 2,035 (91.5%) symptomatic dengue cases were included in our study. The estimated cost for dengue for the epidemic season (2012-2013) in the societal perspective was US$ 468 million (90% CL: 349-590) or US$ 1,212 million (90% CL: 904-1,526) after adjusting for under-reporting. Considering the time series of dengue (2009-2013) the estimated cost of dengue varied from US$ 371 million (2009) to US$ 1,228 million (2013).
   Conclusions
   The economic burden associated with dengue in Brazil is substantial with large variations in reported cases and consequently costs reflecting the dynamic of dengue transmission.
C1 [Turchi Martelli, Celina Maria; Braga, Cynthia; de Souza, Wayner Vieira] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Dept Publ Hlth, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria; Siqueira Junior, Joao Bosco; de Sene Amancio Zara, Ana Laura] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil.
   [Palha Dias Parente, Mirian Perpetua] Univ Estadual Piaui, Dept Community Hlth, Teresina, Brazil.
   [Oliveira, Consuelo Silva] Univ Estado Para, Belem, Para, Brazil.
   [Pimenta Junior, Fabiano Geraldo; Ooteman Mendes, Marcia Costa] Secretaria Municipal Saude Belo Horizonte, Dept Hlth Surveillance, Belo Horizonte, MG, Brazil.
   [Cortes, Fanny] Univ Pernambuco, Dept Hlth Sci, Recife, PE, Brazil.
   [Guillermo Lopez, Juan] Sanofi Pasteur Latin Amer, Hlth Econ & Market Access, Mexico City, DF, Mexico.
   [Bahia, Luciana Ribeiro; Machado da Rosa, Michelle Quarti] Univ Estado Rio De Janeiro, Dept Internal Med, Rio De Janeiro, Brazil.
   [de Siqueira Filha, Noemia Teixeira] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.
   [Constenla, Dagna] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
RP Martelli, CMT (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Dept Publ Hlth, Recife, PE, Brazil.
EM turchicm@gmail.com
RI Souza, Wayner V/H-3798-2013; de Sene Amancio Zara, Ana
   Laura/P-3993-2019; Zara, Ana Laura S. A./C-3952-2018; Braga, Maria
   Cynthia/A-8204-2013
OI de Sene Amancio Zara, Ana Laura/0000-0001-7012-9078; Zara, Ana Laura S.
   A./0000-0001-7012-9078; Braga, Maria Cynthia/0000-0002-7862-6455; Souza,
   Wayner/0000-0002-0939-9332; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Sanofi Pasteur; CNPqNational Council for Scientific and Technological
   Development (CNPq) [306489/2010-4, 305947/20060]; CNPq/IATS
FX Funding for this Study was provided by Sanofi Pasteur. CMTM and WVdS
   received fellowship grants (CNPq# 306489/2010-4, #305947/20060). CMTM,
   WVdS, CB, and JBSB are research members of the National Institute of
   Science and Technology for Health Technology Assessment (IATS). ALdSAZ,
   FC and NTdSF received scholarships from CNPq/IATS. CMTM, ALdSAZ, MPPDP,
   FC, NTdSF, FGJP, MCOM, LRB, MQMdR, CSO, CB, and JBSJ received funds to
   their institutes from Sanofi Pasteur to support their work in the
   Multicenter Cost Study. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2009, DIR NAC PREV CONTR E
   Armien B, 2012, COSTING DENGUE CASES
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Analise de Situacao em saude, 2013, SAUD BRAS 2012 AN SI, P189
   Butchart A, 2015, MANUAL ESTIMATING EC
   Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002
   Carvalho Déa Mara Tarbes de, 2007, Ciênc. saúde coletiva, V12, P879, DOI 10.1590/S1413-81232007000400010
   Drummond M., 2005, METHODS EC EVALUATIO
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Cuong HQ, 2013, EMERG INFECT DIS, V19, P945, DOI 10.3201/eid1906.121323
   IBGE, 2010, CENS 2010
   Instituto Brasileiro de Geografia e Estatistica, 2013, PESQ MENS EMPR 2013, V2013, P32
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Ministerio da Saude (Brasil), 2014, SIGTAP SIST GER TAB
   Ministry of Health (Brazil), 2014, DENG DIAGN CLIN HAND
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Prefeitura Municipal de Belo Horizonte, 2013, DIARIO OFICIAL MUNIC, P4279
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   Santos IS, 2008, CIENC SAUDE COLETIVA, V13, P1431, DOI 10.1590/S1413-81232008000500009
   Sculpher M, 2001, EC EVALUATION HLTH C, P94
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Suaya JA, 2006, TDRSWG08 WHO, VTDR/SWG/08
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2012, GLOB STRAT DENG PREV
NR 34
TC 30
Z9 32
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2015
VL 9
IS 9
AR e0004042
DI 10.1371/journal.pntd.0004042
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CT7YI
UT WOS:000363031200028
PM 26402905
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Vasconcelos, MP
   Braga, C
   Gouveia, GC
   de Souza, WV
AF de Vasconcelos, Marina Pereira
   Braga, Cynthia
   Gouveia, Giselle Campozana
   de Souza, Wayner Vieira
TI Pilgrimages in Juazeiro do Norte, Ceara, Brazil: profile of demand for
   healthcare assistance and seasonality of hospitalizations
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA Portuguese
DT Article
DE Morbidity; Health Services Accessibility; Temporal Distribution;
   Epidemiology; Descriptive
AB Objective: to describe the morbidity pattern among pilgrims and investigate seasonal hospitalization variation in periods of pilgrimage in Juazeiro do Norte, Ceara, Brazil. Methods: a cross-sectional study with medical assistance data during the November 2nd 2012, All Soul's Day pilgrimage; and an ecological time series study to investigate hospitalization seasonality between 2007 and 2012; seasonal indexes (SI) were calculated. Results: among the 377 assisted pilgrims, most of them were more than 55 years old (53.5%) and looked for medical assistance to measure blood pressure (71.1%); seasonal hospitalization increase was observed for respiratory diseases in April (SI=1.40, 95% CI 1.13-1.67), May (SI=1.21; 95% CI 1.03-1.40) and June (IS=1.30; 95% CI 1.04-1.55), and for circulatory diseases in June (SI=1.23; 95% CI 1.16-1.31), July (SI=1.15; 95% CI 1.06-1,24) and August (SI=1.09; 95% CI 1.06-1.11). Conclusion: the morbidity pattern with prevalence of circulatory diseases was compatible with the age of pilgrims; there was no increase in hospitalizations in the period of pilgrimage.
C1 [de Vasconcelos, Marina Pereira] Secretaria Municipal Saude, Dept Vigilancia Sanit, Juazeiro Do Norte, CE, Brazil.
   [Braga, Cynthia; Gouveia, Giselle Campozana; de Souza, Wayner Vieira] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Prof Moraes Rego S-N,Campus UFPE, BR-50670420 Recife, PE, Brazil.
RP Braga, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Prof Moraes Rego S-N,Campus UFPE, BR-50670420 Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Souza, Wayner V/H-3798-2013; Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
CR Al-Ghamdi SM, 2003, SAUDI MED J, V24, P1073
   Al-Tawfiq JA, 2013, E MEDITERR HEALTH J, V19, pS48
   Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005
   Alzahrani AG, J INFECT PUBLIC HLTH
   [Anonymous], 2012, HUFF POST RELIG
   Arguin PM, 2009, EMERG INFECT DIS, V15, P1713, DOI 10.3201/eid1511.091426
   Balaban V, 2012, J TRAVEL MED, V19, P163, DOI 10.1111/j.1708-8305.2012.00602.x
   Duarte EC, 2012, EPIDEMIOL SERV SAUDE, V21, P529, DOI 10.5123/S1679-49742012000400001
   Emamian MH, 2013, IRAN RED CRESCENT ME, V15, P317, DOI 10.5812/ircmj.3681
   Gautret P, 2009, J TRAVEL MED, V16, P377, DOI 10.1111/j.1708-8305.2009.00358.x
   GUIMARAES F. N., 1947, Memorias do Instituto Oswaldo Cruz, V45, P211, DOI 10.1590/S0074-02761947000100012
   Instituto Brasileiro de Geografia e Estatistica, 2010, CID JUAZ NORT CE CEN
   Karami M, IRAN J PUBLIC HLTH
   Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9
   Khan NA, 2015, SAUDI MED J, V36, P962
   Latorre M., 2001, REV BRAS EPIDEMIOL, V4, P145, DOI [DOI 10.1590/S1415-790X2001000300002, 10.1590/S1415-790X2001000300002]
   Madani TA, 2006, ANN SAUDI MED, V26, P346, DOI 10.5144/0256-4947.2006.346
   Memish ZA, 2003, INT J ANTIMICROB AG, V21, P96, DOI 10.1016/S0924-8579(02)00364-3
   Ministerio do Turismo (BR), 2013, TIP DE TUR
   Pane M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073243
   Polkinghorne BG, 2013, PUBLIC HEALTH, V127, P32, DOI 10.1016/j.puhe.2012.09.014
   da Silva JLR, 2011, J BRAS PNEUMOL, V37, P759, DOI 10.1590/S1806-37132011000600009
   Santos D., 2013, MILHARES SE UNEM ORA
   Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1
   Steffen R, 2013, THER UMSCH, V70, P350, DOI 10.1024/0040-5930/a000415
   Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6
   Teixeira MSG, 2013, TURISMO RELIG ALTERN
   World Health Organization, 2009, INT PLANN CONS MASS
NR 28
TC 5
Z9 5
U1 0
U2 1
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PD JAN-MAR
PY 2015
VL 24
IS 1
BP 39
EP 48
DI 10.5123/S1679-49742015000100005
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VE5UM
UT WOS:000439656100005
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Martelli, CMT
   Zara, ALSA
   Oliveira, CS
   Braga, C
   Pimenta, FGJ
   Cortes, FJM
   Siqueira, JBJ
   Bahia, LR
   Mendes, MCO
   Rosa, MQM
   Parente, MPPD
   Siqueira, NTF
   Souza, WV
AF Martelli, C. M. T.
   Zara, A. L. S. A.
   Oliveira, C. S.
   Braga, C.
   Pimenta, F. G. J.
   Cortes, F. J. M.
   Siqueira, J. B. J.
   Bahia, L. R.
   Mendes, M. C. O.
   Rosa, M. Q. M.
   Parente, M. P. P. D.
   Siqueira, N. T. F.
   Souza, W., V
TI ECONOMIC IMPACT OF DENGUE EPISODE: MULTICENTER STUDY ACROSS FOUR
   BRAZILIAN REGIONS
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Martelli, C. M. T.; Braga, C.; Cortes, F. J. M.; Siqueira, N. T. F.; Souza, W., V] Fundacao Oswaldo Cruz CPqAM Pernambuco, Recife, PE, Brazil.
   [Zara, A. L. S. A.; Siqueira, J. B. J.] Univ Fed Goias, Goiania, Go, Brazil.
   [Oliveira, C. S.] Univ Estado Para, Belem, Para, Brazil.
   [Pimenta, F. G. J.; Mendes, M. C. O.] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil.
   [Bahia, L. R.; Rosa, M. Q. M.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
   [Parente, M. P. P. D.] Univ Estadual Piaui, Teresina, Brazil.
RI de Sene Amancio Zara, Ana Laura/P-3993-2019; Zara, Ana Laura S.
   A./C-3952-2018; Braga, Maria Cynthia/A-8204-2013
OI de Sene Amancio Zara, Ana Laura/0000-0001-7012-9078; Zara, Ana Laura S.
   A./0000-0001-7012-9078; Braga, Maria Cynthia/0000-0002-7862-6455
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD NOV
PY 2014
VL 17
IS 7
MA PIN28
BP A668
EP A668
DI 10.1016/j.jval.2014.08.2469
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA AX4QT
UT WOS:000346917303016
PM 27202443
OA Bronze
DA 2020-12-01
ER

PT J
AU de Lyra, JMA
   Maruza, M
   Verza, M
   Carneiro, MM
   de Albuquerque, MDM
   Rossetti, ML
   Ximenes, R
   Braga, MC
   Lucena-Silva, N
AF Azevedo de Lyra, Juliana Maria
   Maruza, Magda
   Verza, Mirela
   Carneiro, Maria Madileuza
   Militao de Albuquerque, Maria de Fatima
   Rossetti, Maria Lucia
   Ximenes, Ricardo
   Braga, Maria Cynthia
   Lucena-Silva, Norma
TI Evaluation of four molecular methods for the diagnosis of tuberculosis
   in pulmonary and blood samples from immunocompromised patients
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE tuberculosis; paucibacillary; Gen-Probe; Detec-TB; real-time PCR
ID POLYMERASE-CHAIN-REACTION; XPERT MTB/RIF ASSAY; TIME PCR ASSAY;
   MYCOBACTERIUM-TUBERCULOSIS; AMPLIFICATION TESTS; SMEAR; CULTURE;
   METAANALYSIS; ACCURACY; IS6110
AB The present study analysed the concordance among four different molecular diagnostic methods for tuberculosis (TB) in pulmonary and blood samples from immunocompromised patients. A total of 165 blood and 194 sputum samples were collected from 181 human immunodeficiency virus (HIV)-infected patients with upper respiratory complaints, regardless of suspicious for TB. The samples were submitted for smear microscopy, culture and molecular tests: a laboratory-developed conventional polymerase chain reaction (PCR) and real-time quantitative PCR (qPCR) and the Gen-Probe and Detect-TB Ampligenix kits. The samples were handled blindly by all the technicians involved, from sample processing to results analysis. For sputum, the sensitivity and specificity were 100% and 96.7% for qPCR, 81.8% and 94.5% for Gen-Probe and 100% and 66.3% for Detect-TB, respectively. qPCR presented the best concordance with sputum culture [kappa (k) = 0.864)], followed by Gen-Probe (k = 0.682). For blood samples, qPCR showed 100% sensitivity and 92.3% specificity, with a substantial correlation with sputum culture (k = 0.754) and with the qPCR results obtained from sputum of the corresponding patient (k = 0.630). Conventional PCR demonstrated the worst results for sputa and blood, with a sensitivity of 100% vs. 88.9% and a specificity of 46.3% vs. 32%, respectively. Commercial or laboratory-developed molecular assays can overcome the difficulties in the diagnosis of TB in paucibacillary patients using conventional methods available in most laboratories.
C1 [Azevedo de Lyra, Juliana Maria; Lucena-Silva, Norma] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Imunol, Recife, PE, Brazil.
   [Militao de Albuquerque, Maria de Fatima] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Saude Publ, Recife, PE, Brazil.
   [Braga, Maria Cynthia] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Parasitol, Recife, PE, Brazil.
   [Maruza, Magda] Secretaria Estado Pernambuco, Hosp Correia Picanco, Recife, PE, Brazil.
   [Carneiro, Maria Madileuza] Secretaria Estado Pernambuco, Lab Cent Pernambuco, Recife, PE, Brazil.
   [Verza, Mirela; Rossetti, Maria Lucia] Fundacao Estadual Producao & Pesquisa Saude, Porto Alegre, RS, Brazil.
   [Rossetti, Maria Lucia] Univ Luterana Brasil, Porto Alegre, RS, Brazil.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
RP de Lyra, JMA (corresponding author), Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Imunol, Recife, PE, Brazil.
EM juli_lyra@hotmail.com
RI Lucena-Silva, Norma/AAH-9437-2019; Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
CR Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345
   Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001
   Al Zahrani K, 2001, INT J TUBERC LUNG D, V5, P855
   Al-Darraji HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073717
   Almeda J, 2000, EUR J CLIN MICROBIOL, V19, P859, DOI 10.1007/s100960000375
   Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10
   Balcells ME, 2012, INT J TUBERC LUNG D, V16, P1349, DOI 10.5588/ijtld.12.0156
   Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8
   Bollela VR, 1999, REV SAUDE PUBL, V33, P281, DOI 10.1590/S0034-89101999000300009
   Burroughs M, 1999, PEDIATR INFECT DIS J, V18, P440, DOI 10.1097/00006454-199905000-00008
   Carriquiry G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044626
   Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005
   Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243
   Davis JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016321
   Feasey NA, 2013, J CLIN MICROBIOL, V51, P2311, DOI 10.1128/JCM.00330-13
   Gomez DI, 2011, TUBERCULOSIS, V91, pS43, DOI 10.1016/j.tube.2011.10.009
   Hida Y, 2012, J CLIN MICROBIOL, V50, P3604, DOI 10.1128/JCM.01654-12
   Huyen MNT, 2013, INT J TUBERC LUNG D, V17, P1479, DOI 10.5588/ijtld.13.0149
   Kivihya-Ndugga L, 2004, J CLIN MICROBIOL, V42, P1012, DOI 10.1128/JCM.42.3.1012-1015.2004
   Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2
   Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067
   Lira LAS, 2013, J APPL MICROBIOL, V114, P1103, DOI 10.1111/jam.12119
   de Albuquerque YMM, 2014, REV INST MED TROP SP, V56, P139, DOI 10.1590/S0036-46652014000200009
   MCADAM RA, 1990, MOL MICROBIOL, V4, P1607, DOI 10.1111/j.1365-2958.1990.tb02073.x
   Michelon CT, 2011, MEM I OSWALDO CRUZ, V106, P194, DOI 10.1590/S0074-02762011000200013
   Nakiyingi L, 2013, AFR HEALTH SCI, V13, P522, DOI 10.4314/ahs.v13i2.46
   O'Donnell N, 2012, BRIT J BIOMED SCI, V69, P164, DOI 10.1080/09674845.2012.12069146
   O'Grady J, 2012, CLIN INFECT DIS, V55, P1171, DOI 10.1093/cid/cis631
   Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6
   Papaventsis D, 2012, INT J TUBERC LUNG D, V16, P384, DOI 10.5588/ijtld.11.0276
   Park KS, 2013, J CLIN MICROBIOL, V51, P3225, DOI 10.1128/JCM.01335-13
   Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966
   Portillo-Gomez L, 2000, INT J TUBERC LUNG D, V4, P361
   Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088626
   RICHELDI L, 1995, EUR RESPIR J, V8, pS689
   Roberts SA, 2012, DIAGN MICR INFEC DIS, V74, P415, DOI 10.1016/j.diagmicrobio.2012.08.007
   Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003
   Scherer LC, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-15
   Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061
   Silva MR, 2012, BRAZ J MICROBIOL, V43, P261
   Smith KC, 1996, PEDIATRICS, V97, P155
   Sperhacke RD, 2004, INT J TUBERC LUNG D, V8, P312
   Syre H, 2009, J CLIN MICROBIOL, V47, P3635, DOI 10.1128/JCM.00411-09
   Theron G, 2013, THORAX, V68, P1043, DOI 10.1136/thoraxjnl-2013-203485
   THIERRY D, 1990, NUCLEIC ACIDS RES, V18, P188, DOI 10.1093/nar/18.1.188
   VLASPOLDER F, 1995, J CLIN MICROBIOL, V33, P2699, DOI 10.1128/JCM.33.10.2699-2703.1995
   Walusimbi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-507
   *WHO, 2008, GLOB TUB CONTR SURV
NR 48
TC 5
Z9 5
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2014
VL 109
IS 6
BP 805
EP 813
DI 10.1590/0074-0276130542
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AR5CZ
UT WOS:000343604100015
PM 25317709
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Salvi, CCB
   Braga, MC
   Batista, M
AF Bresani Salvi, Cristiane C.
   Braga, Maria Cynthia
   Batista Filho, Malaquias
TI Diagnostic accuracy of hemoglobin for iron deficiency in pregnancy:
   disclosing results of a cited clinical trial
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Anemia, iron-deficiency; pregnancy; erythrocyte indices; sensitivity and
   specificity; clinical trial; Brazil
ID SERUM FERRITIN; BIRTH-WEIGHT; ANEMIA; WOMEN; SUPPLEMENTATION;
   PREDICTION; INDEXES
AB Objective. To analyze the accuracy of hemoglobin (Hb) concentrations as a diagnostic indicator of iron deficiency in pregnant women and to measure the efficacy of oral iron therapy using Hb z-scores rather than Hb absolute values.
   Methods. The sensitivity and specificity of Hb < 11.0 g/dL, and its receiver operating characteristic (ROC) curve, in the diagnosis of iron deficiency (serum ferritin (SF) < 12.0 ng/mL) were determined in 318 women in their second trimester of pregnancy who had been screened for a clinical trial conducted in 2001 in Northeast Brazil. A secondary analysis of iron therapy efficacy was carried out using data from the trial's three different treatments (60 mg of oral iron once per week (n = 46), twice per week (n = 50), and once per day (n = 44)). The mean differences between post-and pre-treatment Hb absolute values (g/dL) and z-scores (standard deviation (SD)) were calculated for the three treatment groups for study participants with and without iron deficiency.
   Results. Hb sensitivity, specificity, and area under the ROC curve were 60.7%, 44.3%, and 0.54 respectively. Women without iron deficiency showed improvements in Hb absolute values (as in the clinical trial's overall results) but did not have improved Hb z-scores (with scores of -0.6 SD (95% confidence interval (CI): -0.99, -0.28); -0.2 SD (95% CI: -0.47, 0.08); and -0.1 SD (95% CI: -0.33, 0.18) for weekly, twice-per-week, and daily iron treatment schemes respectively). In contrast, iron-deficient women treated with the intermittent schemes had reductions in both Hb absolute values and Hb z-scores, respectively: weekly = -0.42 g/dL (95% CI: -0.72, -0.12) and -1.4 SD (95% CI: -1.74, -0.99); twice per week = -0.14 g/dL (95% CI: -0.46, 0.17) and -1.1 SD (95% CI: -1.44, -0.75).
   Conclusions. These analyses revealed that Hb concentrations were not an accurate indicator of either iron needs or iron-therapy response in pregnant women.
C1 [Bresani Salvi, Cristiane C.] Inst Med Integral Prof Fernando Figueira, Nutr Res Grp, Recife, PE, Brazil.
   [Braga, Maria Cynthia] Inst Med Integral Prof Fernando Figueira, Postgrad Program Maternal & Child Hlth, Recife, PE, Brazil.
   [Batista Filho, Malaquias] Fundacao Oswaldo Cruz, Postgrad Program Publ Hlth, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP Salvi, CCB (corresponding author), Inst Med Integral Prof Fernando Figueira, Nutr Res Grp, Recife, PE, Brazil.
EM cristiane.bresani@inss.gov.br
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
CR Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s
   Beaton G, 1999, EFFICACY INTERMITTEN
   Bendell J, 2005, HEMATOLOGY BASIC PRI, P2629
   Bresani CC, 2007, THESIS I MED INTEGRA
   Bresani CC, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-13
   Cao C, 2013, NUTR REV, V71, P35, DOI 10.1111/j.1753-4887.2012.00550.x
   Casanova BF, 2005, AM J OBSTET GYNECOL, V193, P460, DOI 10.1016/j.ajog.2004.12.008
   Cogswell ME, 2003, AM J CLIN NUTR, V78, P773
   Cortes MH, 2009, REV NUTR, V22, P409, DOI 10.1590/S1415-52732009000300011
   de Souza AI, 2009, CAD SAUDE PUBLICA, V25, P1225, DOI 10.1590/S0102-311X2009000600005
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1257/jep.15.4.143
   KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643
   Mei ZG, 2005, J NUTR, V135, P1974
   Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195
   Milman N, 2000, ACTA OBSTET GYN SCAN, V79, P89, DOI 10.1034/j.1600-0412.2000.079002089.x
   Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2
   Mumtaz Z, 2000, J NUTR, V130, P2697
   MURPHY JF, 1986, LANCET, V1, P992
   Pavord S, 2012, BRIT J HAEMATOL, V156, P588, DOI 10.1111/j.1365-2141.2011.09012.x
   Puolakka J, 1980, ACTA OBSTET GYNECO S, V95, pS57
   Rasmussen KM, 2001, J NUTR, V131, p590S, DOI 10.1093/jn/131.2.590S
   Reveiz L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003094.pub3
   Roberfroid D, 2011, AM J CLIN NUTR, V93, P1012, DOI 10.3945/ajcn.110.006239
   Scholl TO, 2000, J NUTR, V130, p443S, DOI 10.1093/jn/130.2.443S
   Souza Ariani Impieri de, 2004, Rev Panam Salud Publica, V15, P313
   STEER P, 1995, BRIT MED J, V310, P489, DOI 10.1136/bmj.310.6978.489
   Stoltzfus RJ, 2003, FOOD NUTR BULL, V24, pS99, DOI [10.1177/15648265030244S206, DOI 10.1177/15648265030244S206]
   Szarfarc SC, 2010, REV BRAS HEMATOL S2, V32, pS2
   Tam KF, 1999, OBSTET GYNECOL, V93, P427, DOI 10.1016/S0029-7844(98)00422-0
   THOMPSON WG, 1988, AM J OBSTET GYNECOL, V159, P1132, DOI 10.1016/0002-9378(88)90429-2
   van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x
   VANBUUL EJA, 1995, NETH J MED, V46, P73, DOI 10.1016/0300-2977(94)00104-H
   Volpi E, 1991, Minerva Ginecol, V43, P387
   Walker P, 2000, 395 FAO FISH
   WHO, 2008, WORLDWIDE PREVALENCE
   WHO, 2011, HAEM CONC DIAGN AN A
   World Health Organization, 1975, WHO TECHN REP SER, V580
   World Health Organization, 2011, SER FERR CONC ASS IR
   World Health Organization, 2001, IR DEF AN ASS PREV C
   World Health Organization Regional Office for Europe; United Nation's Children's Fund Regional Office for Central and Eastern Europe the Commonwealth of Independence States and the Baltic States, 1999, UNICEF WHO REG CONS
   Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S
   Yip R, 1998, MMWR RECOMM REP, V47, P1
NR 43
TC 1
Z9 1
U1 0
U2 6
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD AUG
PY 2014
VL 36
IS 2
BP 110
EP 116
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AS8AR
UT WOS:000344473400006
PM 25345532
DA 2020-12-01
ER

PT J
AU Leite, RC
   Souza, AI
   Castanha, PMS
   Cordeiro, MT
   Martelli, CT
   Ferreira, ALG
   Katz, L
   Braga, C
AF Leite, Rachel C.
   Souza, Ariani I.
   Castanha, Priscila M. S.
   Cordeiro, Marli T.
   Martelli, Celina T.
   Ferreira, Ana Laura G.
   Katz, Leila
   Braga, Cynthia
TI Dengue infection in pregnancy and transplacental transfer of anti-dengue
   antibodies in Northeast, Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Dengue virus; Epidemiology; Pregnancy; Prevalence; Vertical infectious
ID HEMORRHAGIC-FEVER; MATERNAL DENGUE; RISK-FACTORS; VIRUS; REEMERGENCE;
   PREVALENCE; EPIDEMIC; DYNAMICS; OUTCOMES
AB Background: Dengue affects nearly 400 million people annually worldwide and considered one of the most serious health threats in tropical and subtropical countries.
   Objective: To analyze the occurrence of dengue infection among the parturient who have formed the baseline of an ongoing birth cohort study in the city of Recife, Northeast of Brazil. Study design: From March 2011 to May 2012, we recruited 417 parturients with low-risk pregnancies at maternity ward who agreed to a follow-up of their babies. Dengue infection was accessed through DENVRT-PCR and anti-dengue antibodies (IgM and IgG). The prevalence of IgG antibodies in the parturients and their concepts were determined. The concordance among the pairs was tested using Kappa. The association of recent infection (IgM and/or DENV RT-PCR positive) with the maternal characteristics and clinical features of the neonates was analyzed through logistic regression.
   Results: The prevalence of IgG antibodies in the maternal and cord blood samples was 95.1% (95% CI: 92.6-96.9%) and 95.8% (95% CI: 93.4-97.5%), respectively, with high agreement between maternal-cord pairs (Kappa = 0.93). The prevalence of recent infection was 10.6% (95% CI: 7.9-14.2%) in the parturients. Reported fever during pregnancy was associated to recent infection (p =0.023).
   Conclusion: The data draw attention for the high frequency of anti-dengue antibodies in the women studied and for the high occurrence of infection during pregnancy in this region of Brazil. There is a need for further studies to better characterize dengue infection in pregnant women. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Leite, Rachel C.; Souza, Ariani I.; Ferreira, Ana Laura G.; Katz, Leila; Braga, Cynthia] Inst Med Integral Prof Fernando Figueira IMIP, BR-50070550 Recife, PE, Brazil.
   [Martelli, Celina T.] Ctr Pesquisas Aggeu Magalhaes FIOCRUZ, BR-50670420 Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Cordeiro, Marli T.; Braga, Cynthia] Inst Patol Trop & Saude Publ UFGO, Setor Univ, BR-74605050 Goiania, Go, Brazil.
RP Souza, AI (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM rachelcaroline@hotmail.com; ariani@imip.org.br;
   castanha.priscila@gmail.com; marli@cpqam.fiocruz.br; celina@pq.cnpq.br;
   analaura@imip.org.br; katzleila@gmail.com; braga@cpqam.fiocruz.br
RI amsalu, ribka/G-8780-2019; Marques, Ernesto T. A/L-4967-2013; Souza,
   Ariani I/C-1568-2015; Katz, Leila/M-5291-2013; Braga, Maria
   Cynthia/A-8204-2013; Da Silva Castanha, Priscila Mayrelle/G-1785-2012;
   de Souza, Ariani Impieri/AAR-6884-2020
OI Marques, Ernesto T. A/0000-0003-3826-9358; Souza, Ariani
   I/0000-0002-7917-5983; Katz, Leila/0000-0001-9854-7917; Braga, Maria
   Cynthia/0000-0002-7862-6455; Da Silva Castanha, Priscila
   Mayrelle/0000-0002-1220-5308; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   (National Council for Scientific and Technological Development)National
   Council for Scientific and Technological Development (CNPq) [MCT/CNPq -
   14/2010, 482915/2010-2]; PAPES VINational Council for Scientific and
   Technological Development (CNPq) [407697/2012-8]
FX This research is funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq (National Council for Scientific and
   Technological Development), grants MCT/CNPq - 14/2010, number
   482915/2010-2 and PAPES VI, number 407697/2012-8.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brazilian Ministry of Health, 2011, SIST INF NASC VIV SI
   Brazilian Ministry of Health. Sistema de Informacao sobre Agravos de Notificacao (SINAN), 2012, SIST INF AGR NOT SIN
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Gershman MD, 2013, INFECT DIS RELATED T
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2013, EST POP REC
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Maroun SLC, 2008, J PEDIAT-BRAZIL, V84, P556, DOI 10.1590/S0021-75572008000700014
   PAHO, 2013, NUMB REP CAS DENG SE
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Prince HE, 2008, CLIN VACCINE IMMUNOL, V15, P1304, DOI 10.1128/CVI.00157-08
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tan PC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001637
   Tang KF, 2012, EXPERT REV ANTI-INFE, V10, P895, DOI [10.1586/eri.12.76, 10.1586/ERI.12.76]
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 38
TC 18
Z9 22
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAY
PY 2014
VL 60
IS 1
BP 16
EP 21
DI 10.1016/J.JCV.2014.02.009
PG 6
WC Virology
SC Virology
GA AF1YW
UT WOS:000334510800004
PM 24657101
DA 2020-12-01
ER

PT J
AU Oliveira, P
   Braga, C
   Alexander, N
   Brandao, E
   Silva, A
   Wanderley, L
   Aguiar, AM
   Diniz, G
   Medeiros, Z
   Rocha, A
AF Oliveira, Paula
   Braga, Cynthia
   Alexander, Neal
   Brandao, Eduardo
   Silva, Almerice
   Wanderley, Leandro
   Aguiar, Ana Maria
   Diniz, George
   Medeiros, Zulma
   Rocha, Abraham
TI Evaluation of diagnostic tests for Wuchereria bancrofti infection in
   Brazilian schoolchildren
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Filariasis diagnosis; ELISA; Membrane filtration; Laboratory tests
ID CIRCULATING FILARIAL ANTIGEN; ANTIBODY-BASED ELISA; LYMPHATIC
   FILARIASIS; CARD TEST; KNOTTS CONCENTRATION; SRI-LANKA;
   DIETHYLCARBAMAZINE; BLOOD; MICROFILARIAE; IVERMECTIN
AB Introduction: Since the launch of the Global Programme to Eliminate Lymphatic Filariasis, more than 70% of the endemic countries have implemented mass drug administration (MDA) to interrupt disease transmission. The monitoring of filarial infection in sentinel populations, particularly schoolchildren, is recommended to assess the impact of MDA. A key issue is choosing the appropriate tools for these initial assessments (to define the best intervention) and for monitoring transmission. Methods: This study compared the pre-MDA performance of five diagnostic methods, namely, thick film test, Knott's technique, filtration, Og4C3-ELISA, and the AD12-ICT card test, in schoolchildren from Brazil. Venous and capillary blood samples were collected between 11 pm and 1 am. The microfilarial loads were analyzed with a negative binomial regression, and the prevalence and associated 95% confidence intervals were estimated for all methods. The accuracies of the AD12-ICT card and Og4C3-ELISA tests were assessed against the combination of parasitological test results. Results: A total of 805 schoolchildren were examined. The overall and stratified prevalence by age group and gender detected by Og4C3-ELISA and AD12-ICT were markedly higher than the prevalence estimated by the parasitological methods. The sensitivity of the AD12-ICT card and Og4C3-ELISA tests was approximately 100%, and the positive likelihood ratios were above 6. The specificity of the Og4C3-ELISA was higher than that of the AD12-ICT at different prevalence levels. Conclusions: The ICT card test should be the recommended tool for monitoring school-age populations living in areas with ongoing or completed MDA.
C1 [Oliveira, Paula; Brandao, Eduardo; Aguiar, Ana Maria; Medeiros, Zulma; Rocha, Abraham] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Serv Referencia Nacl Filarioses, Recife, PE, Brazil.
   [Braga, Cynthia; Silva, Almerice; Wanderley, Leandro] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil.
   [Alexander, Neal] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.
   [Diniz, George] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, Recife, PE, Brazil.
RP Oliveira, P (corresponding author), CPqAM, Dept Parasitol, Serv Referencia Nacl Filarioses, Av Prof Moraes Rego S-N,Campus UFPE, BR-50670420 Recife, PE, Brazil.
EM brandaoec@gmail.com
RI Braga, Maria Cynthia/A-8204-2013; Medeiros, Zulma/J-5407-2015
OI Braga, Maria Cynthia/0000-0002-7862-6455; Medeiros,
   Zulma/0000-0002-4434-955X
FU Secretaria de Vigilancia em Saude/Fundacao Oswaldo Cruz/Fundacao para o
   Desenvolvimento Tecnologico em Saude - Vice-Presidencia de Pesquisa e
   Laboratorios de Referencia [(FIOCRUZ/FIOTEC-VPPLR)-002-LIV11-2-1];
   Medical Research CouncilMedical Research Council UK (MRC) [MR/K012126/1]
   Funding Source: researchfish
FX This research was funded by the Secretaria de Vigilancia em
   Saude/Fundacao Oswaldo Cruz/Fundacao para o Desenvolvimento Tecnologico
   em Saude - Vice-Presidencia de Pesquisa e Laboratorios de Referencia
   (FIOCRUZ/FIOTEC-VPPLR)-002-LIV11-2-1 Project.
CR [Anonymous], 2013, Wkly Epidemiol Rec, V88, P389
   Bal MS, 2009, T ROY SOC TROP MED H, V103, P262, DOI 10.1016/j.trstmh.2008.08.006
   Braga Cynthia, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P125, DOI 10.1590/S0036-46652003000300002
   Chandrasena TGAN, 2002, T ROY SOC TROP MED H, V96, P60, DOI 10.1016/S0035-9203(02)90241-5
   CHANTEAU S, 1994, J INFECT DIS, V170, P247, DOI 10.1093/infdis/170.1.247
   Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168
   DENNIS DT, 1971, J PARASITOL, V57, P1146, DOI 10.2307/3277886
   Eberhard ML, 1997, AM J TROP MED HYG, V57, P483, DOI 10.4269/ajtmh.1997.57.483
   EBERHARD ML, 1991, CLIN LAB MED, V11, P977, DOI 10.1016/S0272-2712(18)30531-6
   Freedman DO, 2001, TROP MED INT HEALTH, V6, P37, DOI 10.1046/j.1365-3156.2001.00666.x
   Freedman DO, 1997, LANCET, V350, P1681, DOI 10.1016/S0140-6736(05)64280-8
   Gass K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001479
   Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024
   Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 CAR PO
   Ismail MM, 1996, T ROY SOC TROP MED H, V90, P684, DOI 10.1016/S0035-9203(96)90437-X
   Itoh M, 1999, TROP MED INT HEALTH, V4, P207, DOI 10.1046/j.1365-3156.1999.43379.x
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389
   Knott JA, 1939, T ROY SOC TROP MED H, V32, P191
   Lalitha P, 1998, TROP MED INT HEALTH, V3, P41, DOI 10.1046/j.1365-3156.1998.00170.x
   LAMMIE PJ, 1994, AM J TROP MED HYG, V51, P348, DOI 10.4269/ajtmh.1994.51.348
   Medeiros Z, 1999, TROP MED INT HEALTH, V4, P499, DOI 10.1046/j.1365-3156.1999.00427.x
   Melrose WD, 2000, T ROY SOC TROP MED H, V94, P176, DOI 10.1016/S0035-9203(00)90266-9
   MORE SJ, 1990, TROP MED PARASITOL, V41, P403
   Nicolas L, 1997, J INFECT DIS, V175, P489, DOI 10.1093/infdis/175.2.489
   Njenga SM, 2008, T ROY SOC TROP MED H, V102, P1017, DOI 10.1016/j.trstmh.2008.04.039
   Njenga SM, 2001, J PARASITOL, V87, P1140, DOI 10.1645/0022-3395(2001)087[1140:EOIFCT]2.0.CO;2
   Omar Mohamed S., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P415
   Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, P1
   Ramzy R M, 1999, East Mediterr Health J, V5, P880
   Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2
   RAMZY RMR, 1994, T ROY SOC TROP MED H, V88, P41, DOI 10.1016/0035-9203(94)90490-1
   Reid C, 1995, JAMA-J AM MED ASSOC, V274, P645
   Rocha A, 2004, MEM I OSWALDO CRUZ, V99, P101, DOI 10.1590/S0074-02762004000100018
   Rocha A, 1996, TROP MED INT HEALTH, V1, P859
   Rocha A., 2000, REV BRAS ANAL CLIN, V32, P265
   Rocha A, 2009, MEM I OSWALDO CRUZ, V104, P621, DOI 10.1590/S0074-02762009000400015
   Schuetz A, 2000, AM J TROP MED HYG, V62, P502, DOI 10.4269/ajtmh.2000.62.502
   Shenoy RK, 2007, ANN TROP MED PARASIT, V101, P205, DOI 10.1179/136485907X154548
   Shenoy R K, 2006, J Commun Dis, V38, P118
   STAQUET M, 1981, J CHRON DIS, V34, P599, DOI 10.1016/0021-9681(81)90059-X
   Tisch DJ, 2008, AM J TROP MED HYG, V78, P289, DOI 10.4269/ajtmh.2008.78.289
   Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001
   WEIL GJ, 1987, J INFECT DIS, V156, P350, DOI 10.1093/infdis/156.2.350
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   WHO, 2012, TRANSM ASS SURV GLOB
   Wilson K, 1997, PARASITOL TODAY, V13, P33, DOI 10.1016/S0169-4758(96)40009-6
   Witt C, 2001, TROP MED INT HEALTH, V6, P582, DOI 10.1046/j.1365-3156.2001.00765.x
   World Health Organization, 2005, WHOCDSCPECEE200505
NR 48
TC 5
Z9 6
U1 0
U2 8
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2014
VL 47
IS 3
BP 359
EP 366
DI 10.1590/0037-8682-0093-2014
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AN0SR
UT WOS:000340294800015
PM 25075488
OA DOAJ Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Coimbra, I
   Maruza, M
   Albuquerque, MDPM
   Batista, JDL
   Braga, MC
   Moura, LV
   Miranda, DB
   Montarroyos, UR
   Lacerda, HR
   Rodrigues, LC
   Ximenes, RAD
AF Coimbra, Isabella
   Maruza, Magda
   Pessoa Militao Albuquerque, Maria de Fatima
   Lyra Batista, Joanna D'Arc
   Braga, Maria Cynthia
   Moura, Libia Vilela
   Miranda-Filho, Democrito Barros
   Montarroyos, Ulisses Ramos
   Lacerda, Heloisa Ramos
   Rodrigues, Laura Cunha
   de Alencar Ximenes, Ricardo Arraes
TI Validating a Scoring System for the Diagnosis of Smear-Negative
   Pulmonary Tuberculosis in HIV-Infected Adults
SO PLOS ONE
LA English
DT Article
ID CLINICAL-DIAGNOSIS; EVIDENCE BASE; ADDIS-ABABA; COUNTRIES; CHILDREN;
   HEALTH
AB Background: The challenge of diagnosing smear-negative pulmonary TB (tuberculosis) in people living with HIV justifies the use of instruments other than the smear test for diagnosing the disease. Considering the clinical-radiological similarities of TB amongst HIV-infected adults and children, the proposal of this study was to assess the accuracy of a scoring system used to diagnose smear-negative pulmonary TB in children and adolescents, in HIV-infected adults suspected of having smear-negative pulmonary TB.
   Methods: A Phase III validation study aiming to assess the diagnostic accuracy of a scoring system for diagnosing smear-negative pulmonary TB in HIV-infected adults. The study assessed sensitivity, specificity, positive and negative likelihood ratios, and positive and negative predictive values of the scoring system. Three versions of the scoring system were tested.
   Results: From a cohort of 2,382 (HIV-infected adults), 1276 were investigated and 128 were diagnosed with pulmonary TB. Variables associated with the diagnosis of TB were: coughing, weight loss, fever, malnutrition, chest X-ray, and positive tuberculin test. The best diagnostic performance occurred with the scoring system with new scores, with sensitivity = 81.2% (95%-CI 74.5% -88%), specificity = 78% (75.6% -80.4%), PPV = 29.2% (24.5% -33.9%) and NPV = 97.4% (96.4% -98.4%), LR+ = 3.7 (3.4-4.0) and LR-= 0.24 (0.2-0.4).
   Conclusion: The proposed scoring system (with new scores) presented a good capacity for discriminating patients who did not have pulmonary TB, in the studied population. Further studies are necessary in order to validate it, thus permitting the assessment of its use in diagnosing smear-negative pulmonary TB in HIV-infected adults.
C1 [Coimbra, Isabella; Maruza, Magda; Lyra Batista, Joanna D'Arc; Moura, Libia Vilela; Montarroyos, Ulisses Ramos; Lacerda, Heloisa Ramos; de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Postgrad Program Trop Med, Recife, PE, Brazil.
   [Pessoa Militao Albuquerque, Maria de Fatima; Braga, Maria Cynthia] Fiocruz MS, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Miranda-Filho, Democrito Barros] Univ Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, London WC1, England.
RP Coimbra, I (corresponding author), Univ Fed Pernambuco, Postgrad Program Trop Med, Recife, PE, Brazil.
EM isabella.coimbra@uol.com.br
RI Batista, Joanna d'Arc L/O-9933-2014; Montarroyos, Ulisses/AAJ-7527-2020;
   Braga, Maria Cynthia/A-8204-2013
OI Batista, Joanna d'Arc L/0000-0002-3703-2845; Braga, Maria
   Cynthia/0000-0002-7862-6455; Rodrigues, Laura Cunha/0000-0001-9008-660X
FU Ministerio da Saude do Brasil/Programa DST/AIDS/UNESCO [CSV 182/06];
   Ministerio da Ciencia e Tecnologia-CNPq/MS-SCTIE-DECIT [10567/2006-0];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [308311/2009-4, 301779/2009-0, 310911/2009-5]
FX This study had the financial support of Ministerio da Saude do
   Brasil/Programa DST/AIDS/UNESCO (Projeto CSV 182/06) and of Ministerio
   da Ciencia e Tecnologia-CNPq/MS-SCTIE-DECIT (Processo no 10567/2006-0).
   The authors were partially supported by CNPq (Scholarship 308311/2009-4
   to R.A.A.X and Scholarship 301779/2009-0 para M.F.P.M.A and Scholarship
   310911/2009-5 para H.R.L). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x
   Alavi-Naini R, 2012, ARCH IRAN MED, V15, P22, DOI 012151/AIM.007
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174
   Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488
   Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859
   Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391
   Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651
   Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349
   Knottnerus JA, 2002, BMJ-BRIT MED J, V324, P477, DOI 10.1136/bmj.324.7335.477
   Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502
   Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X
   Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351
   Ministerio da Saude, 2002, GUIA VIG EP, P100
   Ministerio da saude do Brasil, 2011, SER HIST TAX MORT TU
   Ministerio da Saude do Brasil, 2003, PROGR NAC DST AIDS
   Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P402, DOI 10.1590/S0102-311X2008000200019
   Pedrozo C, 2009, INT J TUBERC LUNG D, V13, P413
   RAVIGLIONE MC, 1992, B WORLD HEALTH ORGAN, V70, P515
   Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539
   Sant'Anna CC, 2006, INT J TUBERC LUNG D, V10, P463
   Sant'Anna Clemax Couto, 2004, Braz J Infect Dis, V8, P305, DOI 10.1590/S1413-86702004000400006
   Sant'Anna Clemax Couto, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P103, DOI 10.1590/S0036-46652003000200010
   Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c
   Sharma SK, 2005, INDIAN J MED RES, V121, P550
   Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x
   Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1
   Solari L, 2008, INT J TUBERC LUNG D, V12, P619
   Soto A, 2008, BRAZ J INFECT DIS, V12, P128, DOI 10.1590/S1413-86702008000200006
   Tessema TA, 2001, SCAND J INFECT DIS, V33, P355, DOI 10.1080/003655401750173986
   Viani RM, 2008, INT J TUBERC LUNG D, V12, P411
   Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c
   Wilson D, 2006, INT J TUBERC LUNG D, V10, P31
   Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440
   World Health Organization, 2007, IMPR DIAGN TREATM SM
   World Health Organization, 2011, GLOB TUB CONTR WHO R
NR 36
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 22
PY 2014
VL 9
IS 4
AR e95828
DI 10.1371/journal.pone.0095828
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG2IS
UT WOS:000335240300102
PM 24755628
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-01
ER

PT J
AU Costa, MH
   de Souza, AI
   Braga, MC
   Batista, M
AF Costa, Manuela Hazin
   de Souza, Ariani Impieri
   Braga, Maria Cynthia
   Batista Filho, Malaquias
TI Coexistence of anemia and vitamin A deficiency in women of childbearing
   age in the Northeast region of Brazil
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Anemia; Vitamin A deficiency; Women
ID MICRONUTRIENT DEFICIENCIES; PREGNANT-WOMEN; IRON; SUPPLEMENTATION
AB Objective
   The aim of this study was to investigate the association between anemia and vitamin A deficiency in women of childbearing age in Pernambuco, a state in the Brazilian Northeast.
   Methods
   A cross-sectional study was conducted making a secondary database analysis of "The Third State Survey on Health and Nutrition" done from May to September 2006. Data were collected from 761 women of childbearing age (10-49 years).
   Results
   The simultaneous occurrence of the two deficiencies was found in only seven women (0.9%). The prevalence of anemia was of 15.1%, and of vitamin A deficiency, 8.2%. There was no association between the two conditions (p=0.380), although a positive correlation was found between retinol levels and hemoglobin concentration (r=0.13).
   Conclusion
   Anemia and vitamin A deficiency did not coexist. Anemia was considered a mild public health problem, while vitamin A deficiency was not considered an epidemiological problem.
C1 [Costa, Manuela Hazin] Univ Fed Pernambuco, Dept Clin Med, Disciplina Hematol, Recife, PE, Brazil.
   [de Souza, Ariani Impieri; Braga, Maria Cynthia; Batista Filho, Malaquias] Inst Med Integral Prof Fernando Figueira, Programas Posgrad Saude Maternoinfantil, BR-50070550 Recife, PE, Brazil.
RP de Souza, AI (corresponding author), Inst Med Integral Prof Fernando Figueira, Programas Posgrad Saude Maternoinfantil, R Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM ariani@imip.org.br
RI de Souza, Ariani Impieri/AAR-6884-2020; Braga, Maria
   Cynthia/A-8204-2013; Souza, Ariani I/C-1568-2015
OI de Souza, Ariani Impieri/0000-0002-7917-5983; Braga, Maria
   Cynthia/0000-0002-7862-6455; Souza, Ariani I/0000-0002-7917-5983
CR AMINE EK, 1970, J NUTR, V100, P1033
   AngelesAgdeppa I, 1997, AM J CLIN NUTR, V66, P177
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   Batista-Filho M, 2008, 3 PESQUISA ESTADUAL
   BLOEM MW, 1995, P NUTR SOC, V54, P501, DOI 10.1079/PNS19950018
   Brasil. Ministerio da Saude, 2006, PESQ NAC DEM SAUD MU
   Chagas CB, 2011, NUTR HOSP, V26, P843, DOI [10.3305/nh.2011.26.4.5053, 10.1590/S0212-16112011000400026]
   Darnton-Hill I, 2005, AM J CLIN NUTR, V81, p1198S
   Diaz JR, 2003, EUR J CLIN NUTR, V57, pS70, DOI 10.1038/sj.ejcn.1601820
   Dreyfuss ML, 2000, J NUTR, V130, P2527
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   Fabian C, 2007, CAD SAUDE PUBLICA, V23, P1199, DOI 10.1590/S0102-311X2007000500021
   FURR HC, 1992, METHOD ENZYMOL, V213, P281
   HODGES RE, 1978, AM J CLIN NUTR, V31, P876
   Instituto Brasileiro de Geografia e Estatistica, 2000, POP CENS
   Instituto Brasileiro de Geografia e Estatistica, 2009, PNAD PESQ NAC AM DOM
   Khatib I. M., 2010, Eastern Mediterranean Health Journal, V16, P187
   Milagres Regina Celia Rodrigues Miranda, 2007, Cien Saude Colet, V12, P1253, DOI 10.1590/S1413-81232007000500023
   Ministerio da Saude, 2005, PORT 730 13 MAIO 200
   Pnud-Programa das Nacoes Unidas para o Desenvolvimento, 2010, IND DES HUM
   ROODENBURG AJC, 1995, BRIT J NUTR, V74, P689, DOI 10.1079/BJN19950172
   Santos EN, 2010, CIENC SAUDE COLET S1, V15, P1021, DOI [10.1590/S1413-81232010000700008, DOI 10.1590/S1413-81232010000700008]
   Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320
   Silva Shirley Cristina Lima e, 2008, Rev. bras. epidemiol., V11, P266, DOI 10.1590/S1415-790X2008000200008
   Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S
   SUHARNO D, 1992, AM J CLIN NUTR, V56, P988
   Sure B, 1929, J BIOL CHEM, V83, P375
   United Nation Standing Committee of Nutrition, 2004, P 5 REP WORLD NUTR S, DOI SCN
   WHO, 2008, WORLDWIDE PREVALENCE
   WHO, 2009, GLOB PREV VIT A DEF
   World Health Organization, 2007, PREV CONTR MICR DEF
   Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5
   Zimmermann MB, 2006, AM J CLIN NUTR, V84, P580
NR 33
TC 1
Z9 1
U1 0
U2 1
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
J9 REV NUTR
JI Rev. Nutr.
PD SEP-OCT
PY 2013
VL 26
IS 5
BP 509
EP 516
DI 10.1590/S1415-52732013000500002
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 270VF
UT WOS:000328346600002
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Regis, LN
   Acioli, RV
   Silveira, JC
   Melo-Santos, MAV
   Souza, WV
   Ribeiro, CNMN
   da Silva, JCS
   Monteiro, AMV
   Oliveira, CMF
   Barbosa, RMR
   Braga, C
   Rodrigues, MAB
   Silva, MGNM
   Ribeiro, PJ
   Bonat, WH
   Medeiros, LCD
   Carvalho, MS
   Furtado, AF
AF Regis, Leda N.
   Acioli, Ridelane Veiga
   Silveira, Jose Constantino, Jr.
   Varjal Melo-Santos, Maria Alice
   Souza, Wayner Vieira
   Nogueira Ribeiro, Candida M.
   Serafim da Silva, Juliana C.
   Vieira Monteiro, Antonio Miguel
   Oliveira, Claudia M. F.
   Barbosa, Rosangela M. R.
   Braga, Cynthia
   Benedetti Rodrigues, Marco Aurelio
   Silva, Marilu Gomes N. M.
   Ribeiro, Paulo Justiniano, Jr.
   Bonat, Wagner Hugo
   de Castro Medeiros, Liliam Cesar
   Carvalho, Marilia Sa
   Furtado, Andre Freire
TI Sustained Reduction of the Dengue Vector Population Resulting from an
   Integrated Control Strategy Applied in Two Brazilian Cities
SO PLOS ONE
LA English
DT Article
ID MASS TRAPPING SCHEME; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS;
   BACILLUS-SPHAERICUS; EMILIA-ROMAGNA; URBAN AREA; ALBOPICTUS; CULICIDAE;
   DIPTERA; SURVEILLANCE
AB Aedes aegypti has developed evolution-driven adaptations for surviving in the domestic human habitat. Several trap models have been designed considering these strategies and tested for monitoring this efficient vector of Dengue. Here, we report a real-scale evaluation of a system for monitoring and controlling mosquito populations based on egg sampling coupled with geographic information systems technology. The SMCP-Aedes, a system based on open technology and open data standards, was set up from March/2008 to October/2011 as a pilot trial in two sites of Pernambuco Brazil: Ipojuca (10,000 residents) and Santa Cruz (83,000), in a joint effort of health authorities and staff, and a network of scientists providing scientific support. A widespread infestation by Aedes was found in both sites in 2008-2009, with 96.8%-100% trap positivity. Egg densities were markedly higher in SCC than in Ipojuca. A 90% decrease in egg density was recorded in SCC after two years of sustained control pressure imposed by suppression of >7,500,000 eggs and >3,200 adults, plus larval control by adding fishes to cisterns. In Ipojuca, 1.1 million mosquito eggs were suppressed and a 77% reduction in egg density was achieved. This study aimed at assessing the applicability of a system using GIS and spatial statistic analysis tools for quantitative assessment of mosquito populations. It also provided useful information on the requirements for reducing well-established mosquito populations. Results from two cities led us to conclude that the success in markedly reducing an Aedes population required the appropriate choice of control measures for sustained mass elimination guided by a user-friendly mosquito surveillance system. The system was able to support interventional decisions and to assess the program's success. Additionally, it created a stimulating environment for health staff and residents, which had a positive impact on their commitment to the dengue control program.
C1 [Regis, Leda N.; Silveira, Jose Constantino, Jr.; Varjal Melo-Santos, Maria Alice; Oliveira, Claudia M. F.; Barbosa, Rosangela M. R.] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Entomol, Recife, PE, Brazil.
   [Acioli, Ridelane Veiga] Secretaria Estadual Saude, Recife, PE, Brazil.
   [Souza, Wayner Vieira] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Saude Colet, Recife, PE, Brazil.
   [Nogueira Ribeiro, Candida M.] Secretaria Municipal Saude, Santa Cruz Do Capibaribe, PE, Brazil.
   [Serafim da Silva, Juliana C.] Secretaria Municipal Saude, Ipojuca, PE, Brazil.
   [Vieira Monteiro, Antonio Miguel] INPE, Div Proc Imagens, Sao Jose Dos Campos, SP, Brazil.
   [Braga, Cynthia] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Parasitol, Recife, PE, Brazil.
   [Benedetti Rodrigues, Marco Aurelio; Silva, Marilu Gomes N. M.] Univ Fed Pernambuco, Dept Eletron & Sistemas, Recife, PE, Brazil.
   [Ribeiro, Paulo Justiniano, Jr.; Bonat, Wagner Hugo] Univ Fed Parana, Dept Estat, BR-80060000 Curitiba, PR, Brazil.
   [de Castro Medeiros, Liliam Cesar] Ctr Ciencia Sistema Terr, INPE, Sao Jose Dos Campos, SP, Brazil.
   [Carvalho, Marilia Sa] Fundacao Oswaldo Cruz Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Furtado, Andre Freire] Fundacao Oswaldo Cruz Fiocruz Pe, Dept Virol, Recife, PE, Brazil.
RP Regis, LN (corresponding author), Fundacao Oswaldo Cruz Fiocruz Pe, Dept Entomol, Recife, PE, Brazil.
EM leda@cpqam.fiocruz.br
RI Vieira Monteiro, Antonio Miguel/C-1757-2012; Braga, Maria
   Cynthia/A-8204-2013; Barbosa, Rosangela/AAC-3339-2020; Souza, Wayner
   V/H-3798-2013; CARVALHO, MARILIA/AAD-8283-2020; Medeiros,
   Liliam/J-8593-2014
OI Vieira Monteiro, Antonio Miguel/0000-0003-1477-1749; Braga, Maria
   Cynthia/0000-0002-7862-6455; Barbosa, Rosangela/0000-0002-1171-598X;
   CARVALHO, MARILIA/0000-0002-9566-0284; Medeiros,
   Liliam/0000-0002-8142-6673; Ribeiro Junior, Paulo
   Justiniano/0000-0001-5302-9446; Benedetti Rodrigues, Marco
   Aurelio/0000-0002-5143-3696; Souza, Wayner/0000-0002-0939-9332
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [PQ-301277/2005-2, APQ-479214/2010-7]; FACEPE [APQ-0692-2.13/08];
   PDTSP-FIOCRUZ [RDVE-03]
FX This work received financial support from grants from CNPq,
   http://www.cnpq.br (PQ-301277/2005-2 and APQ-479214/2010-7); FACEPE,
   http://www.facepe.br (APQ-0692-2.13/08); and PDTSP-FIOCRUZ,
   http://www.fiocruz.br (RDVE-03). The State Health Department of
   Pernambuco offered ground transport for people and materials related to
   the project from Recife to Santa Cruz do Capibaribe and Ipojuca, during
   2008-2011. The funders had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Albieri A, 2010, B INSECTOL, V63, P209
   Bailey T.C., 1995, INTERACTIVE SPATIAL
   Barbazan P, 1997, J AM MOSQUITO CONTR, V13, P263
   Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Beech C, 2009, ASIA PAC J MOL BIOL, V17, P75
   Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632
   Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154
   Bonat WH, 2009, REV BRAS BIOM, V27, P519
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Chansang C, 2007, AM J TROP MED HYG, V77, P897, DOI 10.4269/ajtmh.2007.77.897
   De Barro P, 2011, J VERBRAUCH LEBENSM, V6, P1, DOI 10.1007/s00003-011-0692-5
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x
   Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   HOUGARD JM, 1993, B WORLD HEALTH ORGAN, V71, P367
   Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552
   Kaplan L, 2010, BIOL INVASIONS, V12, P3277, DOI 10.1007/s10530-010-9721-z
   Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6
   Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503
   Khatchikian C, 2011, MED VET ENTOMOL, V25, P268, DOI 10.1111/j.1365-2915.2010.00935.x
   Kittayapong P, 2008, AM J TROP MED HYG, V78, P70, DOI 10.4269/ajtmh.2008.78.70
   Kumar A, 1996, J AM MOSQUITO CONTR, V12, P409
   Lenhart AE, 2005, ACTA TROP, V96, P56, DOI 10.1016/j.actatropica.2005.06.020
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   MONTGOMERY BL, 2005, ARBOVIRUS RES AUST, V9, P268
   Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI 10.1590/s0034-89102005000400006
   Obenauer PJ, 2009, J MED ENTOMOL, V46, P1507, DOI 10.1603/033.046.0639
   Polson K. A., 2002, Dengue Bulletin, V26, P178
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Regis L, 2000, T ROY SOC TROP MED H, V94, P488, DOI 10.1016/S0035-9203(00)90061-0
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004
   Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076
   Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x
   Santos S. R. A., 2003, Dengue Bulletin, V27, P156
   SCHOFIELD CJ, 1991, ANN SOC BELG MED TR, V71, P201
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Silva MGNM, 2011, 33 ANN INT C IEEE EN
   Silva-Filha MH, 2001, J AM MOSQUITO CONTR, V17, P45
   Stein M, 2005, REV SAUDE PUBL, V39, P559, DOI [10.1590/S0034-89102005000400007, 10.1590/s0034-89102005000400007]
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   WHO, 2011, TECHNICAL PUBLICATIO, V60
   Williams CR, 2005, ARBOVIRUS RES AUSTR, V9, P397
   Williams CR, 2007, J MED ENTOMOL, V44, P345, DOI 10.1603/0022-2585(2007)44[345:AAPSUB]2.0.CO;2
NR 53
TC 29
Z9 30
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 3
PY 2013
VL 8
IS 7
AR e67682
DI 10.1371/journal.pone.0067682
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182HT
UT WOS:000321733000092
PM 23844059
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Argolo, AFLT
   Feres, VCR
   Silveira, LA
   Oliveira, ACM
   Pereira, LA
   Siqueira, JB
   Braga, C
   Martelli, CMT
AF Argolo, Angela F. L. T.
   Feres, Valeria C. R.
   Silveira, Lucimeire A.
   Oliveira, Anna Carolina M.
   Pereira, Luiz A.
   Siqueira Junior, Joao Bosco
   Braga, Cynthia
   Martelli, Celina M. T.
TI Prevalence and incidence of dengue virus and antibody placental transfer
   during late pregnancy in central Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Prevalence; Incidence; Pregnant; Neonate; Vertical transmission
ID LINKED IMMUNOSORBENT ASSAYS; HEMORRHAGIC-FEVER; MATERNAL DENGUE;
   TRANSMISSION; INFECTION; PATHOGENESIS; CIRCULATION; DIAGNOSIS; SEVERITY;
   EPIDEMIC
AB Background: Maternal dengue antibodies are considered to play a significant role in dengue pathogenesis among infants. Determining the transplacental specific antibody transfer is invaluable for establishing the optimal vaccination age among infants in endemic regions.
   Methods: We conducted a cross-sectional study among pairs of maternal and corresponding umbilical cord blood samples in public hospitals. The prevalence and incidence of dengue infection were determined in 505 pairs of pregnant women and neonates during a large outbreak (2009-2010) in central Brazil. The women were interviewed at late pregnancy to assess current or past symptoms of dengue. All parturients and their neonates were screened using Dengue IgG Indirect ELISA (Panbio) to assess previous dengue exposure. A semi-quantitative measurement of the IgG antibody expressed by the index ratio was calculated using optical density (OD) values according to the manufacturer's instructions. The studied population of parturients and their offspring was also screened for recent dengue infection by the Dengue IgM-capture ELISA (Panbio). Those participants with history of fever and two or more symptoms of dengue at least 10 days before the delivery were also tested for the dengue NS1 antigen using the Dengue Early ELISA (Panbio) and RT-PCR.
   Results: The mean maternal age was 25.8 (SD = 6.4), and 83.6% of deliveries were between 37 and 41 weeks. Approximately half of the 505 women and neonates were IgG-seropositive, yielding 99.3% co-positive mother-child frequency of antibody transfer (Kappa = 0.96). The incidence of dengue infection was 2.8% (95% CI 1.4-4.4%) among the women considering 14 IgM-positive results and one DENV2 detected by RT-PCR. The dengue NS1 antigen was undetectable in the matched pairs.
   Conclusion: This study provides critical data on the prevalence of transplacental transferred maternal-infant antidengue antibodies and incidence of infection. The design of future vaccine trials should consider diverse regional epidemiological scenarios.
C1 [Argolo, Angela F. L. T.; Pereira, Luiz A.] Lab Saude Publ LACEN GO, BR-74853120 Goiania, Go, Brazil.
   [Argolo, Angela F. L. T.; Silveira, Lucimeire A.; Siqueira Junior, Joao Bosco; Martelli, Celina M. T.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Saude Colet, Setor Univ, BR-74605050 Goiania, Go, Brazil.
   [Feres, Valeria C. R.; Oliveira, Anna Carolina M.] Univ Fed Goias, Fac Farm, BR-74605220 Goiania, Go, Brazil.
   [Braga, Cynthia] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50000230 Recife, PE, Brazil.
   [Martelli, Celina M. T.] Univ Fed Pernambuco, BR-50670240 Recife, PE, Brazil.
RP Argolo, AFLT (corresponding author), Lab Saude Publ LACEN GO, Av Contorno 3-556, BR-74853120 Goiania, Go, Brazil.
EM angelafarmaceutica@hotmail.com
RI Braga, Maria Cynthia/A-8204-2013; amsalu, ribka/G-8780-2019
OI Braga, Maria Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Lopes, Angela/0000-0002-7261-2079
FU Fundacao de Amparo a Pesquisa em Golas - FAPEG; CNPqNational Council for
   Scientific and Technological Development (CNPq) [306489/2010-4]
FX This work was made possible by support from Fundacao de Amparo a
   Pesquisa em Golas - FAPEG. Martelli CMT received research scholarship
   (CNPq number 306489/2010-4).
CR Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRAMBELL FWR, 1960, PROC R SOC SER B-BIO, V151, P478, DOI 10.1098/rspb.1960.0011
   Brazilian Minister of Health, IS DENV 4 ROR AM
   Brazilian Minister of Health, PORT SAUD SIST INF A
   Brazilian Ministry of Health, 2010, HLTH BRAZ 2010 HLTH, V7, P156
   Cordeiro MT, 2012, REV INST MED TROP SP, V54, pS10, DOI 10.1590/S0036-46652012000700005
   da Rosa AP T, 1994, ARBOVIRUS BRASIL GEN, P23
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P261
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Laoprasopwattana K, 2005, J INFECT DIS, V192, P510, DOI 10.1086/431520
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pengsaa K, 2006, J INFECT DIS, V194, P1570, DOI 10.1086/508492
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Feres VCR, 2006, J CLIN VIROL, V37, P179, DOI 10.1016/j.jcv.2006.07.004
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   The Brazilian Institute of Geography and Statistics (IBGE), CITIES
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 42
TC 24
Z9 26
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 31
PY 2013
VL 13
AR 254
DI 10.1186/1471-2334-13-254
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA 158MU
UT WOS:000319976700002
PM 23725365
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Castanha, PMS
   Cordeiro, MT
   Martelli, CMT
   Souza, WV
   Marques, ETA
   Braga, C
AF Castanha, P. M. S.
   Cordeiro, M. T.
   Martelli, C. M. T.
   Souza, W. V.
   Marques, E. T. A., Jr.
   Braga, C.
TI Force of infection of dengue serotypes in a population-based study in
   the northeast of Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Dengue; neutralizing antibody; prevalence
ID PLAQUE-REDUCTION NEUTRALIZATION; VIRUS SEROTYPES; HEMORRHAGIC-FEVER;
   CHILDREN; TRANSMISSION; EPIDEMIOLOGY; DETERMINANTS; ADOLESCENTS;
   REEMERGENCE; PREVALENCE
AB This study investigated anti-dengue serotype-specific neutralizing antibodies in a random sample of dengue IgG-positive individuals identified in a survey performed in a hyperendemic setting in northeastern Brazil in 2005. Of 323 individuals, 174 (53.8%) had antibodies to dengue virus serotype 1 (DENV-1), 104 (32.2%) to DENV-2 and 301 (93.2%) to DENV-3. Monotypic infections by DENV-3 were the most frequent infection (35.6%). Of 109 individuals aged < 15 years, 61.5% presented multitypic infections. The force of infection estimated by a catalytic model was 0.9%, 0.4% and 2.5% person-years for DENV-1, DENV-2 and DENV-3, respectively. By the age of 5 years, about 70%, 30% and 40% of participants were immune to DENV-3, DENV-2 and DENV-1, respectively. The data suggest that infection with DENV-1, -2 and -3 is intense at early ages, demonstrating the need for research efforts to investigate dengue infection in representative population samples of Brazilian children during early infancy.
C1 [Castanha, P. M. S.; Braga, C.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Doencas Transmissiveis, Dept Parasitol, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, M. T.; Marques, E. T. A., Jr.] Fundacao Oswaldo Cruz, Lab Virol & Terapia Expt, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Cordeiro, M. T.] Secretaria Saude Pernambuco, Lab Cent Saude Publ, Recife, PE, Brazil.
   [Martelli, C. M. T.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Martelli, C. M. T.] Univ Fed Pernambuco, Dept Med Trop, Recife, PE, Brazil.
   [Souza, W. V.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, BR-50670420 Recife, PE, Brazil.
   [Marques, E. T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Castanha, PMS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM castanha.priscila@gmail.com
RI Publica, Inct Saude/J-9544-2013; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Braga, Maria Cynthia/A-8204-2013; Souza, Wayner
   V/H-3798-2013; Iats, Inct/K-2300-2013; Marques, Ernesto/L-4514-2013;
   Marques, Ernesto T. A/L-4967-2013
OI Da Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Braga, Maria
   Cynthia/0000-0002-7862-6455; Marques, Ernesto/0000-0003-3826-9358;
   Marques, Ernesto T. A/0000-0003-3826-9358; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [BFT-0190-4.06/10]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [306489/2010-4, 305281/2010-0];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI056541, U19AI056541, U19AI082632, U19AI056541, U19AI056541,
   U19AI056541, U19AI082632] Funding Source: NIH RePORTER
FX The authors acknowledge the partial support of the P. M. S. Castanha by
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (Grant
   BFT-0190-4.06/10). C. M. T. Martelli and W. V. Souza received research
   scholarships (CNPq numbers 306489/2010-4, 305281/2010-0) and are
   research members from the National Institute of Science and Technology
   for Health Technology Assessment.
CR Anderson R, 1991, INFECT DIS HUMANS DY, P63
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Cavalcanti LP, 2011, EMERG INFECT DIS, V17, P132, DOI 10.3201/eid1701.100321
   Chang SF, 2008, J MICROBIOL IMMUNOL, V41, P377
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   Sanchez-Burgos GG, 2008, SALUD PUBLICA MEXICO, V50, P362, DOI 10.1590/s0036-36342008000500008
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Montenegro D, 2006, REV SOC BRAS MED TRO, V39, P9, DOI 10.1590/S0037-86822006000100002
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Scheaffer RL, 1979, ELEMENTARY SURVEY SA, P48
   Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426
   Siqueira JC, 2002, FLORA FANEROGAMICA E, P11
   Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
NR 33
TC 25
Z9 26
U1 0
U2 17
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAY
PY 2013
VL 141
IS 5
BP 1080
EP 1088
DI 10.1017/S0950268812001367
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 118YZ
UT WOS:000317064800023
PM 22800513
DA 2020-12-01
ER

PT J
AU Pereira, LMMB
   Martelli, CMT
   Moreira, RC
   Merchan-Hamman, E
   Stein, AT
   Cardoso, MRA
   Figueiredo, GM
   Montarroyos, UR
   Braga, C
   Turchi, MD
   Coral, G
   Crespo, D
   Lima, MLC
   Alencar, LCA
   Costa, M
   dos Santos, AA
   Ximenes, RAA
AF Pereira, Leila M. M. B.
   Martelli, Celina M. T.
   Moreira, Regina C.
   Merchan-Hamman, Edgar
   Stein, Airton T.
   Cardoso, Maria Regina A.
   Figueiredo, Gerusa M.
   Montarroyos, Ulisses R.
   Braga, Cynthia
   Turchi, Marilia D.
   Coral, Gabriela
   Crespo, Deborah
   Lima, Maria Luiza C.
   Alencar, Luis Claudio A.
   Costa, Marcelo
   dos Santos, Alex A.
   Ximenes, Ricardo A. A.
TI Prevalence and risk factors of Hepatitis C virus infection in Brazil,
   2005 through 2009: a cross-sectional study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Hepatitis C virus; Prevalence; Genotype; Cross sectional study; Risk
   factors
ID UNITED-STATES; SPONTANEOUS CLEARANCE; HEMODIALYSIS-PATIENTS; DRUG-USERS;
   EPIDEMIOLOGY; GENOTYPES; REGIONS; IL28B
AB Background: Hepatitis C chronic liver disease is a major cause of liver transplant in developed countries. This article reports the first nationwide population-based survey conducted to estimate the seroprevalence of HCV antibodies and associated risk factors in the urban population of Brazil.
   Methods: The cross sectional study was conducted in all Brazilian macro-regions from 2005 to 2009, as a stratified multistage cluster sample of 19,503 inhabitants aged between 10 and 69 years, representing individuals living in all 26 State capitals and the Federal District. Hepatitis C antibodies were detected by a third-generation enzyme immunoassay. Seropositive individuals were retested by Polymerase Chain Reaction and genotyped. Adjusted prevalence was estimated by macro-regions. Potential risk factors associated with HCV infection were assessed by calculating the crude and adjusted odds ratios, 95% confidence intervals (95% CI) and p values. Population attributable risk was estimated for multiple factors using a case-control approach.
   Results: The overall weighted prevalence of hepatitis C antibodies was 1.38% (95% CI: 1.12%-1.64%). Prevalence of infection increased in older groups but was similar for both sexes. The multivariate model showed the following to be predictors of HCV infection: age, injected drug use (OR = 6.65), sniffed drug use (OR = 2.59), hospitalization (OR = 1.90), groups socially deprived by the lack of sewage disposal (OR = 2.53), and injection with glass syringe (OR = 1.52, with a borderline p value). The genotypes 1 (subtypes 1a, 1b), 2b and 3a were identified. The estimated population attributable risk for the ensemble of risk factors was 40%. Approximately 1.3 million individuals would be expected to be anti-HCV-positive in the country.
   Conclusions: The large estimated absolute numbers of infected individuals reveals the burden of the disease in the near future, giving rise to costs for the health care system and society at large. The known risk factors explain less than 50% of the infected cases, limiting the prevention strategies. Our findings regarding risk behaviors associated with HCV infection showed that there is still room for improving strategies for reducing transmission among drug users and nosocomial infection, as well as a need for specific prevention and control strategies targeting individuals living in poverty.
C1 [Pereira, Leila M. M. B.; Montarroyos, Ulisses R.; Alencar, Luis Claudio A.; Ximenes, Ricardo A. A.] Univ Pernambuco, Fac Ciencias Med Pernambuco, Hosp Univ Oswaldo Cruz, BR-50100130 Recife, PE, Brazil.
   [Pereira, Leila M. M. B.] Inst Figado Pernambuco, BR-50100130 Recife, PE, Brazil.
   [Martelli, Celina M. T.; Turchi, Marilia D.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Saude Colet, BR-74605050 Goiania, Go, Brazil.
   [Martelli, Celina M. T.; Montarroyos, Ulisses R.; Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Dept Trop Med, BR-50670420 Recife, PE, Brazil.
   [Moreira, Regina C.] Adolfo Lutz Inst, BR-01246902 Capital, SP, Brazil.
   [Merchan-Hamman, Edgar] Univ Brasilia, Fac Ciencias Saude, DSC, Fac Saude, BR-70910900 Brasilia, DF, Brazil.
   [Stein, Airton T.; Coral, Gabriela] Fundacao Univ Fed Ciencias Saude Porto Alegre, BR-90050170 Porto Alegre, RS, Brazil.
   [Cardoso, Maria Regina A.; Figueiredo, Gerusa M.] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, BR-01246904 Sao Paulo, Brazil.
   [Braga, Cynthia; Lima, Maria Luiza C.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50000230 Recife, PE, Brazil.
   [Crespo, Deborah] Secretaria Saude Publ Estado Para, BR-66040100 Belem, PA, Brazil.
   [Lima, Maria Luiza C.] Univ Fed Pernambuco, Dept Med Prevent & Social, BR-50670420 Recife, PE, Brazil.
   [Costa, Marcelo] Hosp Base DF, Area Especial, BR-70335900 Brasilia, DF, Brazil.
   [dos Santos, Alex A.] Inst Bioestat IBCT, BR-67150050 Belem, PA, Brazil.
RP Ximenes, RAA (corresponding author), Univ Pernambuco, Fac Ciencias Med Pernambuco, Hosp Univ Oswaldo Cruz, Rua Arnobio Marques,310Santo Amaro, BR-50100130 Recife, PE, Brazil.
EM ricardo.ximenes@pq.cnpq.br
RI AT, Stein/AAD-8391-2020; Stein, Airton T/E-3333-2010; Moreira, Regina
   C/B-1488-2016; Figueiredo, Gerusa M/B-6660-2014; Montarroyos,
   Ulisses/AAJ-7527-2020; Braga, Maria Cynthia/A-8204-2013
OI AT, Stein/0000-0002-8756-8699; Stein, Airton T/0000-0002-8756-8699;
   Moreira, Regina C/0000-0002-8208-8776; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Braga, Maria Cynthia/0000-0002-7862-6455; Turchi
   Martelli, Celina Maria/0000-0002-2491-0688; Cardoso, Maria
   Regina/0000-0001-6092-9215
FU National Hepatitis Study Group; Brazilian Ministry for Health; Pan
   American Health Organization; National Institute of Science and
   Technology for Health Technology Assessment (CNPq)National Council for
   Scientific and Technological Development (CNPq) [308311/2009-4,
   306489/2010-4, 306928/2010-8]
FX We thank to National Hepatitis Study Group whose names are listed below,
   by their collaboration and support in the organization and development
   of the study at local level: Zulma Medeiros (Centro de Pesquisas Aggeu
   Magalhaes-FIOCRUZ), Democrito Miranda Filho (Universidade de
   Pernambuco), Maria Mabel Melo (LACEN-PE), Conceicao Sa
   (Hemocentro-HEMOPI-PI), Carlos Henrique Nery Costa (Universidade Federal
   do Piaui), Arnaldo de Jesus Dominici (Universidade Federal do Maranhao),
   Maria das Gracas Aragao (Universidade Federal do Maranhao), Elizabeth de
   Souza Lima (LACEN-MA), Jose Milton de Castro Lima (Universidade Federal
   do Ceara), Jose Wellington Oliveira Lima (FUNASA-CE), Maria do Carmo
   Vidal Gadelha Lima (LACEN-CE), Gilmar Amorim de Sousa (Universidade
   Federal do Rio Grande do Norte), Marcia Araujo Barreto (Universidade
   Federal do Rio Grande do Norte), Manoel Jaime Xavier Filho (Universidade
   Federal da Paraiba), Joria Viana Guerreiro (Universidade Federal da
   Paraiba), Dayse Mercia Cavalcanti de Oliveira (FUNASA-AL), Maria
   Rosileide Bezerra Alves (Secretaria Estadual de Saude de Alagoas),
   Ivoneide Moreira de Oliveira Barros (LACEN-PB), Tereza Virginia Silva B.
   Nascimento (Universidade Federal de Sergipe), Lucia Maria Sayde de
   Azevedo Tavares (FUNASA-SE), Raymundo Parana Ferreira Filho
   (Universidade Federal da Bahia), Jose Tavares-Neto (Universidade Federal
   da Bahia), Maria Alice Sant'Anna Zarife (LACEN-BA), Rodrigo Sebba Aires
   (Secretaria Estadual de Saude de Goias), Fluvia Pereira A. da Silva
   (Secretaria Municipal de Saude de Goiania), Beatriz Maranhao Bariani
   (LACEN-GO), Jose Ivan Aguiar (Universidade Federal do Mato Grosso do
   Sul), Eugenio Barros (Secretaria Municipal de Saude-Campo Grande), Gilza
   Bastos dos Santos (LACEN-MS), Francisco Souto (Universidade Federal do
   Mato Grosso), Cor Jesus Fernando Fontes (Universidade Federal do Mato
   Grosso), Virginia Correia de Azevedo (LACEN-MT), Roberto de Melo Dusi
   (Secretaria Estadual de Saude - DF), Lidia Maria Pinto Luna (LACEN-DF),
   Jose Carlos da Fonseca (Universidade Federal do Amazonas), Leila Melo
   Brasil (Fundacao Medicina Tropical do Amazonas), Katia Biscuola de
   Campos (Programa Nacional de Prevencao e Controle das Hepatites
   Virais/SVS/Ministerio da Saude), Cirley Maria de Oliveira Lobato
   (Servico de Assistencia Especializada - Secretaria Estadual de Saude-
   AC), Monica de Breu Moraes (Secretaria Estadual de Saude- Acre, Programa
   Estadual de Hepatites), Janaina Mazaro (LACEN, Rio Branco, Acre), Maria
   de Nazare Miranda de Cavalcante (Secretaria de Estado da Saude de
   Amapa); Clovis Omar Sa Miranda (Secretaria de Saude do Estado do Amapa,
   Macapa, Amapa, Brazil), Marcia Socorro Cavalcante Porcy (LACEN-Amapa,
   Brazil), Ana Ruth Silva de Araujo (Universidade Federal do Amazonas),
   Marlucia da Silva Garrido (Fundacao de Vigilancia em Saude do
   Amazonas-Departamento de Vigilancia Epidemiologica), Marcia Noronha
   Barbosa (Fundacao de Vigilancia em Saude-AM), Raimundo Aldo Tavares
   (Secretaria Estadual de Saude Publica - PA), Maria de Fatima Chaves
   Oliveira (Secretaria Estadual de Saude-PA), Jose Americo Lozich de
   Aquino (LACEN-PA), Juan Miguel Villalobos-Salcedo (Universidade Federal
   de Rondonia), Fabio Luiz Storer (Faculdade Sao Lucas, Porto Velho- RO),
   Luiz Renerys de Lima Pinheiro (Secretaria de Saude de Estado da Saude de
   Roraima), Jacqueline de Aguiar Barros (Secretaria de Estado da Saude de
   Roraima), Juliana Cristina Ferreira Lima (LACEN-RR), Nadja Duarte
   Oliveira Souza (Universidade Federal do Tocantins), Arlete Lopes da
   Cunha Otoni (Secretaria de Estado da Saude do Tocantins); Gisele
   Christina O.; Silva (LACEN-TO), Parana Dominique Muzillo (Universidade
   Federal do Parana), Lucimar Bozza (Secretaria Municipal de Saude de
   Curitiba); Yatiyo Matsui Moriya (LACEN-Parana), Esther Buzaglo
   Dantas-Correa (Universidade Federal de Santa Catarina), Ana Cristina
   Vidor (Prefeitura Municipal de Florianopolis), Ana Duarte Cardoso
   (LACEN-SC), Alexandro Alves (Universidade Federal de Ciencias da Saude
   de Porto Alegre), Maria Eugenia Pinto (Universidade Federal de Ciencias
   da Saude de Porto Alegre), Zenaida Marion Alves Nunes Lyra Vidal
   (Instituto de Pesquisa Biologica IPB Lacen RS), Angelica Espinosa
   Barbosa Miranda (Universidade Federal do Espirito Santo), Moacir Soprani
   (Secretaria Estadual de Saude do Espirito Santo), Patricia Rolim Prates
   (LACEN-ES), Cristiane Alves Villela-Nogueira (Universidade Federal do
   Rio de Janeiro), Mariza Miranda Theme-Filha (ENSP-FIOCRUZ), Carlos
   Augusto da Silva Fernandes (LACEN - RJ), Angela Maria Miranda
   Spina(Instituto Adolfo Lutz), Flair Jose Carrilho (Universidade de Sao
   Paulo), Antonio Alci Barone (Universidade de Sao Paulo), Rosangela
   Teixeira (Universidade Federal de Minas Gerais-UFMG); Keli Bahia
   Felicissimo Zocratto (Centro Universitario Newton Paiva), Sonia
   Conceicao Diniz (Secretaria de Estado da Saude de Minas Gerais).; We
   also thank to the Brazilian Ministry for Health and Pan American Health
   Organization by the financial support, to the University of Pernambuco
   Foundation by the administrative support and to the National Institute
   of Science and Technology for Health Technology Assessment (CNPq) by
   providing scholarships to R.A.A.X.(n. 308311/2009-4), C.M.T.M. (n.
   306489/2010-4) and M.D.T.(n. 306928/2010-8).
CR Oliveira MDA, 2009, J CLIN VIROL, V44, P200, DOI 10.1016/j.jcv.2008.12.008
   Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436
   Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297
   Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004
   Brazilian Ministry of Health, 2010, B EP HEP VIR 2010
   BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174
   Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007
   Carneiro MAS, 2001, MEM I OSWALDO CRUZ, V96, P765, DOI 10.1590/S0074-02762001000600003
   Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1
   Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114
   Ximenes RAD, 2010, CAD SAUDE PUBLICA, V26, P1693, DOI 10.1590/S0102-311X2010000900003
   Delarocque-Astagneau E, 2010, J VIRAL HEPATITIS, V17, P435, DOI 10.1111/j.1365-2893.2009.01196.x
   Duailibi Lígia Bonacim, 2008, Cad. Saúde Pública, V24, ps545, DOI 10.1590/S0102-311X2008001600007
   Ferreira OF, 2003, REV SAUDE PUBL, V37, P751, DOI 10.1590/S0034-89102003000600010
   FOCACCIA R, 1998, BRAZ J INFECT DIS, V2, P269
   Fonseca AM, 2010, CIENC SAUDE COLETIVA, V15, P663, DOI 10.1590/S1413-81232010000300008
   FONSECA JC, 1999, GASTROENTEROLOGIA S1, V18, pS3
   Freitas SZ, 2008, MEM I OSWALDO CRUZ, V103, P405, DOI 10.1590/S0074-02762008000400016
   Irving WL, 2008, EURO SURVEILL, V13
   Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x
   King LA, 2009, EUR J PUBLIC HEALTH, V19, P527, DOI 10.1093/eurpub/ckp112
   Lopes Carmen L R, 2009, Rev. Saúde Pública, V43, P43, DOI 10.1590/S0034-89102009000800008
   Lunge VR, 2012, AIDS RES HUM RETROV, V28, P215, DOI 10.1089/aid.2011.0096
   McQuillan GM, 2010, NCHS DATA BRIEF PREV, V27
   Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734
   Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x
   Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046
   Nishioka Sérgio de A., 2002, Braz J Infect Dis, V6, P172, DOI 10.1590/S1413-86702002000400004
   Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240
   Perone C, 2008, REV SOC BRAS MED TRO, V41, P238, DOI 10.1590/S0037-86822008000300003
   Ivantes CAP, 2010, BRAZ J INFECT DIS, V14, P483, DOI 10.1590/S1413-86702010000500010
   Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI
   Rantala M., 2008, EURO SURVEILL, V13
   Schlesselmann JJ, 1982, CASE CONTROL STUDIES
   Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4
   Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009
   The Brazilian Institute of Geography and Statistics (IBGE), DEM CENS 2000 CHAR P
   Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562
   Zarife MAS, 2006, T ROY SOC TROP MED H, V100, P663, DOI 10.1016/j.trstmh.2005.09.009
NR 42
TC 89
Z9 97
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 1
PY 2013
VL 13
AR 60
DI 10.1186/1471-2334-13-60
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA 096KI
UT WOS:000315402300001
PM 23374914
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bresani, CC
   Braga, MC
   Felisberto, DF
   Tavares-de-Melo, CEL
   Salvi, DB
   Batista, M
AF Bresani, Cristiane Campello
   Braga, Maria Cynthia
   Felisberto, Daniel Falcao
   Lopes Tavares-de-Melo, Carlos Eduardo
   Salvi, Debora Bresani
   Batista-Filho, Malaquias
TI Accuracy of erythrogram and serum ferritin for the maternal anemia
   diagnosis (AMA): a phase 3 diagnostic study on prediction of the
   therapeutic responsiveness to oral iron in pregnancy
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Anemia; Iron-deficiency; Diagnosis; Pregnancy; Erythrocyte indices;
   Ferritins; Sensitivity; Specificity; Adverse effects; Patient
   compliance; Ferrous sulfate
ID SUPPLEMENTATION; WOMEN; HEMOGLOBIN; REGIMENS; EFFICACY; INDEXES
AB Background: Pregnancy anemia remains as a public health problem, since the official reports in the 70's. To guide the treatment of iron-deficiency anemia in pregnancy, the haemoglobin concentration is the most used test in spite of its low accuracy, and serum ferritin is the most reliable test, although its cutoff point remains an issue.
   Methods/design: The aim of this protocol is to verify the accuracy of erythrocyte indices and serum ferritin (studied tests) for the diagnosis of functional iron-deficiency in pregnancy using the iron-therapy responsiveness as the gold-standard. This is an ongoing phase III accuracy study initiated in August 2011 and to be concluded in April 2013. The subjects are anemic pregnant women (haemoglobin concentration < 11.0 g/dL) attended at a low-risk prenatal care center in the Northeast of Brazil. The sample size (n 278) was calculated to estimate sensitivity of 90% and 80% of specificity with relative error of 10% and power of 95%. This study has a prospective design with a before-after intervention of 80 mg of daily oral iron during 90 days and will be analyzed as a delayed-type cross-sectional study. Women at the second trimester of pregnancy are being evaluated with clinical and laboratorial examinations at the enrollment and monthly. The 'responsiveness to therapeutic test with oral iron' (gold-standard) was defined to an increase of at least 0.55 Z-score in haemoglobin after 4 weeks of treatment and a total dose of 1200 mg of iron. At the study conclusion, sensitivities, specificities, predictive values, likelihood ratios and areas under the ROC (Receiver Operating Characteristic) curves of serum ferritin and erythrocyte indices (red blood cell count, haematocrit, haemoglobin concentration, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, red blood cell distribution width, reticulocyte count) will be tested. The compliance and adverse effects are considered confounding variables, since they are the main obstacles for the iron-therapy responsiveness.
   Discussion: This study protocol shows a new approach on iron-deficiency anemia in pregnancy from a functional point of view that could bring some insights about the diagnostic misclassifications arising from the dynamic physiologic changes during the gestational cycle.
C1 [Bresani, Cristiane Campello; Salvi, Debora Bresani; Batista-Filho, Malaquias] Inst Med Integral Prof Fernando Figueira IMIP, Nutr Res Grp, BR-50070550 Recife, PE, Brazil.
   [Bresani, Cristiane Campello] MPS, INSS, BR-50040010 Recife, PE, Brazil.
   [Braga, Maria Cynthia; Batista-Filho, Malaquias] Postgrad Program Maternal & Child Hlth IMIP, BR-50070550 Recife, PE, Brazil.
   [Braga, Maria Cynthia] Fiocruz MS, CPQAM, Fundacao Oswaldo Cruz, Postgrad Program Publ Hlth,Ctr Pesquisas Aggeu Ma, BR-50670420 Recife, PE, Brazil.
   [Felisberto, Daniel Falcao; Lopes Tavares-de-Melo, Carlos Eduardo] FPS, BR-51200060 Recife, PE, Brazil.
RP Bresani, CC (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Nutr Res Grp, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM cristiane.bresani@inss.gov.br
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Bresani,
   Cristiane/0000-0002-1295-0885
CR Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s
   Associacao Brasileira de Empresas de Pesqui- sas, 2010, CRIT CLASS EC BRAS
   Atalah E, 1997, REV MED CHILE, V125, P1429
   Beaton G, 1999, EFFICACY INTERMITTEN
   Beaton GH, 2000, AM J CLIN NUTR, V72, p265S, DOI 10.1093/ajcn/72.1.265S
   Bresani CC, 2007, BRAZILIAN J MOTHE S1, V7, P15
   Casanova BF, 2005, AM J OBSTET GYNECOL, V193, P460, DOI 10.1016/j.ajog.2004.12.008
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897
   de Souza AI, 2004, REV PANAM SALUD PUBL, V15, P313, DOI 10.1590/S1020-49892004000500005
   de Souza AI, 2009, CAD SAUDE PUBLICA, V25, P1225, DOI 10.1590/S0102-311X2009000600005
   Ekstrom EC, 2002, AM J CLIN NUTR, V76, P1392
   Ekstrom EC, 1996, AM J CLIN NUTR, V64, P368
   Hyder SMZ, 2002, J HEALTH POPUL NUTR, V20, P175
   Knottnerus JA, 2002, EVIDENCE BASE CLIN D, P39
   Kumar A, 2005, INT J GYNECOL OBSTET, V89, P7, DOI 10.1016/j.ijgo.2005.01.016
   Makrides M, 2003, AM J CLIN NUTR, V78, P145
   Milman N, 2000, ACTA OBSTET GYN SCAN, V79, P89, DOI 10.1034/j.1600-0412.2000.079002089.x
   Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2
   Mumtaz Z, 2000, J NUTR, V130, P2697
   MURPHY JF, 1986, LANCET, V1, P992
   Pena-Rosas JP, INTERMITTENT ORAL IR, DOI 10.1002/14651858.CD009997.pub7
   Petraglia B, 1994, J BRAS GINECOL, V1014, P139
   Puolakka J, 1980, Acta Obstet Gynecol Scand Suppl, V95, P57
   Rasmussen KM, 2001, J NUTR, V131, p590S, DOI 10.1093/jn/131.2.590S
   Reveiz L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003094.pub2
   Sackett D, 2002, EVIDENCE BASE CLIN D, P19
   Saha Lekha, 2007, MedGenMed, V9, P1
   Scholl TO, 2000, J NUTR, V130, p443S, DOI 10.1093/jn/130.2.443S
   STEER P, 1995, BRIT MED J, V310, P489, DOI 10.1136/bmj.310.6978.489
   Stoltzfus RJ, 2003, FOOD NUTR BULL, V24, pS99, DOI [10.1177/15648265030244S206, DOI 10.1177/15648265030244S206]
   Tam KF, 1999, OBSTET GYNECOL, V93, P427, DOI 10.1016/S0029-7844(98)00422-0
   THOMPSON WG, 1988, AM J OBSTET GYNECOL, V159, P1132, DOI 10.1016/0002-9378(88)90429-2
   United Nations Children's Fund/World Health Organization, 1999, PREV CONTR IR DEF AN
   van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x
   VANBUUL EJA, 1995, NETH J MED, V46, P73, DOI 10.1016/0300-2977(94)00104-H
   Volpi E, 1991, Minerva Ginecol, V43, P387
   World Health Organization, 1975, WHO TECHN REP SER, V580
   World Health Organization, 2008, WORLDW PREV AN 1993
   World Health Organization, 2001, IR DEF AN ASS PREV C
   Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S
   Yip R, 1998, MMWR RECOMM REP, V47, P1
   Zhou SJ, 2009, EUR J CLIN NUTR, V63, P183, DOI 10.1038/sj.ejcn.1602926
NR 42
TC 5
Z9 6
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD JAN 16
PY 2013
VL 13
AR 13
DI 10.1186/1471-2393-13-13
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 108AR
UT WOS:000316263500001
PM 23324362
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lima, AW
   Medeiros, Z
   dos Santos, ZC
   da Costa, GM
   Braga, C
AF Lima, Ana Wladia
   Medeiros, Zulma
   dos Santos, Zailde Carvalho
   da Costa, Gertrudes Monteiro
   Braga, Cynthia
TI Adverse reactions following mass drug administration with
   diethylcarbamazine in lymphatic filariasis endemic areas in the
   Northeast of Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Lymphatic filariasis; MDA program; Adverse drug reactions; Prevalence
   study
ID BANCROFTIAN FILARIASIS; ORISSA STATE; PROGRAM; RECIFE; INFECTION;
   EFFICACY; ALBENDAZOLE; COSTS; INDIA
AB Introduction: The Global Programme to Eliminate Lymphatic Filariasis was launched with the goal of eliminating this disease via the annual mass drug administration (MDA) of a single dose of antifilarial drugs. Adverse drug reactions following MDA are a major factor of poor treatment adherence in several countries. This study assessed the occurrence of adverse drug reactions (ADRs) following the first round of mass treatment in two communities treated with different dosages of diethylcarbamazine (DEC) in the City of Recife, Brazil. Methods: Population-based cross-sectional surveys were conducted in a random sample of the population living in both communities (Areas I and II). The dose of DEC recommended by the WHO (6mg/kg) was calculated based on the individual's weight-for-age. In Area II, weight differences between the genders were also considered when determining dosage. Data were obtained through interviews conducted in the first 12 to 48h and on the 5th day after MDA during household visits. Results: A total of 487 and 365 individuals were interviewed in Areas I and II, respectively. The prevalence of ADRs in Area I (23.6; 95% CI: 19.1-29.5) was higher than in Area II (16.2; 95% CI: 11.9-21.5)(p=0.0078). The prevalence of ADRs among females was higher than in males in Area I (p=0.0021). In Area II, no significant difference between the genders was observed (p=0.1840). Age was not associated with ADRs in either area. Conclusions: Adjusting MDA dosage schedules according to weight-for-age and sex may be may contribute to reduce the occurrence of adverse drug reactions in the population.
C1 [Lima, Ana Wladia; dos Santos, Zailde Carvalho] Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil.
   [Medeiros, Zulma; Braga, Cynthia] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [da Costa, Gertrudes Monteiro] Secretaria Saude Recife, Recife, PE, Brazil.
RP Lima, AW (corresponding author), Ctr Acad Vitoria UFPE, Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil.
EM anwladia@bol.com.br
RI Braga, Maria Cynthia/A-8204-2013; Medeiros, Zulma/J-5407-2015
OI Braga, Maria Cynthia/0000-0002-7862-6455; Medeiros,
   Zulma/0000-0002-4434-955X
CR ALBUQUERQUE MFM, 1995, T ROY SOC TROP MED H, V89, P373, DOI 10.1016/0035-9203(95)90014-4
   ANDRADE LD, 1995, T ROY SOC TROP MED H, V89, P319, DOI 10.1016/0035-9203(95)90561-8
   [Anonymous], 2003, Wkly Epidemiol Rec, V78, P315
   [Anonymous], 2010, Wkly Epidemiol Rec, V85, P365
   Babu B, 2004, TROP MED INT HEALTH, V9, P702, DOI 10.1111/j.1365-3156.2004.01247.x
   Babu BV, 2008, T ROY SOC TROP MED H, V102, P1207, DOI 10.1016/j.trstmh.2008.05.023
   Babu BV, 2006, T ROY SOC TROP MED H, V100, P464, DOI 10.1016/j.trstmh.2005.07.016
   Babu BV, 2003, TROP MED INT HEALTH, V8, P1102, DOI 10.1046/j.1360-2276.2003.01146.x
   Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309
   Braga C, 2005, REV SOC BRAS MED TRO, V38, P224, DOI 10.1590/S0037-86822005000300003
   Cantey PT, 2010, TROP MED INT HEALTH, V15, P224, DOI 10.1111/j.1365-3156.2009.02443.x
   DREYER G, 1994, T ROY SOC TROP MED H, V88, P232, DOI 10.1016/0035-9203(94)90311-5
   Dreyer G, 1997, Rev Soc Bras Med Trop, V30, P229, DOI 10.1590/S0037-86821997000300010
   El-Setouhy M, 2007, AM J TROP MED HYG, V77, P1069, DOI 10.4269/ajtmh.2007.77.1069
   Freitas H, 2008, REV SOC BRAS MED TRO, V41, P212, DOI 10.1590/S0037-86822008000200018
   Gunawardena S, 2008, TROP MED INT HEALTH, V13, P1153, DOI 10.1111/j.1365-3156.2008.02120.x
   Horton J, 2000, PARASITOLOGY, V121, pS147, DOI 10.1017/S0031182000007423
   IBGE (Instituto Brasileiro de Geografia e Estatistica), 2000, CENS DEM 2000
   KUCZMARSKI RJ, 2000, CDC GROWTH CHARTS US, P1
   Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x
   Mattos D, 2008, REV SOC BRAS MED TRO, V41, P29, DOI 10.1590/S0037-86822008000100006
   McLaughlin SI, 2003, AM J TROP MED HYG, V68, P568, DOI 10.4269/ajtmh.2003.68.568
   Medeiros Z, 1999, TROP MED INT HEALTH, V4, P499, DOI 10.1046/j.1365-3156.1999.00427.x
   Medeiros Z, 2008, ANN TROP MED PARASIT, V102, P509, DOI 10.1179/136485908X311821
   Nujum ZT, 2011, INT HEALTH, V3, P22, DOI 10.1016/j.inhe.2010.12.001
   OTTESEN EA, 1985, REV INFECT DIS, V7, P341
   Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491
   Pani S. P., 2005, Journal of Communicable Diseases, V37, P12
   Reddy GS, 2000, TROP MED INT HEALTH, V5, P779, DOI 10.1046/j.1365-3156.2000.00644.x
   Rodenburg EM, 2011, BRIT J CLIN PHARMACO, V71, P95, DOI 10.1111/j.1365-2125.2010.03811.x
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P437
   World Health Organization, 2011, LYMPH FIL
   World Health Organization (WHO), 2011, LYMPH FIL EL
NR 33
TC 10
Z9 10
U1 0
U2 7
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2012
VL 45
IS 6
BP 745
EP 750
DI 10.1590/S0037-86822012000600017
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 067HZ
UT WOS:000313286200017
PM 23295880
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Figueiredo, G
   Moreira, R
   Cardoso, MR
   Pereira, L
   Coral, G
   Stein, A
   Braga, C
   Montarroyos, U
   Ximenes, R
AF Figueiredo, G.
   Moreira, R.
   Cardoso, M. R.
   Pereira, L.
   Coral, G.
   Stein, A.
   Braga, C.
   Montarroyos, U.
   Ximenes, R.
TI Impact of immunization against hepatitis B virus in areas of high
   endemicity in Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Figueiredo, G.] Inst Trop Med, Sao Paulo, Brazil.
   [Moreira, R.] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Cardoso, M. R.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Pereira, L.; Braga, C.] Univ Estadual Pernambuco, Recife, PE, Brazil.
   [Coral, G.; Stein, A.] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil.
   [Montarroyos, U.] Univ Fed Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
RI Moreira, Regina C/B-1488-2016; Cardoso, Maria Regina A/J-7280-2012;
   Montarroyos, Ulisses/AAJ-7527-2020; Figueiredo, Gerusa M/B-6660-2014;
   Braga, Maria Cynthia/A-8204-2013
OI Moreira, Regina C/0000-0002-8208-8776; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Braga, Maria Cynthia/0000-0002-7862-6455
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2012
VL 16
SU 1
BP E125
EP E126
DI 10.1016/j.ijid.2012.05.286
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA 999YX
UT WOS:000308353100271
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Maruza, M
   Albuquerque, MFPM
   Braga, MC
   Barbosa, MTS
   Byington, R
   Coimbra, I
   Moura, LV
   Batista, JDL
   Diniz, GTN
   Miranda, DB
   Lacerda, HR
   Rodrigues, LC
   Ximenes, RAA
AF Maruza, M.
   Albuquerque, M. F. P. M.
   Braga, M. C.
   Barbosa, M. T. S.
   Byington, R.
   Coimbra, I.
   Moura, L. V.
   Batista, J. D. L.
   Diniz, G. T. N.
   Miranda-Filho, D. B.
   Lacerda, H. R.
   Rodrigues, L. C.
   Ximenes, R. A. A.
TI Survival of HIV-infected patients after starting tuberculosis treatment:
   a prospective cohort study
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE AIDS; risk; death
ID ACTIVE ANTIRETROVIRAL THERAPY; RISK-FACTORS; MORTALITY; DEATH;
   PREDICTORS; ANEMIA; ERA
AB OBJECTIVES: To estimate the probability of survival and to evaluate risk factors for death in a cohort of persons living with human immunodeficiency virus (PLHIV) who had started tuberculosis (TB) treatment. METHODS: A prospective cohort study was conducted between June 2007 and December 2009 with HIV-infected patients who had started anti-tuberculosis treatment in the State of Pernambuco, Brazil. Survival data were analysed using the Kaplan-Meier estimator, the log-rank test and the Cox model. Hazard ratios and their respective 95%CIs were estimated.
   RESULTS: Of a cohort of 2310 HIV-positive individuals, 333 patients who had commenced treatment for TB were analysed. The mortality rate was 5.25 per 10 000 person-years (95%CI 4.15-6.63). The probability of survival at 30 months was 74%. Risk factors for death in the study population were being female, age >= 30 years, having anaemia, not using highly active antiretroviral therapy (HAART) during treatment for TB and disseminated TB. Protective factors for death were a CD4 lymphocyte count >200 cells/mm(3) and treatment for TB having started in an out-patient clinic.
   CONCLUSIONS: The use of HAART can prevent deaths among HIV-TB patients, corroborating the efficacy of starting HAART early in individuals with TB.
C1 [Maruza, M.; Coimbra, I.; Moura, L. V.; Miranda-Filho, D. B.; Lacerda, H. R.; Ximenes, R. A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Albuquerque, M. F. P. M.; Braga, M. C.; Batista, J. D. L.; Diniz, G. T. N.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Barbosa, M. T. S.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Byington, R.] Inst Nacl Canc, Rio De Janeiro, Brazil.
   [Rodrigues, L. C.] London Sch Hyg & Trop Med, London WC1, England.
RP Maruza, M (corresponding author), Bloco A do Hosp Clin, Ave Moraes Rego Sn,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM magdamaruza@yahoo.com.br
RI Batista, Joanna d'Arc L/O-9933-2014; Iats, Inct/K-2300-2013; Braga,
   Maria Cynthia/A-8204-2013
OI Batista, Joanna d'Arc L/0000-0002-3703-2845; Braga, Maria
   Cynthia/0000-0002-7862-6455; Rodrigues, Laura Cunha/0000-0001-9008-660X
FU Brazilian Ministry of Health/DST/AIDS/UNESCO [CSV 182/06]; Ministry of
   Science and Technology-CNPq/MS-SCTIE-DECIT [10567/2006-0]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [308311/2009-4, 301779/2009-0, 310911/2009-5]; Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco-FACEPE [IBPG 0898-4.06/08]
FX The authors thank the Brazilian Ministry of Health/DST/AIDS/UNESCO
   (Doencas Sexualmente Transmissiveis/Acquired Immune-Deficiency
   Syndrome/United Nations Educational, Scientific and Cultural
   Organization) Programme (Project CSV 182/06) and the Ministry of Science
   and Technology-CNPq/MS-SCTIE-DECIT (Process no. 10567/2006-0) for
   financial support. The authors were partially funded by CNPq
   (scholarship no. 308311/2009-4 for RAAX, scholarship no. 301779/2009-0
   for MFPMA and study grant no. 310911/2009-5 for HRL) and Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE
   (scholarship no. IBPG 0898-4.06/08 for JDLB).
CR ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7
   Aerts D, 2004, INT J TUBERC LUNG D, V8, P785
   Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506
   Blanc FX, 2007, J INFECT DIS, V196, pS46, DOI 10.1086/518658
   Breen RAM, 2006, J INFECT DIS, V193, P1437, DOI 10.1086/503437
   Catala L, 2011, INT J TUBERC LUNG D, V15, P263
   Ciglenecki I, 2007, INT J TUBERC LUNG D, V11, P1121
   Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676
   Fangman John J W, 2005, Curr Hematol Rep, V4, P95
   Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3
   Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7
   Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52
   *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E
   Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848
   Laguardia Josué, 2003, Rev. Esp. Salud Publica, V77, P553, DOI 10.1590/s1135-57272003000500005
   Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028
   Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86
   Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475
   Ministerio da Saude Secretaria de Vigilancia em Saude Brasil, 2003, PROGR NAC DST AIDS C
   Ministerio da Saude Secretaria de Vigilancia em Saude Brasil, 2008, PROGR NAC DST AIDS R
   Ministerio da Saude Secretaria de Vigilancia em Saude Brasil Departamento de DST Aids e Hepatites Virais, 2009, B EP AIDS AN 6 1 JUL
   Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010
   Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012
   Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409
   Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001
   Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e
   Santha T, 2002, INT J TUBERC LUNG D, V6, P780
   Santos R P, 2011, CLIN DEV IMMUNOL
   Sistema de Informacao de Agravos de Notificacao/Secretaria Estadual de Saude/Doencas Sexualmente Transmissiveis-Acquired Immune-Deficiency Syndrome-Programa Estadual Pernambuco, 2010, DAD INF PEL HIV ENTR
   The Global Coalition on Women and AIDS (GCWA), 2010, TACKL TB HIV WOM URG
   Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7
   Whalen C, 1996, AM J RESP CRIT CARE, V153, P1977, DOI 10.1164/ajrccm.153.6.8665064
   Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020
   WHO, 2009, WHOHTMTB2009411
   *WHO, 2009, WHOHTMTB2009426
   World Health Organization, 2009, WHOHTMTB2009420
NR 36
TC 16
Z9 16
U1 0
U2 5
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD MAY
PY 2012
VL 16
IS 5
BP 618
EP 624
DI 10.5588/ijtld.11.0110
PG 7
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 937YR
UT WOS:000303700600012
PM 22410415
DA 2020-12-01
ER

PT J
AU Figueiro, AC
   Hartz, ZMD
   de Brito, CAA
   Samico, I
   Filha, NTD
   Cazarin, G
   Braga, C
   Cesse, EAP
AF Figueiro, Ana Claudia
   de Araujo Hartz, Zulmira Maria
   Antunes de Brito, Carlos Alexandre
   Samico, Isabella
   de Siqueira Filha, Noemia Teixeira
   Cazarin, Gisele
   Braga, Cynthia
   Pessoa Cesse, Eduarda Angela
TI Death from dengue fever as a sentinel event for evaluation of quality of
   healthcare: a case study in two municipalities in Northeast Brazil, 2008
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Dengue; Health Evaluation; Delivery of Health Care; Sentinel
   Surveillance
ID HEMORRHAGIC-FEVER; MEDICAL-CARE
AB Despite the existing resources for adequate dengue patient care in the Brazilian healthcare system, the case-fatality rate for the disease is still high in the country. In order to identify factors associated with dengue-related death, this study evaluated quality of care according to the degree of implementation of specific measures, the technical and scientific quality of care, and access to health services in two municipalities (counties) in Northeast Brazil. An evaluative study of the implementation analysis type was performed, with death from dengue as the sentinel event for quality of care. To assess the degree of implementation and quality of care, the study scored the interview criteria and patient chart analysis; access was evaluated by thematic analysis. As for structure and process, the health services were found to be partially adequate (70%). No geographic or economic barriers were found to explain the occurrence of deaths. Technical and scientific quality failed to achieve adequate levels in the municipalities (46% and 30%) or in the specific services, and clinical management of dengue by the health services proved insufficient.
C1 [Figueiro, Ana Claudia; Samico, Isabella; de Siqueira Filha, Noemia Teixeira; Cazarin, Gisele] Inst Med Integral Prof Fernando Figueira, BR-51020320 Recife, PE, Brazil.
   [de Araujo Hartz, Zulmira Maria] Univ Nova Lisboa, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Braga, Cynthia; Pessoa Cesse, Eduarda Angela] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP Figueiro, AC (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Jose Trajano 170,Apto 301, BR-51020320 Recife, PE, Brazil.
EM anaclaudiafigueiro@yahoo.com.br
RI Braga, Maria Cynthia/A-8204-2013; Hartz, Zulmira/J-4596-2012; Hartz,
   Zulmira/Y-6775-2019
OI Braga, Maria Cynthia/0000-0002-7862-6455; Hartz,
   Zulmira/0000-0001-9780-9428; Hartz, Zulmira/0000-0001-9780-9428
CR Australian Institute of Health and Welfare/Australian Commission on Safety and Quality in Health Care, SENT EV AUSTR PUBL H
   Bellato R, 2008, ATENCAO BASICA INTEG, P167
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Cavalcante Maria das Graças Santos, 2006, Rev. Bras. Saude Mater. Infant., V6, P437, DOI 10.1590/S1519-38292006000400011
   Champagne F, 2009, EVALUATION CONCEPTS, P225
   Dipartimento della Qualita Direzione Generale della Programmazione Sanitaria dei Livelli di Assistenza e dei Principi Etici di Sistema Ufficio III Ministero del Lavoro della Salute e delle Politiche Sociali, LIV AS PRINC ET SIST
   DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969
   DONABEDIAN A, 1990, ARCH PATHOL LAB MED, V114, P1115
   Frenk J, 1985, Salud Publica Mex, V27, P438
   Frias Paulo G., 2002, J. Pediatr. (Rio J.), V78, P509, DOI 10.1590/S0021-75572002000600012
   Gusmao-Filho FAR, 2008, THESIS CTR PESQ AGG
   Halstead S. B., 2009, F1000 MED REP, V1, P73
   Hartz ZMD, 1996, REV SAUDE PUBL, V30, P310
   Hartz Zulmira M. de Araújo, 2004, Cad. Saúde Pública, V20, pS331, DOI 10.1590/S0102-311X2004000800026
   Kalayanarooj S, 2007, AM J TROP MED HYG, V77, P534, DOI 10.4269/ajtmh.2007.77.534
   Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262
   Lopes Rosana Machado, 2004, Cad. Saúde Pública, V20, pS283, DOI 10.1590/S0102-311X2004000800022
   Medina MG, 2006, THESIS U FEDERAL BAH
   *MIN SAUD FUND NAC, 2002, PROGR NAC CONTR DENG
   RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104
   Samico Isabella, 2005, Rev. Bras. Saude Mater. Infant., V5, P229, DOI 10.1590/S1519-38292005000200012
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2010, DENG CAS DOENC BRAS
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2007, DENG DIAGN MAN CLIN
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2009, DIR NAC PREV CONTR E
   Singhi S, 2007, J PEDIAT-BRAZIL, V83, pS22, DOI 10.1590/S0021-75572007000300004
   Teixeira Maria da Glória, 2005, Cad. Saúde Pública, V21, P1307, DOI 10.1590/S0102-311X2005000500002
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   The Joint Commission, SENT EV POL PROC 200
   Torres EM, 2006, REV PANAM SALUD PUBL, V20, P60, DOI 10.1590/S1020-49892006000700013
   Uchimura Kátia Yumi, 2002, Cad. Saúde Pública, V18, P1561, DOI 10.1590/S0102-311X2002000600009
   Vuori H., 1991, DIVULG SAUDE DEBATE, V3, P17
   World Health Organization, DENG DENG HEM FEV FA
   YIN R. K., 2005, ESTUDO CASO PLANEJAM
NR 34
TC 15
Z9 16
U1 0
U2 2
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD DEC
PY 2011
VL 27
IS 12
BP 2373
EP 2385
DI 10.1590/S0102-311X2011001200009
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 873MF
UT WOS:000298886700009
PM 22218580
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Ferreira, ALCG
   Souza, AI
   Pessoa, RE
   Braga, C
AF Carneiro Gomes Ferreira, Ana Laura
   Souza, Ariani Impieri
   Pessoa, Rafaela Evangelista
   Braga, Cynthia
TI The effectiveness of contraceptive counseling for women in the
   postabortion period: an intervention study
SO CONTRACEPTION
LA English
DT Article
DE Abortion; Contraception; Counseling; Postabortion
ID UNINTENDED PREGNANCY; RANDOMIZED-TRIAL; ABORTION; CARE; TERMINATION;
   GUATEMALA
AB Background: Brazilian women who have undergone abortion use contraceptive methods; however, their use of contraceptive methods is inconsistent and/or inappropriate.
   Study Design: This randomized trial evaluated the effectiveness of a personalized counseling on contraceptive acceptability and its use for postabortion women in the northeast of Brazil. It was conducted in July 2008 to September 2009, enrolling 246 women randomly distributed in intervention (n=123) and control (n=123) groups. An intention-to-treat analysis was performed.
   Results: In the follow-up, 98.4% women in the intervention group were using contraceptive methods compared with 70.6% women in the control group (p<.001). The probability of adherence and of the use of any kind of contraceptive method 6 months after the abortion was 41% greater in the intervention group.
   Conclusions: The strategy on individualized contraceptive counseling increased the acceptance and the use of contraceptive methods and increased the adequate use of the methods. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Carneiro Gomes Ferreira, Ana Laura; Souza, Ariani Impieri; Pessoa, Rafaela Evangelista; Braga, Cynthia] Inst Med Integral Prof Fernando Figueira IMIP, Res Dept, BR-50070550 Recife, PE, Brazil.
RP Ferreira, ALCG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Res Dept, Rua Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM analaura@imip.org.br
RI de Souza, Ariani Impieri/AAR-6884-2020; Souza, Ariani I/C-1568-2015;
   Iats, Inct/K-2300-2013; Braga, Maria Cynthia/A-8204-2013
OI de Souza, Ariani Impieri/0000-0002-7917-5983; Souza, Ariani
   I/0000-0002-7917-5983; Braga, Maria Cynthia/0000-0002-7862-6455
FU IMIP
FX We would like to thank IMIP for its support.
CR *A GUTTM I, 2003, ADD IT BEN INV SEX R
   *A GUTTM I, 2009, AB WORLDW DEC UN PRO
   Alves SV, 2007, REPROD HEALTH MATTER, V15, P134, DOI 10.1016/S0968-8080(07)30326-1
   Becker S, 2008, CONTRACEPTION, V78, P424, DOI 10.1016/j.contraception.2008.06.011
   Bender SS, 2004, CONTRACEPTION, V69, P481, DOI 10.1016/j.contraception.2003.12.014
   Ferreira ALCG, 2009, EUR J CONTRACEP REPR, V14, P1, DOI 10.1080/13625180802549970
   Colwell HH, 2006, QUAL LIFE RES, V15, P1621, DOI 10.1007/s11136-006-0026-8
   Dehlendorf C, 2010, CONTRACEPTION, V81, P292, DOI 10.1016/j.contraception.2009.11.006
   DELMANTO C, 2007, CODIGO PENAL COMENTA
   Fasubaa O B, 2004, J Obstet Gynaecol, V24, P298, DOI 10.1080/01443610410001660913
   Homco JB, 2009, CONTRACEPTION, V80, P569, DOI 10.1016/j.contraception.2009.05.127
   Johnson BR, 2002, STUD FAMILY PLANN, V33, P195, DOI 10.1111/j.1728-4465.2002.00195.x
   Kestler E, 2006, REPROD HEALTH MATTER, V14, P138, DOI 10.1016/S0968-8080(06)27235-5
   Kestler E, 2009, CONTRACEPTION, V80, P68, DOI 10.1016/j.contraception.2009.01.006
   LAHTEENMAKI P, 1993, ANN MED, V25, P185, DOI 10.3109/07853899309164166
   *MIN SAUD BRAS, 2008, REL AB SAUD PUBL 20
   Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9
   Moreau C, 2007, CONTRACEPTION, V76, P267, DOI 10.1016/j.contraception.2007.06.008
   Nobili MP, 2007, PATIENT EDUC COUNS, V65, P361, DOI 10.1016/j.pec.2006.09.004
   *PREF REC, 2007, SAUD MULH
   Rasch V, 2005, STUD FAMILY PLANN, V36, P301, DOI 10.1111/j.1728-4465.2005.00072.x
   Rasch V, 2004, TROP MED INT HEALTH, V9, P399, DOI 10.1111/j.1365-3156.2004.01197.x
   RASH V, 2008, BMC PREGNANCY CHILDB, V32, P1
   Schunmann C, 2006, HUM REPROD, V21, P2296, DOI 10.1093/humrep/del168
   Speroff L, 2008, CONTRACEPTION, V78, P90, DOI 10.1016/j.contraception.2008.04.005
   Weisman CS, 2002, WOMEN HEALTH ISS, V12, P79, DOI 10.1016/S1049-3867(01)00147-5
   Zhu JL, 2009, EUR J CONTRACEP REPR, V14, P46, DOI 10.1080/13625180802512994
NR 27
TC 25
Z9 25
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD OCT
PY 2011
VL 84
IS 4
BP 377
EP 383
DI 10.1016/j.contraception.2011.02.003
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 829DY
UT WOS:000295557900007
PM 21920193
DA 2020-12-01
ER

PT J
AU de Melo, MMDC
   de Souza, WV
   de Lima, MLC
   Braga, C
AF Dantas Cabral de Melo, Marcia Maria
   de Souza, Wayner Vieira
   Carvalho de Lima, Maria Luiza
   Braga, Cynthia
TI Factors associated with dental caries in preschoolers in Recife,
   Pernambuco State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Dental Caries; Preeschool Child; Social Conditions; Dental Health
   Services
ID EARLY-CHILDHOOD CARIES; ORAL-HEALTH; CHILDREN; IMPACT; DIET; CARE
AB To investigate factors associated with dental caries in deciduous dentition, a nested case-control study was conducted in a prevalence survey of preschool children (n = 1,690) aged 18 to 36 months and 5 years of age, treated under the Family Health Program in Recife, Pernambuco State, Brazil, in 2006. Cases were children with dmft >= 1 and controls with dmft = 0. The independent variables were analyzed in blocks: demographic, environmental, family structure, health care, and dental services use. OR and 95% CI were estimated. Variables associated with the outcome at p <= 0.20 in the univariate analysis were included in a multivariate logistic regression model. The cutoff for remaining in the final model was p = 0.10. Larger households (more members), lack of running supply, time of residence, maternal (or caregiver's) schooling, attendance in public preschool, demand for dental services, and sugar intake patterns were associated factors. Variables related to social context were the main predictors of caries, thus highlighting the need for comprehensive measures to address other common childhood health problems.
C1 [Dantas Cabral de Melo, Marcia Maria] Univ Fed Pernambuco, Ctr Ciencias Saude, Dept Clin & Odontol Prevent, BR-56670901 Recife, PE, Brazil.
   [Dantas Cabral de Melo, Marcia Maria] Secretaria Saude Estado Pernambuco, Recife, PE, Brazil.
   [de Souza, Wayner Vieira; Carvalho de Lima, Maria Luiza; Braga, Cynthia] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP de Melo, MMDC (corresponding author), Univ Fed Pernambuco, Ctr Ciencias Saude, Dept Clin & Odontol Prevent, Av Prof Moraes Rego S-N, BR-56670901 Recife, PE, Brazil.
EM marciamdcm@hotmail.com
RI Braga, Maria Cynthia/A-8204-2013; Souza, Wayner V/H-3798-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Souza,
   Wayner/0000-0002-0939-9332
CR al Ghanim N A, 1998, Int J Paediatr Dent, V8, P115
   [Anonymous], 1982, INT DENT J, V32, P74
   Antunes José Leopoldo Ferreira, 2006, Ciênc. saúde coletiva, V11, P79, DOI 10.1590/S1413-81232006000100015
   Aquino Rita de Cássia de, 2002, Rev. Saúde Pública, V36, P655, DOI 10.1590/S0034-89102002000700001
   Noro LRA, 2008, CAD SAUDE PUBLICA, V24, P1509, DOI 10.1590/S0102-311X2008000700005
   Baldani MHP, 2003, J BRAS ODONTOPEDIAT, V6, P210
   Beighton David, 2004, Community Dent Health, V21, P96
   Brandão Ioneide Maria Gomes, 2006, Cad. Saúde Pública, V22, P1247, DOI 10.1590/S0102-311X2006000600014
   Mello TRD, 2008, REV PANAM SALUD PUBL, V23, P78
   Dini EL, 2000, COMMUNITY DENT ORAL, V28, P241, DOI 10.1034/j.1600-0528.2000.280401.x
   Antunes JLF, 2010, REV SAUDE PUBL, V44, P360, DOI 10.1590/S0034-89102010000200018
   Frias Antonio Carlos, 2004, Rev. bras. epidemiol., V7, P144, DOI 10.1590/S1415-790X2004000200004
   Hallett KB, 2006, COMMUNITY DENT ORAL, V34, P25, DOI 10.1111/j.1600-0528.2006.00246.x
   Harris Rebecca, 2004, Community Dent Health, V21, P71
   Hashim R, 2006, INT J PAEDIATR DENT, V16, P257, DOI 10.1111/j.1365-263X.2006.00746.x
   HOLM AK, 1990, CARIES RES, V24, P44, DOI 10.1159/000261325
   Leite I C, 2000, Cad Saude Publica, V16, P717, DOI 10.1590/S0102-311X2000000300020
   Losso EM, 2009, J PEDIAT-BRAZIL, V85, P295, DOI [10.2223/JPED.1908, 10.1590/S0021-75572009000400005]
   Marthaler TM, 2004, CARIES RES, V38, P173, DOI 10.1159/000077752
   Martins S, 2003, THESIS U SAO PAULO S
   McGrath C, 2004, COMMUNITY DENT ORAL, V32, P81, DOI 10.1111/j.1600-0528.2004.00149.x
   Menghini G, 2008, COMMUNITY DENT HLTH, V25, P154, DOI 10.1922/CDH_2158Menghini07
   *MIN SAUD, 2004, PROJ SB BRAS 2003 CO
   Ministerio da Sau de. Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2004, DIR POL NAC SAUD BUC
   Moynihan P, 2004, PUBLIC HEALTH NUTR, V7, P201, DOI 10.1079/PHN2003589
   Narvai PC, 2006, REV PANAM SALUD PUBL, V19, P385, DOI 10.1590/S1020-49892006000600004
   Nickel DA, 2008, CAD SAUDE PUBLICA, V24, P241, DOI 10.1590/S0102-311X2008000200002
   Oliveira LB, 2008, EUR J ORAL SCI, V116, P37, DOI 10.1111/j.1600-0722.2007.00507.x
   PAUNIO P, 1993, CARIES RES, V27, P154, DOI 10.1159/000261534
   Peres Marco Aurélio, 2003, Rev. bras. epidemiol., V6, P293, DOI 10.1590/S1415-790X2003000400004
   Pine Cynthia M, 2004, Community Dent Health, V21, P86
   Prefeitura do Recife, 2005, PLAN MUN SAUD REC SA
   Rodrigues C S, 2000, Int J Paediatr Dent, V10, P47, DOI 10.1046/j.1365-263x.2000.00165.x
   Schroth RJ, 2005, PEDIATR DENT, V27, P114
   Skeie MS, 2006, INT J PAEDIATR DENT, V16, P152, DOI 10.1111/j.1365-263X.2006.00720.x
   Souza WV, 2010, PESQUI BRAS ODONTOPE, V10, P337, DOI DOI 10.4034/1519.0501.2010.0103.0002
   Tinanoff Norman, 1997, Pediatric Dentistry, V19, P12
   Traebert Jefferson, 2004, Rev. Nutr., V17, P247, DOI 10.1590/S1415-52732004000200011
   Vadiakas G, 2008, EUR ARCH PAEDIATR DE, V9, P114, DOI 10.1007/BF03262622
   Vanderlei Lygia Carmen de Moraes, 2003, Cad. Saúde Pública, V19, P455, DOI 10.1590/S0102-311X2003000200012
   VASCONCELOS EM, 1999, SAUDE DEBATE, V23, P6
   WOODWARD M, 1994, BRIT DENT J, V176, P297, DOI 10.1038/sj.bdj.4808437
   World Health Organization, 1997, OR HLTH SURV BAS MET
NR 43
TC 12
Z9 19
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAR
PY 2011
VL 27
IS 3
BP 471
EP 485
DI 10.1590/S0102-311X2011000300008
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 754LU
UT WOS:000289856900008
PM 21519698
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Medeiros, LCD
   Castilho, CAR
   Braga, C
   de Souza, WV
   Regis, L
   Monteiro, AMV
AF de Castro Medeiros, Liliam Cesar
   Rodrigues Castilho, Cesar Augusto
   Braga, Cynthia
   de Souza, Wayner Vieira
   Regis, Leda
   Vieira Monteiro, Antonio Miguel
TI Modeling the Dynamic Transmission of Dengue Fever: Investigating Disease
   Persistence
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; RIO-DE-JANEIRO; SCALE-FREE NETWORK; VECTOR-BORNE;
   SURVIVAL RATES; CULICIDAE; VIRUS; DISPERSAL; IMPACT; EPIDEMIOLOGY
AB Background: Dengue is a disease of great complexity, due to interactions between humans, mosquitoes and various virus serotypes as well as efficient vector survival strategies. Thus, understanding the factors influencing the persistence of the disease has been a challenge for scientists and policy makers. The aim of this study is to investigate the influence of various factors related to humans and vectors in the maintenance of viral transmission during extended periods.
   Methodology/Principal Findings: We developed a stochastic cellular automata model to simulate the spread of dengue fever in a dense community. Each cell can correspond to a built area, and human and mosquito populations are individually monitored during the simulations. Human mobility and renewal, as well as vector infestation, are taken into consideration. To investigate the factors influencing the maintenance of viral circulation, two sets of simulations were performed: (1(st)) varying human renewal rates and human population sizes and (2(nd)) varying the house index (fraction of infested buildings) and vector per human ratio. We found that viral transmission is inhibited with the combination of small human populations with low renewal rates. It is also shown that maintenance of viral circulation for extended periods is possible at low values of house index. Based on the results of the model and on a study conducted in the city of Recife, Brazil, which associates vector infestation with Aedes aegytpi egg counts, we question the current methodology used in calculating the house index, based on larval survey.
   Conclusions/Significance: This study contributed to a better understanding of the dynamics of dengue subsistence. Using basic concepts of metapopulations, we concluded that low infestation rates in a few neighborhoods ensure the persistence of dengue in large cities and suggested that better strategies should be implemented to obtain measures of house index values, in order to improve the dengue monitoring and control system.
C1 [de Castro Medeiros, Liliam Cesar] Ctr Ciencia Sistema Terrestre, Inst Nacl Pesquisas Espaciais, Sao Jose Dos Campos, Brazil.
   [Rodrigues Castilho, Cesar Augusto] Univ Fed Pernambuco, Dept Matemat, Recife, PE, Brazil.
   [Braga, Cynthia] Ctr Pesquisa Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil.
   [de Souza, Wayner Vieira] Ctr Pesquisa Aggeu Magalhaes, Dept Saude Coletiva, Recife, PE, Brazil.
   [Regis, Leda] Ctr Pesquisa Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
   [Vieira Monteiro, Antonio Miguel] Inst Nacl Pesquisas Espaciais, Div Processamento Imagens, BR-12201 Sao Jose Dos Campos, Brazil.
RP Medeiros, LCD (corresponding author), Ctr Ciencia Sistema Terrestre, Inst Nacl Pesquisas Espaciais, Sao Jose Dos Campos, Brazil.
EM liliam.castro@inpe.br
RI Medeiros, Liliam/J-8593-2014; Vieira Monteiro, Antonio
   Miguel/C-1757-2012; Braga, Maria Cynthia/A-8204-2013; Iats,
   Inct/K-2300-2013; Souza, Wayner V/H-3798-2013
OI Vieira Monteiro, Antonio Miguel/0000-0003-1477-1749; Braga, Maria
   Cynthia/0000-0002-7862-6455; Medeiros, Liliam/0000-0002-8142-6673;
   Souza, Wayner/0000-0002-0939-9332
FU Coordenacao de Aperfeicoamento de Nivel Superior - CAPESCAPES
FX This work was supported by grants from the Coordenacao de
   Aperfeicoamento de Nivel Superior - CAPES (http://www.capes.gov.br/).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ANDERSON R M, 1991
   Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100
   Lazcano JAB, 2006, REV PANAM SALUD PUBL, V19, P379, DOI 10.1590/S1020-49892006000600003
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006
   Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x
   Clark C.W., 2000, OX ECOL EV
   Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016
   Derouich M, 2006, APPL MATH COMPUT, V177, P528, DOI 10.1016/j.amc.2005.11.031
   Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   GOH KT, 1995, LANCET, V346, P1098, DOI 10.1016/S0140-6736(95)91771-3
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Karim MFA, 2009, CHAOS SOLITON FRACT, V41, P2847, DOI 10.1016/j.chaos.2008.10.029
   Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Maidana NA, 2008, MATH BIOSCI, V215, P64, DOI 10.1016/j.mbs.2008.05.008
   Massad E, 2008, APPL MATH COMPUT, V195, P376, DOI 10.1016/j.amc.2007.04.102
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Nishiura H., 2006, Dengue Bulletin, V30, P51
   OLIVEIRA GMB, 2006, PHYSICA D, V217, P1
   Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005
   *PAN AM HLTH ORG, 2009, EPIDEMIOLOGICAL ALER, V9, P1
   *PAN AM HLTH ORG, 1995, SCI PUBL, V548
   PARKER BM, 1986, ANN ENTOMOL SOC AM, V79, P925, DOI 10.1093/aesa/79.6.925
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Pongsumpun P, 2008, TROP MED INT HEALTH, V13, P1180, DOI 10.1111/j.1365-3156.2008.02124.x
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Ramchurn SK, 2009, EUROSURVEILLANCE, V14, P12
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Rosa-Freitas Maria Goreti, 2006, Rev Panam Salud Publica, V20, P256, DOI 10.1590/S1020-49892006000900006
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Santos LBL, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016102
   Sarkar P, 2000, ACM COMPUT SURV, V32, P80, DOI 10.1145/349194.349202
   Schimit PHT, 2009, ECOL MODEL, V220, P1034, DOI 10.1016/j.ecolmodel.2009.01.014
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   *SEC VIG SAUD, 2009, GUIA VIG EP
   Silva SL, 2007, PHYSICA A, V377, P689, DOI 10.1016/j.physa.2006.11.027
   Slimi R, 2009, APPL MATH MODEL, V33, P1072, DOI 10.1016/j.apm.2007.12.028
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Supriatna AK, 2008, MATH BIOSCI, V216, P114, DOI 10.1016/j.mbs.2008.08.011
   Teixeira  M G, 2001, Rev Soc Bras Med Trop, V34, P269
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Torres JR, 2007, CAD SAUDE PUBLICA, V23, pS23, DOI 10.1590/S0102-311X2007001300004
   Tran A, 2006, THEOR POPUL BIOL, V69, P3, DOI 10.1016/j.tpb.2005.06.008
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Watson TM, 1999, J MED ENTOMOL, V36, P508, DOI 10.1093/jmedent/36.4.508
   White SH, 2007, APPL MATH COMPUT, V186, P193, DOI 10.1016/j.amc.2006.06.126
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   *WHO, 2009, DENG GUID DIAG TREAT
   Yang HM, 2008, APPL MATH COMPUT, V198, P401, DOI 10.1016/j.amc.2007.08.046
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zhang P, 2008, MATH BIOSCI, V211, P166, DOI 10.1016/j.mbs.2007.10.007
NR 74
TC 56
Z9 57
U1 0
U2 36
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2011
VL 5
IS 1
AR e942
DI 10.1371/journal.pntd.0000942
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 711MP
UT WOS:000286596000019
PM 21264356
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Rodriguez-Barraquer, I
   Cordeiro, MT
   Braga, C
   de Souza, WV
   Marques, ET
   Cummings, DAT
AF Rodriguez-Barraquer, Isabel
   Cordeiro, Marli T.
   Braga, Cynthia
   de Souza, Wayner V.
   Marques, Ernesto T.
   Cummings, Derek A. T.
TI From Re-Emergence to Hyperendemicity: The Natural History of the Dengue
   Epidemic in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEMORRHAGIC-FEVER; INFECTION; VIRUS; TRANSMISSION; NICARAGUA; THAILAND;
   DYNAMICS; AMERICA; BANGKOK; DISEASE
AB Background: Dengue virus (DENV) was reintroduced into Brazil in 1986 and by 1995 it had spread throughout the country. In 2007 the number of dengue hemorrhagic fever (DHF) cases more than doubled and a shift in the age distribution was reported. While previously the majority of DHF cases occurred among adults, in 2007 53% of cases occurred in children under 15 years old. The reasons for this shift have not been determined.
   Methods and Findings: Age stratified cross-sectional seroepidemiologic survey conducted in Recife, Brazil in 2006. Serostatus was determined by ELISA based detection of Dengue IgG. We estimated time-constant and time-varying forces of infection of DENV between 1986 and 2006. We used discrete-time simulation to estimate the accumulation of monotypic and multitypic immunity over time in a population previously completely susceptible to DENV. We projected the age distribution of population immunity to dengue assuming similar hazards of infection in future years. The overall prevalence of DENV IgG was 0.80 (n = 1427). The time-constant force of infection for the period was estimated to be 0.052 (95% CI 0.041, 0.063), corresponding to 5.2% of susceptible individuals becoming infected each year by each serotype. Simulations show that as time since re-emergence of dengue goes by, multitypic immunity accumulates in adults while an increasing proportion of susceptible individuals and those with monotypic immunity are among young age groups. The median age of those monotypically immune can be expected to shift from 24 years, 10 years after introduction, to 13 years, 50 years after introduction. Of those monotypically immune, the proportion under 15 years old shifts from 27% to 58%. These results are consistent with the dengue notification records from the same region since 1995.
   Interpretation: Assuming that persons who have been monotypically exposed are at highest risk for severe dengue, the shift towards younger patient ages observed in Brazil can be partially explained by the accumulation of multitypic immunity against DENV-1, 2, and 3 in older age groups, 22 years after the re-introduction of these viruses. Serotype specific seroepidemiologic studies are necessary to accurately estimate the serotype specific forces of infection.
C1 [Rodriguez-Barraquer, Isabel; Cummings, Derek A. T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.
   [Cordeiro, Marli T.; Braga, Cynthia; de Souza, Wayner V.; Marques, Ernesto T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Cordeiro, Marli T.] Cent Publ Hlth Lab, Secretaria Saude Estado Pernambuco, Recife, PE, Brazil.
   [Marques, Ernesto T.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Rodriguez-Barraquer, I (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.
EM irodrigu@jhsph.edu
RI Iats, Inct/K-2300-2013; Braga, Maria Cynthia/A-8204-2013; Marques,
   Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Publica, Inct
   Saude/J-9544-2013; Souza, Wayner V/H-3798-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Marques, Ernesto T.
   A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358;
   Rodriguez-Barraquer, Isabel/0000-0001-6784-1021; Souza,
   Wayner/0000-0002-0939-9332
FU Gates FoundationBill & Melinda Gates Foundation; National Institute of
   General Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [1U54GM088491-01]; National
   Institute of Allergy and Infectious Diseases (NIAID/NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19 AI56541]; PDTIS [RVR09-FIOCRUZ]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico -CNPqNational Council for
   Scientific and Technological Development (CNPq) [305947/2006-0];
   Burroughs Wellcome FundBurroughs Wellcome Fund; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI056541,
   U19AI056541, U19AI056541, U19AI056541, U19AI056541] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491] Funding Source: NIH RePORTER
FX The authors acknowledge the support of the Gates Foundation through the
   Vaccine Modeling Initiative (I. R. B., D. A. T. C.), the National
   Institute of General Medical Sciences MIDAS grant 1U54GM088491-01 (I. R.
   B., D. A. T. C.), the National Institute of Allergy and Infectious
   Diseases (NIAID/NIH), Grant U19 AI56541 and PDTIS RVR09-FIOCRUZ (E. M.).
   W. V. de Souza was partially supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico -CNPq (305947/2006-0). Derek
   Cummings holds a Career Award at the Scientific Interface from the
   Burroughs Wellcome Fund. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   FISCHER DB, 1970, YALE J BIOL MED, V42, P329
   GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859
   Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   *IBGE, 2000, DEM CENS 2000 CHAR P
   KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Mendez Angela, 2003, Biomedica, V23, P180
   *MIN SAUD, 2010, SIST INF HOSP SIH SU
   Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Teixeira MG, 2008, EMERG INFECT DIS, V14, P1663, DOI 10.3201/eid1410.071164
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS4, DOI 10.1590/S0102-311X2009001300001
   WHO/TDR, 2009, DENG GUID DIAGN TREA
NR 28
TC 89
Z9 91
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1935-2727
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2011
VL 5
IS 1
AR e935
DI 10.1371/journal.pntd.0000935
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 711MP
UT WOS:000286596000013
PM 21245922
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Ximenes, RAD
   Pereira, LMB
   Martelli, CMT
   Merchan-Hamann, E
   Stein, AT
   Figueiredo, GM
   Braga, MC
   Montarroyos, UR
   Brasil, LM
   Turchi, MD
   da Fonseca, JCF
   de Lima, MLC
   de Alencar, LCA
   Costa, M
   Coral, G
   Moreira, RC
   Cardoso, MRA
AF de Alencar Ximenes, Ricardo Arraes
   Beltrao Pereira, Leila Maria
   Turchi Martelli, Celina Maria
   Merchan-Hamann, Edgar
   Stein, Airton Tetelbom
   Figueiredo, Gerusa Maria
   Braga, Maria Cynthia
   Montarroyos, Ulisses Ramos
   Brasil, Leila Melo
   Turchi, Marilia Dalva
   Ferraz da Fonseca, Jose Carlos
   Carvalho de Lima, Maria Luiza
   Arraes de Alencar, Luis Claudio
   Costa, Marcelo
   Coral, Gabriela
   Moreira, Regina Celia
   Alves Cardoso, Maria Regina
TI Methodology of a nationwide cross-sectional survey of prevalence and
   epidemiological pattern's of hepatitis A, B and C infection in Brazil
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Morbidity Surveys; Prevalence; Hepatitis Viruses
ID VIRUS-INFECTION; UNITED-STATES; SEROPREVALENCE; POPULATION; NORTHEAST;
   MARKERS; AMAZON; RISK; DNA
AB A population-based survey to provide information on the prevalence of hepatitis viral infection and the pattern of risk factors was carried out in the urban population of all Brazilian state capitals and the Federal District, between 2005 and 2009. This paper describes the design and methodology of the study which involved a population aged 5 to 19 for hepatitis A and 10 to 69 for hepatitis B and C. Interviews and blood samples were obtained through household visits. The sample was selected using stratified multi-stage cluster sampling and was drawn with equal probability from each domain of study (region and age-group). Nationwide, 19,280 households and -31,000 residents were selected. The study is large enough to detect prevalence of viral infection around 0.1% and risk factor assessments within each region. The methodology seems to be a viable way of differentiating between distinct epidemiological patterns of hepatitis A, B and C. These data will be of value for the evaluation of vaccination policies and for the design of control program strategies.
C1 [Braga, Maria Cynthia] Fundacao Oswald Cruz, Dept Parasitol, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Brasil, Leila Melo] Fundacao Med Trop Amazonas, Manaus, Amazonas, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Beltrao Pereira, Leila Maria; Montarroyos, Ulisses Ramos; Arraes de Alencar, Luis Claudio] Univ Fed Pernambuco, Fac Ciencias Med Pernambuco, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [Beltrao Pereira, Leila Maria] Univ Fed Pernambuco, Inst Figado Pernambuco, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria; Turchi, Marilia Dalva] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   [Merchan-Hamann, Edgar] Univ Brasilia, Fac Ciencias Saude, Brasilia, DF, Brazil.
   [Stein, Airton Tetelbom; Coral, Gabriela] Fundacao Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil.
   [Ferraz da Fonseca, Jose Carlos] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Carvalho de Lima, Maria Luiza] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [Costa, Marcelo] Hosp Base Dist Fed, Brasilia, DF, Brazil.
   [Moreira, Regina Celia] Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
   [Alves Cardoso, Maria Regina] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, Brazil.
RP Braga, MC (corresponding author), Fundacao Oswald Cruz, Dept Parasitol, Ctr Pesquisas Aggeu Magalhaes, Av Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Stein, Airton T/E-3333-2010; Cardoso, Maria Regina A/J-7280-2012;
   Figueiredo, Gerusa M/B-6660-2014; Braga, Maria Cynthia/A-8204-2013;
   Moreira, Regina C/B-1488-2016; Montarroyos, Ulisses/AAJ-7527-2020
OI Stein, Airton T/0000-0002-8756-8699; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Braga, Maria Cynthia/0000-0002-7862-6455;
   Moreira, Regina C/0000-0002-8208-8776; Cardoso, Maria
   Regina/0000-0001-6092-9215
FU Brazilian Ministry for Health; Pan American Health Organization;
   National Research Council (CNPq)National Council for Scientific and
   Technological Development (CNPq) [307963/2004-7, 300917/2006-6,
   303049/2007-3]
FX We are grateful for the financial support of the Brazilian Ministry for
   Health, the Pan American Health Organization and for administrative
   support from the University of Pernambuco Foundation. The authors were
   partially supported by National Research Council (CNPq; scholarship
   307963/2004-7 to C.M.T.M. and 300917/2006-6 to R.A.A.X. and
   303049/2007-3 to M.R.A.C.).
CR Almeida LM, 2001, EPIDEMIOL INFECT, V127, P327, DOI 10.1017/S0950268801005945
   Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, GUIA VIG EP
   BROSS I, 1954, BIOMETRICS, V10, P478, DOI 10.2307/3001619
   Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696
   COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408
   Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114
   FONSECA JC, 1999, GASTROENTEROLOGIA S1, V18, pS3
   Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857
   KANEKO S, 1989, P NATL ACAD SCI USA, V86, P312, DOI 10.1073/pnas.86.1.312
   LYRA LG, 1986, REV I MED TROP, V28, P406, DOI 10.1590/S0036-46651986000600005
   Malta Deborah Carvalho, 2008, Rev. bras. epidemiol., V11, P159, DOI 10.1590/S1415-790X2008000500017
   Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1
   McQuillan GM, 2004, AM J PUBLIC HEALTH, V94, P1952, DOI 10.2105/AJPH.94.11.1952
   Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046
   Rothman KJ, 1998, MODERN EPIDEMIOLOGY
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   *SECR SAUD SAO PAU, 2006, REV SAUDE PUBL, V40, P1137
   Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009
   Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4
   Sitnik R, 2004, J CLIN MICROBIOL, V42, P2455, DOI 10.1128/JCM.42.6.2455-2460.2004
   Souto FJD, 2001, MEM I OSWALDO CRUZ, V96, P751, DOI 10.1590/S0074-02762001000600001
   Stern RK, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-62
   Tapia-Conyer R, 1999, AM J TROP MED HYG, V61, P825, DOI 10.4269/ajtmh.1999.61.825
   Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808
   *WHO, 2005, HEP B VACC
   Zarife MAS, 2006, T ROY SOC TROP MED H, V100, P663, DOI 10.1016/j.trstmh.2005.09.009
NR 28
TC 31
Z9 33
U1 0
U2 5
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD SEP
PY 2010
VL 26
IS 9
BP 1693
EP 1704
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 662VL
UT WOS:000282842300003
PM 20877930
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Siqueira, MT
   Braga, C
   Cabral, JE
   Augusto, LGD
   Figueiroa, JN
   Souza, AI
AF de Siqueira, Marilia Teixeira
   Braga, Cynthia
   Cabral-Filho, Jose Eulalio
   da Silva Augusto, Lia Giraldo
   Figueiroa, Jose Natal
   Souza, Ariani Impieri
TI Correlation Between Pesticide Use in Agriculture and Adverse Birth
   Outcomes in Brazil: An Ecological Study
SO BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY
LA English
DT Article
DE Pesticides; Birth weight; Preterm birth; Birth defect
ID EXPOSURE; LENGTH; RISK
AB This ecological study analyzed the association between pesticide use and prematurity, low weight and congenital abnormality at birth, infant death by congenital abnormality, and fetal death in Brazil in 2001. Simple linear regression analysis has determined a positive association between pesticide use and prematurity, low birth weight, and congenital abnormality. The association between pesticide use and low birth weight (p = 0.045) and, congenital abnormality (p = 0.004) and infant death rate by congenital abnormality (p = 0.039) remained after the adjustment made by the proportion of pregnant women with a low number of prenatal care visits.
C1 [de Siqueira, Marilia Teixeira; Braga, Cynthia; Cabral-Filho, Jose Eulalio; Figueiroa, Jose Natal; Souza, Ariani Impieri] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [de Siqueira, Marilia Teixeira; da Silva Augusto, Lia Giraldo] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [de Siqueira, Marilia Teixeira] Secretaria Saude Estado Pernambuco, Recife, PE, Brazil.
   [Braga, Cynthia; da Silva Augusto, Lia Giraldo] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
RP de Siqueira, MT (corresponding author), Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
EM mariliats@ig.com.br
RI Braga, Maria Cynthia/A-8204-2013; Souza, Ariani I/C-1568-2015; de Souza,
   Ariani Impieri/AAR-6884-2020; Iats, Inct/K-2300-2013; da Silva Augusto,
   Lia Giraldo/AAF-5772-2019
OI Braga, Maria Cynthia/0000-0002-7862-6455; Souza, Ariani
   I/0000-0002-7917-5983; de Souza, Ariani Impieri/0000-0002-7917-5983; da
   Silva Augusto, Lia Giraldo/0000-0002-9322-6863
CR *AG NAC VIG SAN, 2009, NOT TECN DIV RES PRO
   *AG NAC VIG SAN, 2005, NOT TECN SOBR LIVR C
   Bell EM, 2001, EPIDEMIOLOGY, V12, P148, DOI 10.1097/00001648-200103000-00005
   Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X
   Fenster L, 2006, ENVIRON HEALTH PERSP, V114, P597, DOI 10.1289/ehp.8423
   Kageyama A., 2003, Agricultura em Sao Paulo, V50, P1
   Longnecker MP, 2005, ENVIRON RES, V97, P127, DOI 10.1016/S0013-9351(03)00108-7
   *MIN AGR PEC AB, 2005, AGR BRAS NUM AN 2005
   *MIN PLAN ORC GEST, 2002, IND DES SUST DIM AMB
   *MIN SAUD, 2001, INF SAUD EST VIT NAS
   *MIN SAUD, 2001, INF SAUD EST VIT MOR
   NURMINEN T, 1995, J OCCUP ENVIRON MED, V37, P935, DOI 10.1097/00043764-199508000-00008
   Peiris-John RJ, 2008, T ROY SOC TROP MED H, V102, P239, DOI 10.1016/j.trstmh.2007.11.012
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742
   Thulstrup AM, 2006, OCCUP MED-OXFORD, V56, P532, DOI 10.1093/occmed/kql115
   Waissmann William, 2007, Ciênc. saúde coletiva, V12, P20, DOI 10.1590/S1413-81232007000100005
   Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641
   Woodruff TJ, 2008, FERTIL STERIL, V89, P281, DOI [10.1016/j.fertnstert.2007.10.002, 10.1016/j.fertnstert.2008.01.065]
NR 18
TC 18
Z9 19
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0007-4861
EI 1432-0800
J9 B ENVIRON CONTAM TOX
JI Bull. Environ. Contam. Toxicol.
PD JUN
PY 2010
VL 84
IS 6
BP 647
EP 651
DI 10.1007/s00128-010-0027-8
PG 5
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA 608HF
UT WOS:000278573500001
PM 20473603
DA 2020-12-01
ER

PT J
AU Ferreira, ALCG
   Souza, AI
   Lima, RA
   Braga, C
AF Ferreira, Ana Laura C. G.
   Souza, Ariani I.
   Lima, Raitza A.
   Braga, Cynthia
TI Choices on contraceptive methods in post-abortion family planning clinic
   in the northeast Brazil
SO REPRODUCTIVE HEALTH
LA English
DT Article
ID WOMEN; PREGNANCY; KNOWLEDGE; ABORTION; TERMINATION; UNIVERSITY;
   STUDENTS; CARE
AB Background: In Brazil, a Ministry of Health report revealed women who underwent an abortion were predominantly in the use of contraceptive methods, but mentioned inconsistent or erroneously contraceptive use. Promoting the use of contraceptive methods to prevent unwanted pregnancies is one of the most effective strategies to reduce abortion rates and maternal morbidity and mortality. Therefore, providing post-abortion family planning services that include structured contraceptive counseling with free and easy access to contraceptive methods can be suitable. So the objective of this study is to determine the acceptance and selection of contraceptive methods followed by a post-abortion family planning counseling.
   Methods: A cross-sectional study was carried out from July to October 2008, enrolling 150 low income women to receive post-abortion care at a family planning clinic in a public hospital located in Recife, Brazil. The subjects were invited to take part of the study before receiving hospital leave from five different public maternities. An appointment was made for them at a family planning clinic at IMIP from the 8th to the 15th day after they had undergone an abortion. Every woman received information on contraceptive methods, side effects and fertility. Counseling was individualized and addressed them about feelings, expectations and motivations regarding contraception as well as pregnancy intention.
   Results: Of all women enrolled in this study, 97.4% accepted at least one contraceptive method. Most of them (73.4%) had no previous abortion history. Forty of the women who had undergone a previous abortion, 47.5% reported undergoing unsafe abortion. Slightly more than half of the pregnancies (52%) were unwanted. All women had knowledge of the use of condoms, oral contraceptives and injectables. The most chosen method was injectables, followed by oral contraceptives and condoms. Only one woman chose an intrauterine device.
   Conclusion: The acceptance rate of post-abortion contraceptive methods was greater and the most chosen method was the best-known one. Implementing a specialized family planning post abortion service may promote an acceptance, regardless of the chosen method. Most important is they do receive contraception if they do not wish for an immediate pregnancy.
C1 [Ferreira, Ana Laura C. G.; Souza, Ariani I.; Lima, Raitza A.; Braga, Cynthia] Inst Med Integral Prof Fernando Figueira IMIP, Res Dept, BR-50070550 Recife, PE, Brazil.
RP Ferreira, ALCG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Res Dept, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM analaura@imip.org.br
RI Iats, Inct/K-2300-2013; de Souza, Ariani Impieri/AAR-6884-2020; Braga,
   Maria Cynthia/A-8204-2013; Souza, Ariani I/C-1568-2015
OI de Souza, Ariani Impieri/0000-0002-7917-5983; Braga, Maria
   Cynthia/0000-0002-7862-6455; Souza, Ariani I/0000-0002-7917-5983
FU IMIP
FX The authors wish to thank IMIP for the support.
CR Addo VN, 2009, INT J GYNECOL OBSTET, V105, P206, DOI 10.1016/j.ijgo.2009.01.008
   Alan Guttmacher Institute, 1999, SHAR RESP WOM SOC AB
   Alves SV, 2007, REPROD HEALTH MATTER, V15, P134, DOI 10.1016/S0968-8080(07)30326-1
   Bender SS, 2004, CONTRACEPTION, V69, P481, DOI 10.1016/j.contraception.2003.12.014
   Bjelica A, 2008, EUR J CONTRACEP REPR, V13, P422, DOI 10.1080/13625180802296747
   Ferreira ALCG, 2009, EUR J CONTRACEP REPR, V14, P1, DOI 10.1080/13625180802549970
   Cheng YM, 2008, INT J GYNECOL OBSTET, V103, P140, DOI 10.1016/j.ijgo.2008.06.013
   Correia DS, 2009, THESCIENTIFICWORLDJO, V9, P37, DOI 10.1100/tsw.2009.8
   DELMANTO C, 2007, CODIGO PENAL COMENTA
   Espejo X, 2003, REV SAUDE PUBL, V37, P583, DOI 10.1590/S0034-89102003000500006
   Fasubaa O B, 2004, J Obstet Gynaecol, V24, P298, DOI 10.1080/01443610410001660913
   Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6
   Johnson BR, 2002, STUD FAMILY PLANN, V33, P195, DOI 10.1111/j.1728-4465.2002.00195.x
   Kero A, 2001, EUR J CONTRACEP REPR, V6, P205, DOI 10.1080/713604264
   Kost K, 2008, CONTRACEPTION, V77, P10, DOI 10.1016/j.contraception.2007.09.013
   Ministerio da Saude do Brasil, REL AB SAUD PUBL 20
   MORAES OB, 1997, REV IMIP, V11, P32
   Nobili MP, 2007, PATIENT EDUC COUNS, V65, P361, DOI 10.1016/j.pec.2006.09.004
   PNDS, 2006, PESQ NAC DEM SAUD MU
   Prager SW, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.007
   Rasch V, 2004, TROP MED INT HEALTH, V9, P399, DOI 10.1111/j.1365-3156.2004.01197.x
   RASH V, 2008, BMC PREGNANCY CHILDB, V32, P1
   Schor N, 2000, Cad Saude Publica, V16, P377, DOI 10.1590/S0102-311X2000000200008
   Schunmann C, 2006, HUM REPROD, V21, P2296, DOI 10.1093/humrep/del168
   Weisman CS, 2002, WOMEN HEALTH ISS, V12, P79, DOI 10.1016/S1049-3867(01)00147-5
NR 25
TC 11
Z9 12
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD MAY 10
PY 2010
VL 7
AR 5
DI 10.1186/1742-4755-7-5
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V27IE
UT WOS:000208606100002
PM 20459754
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Braga, C
   Luna, CF
   Martelli, CM
   de Souza, WV
   Cordeiro, MT
   Alexander, N
   de Albuquerque, MDPM
   Silveira, JC
   Marques, ET
AF Braga, Cynthia
   Luna, Carlos Feitosa
   Martelli, Celina MariaTurchi
   de Souza, Wayner Vieira
   Cordeiro, Marli Tenorio
   Alexander, Neal
   Pessoa Militao de Albuquerque, Maria de Fatima
   Silveira Junior, Jose Constantino
   Marques, Ernesto T.
TI Seroprevalence and risk factors for dengue infection in
   socio-economically distinct areas of Recife, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Seroprevalence; Risk factors; Spatial analysis
ID VIRUS-INFECTION; TRANSMISSION; EPIDEMIC; SURVEILLANCE; CIRCULATION;
   PREVENTION; SINGAPORE; DYNAMICS; CHILDREN; FEVER
AB Brazil currently accounts for the majority of dengue cases reported in the Americas, with co-circulation of DENV 1-3. Striking variation in the epidemiological pattern of infection within cities has been observed. Therefore, investigation of dengue transmission in small areas is important to formulate control strategies. A population-based household survey was performed in three diverse socio-economic and environmental areas of Recife, a large urban center of Brazil, between 2005 and 2006. Dengue serostatus and individual- and household-level risk factors for infection were collected in residents aged between 5 and 64 years. A total of 2833 individuals were examined, and their residences were geo-referenced. Anti-dengue IgG antibodies were measured using commercial ELISA. The dengue seroprevalence and the force of infection were estimated in each area. Individual and household variables associated with seropositivity were assessed by multilevel models for each area. A spatial analysis was conducted to identify risk gradients of dengue seropositivity using Generalized Additive Models (GAM). The dengue seroprevalence was 91.1%,87.4% 74.3%, respectively, in the deprived, intermediate and high socio-economic areas, inversely related to their socio-economic status. In the deprived area, 59% of children had already been exposed to dengue virus by the age of 5 years and the estimated force of infection was three times higher than that in the privileged area. The risk of infection increased with age in the three areas. Not commuting away from the area was a risk factor for seropositivity in the deprived area (OR = 2.26; 95% CI: 1.18-4.30). Number of persons per room was a risk factor for seropositivity in the intermediate (OR = 3.00; 95% CI: 3.21-7.37) and privileged areas (OR = 1.81; 95% Cl: 1.07-3.04). Living in a house, as opposed to an apartment, was a risk factor for seropositivity in the privileged area (OR = 3.62; 95% Cl: 2.43-5.41). The main difference between the privileged and other areas could be attributed to the much larger proportion of apartment dwellers. Intensive vector control, surveillance and community education should be considered in deprived urban areas where a high proportion of children are infected by an early age. (C) 2009 Published by Elsevier B.V.
C1 [Braga, Cynthia; Luna, Carlos Feitosa; de Souza, Wayner Vieira; Cordeiro, Marli Tenorio; Pessoa Militao de Albuquerque, Maria de Fatima; Silveira Junior, Jose Constantino; Marques, Ernesto T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Braga, Cynthia] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Martelli, Celina MariaTurchi] Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Saude Colet, Setor Univ, BR-74605050 Goiania, Go, Brazil.
   [Cordeiro, Marli Tenorio] Secretaria Saude Estado Pernambuco, Lab Cent Saude Publ, BR-50050210 Recife, PE, Brazil.
   [Alexander, Neal] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England.
   [Pessoa Militao de Albuquerque, Maria de Fatima] Univ Fed Pernambuco, Dept Trop Med, Hosp Clin, BR-50670420 Recife, PE, Brazil.
   [Marques, Ernesto T.] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD 21205 USA.
RP Braga, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Av Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Souza, Wayner V/H-3798-2013; Iats, Inct/K-2300-2013; Marques, Ernesto T.
   A/L-4967-2013; Publica, Inct Saude/J-9544-2013; Marques,
   Ernesto/L-4514-2013; Braga, Maria Cynthia/A-8204-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Marques,
   Ernesto/0000-0003-3826-9358; Braga, Maria Cynthia/0000-0002-7862-6455;
   Souza, Wayner/0000-0002-0939-9332; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688
FU National Institute of Allergy and Infectious Diseases (NIAID/NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19 AI56541, PDTIS RVR09-FIOCRUZ]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico -CNPqNational Council for
   Scientific and Technological Development (CNPq) [307963/2004-7,
   305947/2006-0]; Medical Research CouncilMedical Research Council UK
   (MRC) [G0700837] Funding Source: researchfish; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI056541,
   U19AI056541, U19AI056541, U19AI056541, U19AI056541] Funding Source: NIH
   RePORTER
FX The authors acknowledge the support of the National Institute of Allergy
   and Infectious Diseases (NIAID/NIH), Grant U19 AI56541 and PDTIS
   RVR09-FIOCRUZ. Martelli CMT, Albuquerque MFP and Souza WV were partially
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico -CNPq (scholarships 307963/2004-7, 305947/2006-0,
   respectively)
CR Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Collett D., 2002, MODELLING BINARY DAT
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   *IBGE, 2000, DEM CENS 2000 CHAR P
   *IBGE, 2009, IBGE CIT
   *ITEP, 2009, CLIM
   Kelsall JE, 1998, J ROY STAT SOC C-APP, V47, P559, DOI 10.1111/1467-9876.00128
   KO YC, 1992, AM J EPIDEMIOL, V136, P214, DOI 10.1093/oxfordjournals.aje.a116487
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lian CW, 2006, TROP BIOMED, V23, P85
   Almeida MCD, 2008, CAD SAUDE PUBLICA, V24, P2385, DOI 10.1590/S0102-311X2008001000019
   *PAHO, 2008, EID UPD EM REEM INF
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Torralba JM, 2007, ADV MATER RES-SWITZ, V23, P1, DOI 10.4028/www.scientific.net/AMR.23.1
   Vallee J, 2009, TROP MED INT HEALTH, V14, P1134, DOI 10.1111/j.1365-3156.2009.02319.x
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   WHO, 2007, GUID PLAQ RED NEUTR
   *WHO, 2009, 117 WHO
   Wood S., 2006, GEN ADDITIVE MODELS
   Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 38
TC 111
Z9 114
U1 0
U2 30
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAR
PY 2010
VL 113
IS 3
BP 234
EP 240
DI 10.1016/j.actatropica.2009.10.021
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 570KZ
UT WOS:000275677700005
PM 19896921
OA Green Accepted
DA 2020-12-01
ER

PT J
AU Figueiredo, G
   Cardoso, MR
   Moreira, R
   Pereira, L
   Montarroyos, U
   Braga, C
   Stein, A
   Coral, G
   Ximenez, R
AF Figueiredo, G.
   Cardoso, M. R.
   Moreira, R.
   Pereira, L.
   Montarroyos, U.
   Braga, C.
   Stein, A.
   Coral, G.
   Ximenez, R.
TI Seroprevalence of hepatitis A among children and adolescent from south
   and southeast region of Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Figueiredo, G.] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil.
   [Cardoso, M. R.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Moreira, R.] Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
   [Pereira, L.; Montarroyos, U.; Ximenez, R.] Univ Estadual Pernambuco, Recife, PE, Brazil.
   [Braga, C.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Stein, A.; Coral, G.] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil.
RI Figueiredo, Gerusa M/B-6660-2014; Cardoso, Maria Regina A/J-7280-2012;
   Montarroyos, Ulisses/AAJ-7527-2020; Braga, Maria Cynthia/A-8204-2013;
   Moreira, Regina C/B-1488-2016
OI Figueiredo, Gerusa M/0000-0001-9657-9675; Braga, Maria
   Cynthia/0000-0002-7862-6455; Moreira, Regina C/0000-0002-8208-8776
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2010
VL 14
SU 1
BP E234
EP E235
DI 10.1016/j.ijid.2010.02.2010
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA 578MQ
UT WOS:000276298201099
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Figueiredo, G
   Moreira, R
   Pereira, L
   Cardoso, MR
   Coral, G
   Stein, A
   Montarroyos, U
   Braga, C
   Ximenez, R
AF Figueiredo, G.
   Moreira, R.
   Pereira, L.
   Cardoso, M. R.
   Coral, G.
   Stein, A.
   Montarroyos, U.
   Braga, C.
   Ximenez, R.
TI Household survey of hepatitis B infection and risk factor assessment in
   the from South and Southeast region of Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Figueiredo, G.] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil.
   [Moreira, R.] Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
   [Pereira, L.; Montarroyos, U.; Ximenez, R.] Univ Estadual Pernambuco, Recife, PE, Brazil.
   [Cardoso, M. R.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Coral, G.; Stein, A.] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil.
   [Braga, C.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RI Moreira, Regina C/B-1488-2016; Braga, Maria Cynthia/A-8204-2013;
   Cardoso, Maria Regina A/J-7280-2012; Figueiredo, Gerusa M/B-6660-2014;
   Montarroyos, Ulisses/AAJ-7527-2020
OI Moreira, Regina C/0000-0002-8208-8776; Braga, Maria
   Cynthia/0000-0002-7862-6455; Figueiredo, Gerusa M/0000-0001-9657-9675; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2010
VL 14
SU 1
BP E235
EP E235
DI 10.1016/j.ijid.2010.02.2011
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 578MQ
UT WOS:000276298201100
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Moreira, R
   Figueiredo, GM
   Ximenez, R
   Montarroyos, U
   Braga, C
   Cardoso, MR
   Coral, G
   Carrilho, F
   Stein, A
   Marion, Z
   Spina, A
   Cardoso, A
   Moriya, Y
   Alves, A
   Correa, EBD
   Theme-Filha, M
   Muzzillo, D
   Vidor, AC
   Nogueira, CV
   Pinto, ME
   Barone, AA
   Ferreira, L
   Pereira, L
AF Moreira, R.
   Figueiredo, G. M.
   Ximenez, R.
   Montarroyos, U.
   Braga, C.
   Cardoso, M. R.
   Coral, G.
   Carrilho, F.
   Stein, A.
   Marion, Z.
   Spina, A.
   Cardoso, A.
   Moriya, Y.
   Alves, A.
   Correa, E. B. D.
   Theme-Filha, M.
   Muzzillo, D.
   Vidor, A. C.
   Nogueira, C. V.
   Pinto, M. E.
   Barone, A. A.
   Ferreira, L.
   Pereira, L.
TI Population-based seroprevalence of hepatitis C virus infection in the
   South and Southeast regions of Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Moreira, R.; Spina, A.] Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
   [Figueiredo, G. M.] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil.
   [Ximenez, R.; Montarroyos, U.; Braga, C.; Pereira, L.] Univ Estadual Pernambuco, Recife, PE, Brazil.
   [Cardoso, M. R.; Carrilho, F.; Barone, A. A.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Coral, G.; Stein, A.; Alves, A.] Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil.
   [Marion, Z.] LACEN Porto Alegre, Porto Alegre, RS, Brazil.
   [Cardoso, A.] LACEN Santa Catarina, Florianopolis, SC, Brazil.
   [Moriya, Y.] LACEN Parana, Curitiba, Parana, Brazil.
   [Correa, E. B. D.] Univ Fed Florianopolis, Florianopolis, SC, Brazil.
   [Theme-Filha, M.] Escola Nacl Saude Publica, Rio De Janeiro, Brazil.
   [Muzzillo, D.] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
   [Vidor, A. C.] Secretaria Muncipal Saude Florianopolis, Florianopolis, SC, Brazil.
   [Nogueira, C. V.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Pinto, M. E.] Univ Fed Ciencias Med, Porto Alegre, RS, Brazil.
   [Barone, A. A.] Secretaria Municipal Saude Curitiba, Curitiba, Parana, Brazil.
RI Braga, Maria Cynthia/A-8204-2013; Figueiredo, Gerusa M/B-6660-2014;
   Montarroyos, Ulisses/AAJ-7527-2020; Carrilho, Flair J/I-3046-2012;
   Moreira, Regina C/B-1488-2016; Cardoso, Maria Regina A/J-7280-2012;
   Barone, Antonio A/C-5531-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Moreira, Regina C/0000-0002-8208-8776; Barone,
   Antonio A/0000-0001-9895-3886
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2010
VL 14
SU 1
BP E274
EP E274
DI 10.1016/j.ijid.2010.02.2095
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 578MQ
UT WOS:000276298201184
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Ximenes, R
   Martelli, CT
   Merchan-Hamman, E
   Montarroyos, U
   Braga, C
   Moreira, R
   Figueiredo, GM
   Cardoso, MR
   Turchi, M
   Coral, G
   Stein, A
   Lima, ML
   Costa, M
   Arraes-Alencar, LC
   Crespo, D
   dos Santos, AS
   Pereira, L
AF Ximenes, R.
   Martelli, C. T.
   Merchan-Hamman, E.
   Montarroyos, U.
   Braga, C.
   Moreira, R.
   Figueiredo, G. M.
   Cardoso, M. R.
   Turchi, M.
   Coral, G.
   Stein, A.
   Lima, M. L.
   Costa, M.
   Arraes-Alencar, L. C.
   Crespo, D.
   dos Santos, A. Santos
   Pereira, L.
TI Patterns of hepatitits A infection by Brazilian regions: Results of the
   national household survey 2004-2009
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Ximenes, R.] Univ Pernambuco, Recife, PE, Brazil.
   [Martelli, C. T.; Braga, C.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Merchan-Hamman, E.] Univ Brasilia, Brasilia, DF, Brazil.
   [Montarroyos, U.; Pereira, L.] Univ Estadual Pernambuco, Recife, PE, Brazil.
   [Moreira, R.] Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
   [Figueiredo, G. M.] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil.
   [Cardoso, M. R.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Turchi, M.] Univ Fed Goias, Goiania, Go, Brazil.
   [Coral, G.; Stein, A.] Santa Casa Porto Alegre, Porto Alegre, RS, Brazil.
   [Lima, M. L.; Arraes-Alencar, L. C.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Costa, M.] Hosp Base DF, Brasilia, DF, Brazil.
   [Crespo, D.] Nucleo Estudos & Pesquisas Hepatol Amazonia, Belem, Para, Brazil.
   [dos Santos, A. Santos] Inst Bioestat Ciencia & Tecnol, Belem, Para, Brazil.
RI Cardoso, Maria Regina A/J-7280-2012; Montarroyos, Ulisses/AAJ-7527-2020;
   Moreira, Regina C/B-1488-2016; Figueiredo, Gerusa M/B-6660-2014; Braga,
   Maria Cynthia/A-8204-2013
OI Moreira, Regina C/0000-0002-8208-8776; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Braga, Maria Cynthia/0000-0002-7862-6455
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2010
VL 14
SU 1
BP E237
EP E238
DI 10.1016/j.ijid.2010.02.2017
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA 578MQ
UT WOS:000276298201106
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pereira, LMMB
   Martelli, CMT
   Merchan-Hamann, E
   Montarroyos, UR
   Braga, MC
   de Lima, MLC
   Cardoso, MRA
   Turchi, MD
   Costa, MA
   de Alencar, LCA
   Moreira, RC
   Figueiredo, GM
   Ximenes, RAA
AF Pereira, Leila M. M. B.
   Martelli, Celina M. T.
   Merchan-Hamann, Edgar
   Montarroyos, Ulisses R.
   Braga, Maria C.
   de Lima, Maria L. C.
   Cardoso, Maria R. A.
   Turchi, Marilia D.
   Costa, Marcelo A.
   de Alencar, Luiz C. A.
   Moreira, Regina C.
   Figueiredo, Gerusa M.
   Ximenes, Ricardo A. A.
CA Hepatitis Study Grp
TI Population-Based Multicentric Survey of Hepatitis B Infection and Risk
   Factor Differences among Three Regions in Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS-INFECTION; UNITED-STATES; SEROLOGICAL MARKERS; NATIONAL-HEALTH;
   PREVALENCE; GENOTYPES; NORTHEAST; DNA
AB This multicentric population-based study in Brazil is the first national effort to estimate the prevalence of hepatitis B (HBV) and risk factors in the capital cities of the Northeast. Central-West, and Federal Districts (2004-2005). Random multistage cluster sampling was used to select persons 13-69 years of age. Markers for HBV were tested by enzyme-linked immunosorbent assay. The HBV genotypes were determined by sequencing hepatitis B surface antigen (HBsAg). Multivariate analyses and simple catalytic model were performed. Overall. 7,881 persons were inculded < 70% were not vaccinated. Positivity for HBsAg was less than 1% among non-vaccinated persons and genotypes A, D, and F co-circulated. The incidence of infection increased with age with similar force of infection in all regions. Males and persons having initiated sexual activity were associated with HBV infection in the two settings: healthcare jobs and prior hospitalization were risk factors in the Federal District. Our survey classified these regions as areas with HBV endemicity and highlighted the risk factors differences among the settings.
C1 Univ Fed Pernambuco, Fac Ciencias Med Pernambuco, Hosp Univ Oswaldo Cruz, BR-50100130 Recife, PE, Brazil.
   Univ Fed Goias, Dept Saude Colet, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
   Univ Brasilia, Dept Saude Colet, Fac Ciencias Saude, Brasilia, DF, Brazil.
   Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Social Med Nucleo Saude Publ, BR-50100130 Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Trop Med, BR-50100130 Recife, PE, Brazil.
   Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01255 Sao Paulo, Brazil.
   Hosp Base DF, Brasilia, DF, Brazil.
   Adolfo Lutz Inst, Sao Paulo, Brazil.
   Minist Saude, Program Nacl Prevencao & Controle Hepatites Virai, Brasilia, DF, Brazil.
   Univ Fed Pernambuco, Inst Figado Pernambuco, BR-50100130 Recife, PE, Brazil.
RP Pereira, LMMB (corresponding author), Univ Fed Pernambuco, Fac Ciencias Med Pernambuco, BR-50100130 Recife, PE, Brazil.
EM leilapereira@pq.cnpq.br
RI Moreira, Regina C/B-1488-2016; Cardoso, Maria Regina A/J-7280-2012;
   Figueiredo, Gerusa M/B-6660-2014; Braga, Maria Cynthia/A-8204-2013;
   Montarroyos, Ulisses/AAJ-7527-2020
OI Moreira, Regina C/0000-0002-8208-8776; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Braga, Maria Cynthia/0000-0002-7862-6455; Turchi
   Martelli, Celina Maria/0000-0002-2491-0688
FU Brazilian Ministry of Health and the Pan American Health Organization;
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [307963/2004-7, 303049/2007-3, 300917/2006-6]
FX This study was supported by the Brazilian Ministry of Health and the Pan
   American Health Organization. The authors were partially supported by
   CNPq (scholarship 307963/2004-7 to C.M.T.M. 303049/2007-3 to M.R.A.C.
   and 300917/2006-6 to R.A.A.X).
CR ANDERSON R M, 1991
   Bertolini DA, 2006, BRAZ J MED BIOL RES, V39, P1083, DOI 10.1590/S0100-879X2006000800011
   Ribeiro NRC, 2006, LIVER INT, V26, P636, DOI 10.1111/j.1478-3231.2006.01280.x
   Clemens S A, 2000, Rev Soc Bras Med Trop, V33, P1, DOI 10.1590/S0037-86822000000100001
   Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696
   Ximenes RAD, 2008, INT J EPIDEMIOL, V37, P852, DOI 10.1093/ije/dyn114
   Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004
   Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003
   El Khouri Marcelo, 2005, Clinics, V60, P29, DOI 10.1590/S1807-59322005000100007
   FOCACCIA R, 1998, BRAZ J INFECT DIS, V2, P269
   FONSECA JC, 1999, GASTROENTEROLOGIA S1, V18, pS3
   Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192
   KANEKO S, 1989, P NATL ACAD SCI USA, V86, P312, DOI 10.1073/pnas.86.1.312
   Kiesslich D, 2002, T ROY SOC TROP MED H, V96, P215, DOI 10.1016/S0035-9203(02)90311-1
   Lewis E, 2001, PEDIATR INFECT DIS J, V20, P1049, DOI 10.1097/00006454-200111000-00009
   LYRA LG, 1986, REV I MED TROP, V28, P406, DOI 10.1590/S0036-46651986000600005
   Marchesini Angela Mattos, 2007, Rev. Saúde Pública, V41, P57, DOI 10.1590/s0034-89102007000900010
   Martelli C M, 1999, Rev Panam Salud Publica, V6, P69, DOI 10.1590/S1020-49891999000600018
   Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1
   McQuillan GM, 2004, AM J PUBLIC HEALTH, V94, P1952, DOI 10.2105/AJPH.94.11.1952
   McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14
   Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103
   Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046
   PEREIRA LMMB, 1994, J MED VIROL, V42, P203, DOI 10.1002/jmv.1890420219
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   *SECR SAUD SAO PAU, 2006, REV SAUDE PUBL, V40, P1137
   Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009
   Silveira T R, 1999, Rev Panam Salud Publica, V6, P378
   Sitnik R, 2004, J CLIN MICROBIOL, V42, P2455, DOI 10.1128/JCM.42.6.2455-2460.2004
   Souto F J, 2001, Rev Panam Salud Publica, V10, P388, DOI 10.1590/S1020-49892001001200004
   Souto FJD, 1997, ANN TROP MED PARASIT, V91, P411, DOI 10.1080/00034989761030
   Souto FJD, 2001, MEM I OSWALDO CRUZ, V96, P751, DOI 10.1590/S0074-02762001000600001
   Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808
   WHO, 2000, HEP B
NR 34
TC 97
Z9 105
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD AUG
PY 2009
VL 81
IS 2
BP 240
EP 247
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 475LK
UT WOS:000268360400012
PM 19635877
DA 2020-12-01
ER

PT J
AU Pacheco, SS
   Braga, C
   de Souza, AI
   Figueiroa, JN
AF Pacheco, Samya Silva
   Braga, Cynthia
   de Souza, Ariani Impieri
   Figueiroa, Jose Natal
TI Effects of folic acid fortification on the prevalence of neural tube
   defects
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Foods for Pregnants and Breastfeeding Mothers; Food, Fortified; Folic
   Acid; Neural Tube Defects, prevention & control; Prenatal Nutrition;
   Evaluation of Results of Preventive Actions
ID RISK; GENE
AB OBJECTIVE: To analyze the effect of folic acid-fortified foods on the prevalence of neural tube defects in live newborns.
   METHODS: Longitudinal study with newborns from the city of Recife, Northeastern Brazil, between 2000 and 2006. Data analyzed were obtained from the Sistema Nacional de Informacoes de Nascidos Vivos (National Information System on Live Births). Neural tube defects were defined in accordance with the International Classification of Diseases, 10th revision (ICD-10): anencephaly, encephalocele, and spina bifida. Prevalences from the periods before (2000-2004) and after (2005-2006) the mandatory fortification period were compared. Time trend of three-month prevalences of neural tube defects were analyzed using Mann-Kendall test and Sen's Slope estimator.
   RESULTS: Tendency towards reduction in the occurrence of outcome (Mann-Kendall test; p=0.270; Sen's Slope estimator=-0.008) was not identified in the period studied. The difference between prevalences of neural tube defects in the periods before and after food fortification with folic acid was not statistically significant, according to maternal characteristics.
   CONCLUSIONS: Even though reduction in neural tube defects after the period of mandatory food fortification with folic acid was not observed, results found do not enable its benefit to prevent malformations to be ruled out. Studies assessing longer periods and considering the level of consumption of fortified products by women of fertile age are necessary.
C1 [Pacheco, Samya Silva] Univ Pernambuco, Curso Grad Med, Fac Ciencias Med, Recife, PE, Brazil.
   [Braga, Cynthia] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Braga, Cynthia; de Souza, Ariani Impieri; Figueiroa, Jose Natal] Inst Med Integral Prof Fernando Figueira, Programa Pos Grad Saude Materno Infantil, Recife, PE, Brazil.
RP Pacheco, SS (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pesquisa, Grp Saude Mulher, R dos Coelhos,300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM samya_spacheco@yahoo.com.br
RI Iats, Inct/K-2300-2013; Souza, Ariani I/C-1568-2015; de Souza, Ariani
   Impieri/AAR-6884-2020; Braga, Maria Cynthia/A-8204-2013
OI Souza, Ariani I/0000-0002-7917-5983; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Braga, Maria Cynthia/0000-0002-7862-6455
CR Aguiar Marcos J.B., 2003, J. Pediatr. (Rio J.), V79, P129, DOI 10.1590/S0021-75572003000200007
   Bentley TGK, 2006, AM J PUBLIC HEALTH, V96, P2040, DOI 10.2105/AJPH.2005.067371
   Botto LD, 2005, BMJ-BRIT MED J, V330, P571, DOI 10.1136/bmj.38336.664352.82
   Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166
   CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602
   Defoort EN, 2006, MOL PHARMACOL, V69, P1304, DOI 10.1124/mol.105.017855
   DOLK H, 1991, TERATOLOGY, V44, P547, DOI 10.1002/tera.1420440508
   Fine EL, 1999, DIABETES, V48, P2454, DOI 10.2337/diabetes.48.12.2454
   Green-Raleigh K, 2006, MATERN CHILD HLTH J, V10, pS177, DOI 10.1007/s10995-006-0104-0
   Grillo Eugênio, 2003, J. Pediatr. (Rio J.), V79, P105, DOI 10.1590/S0021-75572003000200003
   Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981
   *I MED FOOD NUTR, 1998, FOL AC DIET REF INT, P193
   Liu S, 2004, BMC PREGNANCY CHILDB, V4, P20, DOI DOI 10.1186/1471-2393-4-20
   LUMLEY J, 2000, COCHRANE DB SYST REV
   Moretti ME, 2005, EPIDEMIOLOGY, V16, P216, DOI 10.1097/01.ede.0000152903.55579.15
   Nasser Carina, 2005, J. epilepsy clin. neurophysiol., V11, P199, DOI 10.1590/S1676-26492005000400009
   Santos LMP, 2007, CAD SAUDE PUBLICA, V23, P17, DOI 10.1590/S0102-311X2007000100003
   Persad VL, 2002, CAN MED ASSOC J, V167, P241
   Rader JI, 2006, PEDIATRICS, V117, P1394, DOI 10.1542/peds.2005-2745
   Ray JG, 2005, OBSTET GYNECOL, V105, P261, DOI 10.1097/01.AOG.0000151988.84346.3e
   SEN PK, 1968, J AM STAT ASSOC, V63, P1379
   Sneyers R, 1975, 143 OMM
NR 22
TC 25
Z9 29
U1 0
U2 9
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 2009
VL 43
IS 4
BP 565
EP 571
DI 10.1590/S0034-89102009005000033
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 485LH
UT WOS:000269122500001
PM 19488664
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Rocha, A
   Braga, C
   Belem, M
   Carrera, A
   Aguiar-Santos, A
   Oliveira, P
   Texeira, MJ
   Furtado, A
AF Rocha, Abraham
   Braga, Cynthia
   Belem, Marcela
   Carrera, Arturo
   Aguiar-Santos, Ana
   Oliveira, Paula
   Texeira, Maria Jose
   Furtado, Andre
TI Comparison of tests for the detection of circulating filarial antigen
   (Og4C3-ELISA and AD12-ICT) and ultrasound in diagnosis of lymphatic
   filariasis in individuals with microfilariae
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Wuchereria bancrofti; circulating filarial antigen; ultrasound;
   diagnosis
ID WUCHERERIA-BANCROFTI INFECTION; ADULT WORMS; RECIFE; DIETHYLCARBAMAZINE;
   BRAZIL; BLOOD; ELISA; AREA
AB Significant advances were made in the diagnosis of filariasis in the 1990s with the emergence of three new alternative tools: ultrasound and tests to detect circulating antigen using two monoclonal antibodies, Og4C3 and AD12-ICT-card. This study aimed to identify which of these methods is the most sensitive for diagnosis of infection. A total of 256 individuals, all male and carrying microfilariae (1-15,679 MF/mL), diagnosed by nocturnal venous blood samples, were tested by all three techniques. The tests for circulating filarial antigen concurred 100% and correctly identified 246/256 (96.69%) of the positive individuals, while ultrasound detected only 186/256 (73.44%). Of the circulating antigen tests, ICT-card was the most convenient method for identification of Wuchereria bancrofti carriers. It was easy to perform, practical and quick.
C1 [Rocha, Abraham; Braga, Cynthia; Belem, Marcela; Carrera, Arturo; Aguiar-Santos, Ana; Oliveira, Paula; Texeira, Maria Jose] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Parasitol, Serv Referencia Nacl Filarioses, BR-50670420 Recife, PE, Brazil.
   [Rocha, Abraham; Braga, Cynthia; Belem, Marcela; Carrera, Arturo; Aguiar-Santos, Ana; Oliveira, Paula; Texeira, Maria Jose] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Serv Referencia Culicideos Vetores, BR-50670420 Recife, PE, Brazil.
   [Furtado, Andre] Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Entomol, BR-50670420 Recife, PE, Brazil.
RP Rocha, A (corresponding author), Ctr Pesquisas Aggeu Magalhaes Fiocruz, Dept Parasitol, Serv Referencia Nacl Filarioses, Av Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM rocha@cpqam.fiocruz.br
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
FU FIOCRUZ/FUNASA [268-369-433, 17]; FIOTEC/SVS [573-17, 801-17];
   Departamento de Parasitologia do Centro de Pesquisas Aggeu Magalhaes
FX Financial support: FIOCRUZ/FUNASA (projects 268-369-433, subproject 17),
   FIOTEC/SVS (projects 573-17 and 801-17), Departamento de Parasitologia
   do Centro de Pesquisas Aggeu Magalhaes
CR AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753
   CHANDRASHEKAR R, 1994, MOL BIOCHEM PARASIT, V64, P261, DOI 10.1016/0166-6851(94)00035-2
   Cox FEG, 2000, PARASITOL TODAY, V16, P135, DOI 10.1016/S0169-4758(00)01647-1
   DENHAM DA, 1971, T ROY SOC TROP MED H, V65, P521, DOI 10.1016/0035-9203(71)90163-5
   DENNIS DT, 1971, J PARASITOL, V57, P1146, DOI 10.2307/3277886
   Dreyer G, 1996, TROP MED INT HEALTH, V1, P264
   DREYER G, 1995, T ROY SOC TROP MED H, V89, P441, DOI 10.1016/0035-9203(95)90049-7
   Dreyer G, 1998, AM J TROP MED HYG, V59, P399, DOI 10.4269/ajtmh.1998.59.399
   Eberhard ML, 1997, AM J TROP MED HYG, V57, P483, DOI 10.4269/ajtmh.1997.57.483
   EBERHARD ML, 1991, CLIN LAB MED, V11, P977, DOI 10.1016/S0272-2712(18)30531-6
   Faris R, 1998, AM J TROP MED HYG, V59, P864, DOI 10.4269/ajtmh.1998.59.864
   GROVE DI, 1978, AM J TROP MED HYG, V27, P508, DOI 10.4269/ajtmh.1978.27.508
   Itoh M, 1999, TROP MED INT HEALTH, V4, P207, DOI 10.1046/j.1365-3156.1999.43379.x
   KNOTT J., 1939, TRANS ROY SOC TROP MED AND HYG, V33, P191, DOI 10.1016/S0035-9203(39)90101-X
   Lalitha P, 1998, TROP MED INT HEALTH, V3, P41, DOI 10.1046/j.1365-3156.1998.00170.x
   McCarthy J, 2000, TROP MED SCI PRACT, V1, P127
   Medeiros Z, 1999, TROP MED INT HEALTH, V4, P499, DOI 10.1046/j.1365-3156.1999.00427.x
   Molyneaux DH, 2000, T ROY SOC TROP MED H, V94, P589, DOI 10.1016/S0035-9203(00)90198-6
   Molyneux DH, 2001, CURR OPIN INFECT DIS, V14, P155, DOI 10.1097/00001432-200104000-00008
   MORE SJ, 1990, TROP MED PARASITOL, V41, P403
   Nicolas L, 1997, J INFECT DIS, V175, P489, DOI 10.1093/infdis/175.2.489
   Noroes J, 1996, T ROY SOC TROP MED H, V90, P55, DOI 10.1016/S0035-9203(96)90478-2
   Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x
   Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491
   Rocha A, 2004, MEM I OSWALDO CRUZ, V99, P101, DOI 10.1590/S0074-02762004000100018
   Rocha A, 1996, TROP MED INT HEALTH, V1, P859
   ROCHA A, 2004, THESIS I O CRUZFIOCR
   Rocha A., 2000, REV BRAS ANAL CLIN, V32, P265
   Rocha Abraham, 2002, Revista de Patologia Tropical, V31, P161
   SASA M, 1976, HUMAN FILARIASIS GLO, P3
   SMITHERS SR, 1968, DIAGNOSIS CAUSATIVE, P55
   *TROPBI, 1996, ELISA KIT DET QUANT
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   *WHO CTD TDR, 1994, STRAT CONTR LYMPH FI, P22
   WONG MM, 1969, T ROY SOC TROP MED H, V63, P796, DOI 10.1016/0035-9203(69)90123-0
   Zhong M, 1996, AM J TROP MED HYG, V54, P357, DOI 10.4269/ajtmh.1996.54.357
NR 36
TC 22
Z9 23
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2009
VL 104
IS 4
BP 621
EP 625
DI 10.1590/S0074-02762009000400015
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 489ZU
UT WOS:000269466900015
PM 19722087
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Ximenes, RAD
   Martelli, CMT
   Merchan-Hamann, E
   Montarroyos, UR
   Braga, MC
   de Lima, MLC
   Cardoso, MRA
   Turchi, MD
   Costa, MA
   de Alencar, LCA
   Moreira, RC
   Figueiredo, GM
   Pereira, LMMB
AF de Alencar Ximenes, Ricardo Arraes
   Turchi Martelli, Celina Maria
   Merchan-Hamann, Edgar
   Montarroyos, Ulisses Ramos
   Braga, Maria Cynthia
   Carvalho de Lima, Maria Luiza
   Alves Cardoso, Maria Regina
   Turchi, Marilia Dalva
   Costa, Marcelo Abrahao
   Arraes de Alencar, Luiz Claudio
   Moreira, Regina Celia
   Figueiredo, Gerusa Maria
   Moreira Beltrao Pereira, Leila Maria
CA Hepatitis Study Grp
TI Multilevel analysis of hepatitis A infection in children and
   adolescents: a household survey in the Northeast and Central-west
   regions of Brazil
SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE hepatitis A infection; multilevel analysis; Brazil; risk factors;
   contextual effects
ID RIO-DE-JANEIRO; EPIDEMIOLOGIC PATTERN; UNITED-STATES; VACCINATION;
   HEALTH; SEROPREVALENCE
AB Background The objectives were to estimate the prevalence of hepatitis A among children and adolescents from the Northeast and Midwest regions and the Federal District of Brazil and to identify individual-, household- and area-levels factors associated with hepatitis A infection.
   Methods This population-based survey was conducted in 20042005 and covered individuals aged between 5 and 19 years. A stratified multistage cluster sampling technique with probability proportional to size was used to select 1937 individuals aged between 5 and 19 years living in the Federal capital and in the State capitals of 12 states in the study regions. The sample was stratified according to age (59 and 10- to 19-years-old) and capital within each region. Individual- and household-level data were collected by interview at the home of the individual. Variables related to the area were retrieved from census tract data. The outcome was total antibodies to hepatitis A virus detected using commercial EIA. The age distribution of the susceptible population was estimated using a simple catalytic model. The associations between HAV infection and independent variables were assessed using the odds ratio and corrected for the random design effect and sampling weight. Multilevel analysis was performed by GLLAMM using Stata 9.2.
   Results The prevalence of hepatitis A infection in the 59 and 1019 age-group was 41.5 and 57.4, respectively for the Northeast, 32.3 and 56.0, respectively for the Midwest and 33.8 and 65.1 for the Federal District. A trend for the prevalence of HAV infection to increase according to age was detected in all sites. By the age of 5, 31.5 of the children had already been infected with HAV in the Northeast region compared with 20.0 in the other sites. By the age of 19 years, seropositivity was 70 in all areas. The curves of susceptible populations differed from one area to another. Multilevel modeling showed that variables relating to different levels of education were associated with HAV infection in all sites.
   Conclusion The study sites were classified as areas with intermediate endemicity area for hepatitis A infection. Differences in age trends of infection were detected among settings. This multilevel model allowed for quantification of contextual predictors of hepatitis A infection in urban areas.
C1 [de Alencar Ximenes, Ricardo Arraes; Montarroyos, Ulisses Ramos; Arraes de Alencar, Luiz Claudio; Moreira Beltrao Pereira, Leila Maria] State Univ Pernambuco, Oswaldo Cruz Univ Hosp, Sch Med Sci, BR-50100130 Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Univ Hosp, BR-50670420 Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria; Turchi, Marilia Dalva] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, BR-74605050 Goiania, Go, Brazil.
   [Merchan-Hamann, Edgar] Univ Brasilia, Sch Hlth Sci, Dept Collect Hlth, BR-70910900 Brasilia, DF, Brazil.
   [Braga, Maria Cynthia; Carvalho de Lima, Maria Luiza] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Dept Parasitol, BR-50000230 Recife, PE, Brazil.
   [Carvalho de Lima, Maria Luiza] Univ Fed Pernambuco, Dept Social Med, Univ Hosp, BR-50670420 Recife, PE, Brazil.
   [Alves Cardoso, Maria Regina] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, BR-01246904 Sao Paulo, Brazil.
   [Costa, Marcelo Abrahao] Base Hosp Fed Dist, Area Especial, BR-70335900 Brasilia, DF, Brazil.
   [Moreira, Regina Celia] Adolfo Lutz Inst, BR-01246904 Sao Paulo, Brazil.
   [Figueiredo, Gerusa Maria] Minist Hlth, Natl Program Prevent & Control Viral Hepatitis, BR-70304000 Brasilia, DF, Brazil.
RP Ximenes, RAD (corresponding author), State Univ Pernambuco, Sch Med Sci, Recife, PE, Brazil.
EM Ricardo.ximenes@pq.cnpq.br
RI Braga, Maria Cynthia/A-8204-2013; Figueiredo, Gerusa M/B-6660-2014;
   Montarroyos, Ulisses/AAJ-7527-2020; Cardoso, Maria Regina A/J-7280-2012;
   Moreira, Regina C/B-1488-2016
OI Braga, Maria Cynthia/0000-0002-7862-6455; Figueiredo, Gerusa
   M/0000-0001-9657-9675; Moreira, Regina C/0000-0002-8208-8776; Turchi
   Martelli, Celina Maria/0000-0002-2491-0688
CR Almeida LM, 2001, EPIDEMIOL INFECT, V127, P327, DOI 10.1017/S0950268801005945
   ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X
   [Anonymous], 2000, Wkly Epidemiol Rec, V75, P38
   Bell BP, 2005, VACCINE, V23, P5798, DOI 10.1016/j.vaccine.2005.03.060
   Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518
   Comm Infect Dis, 2007, PEDIATRICS, V120, P189, DOI 10.1542/peds.2007-1088
   Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171
   Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857
   Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550
   Pinho Joao Renato Rebello, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P105, DOI 10.1590/S0036-46651998000200007
   Queiroz D. A. O., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P427, DOI 10.1590/S0036-46651995000500008
   Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI
   Rosenthal P, 2003, HEPATOLOGY, V37, P44, DOI 10.1053/jhep.2003.50016
   Saback FL, 2001, SCAND J INFECT DIS, V33, P121, DOI 10.1080/003655401750065508
   Struchiner CJ, 1999, INT J EPIDEMIOL, V28, P776, DOI 10.1093/ije/28.4.776
   Tapia-Conyer R, 1999, AM J TROP MED HYG, V61, P825, DOI 10.4269/ajtmh.1999.61.825
   The Brazilian Institute of Geography and Statistics (IBGE), DEM CENS 2000 CHAR P
   Vitral CL, 2006, MEM I OSWALDO CRUZ, V101, P119, DOI 10.1590/S0074-02762006000200001
   Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012
   WHO, 2005, VACC INTR GUID ADD V
   Ximenes R A, 1999, Cad Saude Publica, V15, P53
NR 21
TC 37
Z9 40
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0300-5771
EI 1464-3685
J9 INT J EPIDEMIOL
JI Int. J. Epidemiol.
PD AUG
PY 2008
VL 37
IS 4
BP 852
EP 861
DI 10.1093/ije/dyn114
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 330SQ
UT WOS:000257963500027
PM 18653514
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Bandeira, FMGC
   Santos, MNN
   Bezerra, MAC
   Gomes, YM
   Araujo, AS
   Braga, MC
   Souza, WV
   Abath, FGC
AF Bandeira, Flavia Miranda Gomes C.
   Nunes Santos, Magnun Nueldo
   Bezerra, Marcos Andre C.
   Gomes, Yara M.
   Araujo, Aderson Silva
   Braga, Maria Cynthia
   Souza, Wayner Vieira
   Abath, Frederico G. C.
TI Family screening for HBB*S gene and detection of new cases of sickle
   cell trait in Northeastern Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
ID PUBLIC-HEALTH; DISEASE; POPULATION; ISSUES
AB OBJECTIVE: To estimate the additional number of affected individuals based on the prevalence of sickle-cell syndromes among relatives of index cases.
   METHODS: Cross-sectional study of relatives of a random sample of index cases identified through a neonatal screening program in Northeastern Brazil, between 2001 and 2005. The extended family trial model included 463 relatives of 21 index cases. Relatives were classified as nuclear family (NF: father, mother, and siblings); first degree extended family (N1: grandparents, uncles and aunts, and first cousins); second degree extended family (N2: children of first cousins); extended family (NA: NF+N1+N2); and extended nuclear family (NA1: NF+ N1). The presence of HBB* S and other abnormal hemoglobins was confirmed by high-performance liquid chromatography. The association between the presence of HBB* S and other variables was calculated using prevalence ratios and their respective 95% confidence intervals, and differences between means were calculated using Student's t test with a 5% significance level.
   RESULTS: Of relatives, 81% had no knowledge of sickle-cell anemia and HBB* S was present in 114 family members. A total of 53.3% of the studied population was considered as of reproductive age, and 80% of HBB* S carriers had already had children. Frequency was higher among NF (69%), but was also high in N1 (22.8%). NA1 screening resulted in the detection of 69 carriers additional (a 172% increase).
   CONCLUSIONS: These results indicate that family screening for the identification of sickle-cell carriers should be extended to first degree relatives.
C1 [Gomes, Yara M.; Braga, Maria Cynthia; Souza, Wayner Vieira; Abath, Frederico G. C.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Imunol, Fundacao Oswaldo Cruz, BR-50670420 Recife, PE, Brazil.
   [Bandeira, Flavia Miranda Gomes C.; Nunes Santos, Magnun Nueldo; Bezerra, Marcos Andre C.; Araujo, Aderson Silva] Fundacao Hematol & Hemoterapia Pernambuco, Recife, PE, Brazil.
RP Gomes, YM (corresponding author), Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Dept Imunol, Fundacao Oswaldo Cruz, Av Morais Rego,S-N Cidade Univ, BR-50670420 Recife, PE, Brazil.
EM yara@cpqam.fiocruz.br
RI Santos, Magnun/M-2013-2014; Souza, Wayner V/H-3798-2013; Braga, Maria
   Cynthia/A-8204-2013; Bandeira, Flavia Miranda/D-2369-2016
OI Braga, Maria Cynthia/0000-0002-7862-6455; 
CR Adekile A, 2005, CURR PAEDIAT, V5, P57, DOI 10.1016/j.cupe.2004.10.009
   Ahmed S, 2002, NEW ENGL J MED, V347, P1162, DOI 10.1056/NEJMsa013234
   Aspinall P, 2003, ANAESTHESIA, V58, P1121, DOI 10.1046/j.1365-2044.2003.03487.x
   Bandeira F M, 1999, J Pediatr (Rio J), V75, P167
   Bezerra MAC, 2007, HEMOGLOBIN, V31, P83, DOI 10.1080/03630260601057153
   Brandelise S, 2004, CLIN LAB HAEMATOL, V26, P15, DOI 10.1111/j.0141-9854.2003.00576.x
   Cunniff C, 2004, PEDIATRICS, V114, P889, DOI 10.1542/peds.2004-1368
   Cunniff C, 2000, PEDIATRICS, V106, P1494
   Desposito F, 1996, PEDIATRICS, V98, P467
   HARPER PS, 1993, LANCET, V341, P224, DOI 10.1016/0140-6736(93)90080-Z
   Nelson RM, 2001, PEDIATRICS, V107, P1451
   Peckham CS, 1998, BRIT MED BULL, V54, P767
   POWARS D, 1981, JAMA-J AM MED ASSOC, V245, P1839, DOI 10.1001/jama.245.18.1839
   Ramalho A S, 1999, Cad Saude Publica, V15, P591, DOI 10.1590/S0102-311X1999000300016
   Ramalho Antonio Sérgio, 2003, Cad. Saúde Pública, V19, P1195, DOI 10.1590/S0102-311X2003000400040
   Ramalho AS, 1985, B SOC BRAS HEMATOL H, V7, P133
   RAMALHO AS, 1976, J PEDIAT, V41, P9
   Ruiz MA, 1986, B SOC BRAS HEMATOL H, V8, P8
   SILVA RBDE, 1993, REV SAUDE PUBL, V27, P54
   TEIXEIRA RC, 1994, REV BRAS GENET, V17, P435
   *WHO, 1994, HER DIS PROGR GUID C
   WILFOND BS, 1995, AM J HUM GENET, V57, P1233
NR 22
TC 0
Z9 0
U1 0
U2 0
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 2008
VL 42
IS 2
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 298IS
UT WOS:000255682000007
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pereira, LB
   Moreira, R
   Braga, C
   Montarroyos, U
   Martelli, C
   Turchi, M
   Lima, L
   Arraes, LC
   Costa, MA
   Ximenes, R
AF Pereira, Leila B.
   Moreira, Regina
   Braga, Cynthia
   Montarroyos, Ulisses
   Martelli, Celina
   Turchi, Marilia
   Lima, Luiza
   Arraes, Luiz C.
   Costa, Marcelo A.
   Ximenes, Ricardo
TI Population based hepatites A, B and C serosurvey and genotyping in
   Brazil in capitals
SO HEPATOLOGY
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Association-for-the-Study-of-Liver-Diseases
CY NOV 02-06, 2007
CL Boston, MA
SP Amer Assoc Study Liver Dis
C1 Univ Fed Pernambuco, BR-50000 Recife, PE, Brazil.
   Aggeu Magalhaes Ctr Res, Recife, PE, Brazil.
   Adolfo Lutz Inst, Sao Paulo, Brazil.
   Univ Fed Goias, Goiania, Go, Brazil.
   Univ Fed Pernambuco, BR-50000 Recife, PE, Brazil.
   Base Hosp Brasilia, Brasilia, DF, Brazil.
RI Moreira, Regina C/B-1488-2016; Braga, Maria Cynthia/A-8204-2013
OI Moreira, Regina C/0000-0002-8208-8776; Braga, Maria
   Cynthia/0000-0002-7862-6455
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2007
VL 46
IS 4
SU S
MA 884
BP 629A
EP 629A
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 216WT
UT WOS:000249910401147
DA 2020-12-01
ER

PT J
AU Ximenes, R
   Moreira, R
   Montarroyos, U
   Braga, C
   Lima, ML
   Alencar, LC
   Nascimento, T
   Tavares, L
   Lima, JM
   Lima, JW
   Guerreiro, J
   Xavier, MJ
   Oliveira, D
   Alves, R
   Souza, G
   Barreto, M
   Miranda, D
   Medeiros, Z
   Parana, R
   Carneiro-Neto, J
   Dominici, A
   Aragao, MDG
   Sa, C
   Costa, CH
   Teixeira, KM
   Pereira, L
AF Ximenes, R.
   Moreira, R.
   Montarroyos, U.
   Braga, C.
   Lima, M. L.
   Alencar, L. C.
   Nascimento, T.
   Tavares, L.
   Lima, J. M.
   Lima, J. W.
   Guerreiro, J.
   Xavier-Filho, M. J.
   Oliveira, D.
   Alves, R.
   Souza, G.
   Barreto, M.
   Miranda-Filho, D.
   Medeiros, Z.
   Parana, R.
   Carneiro-Neto, J.
   Dominici, A.
   Aragao, M. D. G.
   Sa, C.
   Costa, C. H.
   Teixeira, K. M.
   Pereira, L.
TI Genotyping and population-based seroprevalence of hepatites A, B and C
   virus infection in the northeast region of Brazil
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Ximenes, R.; Montarroyos, U.; Lima, M. L.; Alencar, L. C.; Pereira, L.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Moreira, R.] Minist Hlth, LACEN, Distrito Fed, Brazil.
   [Braga, C.; Medeiros, Z.; Teixeira, K. M.] Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Nascimento, T.; Tavares, L.] Univ Fed Sergipe, Sergipe, Brazil.
   [Lima, J. M.] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [Lima, J. W.] Natl Fdn Hlth, Fortaleza, Ceara, Brazil.
   [Guerreiro, J.; Xavier-Filho, M. J.] Univ Fed Paraiba, BR-58059900 Joao Pessoa, Paraiba, Brazil.
   [Oliveira, D.] Hlth Secretariat Alagoas, Maceio, Brazil.
   [Alves, R.] Hlth Secretariat Maceio, Maceio, Brazil.
   [Barreto, M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Parana, R.; Carneiro-Neto, J.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Dominici, A.; Aragao, M. D. G.] Univ Fed Maranhao, Sao Luis, Brazil.
   [Sa, C.; Costa, C. H.] Univ Fed Piaui, Teresina, Brazil.
RI Montarroyos, Ulisses/AAJ-7527-2020; Braga, Maria Cynthia/A-8204-2013;
   Barreto, Mauricio L/B-1752-2008
OI Braga, Maria Cynthia/0000-0002-7862-6455; Barreto, Mauricio
   L/0000-0002-0215-4930
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD MAY
PY 2007
VL 12
SU 1
BP 141
EP 142
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 302FP
UT WOS:000255954500399
DA 2020-12-01
ER

PT J
AU Rocha, IEGM
   Victor, EG
   Braga, MC
   Silva, OBE
   Becker, MDC
AF Goncalves Moreira Rocha, Isaura Elaine
   Victor, Edgar Guimaraes
   Braga, Maria Cynthia
   Barbosa E Silva, Oswaldo
   Chaves Becker, Monica de Moraes
TI Echocardiography evaluations for asymptomatic patients with severe
   obesity (vol 88, pg 52, 2007)
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA Portuguese
DT Correction
DE left ventricular hypertrophy; obesity cardiomyopathy; severe obesity;
   echocardiography
AB Objective: To study the systolic and diastolic function of asymptomatic patients with severe obesity using a Doppler echocardiography.
   Methods: Thirty candidates for bariatric surgery, with an average BMI of 49.2 +/- 8.8 kg/m(2) and no previous history of heart disease were evaluated through transthoracic echocardiography.
   Results: Enlarged left chambers were observed in 42.9% of the sample, diastolic dysfunction in 54.6% and left ventricular hypertrophy in 82.1%, of which 50% of the cases presented the geometric pattern of eccentric hypertrophy. Indexation of left ventricular mass to height resulted in a significantly higher number of diagnoses for hypertrophy than indexation to body surface area (p = 0.0053), demonstrating that this index is more appropriate to determine ventricular hypertrophy in obese people. Correlations between left ventricular hypertrophy with obesity duration and pressure levels were positive as well as correlations between body mass index and diastolic dysfunction indicators.
   Conclusion: This study demonstrated that echocardiograms performed on asymptomatic severely obese patients can detect alterations in the cardiac structure that are common in cases of obesity cardiomyopathy and can be associated with the development of heart failure, arrhythmias and sudden death, enabling the identification of patients with greater cardiovascular risk.
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
CR Rocha IEGM, 2007, ARQ BRAS CARDIOL, V88, P52, DOI 10.1590/S0066-782X2007000100009
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI SAO PAULO
PA RUA BEIRA RIO 45-3 ANDAR, SAO PAULO, SP 04548-050, BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD APR
PY 2007
VL 88
IS 4
BP 499
EP 499
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 278IJ
UT WOS:000254278200025
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Rocha, IEGM
   Victor, EG
   Braga, MC
   Silva, OBE
   Becker, MDC
AF Goncalves Moreira Rocha, Isaura Elaine
   Victor, Edgar Guimaraes
   Braga, Maria Cynthia
   Barbosa e Silva, Odwaldo
   Chaves Becker, Monica de Moraes
TI Echocardiography evaluation for asymptomatic patients with severe
   obesity
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA Portuguese
DT Article
DE left ventricular hypertrophy; obesity cardiomyopathy; severe obesity;
   echocardiography
ID LEFT-VENTRICULAR HYPERTROPHY; DOPPLER-ECHOCARDIOGRAPHY; SYSTOLIC
   FUNCTION; HEART-DISEASE; TASK-FORCE; RECOMMENDATIONS; CARDIOMYOPATHY;
   HEALTH; MASS
AB Objective: To study the systolic and diastolic function of asymptomatic patients with severe obesity using a Doppler echocardiography.
   Methods: Thirty candidates for bariatric surgery, with an average BMI of 49.2 +/- 8.8 Kg/m(2) and no previous history of heart disease were evaluated through transthoracic echocardiography.
   Results: Enlarged left chambers were observed in 42.9% of the sample, diastolic dysfunction in 54.6% and left ventricular hypertrophy in 82.1% of which 50% of the cases presented the geometric pattern of eccentric hypertrophy. Indexation of left ventricular mass to height resulted in a significantly higher number of diagnoses for hypertrophy than indexation to body surface area (p = 0.0053), demonstrating that this index is more appropriate to determine ventricular hypertrophy in obese people. Correlations between left ventricular hypertrophy with obesity duration and pressure levels were positive as well as correlations between body mass index and diastolic dysfunction indicators.
   Conclusion: This study demonstrated that echocardiograms performed on asymptomatic severely obese patients can detect alterations in the cardiac structure that are common in cases of obesity cardiomyopathy and can be associated with the development of heart failure, arrhythmias and sudden death.
C1 Univ Fed Pernambuco, Fac Med Juazeiro Norte, Recife, PE, Brazil.
RP Rocha, IEGM (corresponding author), Rua Odete Matos De Alencar,338 Lagoa Seca 63040270, Juazeiro Do Norte, PE, Brazil.
EM elainegoncalves@cardiol.br
RI Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455
CR *3 DIR BRAS DISL D, 2001, ARQ BRAS CARDIOL S3, V77, P1
   *3 REP NATL CHOL E, 2001, JAMA-J AM MED ASSOC, V19, P2486
   *4 DIR BRAS HIP AR, 2002, REV BRAS HIPERTENS, V9, P359
   ALEXANDER JK, 1985, PROG CARDIOVASC DIS, V27, P325, DOI 10.1016/S0033-0620(85)80002-5
   Alexander JK, 2001, AM J MED SCI, V321, P215, DOI 10.1097/00000441-200104000-00002
   ALEXANDER JK, 1978, MED COMPLICATIONS OB, P178
   ALPERT MA, 1993, AM J CARDIOL, V71, P733, DOI 10.1016/0002-9149(93)91019-E
   Alpert MA, 1997, AM J CARDIOL, V80, P736, DOI 10.1016/S0002-9149(97)00505-5
   Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003
   ALPERT MA, 1995, AM J CARDIOL, V76, P1194, DOI 10.1016/S0002-9149(99)80338-5
   [Anonymous], 2002, Arq Bras Cardiol, V78 Suppl 2, P1
   [Anonymous], 1985, ANN INTERN MED, V103, P1073, DOI 10.7326/0003-4819-103-6-1073
   Aronne LJ, 2002, OBES RES, V10, p105S, DOI 10.1038/oby.2002.203
   BENOTTI PN, 1992, AM J CLIN NUTR, V55, P586
   DEDIVITIIS O, 1981, CIRCULATION, V64, P477, DOI 10.1161/01.CIR.64.3.477
   DENMEAUX G, 2001, ECHOCARDIOGRAPHIE ME
   deOnis M, 1996, AM J CLIN NUTR, V64, P650
   DESIMONE G, 1994, HYPERTENSION, V23, P600, DOI 10.1161/01.HYP.23.5.600
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   GARAVAGLIA GE, 1988, AM J CARDIOL, V62, P594, DOI 10.1016/0002-9149(88)90662-5
   Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876
   Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X
   HERSZKOWICZ N, 2001, ARQ BRAS CARDIOL, V76, P193
   MANCINI M.C., 2001, ARQUIVOS BRASILEIROS, V45, P584
   Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7
   Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202
   Rosa Eduardo Cantoni, 2002, Arq Bras Cardiol, V78, P341
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Smith HL, 1933, ARCH INTERN MED, V52, P911, DOI 10.1001/archinte.1933.00160060085007
   ZARICH SW, 1991, AM J CARDIOL, V68, P377, DOI 10.1016/0002-9149(91)90835-9
   2004, ARQ BRAS CARDIOL S2, V82, P11
   2000, ARQ BRAS ENDOCRIN S1, V44, P8
NR 33
TC 21
Z9 22
U1 0
U2 2
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI RIO DE JANEIRO
PA AVENIDA MARECHAL CAMARA 160-330 CENTRO, RIO DE JANEIRO, RJ 20 020-907,
   BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD JAN
PY 2007
VL 88
IS 1
BP 52
EP 58
DI 10.1590/S0066-782X2007000100009
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 272UO
UT WOS:000253886000021
PM 17364119
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Braga, C
   Dourado, I
   Ximenes, R
   Miranda, J
   Alexander, N
AF Braga, C
   Dourado, I
   Ximenes, R
   Miranda, J
   Alexander, N
TI Bancroftian filariasis in an endemic area of Brazil: differences between
   genders during puberty
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE filariasis; gender differences; puberty; risk factors
ID SEX-DIFFERENCES; HORMONES; SUSCEPTIBILITY; INFECTION; TESTOSTERONE;
   PREGNANCY; PATTERNS; IMMUNITY; STEROIDS; ANTIGEN
AB Gender differences in susceptibility to infectious diseases have been observed in various studies. A survey was performed in a bancroftian filariasis endemic area in the city of Olinda, Brazil. All residents aged 5 years or older were examined by thick blood film. People aged 9 to 16 years were interviewed and also tested for filarial antigenaemia. Data were analyzed by contingency table methods and regression models. The risk of microfilaraemia for males was significantly higher. Among those aged 9 to 16 years, the analysis of gender and filariasis by age showed that boys from 15 to 16 years had a higher risk of infection than girls. No association was found between menarche and filariasis in girls. The data suggest that variations between gender in filariasis could result, at least in part, from an increase in susceptibility of men. This epidemiologic feature needs to be considered while formulating elimination plans.
C1 Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
   Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   Univ London, London Sch Hyg & Trop Med, London, England.
RP Braga, C (corresponding author), Cidade Univ, FIOCRUZ, Dept Parasitol 2, CPqAM, Av Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM braga@cpqam.fiocruz.br
RI Dourado, Ines/Q-6535-2016; Braga, Maria Cynthia/A-8204-2013
OI Dourado, Ines/0000-0003-1675-2146; Braga, Maria
   Cynthia/0000-0002-7862-6455
CR ALEXANDER J, 1988, PARASITOL TODAY, V4, P189, DOI 10.1016/0169-4758(88)90077-4
   Alexander NDE, 1999, PARASITOLOGY, V119, P151, DOI 10.1017/S0031182099004527
   BRABIN L, 1990, EPIDEMIOL INFECT, V105, P335, DOI 10.1017/S0950268800047932
   BRABIN L, 1992, ADV PARASIT, V31, P1, DOI 10.1016/S0065-308X(08)60020-2
   Braga C, 2001, Cad Saude Publica, V17, P1211, DOI 10.1590/S0102-311X2001000500021
   BUNDY D, 1998, PARASITOL TODAY, V4, P196
   CHANDRA G, 1995, AM J TROP MED HYG, V53, P378, DOI 10.4269/ajtmh.1995.53.378
   CHANTEAU S, 1995, INT J PARASITOL, V25, P81, DOI 10.1016/0020-7519(94)00088-6
   de Albuquerque M de F, 1995, Rev Inst Med Trop Sao Paulo, V37, P225
   Elliot J. M., 1977, SOME METHODS STAT AN
   GOBLE FC, 1973, T NEW YORK ACAD SCI, V35, P325, DOI 10.1111/j.2164-0947.1973.tb01971.x
   Itoh M, 1999, TROP MED INT HEALTH, V4, P207, DOI 10.1046/j.1365-3156.1999.43379.x
   KANDRACK MA, 1991, SOC SCI MED, V32, P579, DOI 10.1016/0277-9536(91)90293-L
   Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0
   Maciel A, 1996, MEM I OSWALDO CRUZ, V91, P449, DOI 10.1590/S0074-02761996000400011
   MAVOUNGOU D, 1989, J STEROID BIOCHEM, V34, P577, DOI 10.1016/0022-4731(89)90149-0
   McCarthy J, 2000, TROP MED SCI PRACT, V1, P127
   MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988
   NAKANISHI H, 1989, J PARASITOL, V75, P455, DOI 10.2307/3282605
   Nakazawa M, 1997, EXP PARASITOL, V85, P233, DOI 10.1006/expr.1997.4148
   Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813
   Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001
   Roberts CW, 1996, PARASITOL TODAY, V12, P382, DOI 10.1016/0169-4758(96)10060-0
   SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3
   Steel C, 2001, AM J TROP MED HYG, V65, P498, DOI 10.4269/ajtmh.2001.65.498
   STYRT B, 1991, REV INFECT DIS, V13, P1139
   Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011
   Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3
   Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]
NR 29
TC 13
Z9 15
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2005
VL 38
IS 3
BP 224
EP 228
DI 10.1590/S0037-86822005000300003
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 949MS
UT WOS:000230793400003
PM 15895172
OA DOAJ Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU dos Santos, MAPS
   Albuquerque, MFPM
   Ximenes, RAA
   Lucena-Silva, NLCL
   Braga, C
   Campelo, ARL
   Dantas, OMS
   Montarroyos, UR
   Souza, WV
   Kawasaki, AM
   Rodrigues, LC
AF dos Santos, MAPS
   Albuquerque, MFPM
   Ximenes, RAA
   Lucena-Silva, NLCL
   Braga, C
   Campelo, ARL
   Dantas, OMS
   Montarroyos, UR
   Souza, WV
   Kawasaki, AM
   Rodrigues, LC
TI Risk factors for treatment delay in pulmonary tuberculosis in Recife,
   Brazil
SO BMC PUBLIC HEALTH
LA English
DT Article
ID HEALTH-SEEKING BEHAVIOR; CARE-SYSTEM DELAYS; DIAGNOSIS; PATIENT
AB Background: Tuberculosis is still a great challenge to public health in Brazil and worldwide. Early detection followed by effective therapy is extremely important in controlling the disease. Recent studies have investigated reasons for delays in treatment, but there is no agreed definition of what constitutes an "acceptable" delay. This study investigates factors associated with total delay in treatment of tuberculosis.
   Methods: A cohort of adult cases of pulmonary tuberculosis diagnosed over a two-year period was studied. Patients were interviewed on entry, reporting the duration of symptoms before the start of treatment, and sputum and blood samples were collected. It was decided that sixty days was an acceptable total delay. Associations were investigated using univariable and multivariable analysis and the population attributable fraction was estimated.
   Results: Of 1105 patients, 62% had a delay of longer than 60 days. Age, sex, alcoholism and difficulty of access were not associated with delays, but associations were found in the case of unemployment, having given up smoking, having lost weight and being treated in two of the six health districts. The proportion attributable to: not being an ex-smoker was 31%; unemployment, 18%; weight loss, 12%, and going to the two worst health districts, 25%.
   Conclusion: In this urban area, delays seem to be related to unemployment and general attitudes towards health. Although they reflect the way health services are organized, delays are not associated with access to care.
C1 Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Rio De Janeiro, Brazil.
   Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England.
   Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
RP Braga, C (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Rio De Janeiro, Brazil.
EM martinhoapsantos@hotmail.com; militao@cpqam.fiocruz.br;
   rximenes@elogica.com.br; nlucena@cpqam.fiocruz.br;
   braga@cpqam.fiocruz.br; robertocampelo@terra.com.br;
   odimariles@globo.com; ulisses@cpqam.fiocruz.br; wayner@cpqam.fiocruz.br;
   amkawasaki@ig.com.br; laura.rodrigues@lshtm.ac.uk
RI Souza, Wayner V/H-3798-2013; Braga, Maria Cynthia/A-8204-2013;
   Montarroyos, Ulisses/AAJ-7527-2020; Lucena-Silva, Norma/AAH-9437-2019
OI Braga, Maria Cynthia/0000-0002-7862-6455; Souza,
   Wayner/0000-0002-0939-9332; Rodrigues, Laura Cunha/0000-0001-9008-660X
CR Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23
   Gomez MNA, 2003, ARCH BRONCONEUMOL, V39, P146
   Guneylioglu D, 2004, MED SCI MONITOR, V10, pCR62
   JOB JRPP, 1986, REV SAUDE PUBL, V20, P21, DOI 10.1590/S0034-89101986000100002
   Lawn SD, 2000, INT J TUBERC LUNG D, V4, P1190
   Lewis K E, 2003, Commun Dis Public Health, V6, P133
   Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233
   Long NH, 1999, INT J TUBERC LUNG D, V3, P388
   Ngamvithayapong J, 2001, INT J TUBERC LUNG D, V5, P1013
   Odusanya OO, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-18
   Paynter S, 2004, INT J TUBERC LUNG D, V8, P180
   PIRKIS JE, 1996, TUBERCLE LUNG DIS, V77, P389
   Pitman R, 2002, INT J TUBERC LUNG D, V6, P485
   Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789
   Rodger A, 2003, BRIT MED J, V326, P909, DOI 10.1136/bmj.326.7395.909
   Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088
   SHIMAO T, 1985, B UNION INT TUBERC E, V60, P122
   Steen TW, 1998, INT J TUBERC LUNG D, V2, P627
   Thorson A, 2000, LANCET, V356, P1823, DOI 10.1016/S0140-6736(00)03241-4
   Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133
   Ward J, 2001, INT J TUBERC LUNG D, V5, P1021
   World Health Organization, 2004, GLOB TUB CONTR SURV
NR 22
TC 52
Z9 55
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 18
PY 2005
VL 5
AR 25
DI 10.1186/1471-2458-5-25
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 919CJ
UT WOS:000228595600001
PM 15777473
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-01
ER

PT J
AU Tang, JM
   Freedman, DO
   Allen, S
   Karita, E
   Musonda, R
   Braga, C
   Margolick, J
   Kaslow, RA
AF Tang, JM
   Freedman, DO
   Allen, S
   Karita, E
   Musonda, R
   Braga, C
   Margolick, J
   Kaslow, RA
TI TAP1 polymorphisms in several human ethnic groups: Characteristics,
   evolution, and genotyping strategies
SO HUMAN IMMUNOLOGY
LA English
DT Article
DE evolution; genetics; genotyping; polymorphism; SNP; TAP1
ID MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; HLA CLASS-I;
   DEPENDENT DIABETES-MELLITUS; ANTIGEN-PROCESSING TAP; GRADIENT
   GEL-ELECTROPHORESIS; LINKAGE DISEQUILIBRIUM; RHEUMATOID-ARTHRITIS;
   PEPTIDE-TRANSPORT; GENE POLYMORPHISM
AB Genetic variations in the locus encoding the transporter associated with antigen processing, subunit 1 (TAP1), were systematically studied using samples from Caucasians, Africans, Brazilians, and compared with data from:chimpanzees. PCR-amplified genomic se quences corresponding to the 11 exons were analyzed by single-strand conformation polymorphism (SSCP) and sequencing. Six nonsynonymous and 2 synonymous single nucleotide polymorphisms (SNPs) were found to be common in-one ethnic group or another, and they involved codons 254 (Gly-GGC/Gly-GGT) in exon 3, 333 (Ile-ATC/Val-GTC) in exon 4, 370 (Ala-GCT/Val-GTT) in exon 5,- 458 (Val-GTG/Leu-TTG) in exon 6,518 (Val-GTC/Ile-ATC) in exon 7, 637 (Asp-GAC/Gly-GGC), 648 (Arg-CGA/Gln-CAA) and 661 (Pro-CCG/Pro-CCA) in exon 10. At each SNP site the sequence listed first was predominant.:in all ethnic groups. Several SNPs segregated on the same chromosome regardless of populations and species. Together, the SNPs produced 5 major human TAP1 alleles, 4 of which matched the officially recognized alleles *0101, *02011, *0301, and *0401; the 5th allele differed from each of those by at least 4 SNPs. Overall, TAP1*0101 was the predominant allele in all ethnic groups, with frequencies ranging from 0.667 in Zambians to 0.808 in US Caucasians. The TAP1*0401 frequency showed the greatest difference between Africans (0.221-0.254) and Caucasians (0.033), with Brazilians (0.058) fitting in the middle. Consistent with earlier work based on Caucasians and gorillas, *0101 appeared to be the newest human TAP1 allele, suggesting a dramatic spread of *0101 into all human populations examined. Characterization of TAP1 polymorphisms allowed the design of a PCR-based genotyping scheme that targeted 7 SNP sites and required 2 separate genotyping techniques. Human Immunology 62, 256-268 (2001). (C) American Society for Histocompatibility and Immunogenetics, 2001. Published by Elsevier Science Inc.
C1 Univ Alabama, Program Epidemiol Infect & Immun, Sch Publ Hlth, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Med, Div Geog Med, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA.
   Natl AIDS Control Program, Kigali, Rwanda.
   Trop Dis Res Ctr, Ndona, Zambia.
   Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA.
RP Tang, JM (corresponding author), Univ Alabama, Program Epidemiol Infect & Immun, Sch Publ Hlth, 610 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.
RI Freedman, David O./AAV-2999-2020; Tang, Jianming/O-4980-2019; Braga,
   Maria Cynthia/A-8204-2013
OI Freedman, David O./0000-0002-5642-5257; Braga, Maria
   Cynthia/0000-0002-7862-6455; Tang, Jianming/0000-0003-0137-7486
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI041530, U01AI041530, U01AI041530, U01AI041530, R01AI031552,
   U01AI041530, R01AI040951, R01AI031552, U01AI041530, R01AI031552,
   R01AI040951, R01AI031552, R01AI040951, R01AI031552, R01AI031552,
   R01AI031552, R01AI040951, R01AI040951, U01AI041530, U01AI041530,
   R01AI031552, U01AI041530, U01AI041530, R01AI031552, R01AI040951] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI-40951, AI-31552,
   AI-41530, AI-42454] Funding Source: Medline
CR ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716
   Armandola EA, 1996, EUR J IMMUNOL, V26, P1748, DOI 10.1002/eji.1830260813
   BARAM A, 1991, P NATL ACAD SCI USA, V88, P10094
   BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0
   Bodmer JG, 1999, TISSUE ANTIGENS, V53, P407, DOI 10.1034/j.1399-0039.1999.530421.x
   CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C
   CARRINGTON M, 1993, IMMUNOGENETICS, V37, P266
   Cereb N, 1997, IMMUNOGENETICS, V47, P30, DOI 10.1007/s002510050323
   Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210
   CHEVRIER D, 1995, TRANSPLANTATION, V60, P292, DOI 10.1097/00007890-199508000-00015
   Clayton J, 1997, GENETIC DIVERSITY HL, V1, P665
   COLONNA M, 1992, P NATL ACAD SCI USA, V89, P3932, DOI 10.1073/pnas.89.9.3932
   Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031
   Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x
   CULLEN M, 1995, AM J HUM GENET, V56, P1350
   Cullen M, 1997, AM J HUM GENET, V60, P397
   Daniel S, 1998, J IMMUNOL, V161, P617
   de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687
   DEGLIESPOSTI MA, 1992, HUM IMMUNOL, V34, P242, DOI 10.1016/0198-8859(92)90023-G
   DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574
   Detels R, 1996, IMMUNOL LETT, V51, P29, DOI 10.1016/0165-2478(96)02551-5
   DONN RP, 1994, EUR J IMMUNOGENET, V21, P159, DOI 10.1111/j.1744-313X.1994.tb00187.x
   Felsenstein J, 1993, PHYLIP PHYLOGENY INF
   Freedman DO, 1999, J IMMUNOL, V162, P1756
   Furukawa H, 1999, J CLIN INVEST, V103, P755, DOI 10.1172/JCI5335
   Gaudieri S, 1997, J MOL EVOL, V45, P17, DOI 10.1007/PL00006194
   GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0
   HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335
   Hohler T, 1996, HUM IMMUNOL, V51, P49, DOI 10.1016/S0198-8859(96)00156-5
   HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532
   HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440
   Ishihara M, 1996, HUM IMMUNOL, V45, P105, DOI 10.1016/0198-8859(95)00167-0
   JACKSON DG, 1993, P NATL ACAD SCI USA, V90, P11079, DOI 10.1073/pnas.90.23.11079
   Johnsen A, 1998, CANCER RES, V58, P3660
   Johnsen AK, 1999, J IMMUNOL, V163, P4224
   Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405
   Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862
   KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0
   Kobayashi T, 2000, HUM IMMUNOL, V61, P670, DOI 10.1016/S0198-8859(00)00124-5
   Kulig K, 1998, J EXP MED, V187, P865, DOI 10.1084/jem.187.6.865
   Laud PR, 1996, HUM IMMUNOL, V50, P91, DOI 10.1016/0198-8859(96)00137-1
   Li SL, 1999, J BIOL CHEM, V274, P8649, DOI 10.1074/jbc.274.13.8649
   Lobigs M, 1999, IMMUNOGENETICS, V49, P931, DOI 10.1007/s002510050576
   MAKSYMOWYCH WP, 1995, TISSUE ANTIGENS, V45, P328, DOI 10.1111/j.1399-0039.1995.tb02462.x
   Maruya E, 1996, GENOME RES, V6, P51, DOI 10.1101/gr.6.1.51
   Maugendre D, 1996, TISSUE ANTIGENS, V48, P540, DOI 10.1111/j.1399-0039.1996.tb02667.x
   Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397
   MOINSTEISSERENC H, 1995, IMMUNOGENETICS, V42, P308, DOI 10.1007/BF00176453
   Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X
   Mora B, 1999, EUR J IMMUNOGENET, V26, P331, DOI 10.1046/j.1365-2370.1999.00166.x
   Neisig A, 1996, J IMMUNOL, V156, P3196
   Nijenhuis M, 1996, J IMMUNOL, V157, P5467
   Nijenhuis M, 1996, J IMMUNOL, V156, P2186
   OBST R, 1995, EUR J IMMUNOL, V25, P2170, DOI 10.1002/eji.1830250808
   Ofosu MH, 1998, IMMUNOL INVEST, V27, P281, DOI 10.3109/08820139809070901
   OLERUP O, 1993, HDB HLA TYPING TECHN, P149
   Perry CL, 1998, TISSUE ANTIGENS, V52, P88, DOI 10.1111/j.1399-0039.1998.tb03030.x
   POWIS SH, 1993, IMMUNOGENETICS, V38, P345
   POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802
   POWIS SH, 1994, TISSUE ANTIGENS, V43, P261, DOI 10.1111/j.1399-0039.1994.tb02336.x
   Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9
   Quadri SA, 1998, IMMUNOL LETT, V61, P25, DOI 10.1016/S0165-2478(97)00157-0
   Rau H, 1997, TISSUE ANTIGENS, V49, P16, DOI 10.1111/j.1399-0039.1997.tb02704.x
   Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203
   Shi L, 1997, TISSUE ANTIGENS, V49, P421, DOI 10.1111/j.1399-0039.1997.tb02772.x
   Shitaye H, 1999, HUM IMMUNOL, V60, P1289, DOI 10.1016/S0198-8859(99)00123-8
   Solheim JC, 1997, J IMMUNOL, V158, P541
   SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0
   Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337
   SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286
   Suh WK, 1999, J IMMUNOL, V162, P1530
   SZAFER F, 1994, IMMUNOGENETICS, V39, P374
   Takeuchi F, 1997, TISSUE ANTIGENS, V49, P280, DOI 10.1111/j.1399-0039.1997.tb02753.x
   Tang J, 1998, TISSUE ANTIGENS, V51, P556, DOI 10.1111/j.1399-0039.1998.tb02992.x
   Tang JM, 1999, AIDS RES HUM RETROV, V15, P317, DOI 10.1089/088922299311277
   TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0
   VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594
   VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6
   Vejbaesya S, 2000, HUM IMMUNOL, V61, P309, DOI 10.1016/S0198-8859(99)00163-9
   Vitale M, 1998, CANCER RES, V58, P737
   Vos JC, 1999, J IMMUNOL, V163, P6679
   Vos JC, 2000, CURR BIOL, V10, P1, DOI 10.1016/S0960-9822(99)00257-2
   Wang P, 1996, J IMMUNOL, V157, P213
   WARBURTON RJ, 1994, HUM IMMUNOL, V39, P261, DOI 10.1016/0198-8859(94)90269-0
   Yan G, 1997, TISSUE ANTIGENS, V50, P576, DOI 10.1111/j.1399-0039.1997.tb02915.x
   ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407
NR 86
TC 12
Z9 13
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0198-8859
J9 HUM IMMUNOL
JI Hum. Immunol.
PD MAR
PY 2001
VL 62
IS 3
BP 256
EP 268
DI 10.1016/S0198-8859(00)00259-7
PG 13
WC Immunology
SC Immunology
GA 412WQ
UT WOS:000167577700007
PM 11250043
DA 2020-12-01
ER

PT J
AU Tang, J
   Freedman, DO
   Allen, S
   Karita, E
   Musonda, R
   Braga, C
   Jamieson, BD
   Louie, L
   Kaslow, RA
AF Tang, J
   Freedman, DO
   Allen, S
   Karita, E
   Musonda, R
   Braga, C
   Jamieson, BD
   Louie, L
   Kaslow, RA
TI Genotyping TAP2 variants in North American Caucasians, Brazilians, and
   Africans
SO GENES AND IMMUNITY
LA English
DT Article
DE allele; genetics; polymorphism; population; SNP; TAP2
ID MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; HLA CLASS-II;
   DEPENDENT DIABETES-MELLITUS; ANTIGEN-PROCESSING GENES; LINKAGE
   DISEQUILIBRIUM; RECOMBINATION HOTSPOT; SUBSTRATE-SPECIFICITY;
   RENAL-TRANSPLANTATION; PEPTIDE TRANSPORTER
AB The protein forms of transporter associated with antigen processing, subunit 2 (TAP2), differ either by amino acid substitutions (Thr374Ala, Ile379Val, Ile467Val, Thr565Ala, Va1577Met, Cys651Arg, and Ala665Thr) or by a truncation (Gln687Stop) of 17 amino acid residues at the C-terminus. Nonsynonymous single nucleotide polymorphisms (N-SNPs) causing these amino acid variations except 577Val were detected in genomic DNA samples from North American Caucasians (n = 76), Brazilians (n = 148), Rwandans (n = 285), and Zambians (n = 117). Exclusive (100%) and nearly exclusive (>95%) linkage disequilibrium was seen with a number of N-SNPs. The average heterozygosity at any given dimorphic site ranged from 7.3% to 44.6%, and at least four N-SNPs showed clear population specificity. N-SNP combinations alone led to the identification of 16 relatively common alleles, which appeared to form at least three lineages. Further analyses of 101 cDNA samples from Brazilians detected nine expressed TAP2 alleles, four of which matched the official assignments. Genetic complexity at the TAP2 locus was further enhanced by two out of five synonymous SNPs (S-SNPs), especially the GGT386GGG (Gly) that had similar heterozygosity rates in Caucasians (28.9%), Rwandans (33.3%), and Zambians (33.3%). Overall, distribution of both synonymous and nonsynonymous SNPs in the various ethnic groups examined here conformed well to the Hardy-Weinberg equilibrium, and between 57.9% and 77.0% of subjects in each ethnic group were heterozygous with two TAP2 alleles predicted to differ by at least one amino acid residue. Such complexity of TAP2 polymorphisms, in the form of SNPs as well as alleles, is likely to complicate the analyses of disease associations and haplotype structures in the HLA class II region. Genes and Immunity (2001) 2, 32-40.
C1 Univ Alabama, Sch Publ Hlth, Program Epidemiol Infect & Immun, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Med, Div Geog Med, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA.
   Trop Dis Res Ctr, Ndona, Zambia.
   Natl AIDS Control Program, Kigali, Rwanda.
   Ctr Pesquisas Aggeu Magalliaes, Recife, PE, Brazil.
   Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.
RP Tang, J (corresponding author), Univ Alabama, Sch Publ Hlth, Program Epidemiol Infect & Immun, 610 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.
RI Braga, Maria Cynthia/A-8204-2013; Tang, Jianming/O-4980-2019; Freedman,
   David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257; Tang, Jianming/0000-0003-0137-7486
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-41951, AI-36661, AI-31552] Funding
   Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI036661, R01AI031552, R01AI031552,
   R01AI041951, R01AI041951, R01AI031552, R01AI041951, R01AI036661,
   R01AI036661, R01AI041951, R01AI041951, R01AI041951, R01AI036661,
   R01AI031552, R01AI036661, R01AI031552, R01AI041951, R01AI031552,
   R01AI041951, R01AI031552, R01AI031552, R01AI041951, R01AI031552] Funding
   Source: NIH RePORTER
CR ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716
   AOKI Y, 1993, IMMUNOGENETICS, V38, P382
   Armandola EA, 1996, EUR J IMMUNOL, V26, P1748, DOI 10.1002/eji.1830260813
   AWOMOYI AAO, 1995, EUR J IMMUNOGENET, V22, P187, DOI 10.1111/j.1744-313X.1995.tb00229.x
   Bodmer JG, 1999, TISSUE ANTIGENS, V53, P407, DOI 10.1034/j.1399-0039.1999.530421.x
   CAILLATZUCMAN S, 1995, HUM IMMUNOL, V44, P80, DOI 10.1016/0198-8859(95)00062-9
   CANO P, 1995, TISSUE ANTIGENS, V45, P139, DOI 10.1111/j.1399-0039.1995.tb02431.x
   CARRINGTON M, 1993, IMMUNOGENETICS, V37, P266
   Carrington M, 1997, MOL BIOL EVOL, V14, P892, DOI 10.1093/oxfordjournals.molbev.a025831
   Cesari MM, 1997, IMMUNOGENETICS, V45, P280, DOI 10.1007/s002510050205
   COLONNA M, 1992, P NATL ACAD SCI USA, V89, P3932, DOI 10.1073/pnas.89.9.3932
   CULLEN M, 1995, AM J HUM GENET, V56, P1350
   Cullen M, 1997, AM J HUM GENET, V60, P397
   DjilaliSaiah I, 1996, TISSUE ANTIGENS, V48, P87, DOI 10.1111/j.1399-0039.1996.tb02612.x
   DONATO L, 1995, J PEDIATR-US, V127, P895, DOI 10.1016/S0022-3476(95)70024-2
   Faucz FR, 2000, EUR J IMMUNOGENET, V27, P5
   Felsenstein J, 1993, PHYLIP PHYLOGENY INF
   Foley PJ, 1999, AM J RESP CRIT CARE, V160, P1009, DOI 10.1164/ajrccm.160.3.9810032
   Freedman DO, 1999, J IMMUNOL, V162, P1756
   Grimholt U, 1997, IMMUNOGENETICS, V46, P213, DOI 10.1007/s002510050264
   GUILLEMOT F, 1988, EMBO J, V7, P2775, DOI 10.1002/j.1460-2075.1988.tb03132.x
   Hansen JD, 1999, J IMMUNOL, V163, P774
   Hayney MS, 1997, VACCINE, V15, P3, DOI 10.1016/S0264-410X(96)00133-8
   HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7
   HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335
   Hess M, 1999, CYTOGENET CELL GENET, V85, P244, DOI 10.1159/000015302
   HILARBY MC, 1996, CLIN EXP RHEUMATOL, V14, P67
   Hogstrand K, 1999, IMMUNOGENETICS, V49, P446, DOI 10.1007/s002510050518
   Hogstrand K, 1999, IMMUNOL REV, V167, P305, DOI 10.1111/j.1600-065X.1999.tb01400.x
   Hughes AL, 1996, IMMUNOL CELL BIOL, V74, P444, DOI 10.1038/icb.1996.74
   HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440
   HUGHES AL, 1993, GENETICS, V133, P669
   Ishihara M, 1997, TISSUE ANTIGENS, V49, P107, DOI 10.1111/j.1399-0039.1997.tb02722.x
   Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725
   JOLY E, 1993, UNPUB DISTRIBUTION T
   Kasahara M, 1999, IMMUNOGENETICS, V50, P134, DOI 10.1007/s002510050589
   Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405
   Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862
   Keicho N, 1999, TISSUE ANTIGENS, V53, P366, DOI 10.1034/j.1399-0039.1999.530407.x
   KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0
   Kobayashi T, 1998, TRANSPLANT P, V30, P29, DOI 10.1016/S0041-1345(97)01170-6
   Kobayashi T, 2000, HUM IMMUNOL, V61, P670, DOI 10.1016/S0198-8859(00)00124-5
   Kumagai S, 1997, ARTHRITIS RHEUM, V40, P1685, DOI 10.1002/art.1780400919
   Lapinski PE, 2000, J BIOL CHEM, V275, P6831, DOI 10.1074/jbc.275.10.6831
   LIFSON AR, 1995, ANN INTERN MED, V122, P262, DOI 10.7326/0003-4819-122-4-199502150-00004
   LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320
   Lobigs M, 1999, IMMUNOGENETICS, V49, P931, DOI 10.1007/s002510050576
   Loflin PT, 1996, IMMUNOGENETICS, V44, P161
   Marusina K, 1997, J IMMUNOL, V158, P5251
   MCADAM SN, 1994, P NATL ACAD SCI USA, V91, P5893, DOI 10.1073/pnas.91.13.5893
   McKenna SL, 1997, AIDS, V11, pS103
   MEINZENDERR J, 2001, IN PRESS AM J PUB HL
   MOINSTEISSERENC H, 1995, IMMUNOGENETICS, V42, P308, DOI 10.1007/BF00176453
   Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X
   Momburg F, 1996, J IMMUNOL, V156, P1756
   Mora B, 1999, EUR J IMMUNOGENET, V26, P331, DOI 10.1046/j.1365-2370.1999.00166.x
   Nijenhuis M, 1996, J IMMUNOL, V157, P5467
   OBST R, 1995, EUR J IMMUNOL, V25, P2170, DOI 10.1002/eji.1830250808
   Ocal L, 1996, BRIT J RHEUMATOL, V35, P529
   Ohta Y, 1999, IMMUNOGENETICS, V49, P171, DOI 10.1007/s002510050478
   POWIS SH, 1993, IMMUNOGENETICS, V38, P345
   POWIS SH, 1992, P NATL ACAD SCI USA, V89, P1463, DOI 10.1073/pnas.89.4.1463
   POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802
   Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9
   Rau H, 1997, TISSUE ANTIGENS, V49, P16, DOI 10.1111/j.1399-0039.1997.tb02704.x
   RONNINGEN KS, 1993, EUR J IMMUNOL, V23, P1050, DOI 10.1002/eji.1830230511
   Shiina T, 1999, IMMUNOGENETICS, V49, P384, DOI 10.1007/s002510050511
   Singal DP, 1998, INT J CANCER, V75, P112, DOI 10.1002/(SICI)1097-0215(19980105)75:1<112::AID-IJC17>3.3.CO;2-I
   SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0
   Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337
   SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286
   Suh WK, 1999, J IMMUNOL, V162, P1530
   SZAFER F, 1994, IMMUNOGENETICS, V39, P374
   Takami K, 1997, J IMMUNOL, V159, P6052
   Takeuchi F, 1997, TISSUE ANTIGENS, V49, P280, DOI 10.1111/j.1399-0039.1997.tb02753.x
   Takeuchi F, 1996, ANN RHEUM DIS, V55, P924, DOI 10.1136/ard.55.12.924
   Tang J, 1998, TISSUE ANTIGENS, V51, P556, DOI 10.1111/j.1399-0039.1998.tb02992.x
   Tang JM, 1999, AIDS RES HUM RETROV, V15, P317, DOI 10.1089/088922299311277
   VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594
   Vos JC, 1999, J IMMUNOL, V163, P6679
   Wang P, 1996, J IMMUNOL, V157, P213
   Yamaguchi Y, 1999, FEBS LETT, V457, P231, DOI 10.1016/S0014-5793(99)01042-X
   ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407
   Zhu KC, 1999, ONCOGENE, V18, P7740, DOI 10.1038/sj.onc.1203235
NR 84
TC 15
Z9 17
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND
SN 1466-4879
J9 GENES IMMUN
JI Genes Immun.
PD FEB
PY 2001
VL 2
IS 1
BP 32
EP 40
DI 10.1038/sj.gene.6363731
PG 9
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 407WL
UT WOS:000167293700006
PM 11294565
OA Bronze
DA 2020-12-01
ER

PT J
AU Freedman, DO
   Plier, DA
   de Almeida, AB
   de Oliveira, AL
   Miranda, J
   Braga, C
AF Freedman, DO
   Plier, DA
   de Almeida, AB
   de Oliveira, AL
   Miranda, J
   Braga, C
TI Effect of aggressive prolonged diethylcarbamazine therapy on circulating
   antigen levels in bancroftian filariasis
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE W. bancrofti; DEC; antigenaemia; control programmes
ID IVERMECTIN; CLEARANCE; EFFICACY
AB BACKGROUND Single dose diethylcarbamazine (DEC) as used in control programmes is effectively microfilaricidal for periods of up to a year or more but has incomplete ability to kill Wuchereria bancrofti adult parasites. These regimens can be effective in breaking transmission by suppression of circulating microfilariae available to mosquito vectors. Whether prolonged or aggressive therapy with DEC has a significant effect on adult worms, which may live up to 12 years or more, and is important in the context of the treatment of individual patients, is still incompletely understood.
   METHODS In order to investigate the adulticidal effect of aggressive therapy, DEC was given at 6 mg/kg/day for 12-day courses at 0, 6, 12, and 18 months and Og4C3 antigenaemia followed over two years in 38 CAg + Brazilians in a W. bancrofti endemic area.
   RESULTS At two year follow-up, the median level of antigenaemia was 21% of the pre-treatment value. 92% of individuals had antigen levels < 50% of pretreatment values, but only 26% had completely cleared antigenaemia. The clearance rate at 24 months was only 12% (3/26) in the asymptomatic CAg + patients but 58% (7/12) in those with clinical manifestations of filariasis. The latter individuals cleared significantly more antigen (median of 0% pretreatment antigenaemia vs. 26%; P = 0.02) than asymptomatic but infected individuals.
   CONCLUSION Aggressive repeated therapy with DEC alone is ineffective in consistently eradicating adult W. bancrofti, especially in infected but asymptomatic individuals. prolonged courses of combination therapy with other antifilarial drugs should be investigated for treatment of individual patients with the means to pursue aggressive personal medical care.
C1 Univ Alabama, Dept Med, Div Geog Med, Birmingham, AL 35294 USA.
   Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP Freedman, DO (corresponding author), Univ Alabama, Dept Med, Div Geog Med, 1530 3rd Ave S,BBRB 203, Birmingham, AL 35294 USA.
RI Braga, Maria Cynthia/A-8204-2013; Freedman, David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI 31552] Funding Source:
   Medline
CR Eberhard ML, 1997, AM J TROP MED HYG, V57, P483, DOI 10.4269/ajtmh.1997.57.483
   Freedman DO, 1998, PARASITOL TODAY, V14, P229, DOI 10.1016/S0169-4758(98)01244-7
   Ismail MM, 1998, T ROY SOC TROP MED H, V92, P94, DOI 10.1016/S0035-9203(98)90972-5
   Ismail MM, 1996, T ROY SOC TROP MED H, V90, P684, DOI 10.1016/S0035-9203(96)90437-X
   MCCARTHY JS, 1995, J INFECT DIS, V172, P521, DOI 10.1093/infdis/172.2.521
   MORE SJ, 1990, TROP MED PARASITOL, V41, P403
   Nicolas L, 1997, J INFECT DIS, V175, P489, DOI 10.1093/infdis/175.2.489
   Noroes J, 1997, T ROY SOC TROP MED H, V91, P78, DOI 10.1016/S0035-9203(97)90405-3
   Weil GJ, 1999, AM J TROP MED HYG, V61, P53, DOI 10.4269/ajtmh.1999.61.53
   WEIL GJ, 1988, AM J TROP MED HYG, V38, P589, DOI 10.4269/ajtmh.1988.38.589
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
NR 11
TC 20
Z9 21
U1 0
U2 1
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD JAN
PY 2001
VL 6
IS 1
BP 37
EP 41
DI 10.1046/j.1365-3156.2001.00666.x
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 415CW
UT WOS:000167703800006
PM 11251894
OA Bronze
DA 2020-12-01
ER

PT J
AU Freedman, DO
   Plier, DA
   de Almeida, A
   Miranda, J
   Braga, C
   Silva, MCME
   Tang, JM
   Furtado, A
AF Freedman, DO
   Plier, DA
   de Almeida, A
   Miranda, J
   Braga, C
   Silva, MCME
   Tang, JM
   Furtado, A
TI Biased TCR repertoire in infiltrating lesional T cells in human
   bancroftian filariasis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID LYMPHATIC FILARIASIS; SCHISTOSOMA-MANSONI; HUMAN LEISHMANIASIS; CYTOKINE
   PATTERNS; EXPRESSION; INFECTION; USAGE; SKIN; LYMPHOCYTES; RESPONSES
AB To investigate the hypothesis that T cells recognizing specific Ags localize to the site of disease activity in human bancroftian filariasis, we have compared the repertoire of TCR V beta gene segments in lesions vs blood in individual patients by RT-PCR ELISA, V beta 14 and V beta 24 were overrepresented (5% greater in tissue compared with PBMCs and/or tissue/PBMC ratios in the highest 5% of all tissue/PNMC ratios for all V beta s for all, subjects) in 50% and 40% of study subjects, respectively. Overrepresentation of these two V beta s did not occur in any control subject. In comparing three patient groups, the proportion of individuals meeting at least one criterion for V beta 14 overrepresentation was shown to increase in tandem with our current concepts of disease progression (asymptomatic filariasis = 25%; clinical filariasis with active infection = 60%; clinical filariasis without active infection = 71%). In 6 of the 10 individuals with V beta 4 overrepresentation, V beta 14 represented >20% of the entire lesional V beta repertoire. All but one of the 20 study subjects had at least one V beta gene segment that was overrepresented in tissue compared ffith PBMCs. Only a small number of V beta s, usually three or less, were overrepresented in any single filariasis patient, However, in the same tissue, no differences between patient groups were found when IFN-gamma, TNF-alpha; IL-4, IL-5, and IL-12 mRNA expression were examined. Taken together, these findings suggest that, in principle, in essentially all patients, whether with subclinical or with clinical filariasis, distinct and limited T cell populations are concentrated in affected tissue.
C1 Univ Alabama, Dept Med, Div Geog Med, Birmingham, AL 35294 USA.
   Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
RP Freedman, DO (corresponding author), Univ Alabama, Dept Med, Div Geog Med, 845 19th St S,Room 544,Box 7, Birmingham, AL 35294 USA.
RI Tang, Jianming/O-4980-2019; Braga, Maria Cynthia/A-8204-2013; Freedman,
   David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257; Tang, Jianming/0000-0003-0137-7486
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI-31552] Funding Source:
   Medline
CR ALBUQUERQUE MFM, 1995, T ROY SOC TROP MED H, V89, P373, DOI 10.1016/0035-9203(95)90014-4
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435, DOI 10.1080/00034983.1992.11812690
   CHOI YW, 1990, J EXP MED, V172, P981, DOI 10.1084/jem.172.3.981
   deAlmeida AB, 1996, J INFECT DIS, V173, P1453, DOI 10.1093/infdis/173.6.1453
   DERSIMONIAN H, 1991, J EXP MED, V174, P639, DOI 10.1084/jem.174.3.639
   DERSIMONIAN H, 1991, J EXP MED, V174, P1286
   Dimock KA, 1996, INFECT IMMUN, V64, P2962, DOI 10.1128/IAI.64.8.2962-2967.1996
   DUNN DA, 1993, P NATL ACAD SCI USA, V90, P1267, DOI 10.1073/pnas.90.4.1267
   Freedman DO, 1995, AM J TROP MED HYG, V53, P633
   Freedman DO, 1998, PARASITOL TODAY, V14, P229, DOI 10.1016/S0169-4758(98)01244-7
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927
   Freedman DO, 1996, J IMMUNOL, V156, P2901
   FREEDMAN DO, 1997, LANCET, V350, P1675
   Hall LL, 1998, BIOTECHNIQUES, V24, P652, DOI 10.2144/98244rr02
   Islam D, 1996, INFECT IMMUN, V64, P1391, DOI 10.1128/IAI.64.4.1391-1399.1996
   JUNGMANN P, 1992, J TROP MED HYG, V95, P114
   KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372
   MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2
   Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646
   Moss P, 1997, J INVEST DERMATOL, V109, P14, DOI 10.1111/1523-1747.ep12276338
   Noroes J, 1996, J UROLOGY, V156, P409, DOI 10.1016/S0022-5347(01)65862-2
   NUTMAN TB, 1994, PARASITOL TODAY, V10, P239, DOI 10.1016/0169-4758(94)90127-9
   OHMEN JD, 1994, J INVEST DERMATOL, V103, P751, DOI 10.1111/1523-1747.ep12412288
   OLIVE C, 1995, IMMUNOL CELL BIOL, V73, P297, DOI 10.1038/icb.1995.46
   PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341
   Roessner K, 1998, INFECT IMMUN, V66, P1092, DOI 10.1128/IAI.66.3.1092-1099.1998
   Sartono E, 1997, INT IMMUNOL, V9, P955, DOI 10.1093/intimm/9.7.955
   UYEMURA K, 1993, J IMMUNOL, V151, P7095
   UYEMURA K, 1993, J INVEST DERMATOL, V101, P701, DOI 10.1111/1523-1747.ep12371679
   UYEMURA K, 1992, INFECT IMMUN, V60, P4542, DOI 10.1128/IAI.60.11.4542-4548.1992
   WANG XH, 1993, P NATL ACAD SCI USA, V90, P188, DOI 10.1073/pnas.90.1.188
   WYNN TA, 1993, J IMMUNOL, V151, P1430
   WYNN TA, 1994, J EXP MED, V179, P1551, DOI 10.1084/jem.179.5.1551
   YAMAMURA M, 1992, J IMMUNOL, V149, P1470
   Yamazaki K, 1996, CLIN EXP IMMUNOL, V106, P329, DOI 10.1046/j.1365-2249.1996.d01-834.x
NR 35
TC 17
Z9 17
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD FEB 1
PY 1999
VL 162
IS 3
BP 1756
EP 1764
PG 9
WC Immunology
SC Immunology
GA 160YM
UT WOS:000078261000068
PM 9973439
DA 2020-12-01
ER

PT J
AU de Almeida, AB
   Silva, MCME
   Braga, C
   Freedman, DO
AF de Almeida, AB
   Silva, MCME
   Braga, C
   Freedman, DO
TI Differences in the frequency of cytokine-producing cells in antigenemic
   and nonantigenemic individuals with bancroftian filariasis
SO INFECTION AND IMMUNITY
LA English
DT Article
ID HUMAN LYMPHATIC FILARIASIS; IMMUNE RESPONSIVENESS; CIRCULATING ANTIGEN;
   CLINICAL STATUS; ELEVATED LEVELS; BRUGIA-MALAYI; INFECTION; RESPONSES;
   SUBPOPULATION; INTERLEUKIN-4
AB Individuals with clinical manifestations of lymphatic filariasis may be currently infected or not. Twenty-five individuals from a Wuchereria bancrofti-endemic area of Brazil,were classified as being asymptomatic microfilaremic individuals, antigenemic individuals with clinical filariasis, or nonantigenemic individuals with clinical filariasis, Intracellular cytokine staining of mitogen-stimulated peripheral blood mononuclear cells (PBMC) showed that the frequency of either gamma interferon (IFN-gamma)- or interleukin-4 (IL-4)-producing cells was higher in the nonantigenemic individuals with clinical filariasis than in the asymptomatic microfilaremic individuals (geometric means, 22.1 versus 10.7% (P = 0.02) and 2.9 versus 1.4% (P = 0.01), respectively). When the asymptomatic microfilaremic individuals and antigenemic individuals with clinical filariasis were grouped together to constitute all actively infected individuals, the frequency of IFN-gamma-producing cells was also lower than in the nonantigenemic individuals with clinical filariasis (P = 0.04). Likewise, the frequency of IL-4-producing cells in the actively infected individuals was also lower than in the nonantigenemic individuals with clinical filariasis (P = 0.02). No differences in the frequency of IFN-gamma-, IL-4-, or IL-5-producing cells in purified CD4 T lymphocytes were found among the groups. These findings suggest that the presence of antigenemia, which is an indicator of current active infection, is closely associated with the frequency of IFN-gamma- and IL-4-producing cells in lymphatic filariasis. The differences found in the frequency of cytokine-producing cells among the three groups appear to be due to a subset of cells other than CD4 T cells.
C1 Univ Alabama Birmingham, Div Geog Med, Birmingham, AL 35294 USA.
   Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RP de Almeida, AB (corresponding author), Univ Alabama Birmingham, Div Geog Med, UAB Stn,BBRB 544 Box 7, Birmingham, AL 35294 USA.
EM dflab@geomed.dom.uab.edu
RI Braga, Maria Cynthia/A-8204-2013; Freedman, David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI-31552] Funding Source:
   Medline
CR ALBUQUERQUE MFM, 1995, T ROY SOC TROP MED H, V89, P373, DOI 10.1016/0035-9203(95)90014-4
   ALRAYES H, 1992, J ALLERGY CLIN IMMUN, V90, P630, DOI 10.1016/0091-6749(92)90136-P
   CHANTEAU S, 1994, TROP MED PARASITOL, V45, P255
   deAlmeida AB, 1996, J INFECT DIS, V173, P1453, DOI 10.1093/infdis/173.6.1453
   Dimock KA, 1996, INFECT IMMUN, V64, P2962, DOI 10.1128/IAI.64.8.2962-2967.1996
   DISSANAYAKE S, 1995, T ROY SOC TROP MED H, V89, P517, DOI 10.1016/0035-9203(95)90092-6
   ELSON LH, 1994, INT IMMUNOL, V6, P1003, DOI 10.1093/intimm/6.7.1003
   ELSON LH, 1995, J IMMUNOL, V154, P4294
   FARIS R, 1993, T ROY SOC TROP MED H, V87, P659, DOI 10.1016/0035-9203(93)90277-W
   Freedman DO, 1995, AM J TROP MED HYG, V53, P633
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787, DOI 10.4269/ajtmh.1992.47.787
   FREEDMAN DO, IN PRESS PARASITOL T
   HORGAN KJ, 1991, CURRENT PROTOCOLS IM
   KING CL, 1992, J CLIN INVEST, V89, P1403, DOI 10.1172/JCI115729
   KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752
   LAL RB, 1989, CLIN EXP IMMUNOL, V77, P77
   LAL RB, 1990, IMMUNOL LETT, V26, P85, DOI 10.1016/0165-2478(90)90180-X
   LAMMIE PJ, 1993, J INFECT DIS, V167, P1178, DOI 10.1093/infdis/167.5.1178
   Mahanty S, 1996, EXP PARASITOL, V84, P282, DOI 10.1006/expr.1996.0114
   MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2
   MCCARTHY JS, 1995, J INFECT DIS, V172, P521, DOI 10.1093/infdis/172.2.521
   Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646
   MICHAEL E, 1994, P ROY SOC B-BIOL SCI, V256, P33, DOI 10.1098/rspb.1994.0045
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   MORE SJ, 1990, TROP MED PARASITOL, V41, P403
   Noroes J, 1996, J UROLOGY, V156, P409, DOI 10.1016/S0022-5347(01)65862-2
   NUTMAN TB, 1987, J IMMUNOL, V138, P3954
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   OTTESEN EA, 1977, IMMUNOLOGY, V33, P413
   PEARLMAN E, 1995, J EXP MED, V182, P931, DOI 10.1084/jem.182.4.931
   PIESSENS WF, 1980, AM J TROP MED HYG, V29, P563, DOI 10.4269/ajtmh.1980.29.563
   SWAIN SL, 1991, IMMUNOL REV, V123, P115, DOI 10.1111/j.1600-065X.1991.tb00608.x
   VANBESOUW NM, 1994, J MED PRIMATOL, V23, P42
   *WHO, 1992, WHO TECHN REPORT SER, V821
   WYNN TA, 1993, J IMMUNOL, V151, P1430
   YAZDANBAKHSH M, 1993, EUR J IMMUNOL, V23, P3312, DOI 10.1002/eji.1830231238
   YAZDANBAKHSH M, 1993, J INFECT DIS, V167, P925, DOI 10.1093/infdis/167.4.925
NR 38
TC 16
Z9 16
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD APR
PY 1998
VL 66
IS 4
BP 1377
EP 1383
DI 10.1128/IAI.66.4.1377-1383.1998
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ZD630
UT WOS:000072706100015
PM 9529056
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Braga, C
   Albuquerque, MFPM
   Schindler, HC
   Silva, MRF
   Maciel, A
   Furtado, A
   Carvalho, AB
   Souza, W
   Ximenes, RAA
AF Braga, C
   Albuquerque, MFPM
   Schindler, HC
   Silva, MRF
   Maciel, A
   Furtado, A
   Carvalho, AB
   Souza, W
   Ximenes, RAA
TI Risk factors for the occurrence of bancroftian filariasis infection in
   children living in endemic areas of northeast of Brazil
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
ID LYMPHATIC FILARIASIS; MICROFILAREMIA
AB The objective of this study was to identify biological and social risk factors for the occurrence of microfilaraemia in a population of 1464 children of both sexes aged 5-14 years, living in two highly endemic areas of Recife a city in the northeast of Brazil. A survey was performed from December 1990 to July 1991 and the microfilaraemia was examined by the thick-drop technique using 45 mu l of peripheral blood. Information was obtained about use of bednet, length of time living in area and number of occupants per household. Risk was quantified by the crude and adjusted Odds Ratio. The 95 per cent confidence interval, Likelihood Ratio Statistics, and P value were used to test the statistical significance. An association was established between microfilaraemia in children and adolescents, and age, number of individuals per household, the presence of microfilaraemic adults in the household, length of time living in the area, and bednet use, Maternal microfilaraemia was not found to be a risk factor for the occurrence of microfilaraemia in offspring. These results allow the identification of children with a greater risk of microfilaraemia, In addition, these findings highlight the role of the household environment in the transmission process.
C1 Ctr Pesquisas Aggeu Magalhaes, Fundacao Oswaldo Cruz, BR-50670420 Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
RP Braga, C (corresponding author), Ctr Pesquisas Aggeu Magalhaes, Fundacao Oswaldo Cruz, Av Prof Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
RI Souza, Wayner V/H-3798-2013; Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Souza,
   Wayner/0000-0002-0939-9332
CR AZEVEDO R, 1952, PUBLICACOES AVULSAS, V1, P157
   BRABIN L, 1990, EPIDEMIOL INFECT, V105, P335, DOI 10.1017/S0950268800047932
   de Albuquerque M de F, 1995, Rev Inst Med Trop Sao Paulo, V37, P225
   GRATZ NG, 1973, CRIT REV ENV CONT, V4, P455
   HAIRSTON NG, 1968, B WORLD HEALTH ORGAN, V8, P135
   HIGHTOWER AW, 1993, PARASITOL TODAY, V9, P418, DOI 10.1016/0169-4758(93)90051-G
   *IBGE, 1992, SEC PLAN ORC COORD
   LAMMIE PJ, 1991, LANCET, V337, P1005, DOI 10.1016/0140-6736(91)92661-K
   Maciel A, 1996, MEM I OSWALDO CRUZ, V91, P449, DOI 10.1590/S0074-02761996000400011
   MOTT KE, 1990, B WORLD HEALTH ORGAN, V68, P691
   RACHOU RENE G., 1956, REV BRASIL MALARIOL E DOENCAS TROP, V8, P359
   RAJASEKARIAH GR, 1991, ANN TROP MED PARASIT, V85, P663, DOI 10.1080/00034983.1991.11812623
   *SPSS INC, 1988, GETT START SPSS PC P
   Vanamail P., 1989, Tropical Biomedicine, V6, P67
   *WHO, 1992, TECHN REP SER, V821
NR 15
TC 8
Z9 9
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD APR
PY 1998
VL 44
IS 2
BP 87
EP 91
DI 10.1093/tropej/44.2.87
PG 5
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA ZN083
UT WOS:000073607700008
PM 9604596
OA Bronze
DA 2020-12-01
ER

PT J
AU Freedman, DO
   deAlmeida, A
   Miranda, J
   Plier, DA
   Braga, C
AF Freedman, DO
   deAlmeida, A
   Miranda, J
   Plier, DA
   Braga, C
TI Field trial of a rapid card test for Wuchereria bancrofti
SO LANCET
LA English
DT Letter
ID FILARIASIS
C1 FDN OSWALDO CRUZ,CTR PESQUISAS AGGEU MAGALHAES,RECIFE,PE,BRAZIL.
RP Freedman, DO (corresponding author), UNIV ALABAMA,DEPT MED,DIV GEOG MED,BIRMINGHAM,AL 35294, USA.
RI Braga, Maria Cynthia/A-8204-2013; Freedman, David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257
CR FREEDMAN DO, 1995, J INFECT DIS, V171, P997, DOI 10.1093/infdis/171.4.997
   Maciel A, 1996, MEM I OSWALDO CRUZ, V91, P449, DOI 10.1590/S0074-02761996000400011
   Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7
   *WHO, 1994, WHO CTD TDR CONS M U
NR 4
TC 13
Z9 15
U1 0
U2 0
PU LANCET LTD
PI LONDON
PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL
SN 0140-6736
J9 LANCET
JI Lancet
PD DEC 6
PY 1997
VL 350
IS 9092
BP 1681
EP 1681
DI 10.1016/S0140-6736(05)64280-8
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA YK211
UT WOS:A1997YK21100022
PM 9400522
DA 2020-12-01
ER

PT J
AU Freedman, DO
   ParkerCook, S
   Silva, MCME
   Braga, C
   Maciel, A
AF Freedman, DO
   ParkerCook, S
   Silva, MCME
   Braga, C
   Maciel, A
TI Very late antigen-4/vascular cell adhesion molecule-1 (VLA-4/VCAM-1)
   pathway is involved in the transendothelial migration of lymphocytes in
   bancroftian filariasis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HUMAN LYMPHATIC FILARIASIS; TUMOR-NECROSIS-FACTOR; PARASITE-SPECIFIC
   ANERGY; T-CELLS; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; BRUGIA-PAHANGI;
   IMMUNOLOGICAL-TOLERANCE; IFN-GAMMA; EXPRESSION
AB The role of endothelial vascular cell adhesion molecule-1 (VCAM-1) in the trafficking of lymphocytes from the vascular circulation through endothelium and into sites of filarial inflammation was investigated in asymptomatic microfilaremic (MF; n = 16) and in patients with filaria-associated lymphatic pathology (LP; n = 23), When compared, by human umbilical vein endothelial cell ELISA, with PBMC supernatants generated from MF patients, filarial Ag (Brugia malayi adult Ag (BmA))-stimulated supernatants from LP patients stimulated over 50% more VCAM-1 (lymphatic pathology (LP) = 0.377 relative ELISA units vs MF = 0.246; p = 0.02), No difference was seen between patient groups with nonfilarial Ag (streptolysin O)-stimulated supernatant (LP = 0.160 relative ELISA units vs MF = 0.166), BmA-stimulated supernatants from LP patients stimulated significantly more T cell migration (percentage of relative migration LP = 79.9% vs MF = 25.8%; p = 0.01) through tightly confluent human umbilical vein endothelial cell monolayers cultured on collagen gels, Anti-VCAM-1 inhibited the increased T cell migration induced by BmA-stimulated supernatants by 97.7%, anti-VLA-4 by 74.7%, and blockade of NF-kappa B-dependent VCAM-1 transcription with 50 mu M pyrrolidine dithiocarbamate resulted in 87.7% inhibition, Biopsies from 87.5% of the LP patients, but only 38.5% of the MF patients, demonstrated VCAM-1 on vascular endothelium, BmA-stimulated supernatants pretreated with anti-IL-1 alone resulted in VCAM-1 expression that was 23.7% of that with untreated supernatants while anti-IL-4, anti-IFN-gamma, or anti-TNF alone had essentially no effect on VCAM-1 expression.
C1 AGGEU MAGALHAES RES CTR, RECIFE, PE, BRAZIL.
RP Freedman, DO (corresponding author), UNIV ALABAMA, DIV GEOG MED, 845 19TH ST S203, BIRMINGHAM, AL 35294 USA.
RI Freedman, David O./AAV-2999-2020; Braga, Maria Cynthia/A-8204-2013
OI Freedman, David O./0000-0002-5642-5257; Braga, Maria
   Cynthia/0000-0002-7862-6455
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI-31552] Funding Source:
   Medline
CR AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753
   BENDER JR, 1994, P NATL ACAD SCI USA, V91, P3994, DOI 10.1073/pnas.91.9.3994
   BUNDY DAP, 1991, IMMUNOPARASITOL TOD, pA71, DOI 10.1016/S0167-5699(05)80021-0
   BURROWS NP, 1994, J CLIN PATHOL, V47, P939, DOI 10.1136/jcp.47.10.939
   CARLOS TM, 1994, BLOOD, V84, P2068
   CARLOS TM, 1990, IMMUNOL REV, V114, P5, DOI 10.1111/j.1600-065X.1990.tb00559.x
   CASE T, 1991, LYMPHOLOGY, V24, P174
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435, DOI 10.1080/00034983.1992.11812690
   CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604
   CAVENDER DE, 1991, J IMMUNOL METHODS, V144, P185, DOI 10.1016/0022-1759(91)90085-T
   CHANTEAU S, 1994, TROP MED PARASITOL, V45, P255
   CHISHOLM PL, 1993, EUR J IMMUNOL, V23, P682, DOI 10.1002/eji.1830230317
   CONNOR DH, 1986, Z PARASITENKD, V72, P13, DOI 10.1007/BF00927731
   DENHAM DA, 1987, CIBA F SYMP, V127, P225
   FARIS R, 1993, T ROY SOC TROP MED H, V87, P659, DOI 10.1016/0035-9203(93)90277-W
   FREEDMAN DO, 1995, AM J TROP MED HYG, V52, P258, DOI 10.4269/ajtmh.1995.52.258
   Freedman DO, 1995, AM J TROP MED HYG, V53, P633
   FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787, DOI 10.4269/ajtmh.1992.47.787
   FREEDMAN DO, 1989, J IMMUNOL, V142, P653
   GALEA P, 1994, J IMMUNOL, V153, P529
   GIBBONS A, 1992, SCIENCE, V255, P12
   GROVES RW, 1992, J INVEST DERMATOL, V98, P384, DOI 10.1111/1523-1747.ep12499816
   HECKMANN M, 1994, BRIT J DERMATOL, V131, P311, DOI 10.1111/j.1365-2133.1994.tb08516.x
   HENKLEDUHRSEN K, 1994, MOL BIOCHEM PARASIT, V67, P41, DOI 10.1016/0166-6851(94)90094-9
   HORN TD, 1991, J CUTAN PATHOL, V18, P36, DOI 10.1111/j.1600-0560.1991.tb00599.x
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   IADEMARCO MF, 1993, P NATL ACAD SCI USA, V90, P3943, DOI 10.1073/pnas.90.9.3943
   IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323
   IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650
   KAR SK, 1993, T ROY SOC TROP MED H, V87, P230, DOI 10.1016/0035-9203(93)90505-K
   KING CL, 1992, J CLIN INVEST, V89, P1403, DOI 10.1172/JCI115729
   KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752
   KING CL, 1991, IMMUNOPARASITOL TOD, pA54, DOI 10.1016/S0167-5699(05)80016-7
   KOCH AE, 1991, LAB INVEST, V64, P313
   LAL RB, 1989, CLIN EXP IMMUNOL, V77, P77
   LAL RB, 1990, IMMUNOL LETT, V26, P85, DOI 10.1016/0165-2478(90)90180-X
   MACKAY CR, 1992, EUR J IMMUNOL, V22, P2205, DOI 10.1002/eji.1830220904
   MAIZELS RM, 1991, PARASITOL TODAY, V7, P271, DOI 10.1016/0169-4758(91)90093-4
   MARAZUELA M, 1994, EUR J IMMUNOL, V24, P2483, DOI 10.1002/eji.1830241034
   MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778
   MASUYAMA JI, 1992, J IMMUNOL, V148, P1367
   MICHAEL E, 1994, P ROY SOC B-BIOL SCI, V256, P33, DOI 10.1098/rspb.1994.0045
   MOYNAGH PN, 1994, J IMMUNOL, V153, P2681
   NELSON FK, 1991, J EXP MED, V173, P659, DOI 10.1084/jem.173.3.659
   NUTMAN TB, 1987, J CLIN INVEST, V79, P1516, DOI 10.1172/JCI112982
   O'CONNOR F. W., 1932, TRANS ROY SOC TROP MED AND HYG [LONDON], V26, P13, DOI 10.1016/S0035-9203(32)90087-X
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259
   PIETSCHMANN P, 1992, J IMMUNOL, V149, P1170
   POSTIGO AA, 1993, RES IMMUNOL, V144, P723, DOI 10.1016/S0923-2494(93)80057-6
   POSTIGO AA, 1992, J CLIN INVEST, V89, P1445, DOI 10.1172/JCI115734
   RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369
   ROGERS R, 1974, J HELMINTHOL, V48, P213, DOI 10.1017/S0022149X00022860
   RUITER DJ, 1989, J INVEST DERMATOL, V93, pS25, DOI 10.1111/1523-1747.ep12580902
   SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181
   SILBER A, 1994, J CLIN INVEST, V93, P1554, DOI 10.1172/JCI117134
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   TANG L, 1994, INFECT IMMUN, V62, P961, DOI 10.1128/IAI.62.3.961-967.1994
   THORNHILL MH, 1990, J IMMUNOL, V145, P865
   THORNHILL MH, 1991, J IMMUNOL, V146, P592
   UYEMURA K, 1993, J IMMUNOL, V151, P7095
   VICKERY AC, 1991, ACTA TROP, V49, P45, DOI 10.1016/0001-706X(91)90029-J
   VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924
   WARTMAN WB, 1947, MEDICINE, V26, P333, DOI 10.1097/00005792-194712000-00001
   WEBER C, 1994, ARTERIOSCLER THROMB, V14, P1665, DOI 10.1161/01.ATV.14.10.1665
   WEIL GJ, 1987, J INFECT DIS, V156, P350, DOI 10.1093/infdis/156.2.350
   WELLICOME SM, 1990, J IMMUNOL, V144, P2558
   *WHO, WHO TECH REP SER, V821, P1
   YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582
NR 71
TC 21
Z9 21
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD APR 15
PY 1996
VL 156
IS 8
BP 2901
EP 2908
PG 8
WC Immunology
SC Immunology
GA UE192
UT WOS:A1996UE19200032
PM 8609410
DA 2020-12-01
ER

PT J
AU Freedman, DO
   Horn, TD
   Silva, CME
   Braga, C
   Maciel, A
AF Freedman, DO
   Horn, TD
   Silva, CME
   Braga, C
   Maciel, A
TI Predominant CD8+ infiltrate in limb biopsies of individuals with
   filarial lymphedema and elephantiasis
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID HUMAN LYMPHATIC FILARIASIS; BANCROFTIAN FILARIASIS; BRUGIA-PAHANGI;
   IMMUNOLOGICAL-TOLERANCE; NORTHEASTERN BRAZIL; T-CELLS; SKIN;
   ABNORMALITIES; EXPRESSION; PATHOLOGY
AB In 34 individuals with a spectrum of clinical manifestations of Bancroftian filariasis, we investigated whether immunoperoxidase-stained, random, superficial dermal biopsies could further elucidate the nature of the diffuse damage to superficial lymphatics that had been recently demonstrated by radionuclide lymphoscintigraphy. A total of 78% and 68% of limbs from patients with clinical disease and asymptomatic microfilaremia, respectively, contained EN4+PAL-E- lymphatic vessels that were abnormally dilated. The majority of subjects, regardless of clinical classification, had a CD3+ perivascular but not a perilymphatic infiltrate in tissues and no parasites were present. In contrast to those individuals with asymptomatic infection, a striking predominance of CD8+ T cells was found in the tissue of individuals with clinical disease. Tissue pathology consistent with cutaneous bacterial infection was not observed. The prominent perivenular and pericapillary mononuclear infiltrates likely indicate, in light of current understanding of lymphocyte recirculation, the extravasation of lymphocytes from the vascular circulation into the inflamed filarial tissue.
C1 JOHNS HOPKINS UNIV, DIV DERMOPATHOL & ORAL PATHOL, BALTIMORE, MD USA.
   CTR PESQUISAS AGGEU MAGALHAES, RECIFE, PE, BRAZIL.
RP Freedman, DO (corresponding author), UNIV ALABAMA, DIV GEOG MED, UAB STN, BBRB 203, BIRMINGHAM, AL 35294 USA.
RI Braga, Maria Cynthia/A-8204-2013; Freedman, David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI-31552] Funding Source:
   Medline
CR ADDISS DG, 1995, J INFECT DIS, V171, P755, DOI 10.1093/infdis/171.3.755
   AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753
   [Anonymous], 1992, World Health Organ Tech Rep Ser, V821, P1
   CASE T, 1991, LYMPHOLOGY, V24, P174
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435, DOI 10.1080/00034983.1992.11812690
   CHANTEAU S, 1994, J INFECT DIS, V170, P247, DOI 10.1093/infdis/170.1.247
   CONNOR DH, 1986, Z PARASITENKD, V72, P13, DOI 10.1007/BF00927731
   DEAN GS, 1983, PARASITE IMMUNOL, V5, P113, DOI 10.1111/j.1365-3024.1983.tb00729.x
   DENHAM DA, 1987, CIBA F SYMP, V127, P225
   FARIS R, 1993, T ROY SOC TROP MED H, V87, P659, DOI 10.1016/0035-9203(93)90277-W
   FIGUEREDOSILVA J, 1994, J TROP MED HYG, V97, P55
   FREEDMAN DO, 1995, AM J TROP MED HYG, V52, P258, DOI 10.4269/ajtmh.1995.52.258
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927
   FREEDMAN DO, 1995, J INFECT DIS, V171, P997, DOI 10.1093/infdis/171.4.997
   HORN TD, 1991, J CUTAN PATHOL, V18, P36, DOI 10.1111/j.1600-0560.1991.tb00599.x
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   ISHIKAWA H, 1994, RHEUMATOL INT, V13, P229, DOI 10.1007/BF00290200
   JUNGMANN P, 1992, J TROP MED HYG, V95, P114
   JUNGMANN P, 1991, AM J TROP MED HYG, V45, P325, DOI 10.4269/ajtmh.1991.45.325
   KAR SK, 1993, T ROY SOC TROP MED H, V87, P230, DOI 10.1016/0035-9203(93)90505-K
   KING CL, 1992, J CLIN INVEST, V89, P1403, DOI 10.1172/JCI115729
   KING CL, 1991, IMMUNOPARASITOL TOD, pA54, DOI 10.1016/S0167-5699(05)80016-7
   LAL RB, 1989, CLIN EXP IMMUNOL, V77, P77
   LAL RB, 1990, IMMUNOL LETT, V26, P85, DOI 10.1016/0165-2478(90)90180-X
   LICHTENBERG F, 1957, MT SINAI J MED, V24, P983
   MAIZELS RM, 1991, PARASITOL TODAY, V7, P271, DOI 10.1016/0169-4758(91)90093-4
   MAJEWSKI S, 1991, J INVEST DERMATOL, V97, P667, DOI 10.1111/1523-1747.ep12483739
   MARAZUELA M, 1994, EUR J IMMUNOL, V24, P2483, DOI 10.1002/eji.1830241034
   MICHAEL E, 1994, P ROY SOC B-BIOL SCI, V256, P33, DOI 10.1098/rspb.1994.0045
   NAGLE RB, 1987, LYMPHOLOGY, V20, P20
   NELSON FK, 1991, J EXP MED, V173, P659, DOI 10.1084/jem.173.3.659
   OLSZEWSKI WL, 1994, LYMPHOLOGY, V27, P345
   OLSZEWSKI WL, 1993, TROP MED PARASITOL, V44, P40
   OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259
   OTTESEN EA, 1994, CURR OPIN INFECT DIS, V7, P550, DOI 10.1097/00001432-199410000-00006
   OTTESEN EA, 1984, IMMUNOL TODAY, V12, pA71
   ROHDE D, 1992, J INVEST DERMATOL, V98, P794, DOI 10.1111/1523-1747.ep12499959
   RUITER DJ, 1989, J INVEST DERMATOL, V93, pS25, DOI 10.1111/1523-1747.ep12580902
   SCHLINGEMANN RO, 1991, AM J PATHOL, V138, P1335
   SHARAR SR, 1995, SPRINGER SEMIN IMMUN, V16, P359
   SNOWDEN KF, 1989, T ROY SOC TROP MED H, V83, P670, DOI 10.1016/0035-9203(89)90394-5
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   UYEMURA K, 1993, J IMMUNOL, V151, P7095
   VICKERY AC, 1991, ACTA TROP, V49, P45, DOI 10.1016/0001-706X(91)90029-J
   VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924
   WARTMAN WB, 1947, MEDICINE, V26, P333, DOI 10.1097/00005792-194712000-00001
   WEIL GJ, 1987, J INFECT DIS, V156, P350, DOI 10.1093/infdis/156.2.350
   WELLER PF, 1982, AM J TROP MED HYG, V31, P942, DOI 10.4269/ajtmh.1982.31.942
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
NR 49
TC 22
Z9 22
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 1995
VL 53
IS 6
BP 633
EP 638
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA TR971
UT WOS:A1995TR97100014
PM 8561266
DA 2020-12-01
ER

PT J
AU ALBUQUERQUE, MFM
   MARZOCHI, MC
   SABROZA, PC
   BRAGA, MC
   PADILHA, T
   SILVA, MCM
   SILVA, MRF
   SCHINDLER, HC
   MACIEL, MA
   SOUZA, W
   FURTADO, AF
AF ALBUQUERQUE, MFM
   MARZOCHI, MC
   SABROZA, PC
   BRAGA, MC
   PADILHA, T
   SILVA, MCM
   SILVA, MRF
   SCHINDLER, HC
   MACIEL, MA
   SOUZA, W
   FURTADO, AF
TI BANCROFTIAN FILARIASIS IN 2 URBAN AREAS OF RECIFE, BRAZIL - PRE-CONTROL
   OBSERVATIONS ON INFECTION AND DISEASE
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE FILARIASIS; WUCHERERIA BANCROFTI; EPIDEMIOLOGY; BRAZIL
ID LYMPHATIC FILARIASIS; GENDER
AB Bancroftian filariasis is a major public health problem in the city of Recife in north-eastern Brazil. In some of its urban areas microfilaraemia prevalence reaches 14%. This study describes epidemiological characteristics, infection and disease, in 2 urban areas, Coque and Mustardinha, before control measures were applied. The parasitological survey was performed by a 'door-to-door' census covering 5563 subjects, aged between 5 and 65 years. Microfilaraemia was detected by the thick drop technique, using 45 mu L of peripheral blood collected between 20:00 and 24:00. In both areas the prevalence of microfilaraemia was 10%, and males had higher prevalences of infection and disease than females. The prevalence of microfilaraemia was higher in the 15-24 and 25-34 years age groups in both sexes. Most microfilaria (mf) carriers (72.1% in Coque and 79.7% in Mustadrinha) had mf densities < 100/60 mu L of blood. Females of reproductive age had significantly lower mf densities than males. The overall disease prevalence in both areas was 6.3%. Amongst the subjects who presented with chronic disease 15.7% were microfilaraemic. Chronic disease prevalence increased from 1.4% in the 5-14 years age group to 11.3% in the oldest age group. The most frequent clinical manifestation was hydrocele (5.4%), followed by lymphoedema (1.8%). The epidemiological pattern of filariasis in the populations studied was marked by high prevalence of microfilaraemia, low mf density, and relatively low prevalence of filarial disease considering the level of endemicity.
C1 UNIV FED PERNAMBUCO,DEPT CLIN MED,BR-50670420 RECIFE,PE,BRAZIL.
   FDN OSWALDO CRUZ,ESCOLA NACL SAUDE PUBL,DEPT CIENCIAS BIOL,BR-21041210 RIO JANEIRO,BRAZIL.
   FDN OSWALDO CRUZ,ESCOLA NACL SAUDE PUBL,NUCL DOENCAS ENDEM,BR-21041210 RIO JANEIRO,BRAZIL.
RP ALBUQUERQUE, MFM (corresponding author), FDN OSWALDO CRUZ,CTR PESQUISAS AGGEU MAGALHAES,AVE MORAES REGO S-N,BR-50670420 RECIFE,PE,BRAZIL.
RI Souza, Wayner V/H-3798-2013; Braga, Maria Cynthia/A-8204-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Souza,
   Wayner/0000-0002-0939-9332
CR Albuquerque MFPM, 1993, CAD SAUDE PUBLICA, V9, P487, DOI DOI 10.1590/S0102-311X1993000400009
   AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753
   AZEVEDO R, 1952, PUBLICACOES AVULSAS, V1, P157
   BRABIN L, 1990, EPIDEMIOL INFECT, V105, P335, DOI 10.1017/S0950268800047932
   BUNDY DAP, 1988, PARASITOL TODAY, V4, P186, DOI 10.1016/0169-4758(88)90076-2
   BUNDY DAP, 1991, IMMUNOPARASITOL TOD, pA71, DOI 10.1016/S0167-5699(05)80021-0
   DREYER G, 1989, REV ASS MED BRASILEI, V35, P189
   DREYER G, 1990, CIENCIA HOJE, V12, P6
   MOTT KE, 1990, B WORLD HEALTH ORGAN, V68, P681
   Ottesen EA, 1992, PARASITOLOGY, V104, P571
   PANI SP, 1991, T ROY SOC TROP MED H, V85, P260, DOI 10.1016/0035-9203(91)90048-4
   PANI SP, 1989, INDIAN MED GAZ, V123, P111
   PARTONO F, 1987, CIBA F SYMP, V127, P15
   RACHOU RENE G., 1956, REV BRASIL MALARIOL E DOENCAS TROP, V8, P359
   RAJAGOPALAN PK, 1989, EPIDEMIOL INFECT, V103, P685, DOI 10.1017/S0950268800031083
   ROCHA S., 1990, REV BRAS ECON, V44, P35
   SOUTHGATE BA, 1974, ROY SOC TROP MED HYG, V68, P177
   SRIVIDYA A, 1991, T R SOC TROP MED HYG, V85, P225
   1992, WHO TECHNICAL REPORT, V821
   1983, CONTROLE ENDEMIAS BR
   1984, WHO TECHNICAL REPORT, V703
   1991, PROGRAMA CONTROLE FI
   1990, PROGRAMA CONTROLE FI
   1993, PROGRAMA CONTROLE FI
   1988, LUCHA CONTRA FILARIA
   1992, ANUARIO ESTATISTICO
NR 26
TC 25
Z9 26
U1 0
U2 1
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL-AUG
PY 1995
VL 89
IS 4
BP 373
EP 377
DI 10.1016/0035-9203(95)90014-4
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA RT595
UT WOS:A1995RT59500011
PM 7570866
DA 2020-12-01
ER

PT J
AU FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
   FURTADO, AF
AF FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
   FURTADO, AF
TI ABNORMAL LYMPHATIC FUNCTION IN PRESYMPTOMATIC BANCROFTIAN FILARIASIS
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID HUMAN SERUM-ALBUMIN; LYMPHOSCINTIGRAPHY; EXTREMITIES; LYMPHEDEMA;
   DEXTRAN
AB Despite the common association of filarial infection with elephantiasis, the great majority of those infected are in fact clinically asymptomatic microfilariae carriers, The assumption has been that infection but not disease exists in these presymptomatic persons. In an area of Brazil where Wuchereria bancrofti is endemic, flow studies done with dynamic radionuclide lymphoscintigraphy were used to compare 30 limbs from asymptomatic microfilaremic subjects with 16 control limbs, Geometric mean values for T-1/2 (19.8 vs, 37.7 min; P < .001), appearance time (7.9 vs, 27.9 min; P < .001), percent uptake at the region of interest (0.67% vs, 0.14%; P < .001), and peak activity (62.6 vs, 2.6 cps; P < .001) each indicated an enhanced pattern of rapid, increased lymph flow in asymptomatic microfilaremic subjects, The abnormal lymphatic function in these subjects indicates that current passive intervention strategies may need to change if the debilitating sequelae of this parasitic infection are to be avoided.
C1 LABS CERPE, NUCL MED UNIT, RECIFE, PE, BRAZIL.
   CTR PESQUISAS AGGEU MAGALHAES, RECIFE, PE, BRAZIL.
RP FREEDMAN, DO (corresponding author), UNIV ALABAMA, DIV GEOG MED, UAB STN, BBRB 206, BIRMINGHAM, AL 35294 USA.
RI Braga, Maria Cynthia/A-8204-2013; Freedman, David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI-31552] Funding Source:
   Medline
CR CAMBRIA RA, 1993, J VASC SURG, V18, P773, DOI 10.1016/0741-5214(93)90331-F
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435, DOI 10.1080/00034983.1992.11812690
   COLWELL EJ, 1970, AM J TROP MED HYG, V19, P227, DOI 10.4269/ajtmh.1970.19.227
   FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787, DOI 10.4269/ajtmh.1992.47.787
   HAMON J, 1967, B WORLD HEALTH ORGAN, V37, P217
   HENZE E, 1982, J NUCL MED, V23, P923
   KAISER L, 1990, AM J PHYSIOL, V259, pH648
   NAWAZ MK, 1990, CLIN NUCL MED, V15, P794, DOI 10.1097/00003072-199011000-00004
   OLDFIELD EC, 1993, CLIN INFECT DIS, V16, pS132, DOI 10.1093/clinids/16.Supplement_3.S132
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   RICHARDS FO, 1991, AM J TROP MED HYG, V44, P3, DOI 10.4269/ajtmh.1991.44.3
   SADEK S, 1989, LYMPHOLOGY, V22, P157
   WARTMAN WB, 1947, MEDICINE, V26, P333, DOI 10.1097/00005792-194712000-00001
   WEIL GJ, 1987, J INFECT DIS, V156, P350, DOI 10.1093/infdis/156.2.350
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729, DOI 10.1148/radiology.167.3.3363131
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   1992, WHO TECH REP SER, P821
   1993, B WORLD HEALTH ORGAN, V71, P135
NR 20
TC 35
Z9 37
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR
PY 1995
VL 171
IS 4
BP 997
EP 1001
DI 10.1093/infdis/171.4.997
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA QP912
UT WOS:A1995QP91200034
PM 7706830
DA 2020-12-01
ER

PT J
AU FREEDMAN, DO
   BUI, T
   DEALMEIDA, PJ
   BRAGA, C
   SILVA, MCME
   MACIEL, A
   FURTADO, AF
AF FREEDMAN, DO
   BUI, T
   DEALMEIDA, PJ
   BRAGA, C
   SILVA, MCME
   MACIEL, A
   FURTADO, AF
TI LYMPHOSCINTIGRAPHIC ASSESSMENT OF THE EFFECT OF DIETHYLCARBAMAZINE
   TREATMENT ON LYMPHATIC DAMAGE IN HUMAN BANCROFTIAN FILARIASIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ABNORMALITIES; INFECTION
AB Despite many millions of doses administered over the past 40 years, basic and crucial issues regarding the use, mode of action, and effectiveness of diethylcarbamazine (DEC) in many clinical situations remain unresolved. To directly investigate whether the well-known microfilaricidal and macrofilaricidal actions of DEC actually result in subsequent improvement in existing damage to lymphatic vessels or lymph nodes, 29 study subjects in Recife, Brazil were stratified into three groups according to the severity of clinical manifestations of lymphatic insufficiency. After baseline radionuclide lymphoscintigraphy was performed, subjects were treated with two courses of DEC separated by at least a six-month interval and then rescanned one year after the baseline scan. A side-by-side comparison of images obtained at baseline with those obtained at follow-up in 13 asymptomatic microfilaremic individuals, six individuals with filarial fever, and in 10 individuals with chronic pathology demonstrated essentially unchanged lymphatic morphology in all but one individual whose disease actually progressed in the face of therapy. We conclude that two 12-day treatment courses of DEC did not have a demonstrable direct or indirect effect on existing structural damage to the lymphatic system even in those individuals with preclinical disease.
C1 LABS CERPE, NUCL MED UNIT, RECIFE, PE, BRAZIL.
   CTR PESQUISAS AGGEU MAGALHAES, RECIFE, PE, BRAZIL.
RP FREEDMAN, DO (corresponding author), UNIV ALABAMA, BIRMINGHAM STN, DIV GEOG MED, BBRB 206, BIRMINGHAM, AL 35294 USA.
RI Braga, Maria Cynthia/A-8204-2013; Freedman, David O./AAV-2999-2020
OI Braga, Maria Cynthia/0000-0002-7862-6455; Freedman, David
   O./0000-0002-5642-5257
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI-31552] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER
CR ADDISS DG, 1994, LANCET, V343, P597, DOI 10.1016/S0140-6736(94)91547-4
   DREYER G, 1992, AM J TROP MED HYG, V46, P745, DOI 10.4269/ajtmh.1992.46.745
   FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850
   FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787, DOI 10.4269/ajtmh.1992.47.787
   HEWITT R, 1950, AM J TROP MED, V30, P217
   MARCH HN, 1960, AM J TROP MED HYG, V9, P180, DOI 10.4269/ajtmh.1960.9.180
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   OTTESEN EA, 1985, REV INFECT DIS, V7, P341
   Partono F., 1985, Parasitology Today, V1, P52, DOI 10.1016/0169-4758(85)90115-2
   PARTONO F, 1981, ACTA TROP, V38, P217
   PARTONO F, 1985, T ROY SOC TROP MED H, V79, P44, DOI 10.1016/0035-9203(85)90231-7
   WEIL GJ, 1987, J INFECT DIS, V156, P350, DOI 10.1093/infdis/156.2.350
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   1992, WHO TECH REP SER, V821
NR 15
TC 31
Z9 34
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 1995
VL 52
IS 3
BP 258
EP 261
DI 10.4269/ajtmh.1995.52.258
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA QQ373
UT WOS:A1995QQ37300012
PM 7694968
DA 2020-12-01
ER

PT J
AU FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
AF FREEDMAN, DO
   DEALMEIDA, PJ
   BESH, S
   SILVA, MCME
   BRAGA, C
   MACIEL, A
TI LYMPHOSCINTIGRAPHIC ANALYSIS OF LYMPHATIC ABNORMALITIES IN SYMPTOMATIC
   AND ASYMPTOMATIC HUMAN FILARIASIS
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID WHOLE-BODY LYMPHANGIOSCINTIGRAPHY; BANCROFTIAN FILARIASIS;
   BRUGIA-MALAYI; TC-99M-LABELED DEXTRAN; LYMPHEDEMA; SYSTEM
AB To obtain high-resolution radionuclide lymphoscintigraphic images of affected limbs in persons with both symptomatic and asymptomatic filarial infection, 36 volunteers were recruited from a Wuchereria bancrofti-endemic area of Recife, Brazil, for a prospective, controlled analysis. Subjects were stratified after determination of serologic and clinical determinants of filarial infection status. Widespread lymphatic abnormalities were found in clinically asymptomatic microfilaremic persons, who had been assumed to have infection but not disease. All patients with clinical manifestations of lymphatic pathology had marked abnormalities. No correlation was found between clinical findings and actual lymphatic function as demonstrated by lymphoscintigraphy. The initial diagnosis of lymphatic filariasis, whether asymptomatic or symptomatic, is based an nonimaging laboratory criteria. After diagnosis, lymphoscintigraphy is a valuable tool for initial assessment of any lymphatic damage. Changes in strategies for therapeutic interventions in asymptomatic microfilaremic persons, who are not usually aggressively treated, may be warranted.
C1 LABS CERPE, NUCL MED UNIT, RECIFE, PE, BRAZIL.
   CTR PESQUISAS AGGEU MAGALHAES, RECIFE, PE, BRAZIL.
RP FREEDMAN, DO (corresponding author), UNIV ALABAMA, DIV GEOG MED, UAB STN, BBRB 206, BIRMINGHAM, AL 35294 USA.
RI Freedman, David O./AAV-2999-2020; Braga, Maria Cynthia/A-8204-2013
OI Freedman, David O./0000-0002-5642-5257; Braga, Maria
   Cynthia/0000-0002-7862-6455
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-31552] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI031552, R01AI031552, R01AI031552, R01AI031552, R01AI031552,
   R01AI031552, R01AI031552, R01AI031552, R01AI031552] Funding Source: NIH
   RePORTER
CR ALBUQUERQUE M, 1990, LYMPHOLOGY, V23, P215
   CAHILL KEVIN M., 1964, TRANS ROY SOC TROP MED HYG, V58, P356, DOI 10.1016/0035-9203(64)90205-6
   CASE TC, 1992, ANN TROP MED PARASIT, V86, P435, DOI 10.1080/00034983.1992.11812690
   COHEN LB, 1961, AM J TROP MED HYG, V10, P843, DOI 10.4269/ajtmh.1961.10.843
   COLWELL EJ, 1970, AM J TROP MED HYG, V19, P227, DOI 10.4269/ajtmh.1970.19.227
   FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850
   FREEDMAN DO, 1992, AM J TROP MED HYG, V47, P787, DOI 10.4269/ajtmh.1992.47.787
   FREEDMAN DO, 1989, J IMMUNOL, V142, P653
   GLOVICZKI P, 1989, J VASC SURG, V9, P683, DOI 10.1067/mva.1989.vs0090683
   HENZE E, 1982, J NUCL MED, V23, P923
   HINES SA, 1985, LYMPHOLOGY, V18, P173
   MCNEILL GC, 1989, RADIOLOGY, V172, P495, DOI 10.1148/radiology.172.2.2748831
   NAWAZ MK, 1990, CLIN NUCL MED, V15, P794, DOI 10.1097/00003072-199011000-00004
   OLDFIELD EC, 1993, CLIN INFECT DIS, V16, pS132, DOI 10.1093/clinids/16.Supplement_3.S132
   Ottesen E A, 1984, Trans R Soc Trop Med Hyg, V78 Suppl, P9, DOI 10.1016/0035-9203(84)90309-2
   PFLUG JJ, 1971, BRIT J SURG, V58, P925, DOI 10.1002/bjs.1800581216
   SADEK S, 1989, LYMPHOLOGY, V22, P157
   SAMUELS LD, 1987, LYMPHOLOGY, V20, P4
   SNOWDEN K, 1986, LYMPHOLOGY, V19, P77
   VAQUEIRO M, 1986, J NUCL MED, V27, P1125
   VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924
   WARTMAN WB, 1947, MEDICINE, V26, P333, DOI 10.1097/00005792-194712000-00001
   WEIL GJ, 1987, J INFECT DIS, V156, P350, DOI 10.1093/infdis/156.2.350
   WEISSLEDER H, 1988, RADIOLOGY, V167, P729, DOI 10.1148/radiology.167.3.3363131
   WEISSLEDER R, 1989, RADIOLOGY, V172, P315, DOI 10.1148/radiology.172.2.2748809
   WITTE M, 1988, LYMPHOLOGY, V21, P251
   WITTE MH, 1993, ARCH INTERN MED, V153, P737, DOI 10.1001/archinte.153.6.737
   YANG KTA, 1989, EUR J NUCL MED, V15, P171, DOI 10.1007/BF00253788
   1992, WHO TECH REP SER, V821, P14
NR 29
TC 81
Z9 85
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT
PY 1994
VL 170
IS 4
BP 927
EP 933
DI 10.1093/infdis/170.4.927
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA PJ694
UT WOS:A1994PJ69400027
PM 7523538
DA 2020-12-01
ER

EF